General Information of Disease (ID: DISJYKUO)

Disease Name Colon carcinoma
Synonyms colon cancer; colonic carcinoma; colon carcinoma; carcinoma of the colon; carcinoma of colon
Definition A carcinoma that arises from epithelial cells of the colon
Disease Hierarchy
DISH9F1N: Carcinoma
DISVC52G: Colon cancer
DIS5PYL0: Colorectal carcinoma
:
DISJYKUO: Colon carcinoma
Disease Identifiers
MONDO ID
MONDO_0002032
UMLS CUI
C0699790
MedGen ID
147065
SNOMED CT ID
269533000

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 743 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
ABCC1 TTOI92F Limited Genetic Variation [1]
ABCC3 TTVLG21 Limited Biomarker [2]
ACTG1 TTGAZF9 Limited Biomarker [3]
ACVR2A TTX2DRI Limited Biomarker [4]
ADORA2B TTNE7KG Limited Altered Expression [5]
AKR1B1 TTFBNVI Limited Biomarker [6]
AKT2 TTH24WI Limited Biomarker [7]
ANXA10 TT0NL6U Limited Biomarker [8]
AQP1 TTSF1KH Limited Biomarker [9]
AURKA TTPS3C0 Limited Altered Expression [10]
B2M TTY7FKA Limited Genetic Variation [11]
BGN TT0JPVF Limited Biomarker [12]
CASP2 TT12VNG Limited Altered Expression [13]
CD9 TTZEIBV Limited Altered Expression [14]
CDK1 TTH6V3D Limited Biomarker [15]
CDK6 TTO0FDJ Limited Biomarker [16]
CEACAM6 TTIGH2W Limited Biomarker [17]
CFTR TTRLZHP Limited Biomarker [18]
CHEK1 TTTU902 Limited Biomarker [19]
CHRM3 TTQ13Z5 Limited Biomarker [20]
CRYZ TTP6UO8 Limited Genetic Variation [21]
CXCL2 TTZF0K2 Limited Altered Expression [22]
CXCR1 TTMWT8Z Limited Genetic Variation [23]
CYP24A1 TT82UI1 Limited Altered Expression [24]
DCLK1 TTOHTCY Limited Altered Expression [25]
DDX5 TTZKPVC Limited Biomarker [26]
DICER1 TTTEOPU Limited Altered Expression [27]
EIF2AK3 TT79U1M Limited Biomarker [28]
EIF4E TTZGCP6 Limited Altered Expression [29]
EPHA7 TTAHTVG Limited Biomarker [30]
EPHB1 TT8MDAC Limited Genetic Variation [31]
F2R TTL935N Limited Biomarker [32]
FGFR4 TT1KX2S Limited Biomarker [33]
GADD45B TTMDW9L Limited Biomarker [34]
GAN TT6WNG2 Limited Genetic Variation [35]
GNRHR TT8R70G Limited Biomarker [36]
GRPR TTC1MVT Limited Altered Expression [37]
GUCY2C TTLDPRG Limited Genetic Variation [38]
HCAR2 TTWNV8U Limited Altered Expression [39]
IDO1 TTZJYKH Limited Altered Expression [40]
IFNB1 TT4TZ8J Limited Biomarker [41]
IGFBP2 TTU4QSN Limited Biomarker [42]
IGFBP3 TTZHNQA Limited Genetic Variation [43]
IGFBP7 TTUQ01B Limited Biomarker [44]
IL15 TTJFA35 Limited Biomarker [45]
IL23A TTC1GLB Limited Biomarker [46]
IRF3 TTYR7OH Limited Genetic Variation [47]
IRS2 TTF95B8 Limited Biomarker [48]
ITGA2 TTSJ542 Limited Altered Expression [49]
KAT2B TTVK7SB Limited Biomarker [50]
KLRG1 TT299E6 Limited Biomarker [51]
LIF TTGZ5WN Limited Biomarker [52]
LIN28A TTO50LN Limited Genetic Variation [53]
MAP2K2 TT8H9GB Limited Posttranslational Modification [54]
MAP3K9 TTUNSIX Limited Genetic Variation [55]
MAPK7 TTU6FSC Limited Altered Expression [56]
MSI1 TTSM4BA Limited Biomarker [57]
MTA1 TTO4HUS Limited Biomarker [58]
MTDH TTH6SA5 Limited Biomarker [59]
MUC1 TTBHFYQ Limited Altered Expression [60]
MUTYH TTNB0ZK Limited Genetic Variation [61]
MYD88 TTB6Q2O Limited Altered Expression [62]
NRP1 TTIPJCB Limited Biomarker [63]
PAK1 TTFN95D Limited Biomarker [64]
PBK TTMY6BZ Limited Altered Expression [65]
PDCD1 TTNBFWK Limited Biomarker [66]
PLG TTP86E2 Limited Biomarker [67]
POLB TTA0XPV Limited Genetic Variation [68]
PPARG TTT2SVW Limited Biomarker [69]
PRKDC TTK3PY9 Limited Biomarker [70]
PTGER4 TT79WV3 Limited Biomarker [71]
PTGES TTYLQ8V Limited Altered Expression [72]
PTK6 TT6TH8V Limited Biomarker [73]
PTN TTA9EJK Limited Altered Expression [74]
ROBO1 TTND1YP Limited Altered Expression [75]
S100A9 TT0TMQG Limited Altered Expression [76]
SAA1 TTY0DN9 Limited Biomarker [77]
SDC1 TTYDSVG Limited Altered Expression [78]
SELL TT2IYXF Limited Biomarker [79]
SLC2A4 TTP6MT5 Limited Altered Expression [80]
SREBF1 TTER0UB Limited Altered Expression [81]
TGFB2 TTI0KH6 Limited Altered Expression [82]
TPT1 TT3PTB6 Limited Altered Expression [83]
TXN TTZJ5U9 Limited Altered Expression [84]
TXNRD1 TTR7UJ3 Limited Altered Expression [85]
USP7 TTXU3EQ Limited Biomarker [86]
WNK1 TTJ9UMX Limited Altered Expression [87]
XPA TTGT87E Limited Altered Expression [88]
XRCC5 TTCB9KW Limited Altered Expression [89]
ACAT1 TTK3C21 Disputed Altered Expression [90]
HPSE TTR7GJO Disputed Biomarker [91]
PLA2G2A TTO8QRU Disputed Biomarker [92]
PTK7 TTXH2ZN Disputed Altered Expression [93]
SOCS3 TTI0ME6 Disputed Biomarker [94]
ACLY TT0Z6Y2 moderate Biomarker [95]
ADAM17 TT6AZXG moderate Biomarker [96]
ALKBH5 TTOHB1M moderate Biomarker [97]
ATXN3 TT6A17J moderate Altered Expression [98]
BPHL TTTZ3EU moderate Biomarker [99]
CAD TT2YT1K moderate Altered Expression [100]
CASP6 TTKW4ML moderate Biomarker [101]
CBX7 TTBN3HC moderate Altered Expression [102]
CD24 TTCTYNP moderate Biomarker [103]
CLU TTRL76H moderate Biomarker [104]
DKK1 TTE3RAC moderate Biomarker [105]
EGLN1 TT9ISBX moderate Altered Expression [87]
EHMT2 TTS6RZT moderate Altered Expression [106]
ELAVL1 TTPC9D0 moderate Altered Expression [107]
EPAS1 TTWPA54 moderate Biomarker [108]
ERN1 TTKIAT3 moderate Biomarker [109]
F11R TT3C8EG moderate Biomarker [110]
FOXM1 TTD3KOX moderate Biomarker [111]
FTH1 TT975ZT moderate Biomarker [112]
GLI1 TTJOMH6 moderate Biomarker [113]
GREM1 TTOUZN5 moderate Biomarker [114]
GSK3B TTRSMW9 moderate Biomarker [115]
GSN TTUH7OM moderate Biomarker [116]
HDAC2 TTSHTOI moderate Altered Expression [117]
HDAC9 TT8M4E1 moderate Biomarker [118]
HK2 TTK02H8 moderate Biomarker [7]
HMGCS1 TTQF4TK moderate Biomarker [119]
HPGDS TTCYE56 moderate Biomarker [120]
HSF1 TTN6STZ moderate Biomarker [121]
ID1 TTBXVDE moderate Biomarker [122]
IL32 TTD4G7L moderate Biomarker [123]
INHBA TTVB30D moderate Biomarker [124]
ISG15 TTVOH3T moderate Biomarker [125]
ITGB8 TTIF29E moderate Biomarker [126]
MAP2K1 TTIDAPM moderate Genetic Variation [127]
MAP3K11 TTETX6Q moderate Genetic Variation [128]
MAP3K8 TTGECUM moderate Biomarker [129]
MAPK12 TTYT93M moderate Genetic Variation [130]
MBP TT2RY5P moderate Biomarker [131]
MIA TT5HNVS moderate Biomarker [132]
MKNK1 TTEZAUX moderate Biomarker [133]
MTM1 TTY2TCU moderate Genetic Variation [134]
MYBPC3 TT9WOBN moderate Biomarker [112]
NR0B1 TTTK36V moderate Biomarker [135]
NR4A1 TTMXE2Q moderate Biomarker [136]
OSMR TTAH0KM moderate Posttranslational Modification [137]
PIM1 TTTN5QW moderate Biomarker [138]
PLA2G7 TTDNFMT moderate Altered Expression [139]
PLD2 TTRLMKF moderate Altered Expression [84]
PLK1 TTH4IP0 moderate Altered Expression [140]
PRKCZ TTBSN0L moderate Biomarker [141]
PRMT1 TTVOJAI moderate Altered Expression [142]
PTBP1 TTWMX0U moderate Altered Expression [143]
RAC1 TT2M9CG moderate Altered Expression [144]
RACK1 TTJ10AL moderate Biomarker [145]
RASA1 TTPNZ1F moderate Altered Expression [146]
RNF43 TTD91BL moderate Genetic Variation [147]
RPL15 TTQRVC9 moderate Biomarker [148]
RPS6KA1 TTIXKA4 moderate Altered Expression [149]
RPS6KA2 TT0ZW9O moderate Altered Expression [149]
RPS6KA3 TTUM2ZR moderate Altered Expression [149]
RRM2 TT1S4LJ moderate Altered Expression [150]
RUNX2 TTD6SZ8 moderate Biomarker [151]
S100A4 TTPR5SX moderate Altered Expression [152]
SATB1 TTLFRIC moderate Biomarker [153]
STAT1 TTN7R6K moderate Altered Expression [154]
SUV39H1 TTUWQTK moderate Altered Expression [155]
TCF7L2 TT80QAL moderate Altered Expression [156]
TLR3 TTD24Y0 moderate Biomarker [157]
TNC TTUCPMY moderate Biomarker [158]
TNFRSF10A TT5WLRX moderate Biomarker [159]
TNFRSF10B TTW20TU moderate Biomarker [159]
TNFRSF9 TTPW9LJ moderate Biomarker [160]
TNFSF14 TTKVENM moderate Biomarker [161]
TRPC5 TT32NQ1 moderate Biomarker [162]
TWIST1 TTX1MY7 moderate Altered Expression [163]
USP10 TT5IH09 moderate Biomarker [164]
VDAC3 TTT48SQ moderate Altered Expression [165]
WNT5A TTKG7F8 moderate Altered Expression [166]
XIAP TTK3WBU moderate Altered Expression [167]
ABCG2 TTIMJ02 Strong Biomarker [168]
ACKR3 TTRQJTC Strong Biomarker [169]
ACR TTAHE2N Strong Biomarker [170]
ADAM9 TTTYQNS Strong Biomarker [171]
ADCYAP1 TTW4LYC Strong Biomarker [172]
ADCYAP1R1 TT5OREU Strong Biomarker [172]
ADIPOQ TTXKA7D Strong Biomarker [173]
ADM TTV14YH Strong Biomarker [174]
ADRA1A TTNGILX Strong Biomarker [169]
AGR2 TT9K86S Strong Altered Expression [175]
AHCY TTE2KUJ Strong Altered Expression [176]
AHR TT037IE Strong Altered Expression [177]
AHSG TTKF4WV Strong Biomarker [178]
AIMP2 TTXWHGF Strong Biomarker [179]
ALCAM TT2AFT6 Strong Altered Expression [180]
ALOX15 TTN9T81 Strong Altered Expression [181]
AMHR2 TTZDCPK Strong Altered Expression [182]
ANG TTURHFP Strong Biomarker [183]
ANGPT1 TTWNQ1T Strong Biomarker [184]
ANGPTL4 TTWALY5 Strong Altered Expression [185]
ANO1 TTOJI4S Strong Biomarker [186]
ANXA5 TT2Z83I Strong Biomarker [187]
APC2 TTSMK36 Strong Altered Expression [188]
APEX1 TTHGL48 Strong Genetic Variation [189]
AREG TT76B3W Strong Biomarker [190]
ARG1 TT7ZQEV Strong Altered Expression [191]
ARSA TTYQANR Strong Biomarker [192]
ASPH TT2KHP7 Strong Altered Expression [193]
ASRGL1 TT4WT91 Strong Altered Expression [194]
ATAT1 TTWUHQ1 Strong Altered Expression [195]
ATF3 TTCE793 Strong Altered Expression [196]
ATIC TT9NVXQ Strong Biomarker [197]
ATP2A2 TTE6THL Strong Genetic Variation [198]
AURKB TT9RTBL Strong Genetic Variation [199]
AZGP1 TTUPYLV Strong Biomarker [200]
BACE2 TT69DB8 Strong Altered Expression [201]
BACH1 TT2ME4S Strong Altered Expression [202]
BBC3 TT7JUKC Strong Biomarker [203]
BCL2A1 TTGT9C7 Strong Biomarker [204]
BCL2L2 TTQ79W8 Strong Biomarker [205]
BECN1 TT5M7LN Strong Biomarker [206]
BIRC3 TTAIWZN Strong Altered Expression [207]
BIRC7 TTHZ8TA Strong Biomarker [208]
BMP1 TT0L58T Strong Biomarker [100]
BMP2 TTP3IGX Strong Altered Expression [209]
BMP4 TTD3BSX Strong Biomarker [210]
BMP7 TTKOBRA Strong Biomarker [211]
BMPR2 TTGKF90 Strong Genetic Variation [212]
BRIP1 TTZV7LJ Strong Genetic Variation [213]
BRS3 TTKYEPM Strong Biomarker [169]
BTG1 TTL7N2W Strong Biomarker [214]
C1QBP TTWTD7F Strong Altered Expression [215]
C5AR1 TTHXFA1 Strong Biomarker [216]
CA13 TTQPHSR Strong Biomarker [217]
CA4 TTZHA0O Strong Biomarker [218]
CAMP TTULOB6 Strong Biomarker [219]
CASP10 TTX5HEK Strong Genetic Variation [220]
CASP7 TTM7Y45 Strong Altered Expression [221]
CASR TTBUYHA Strong Genetic Variation [222]
CBR1 TTVG0SN Strong Altered Expression [223]
CBS TTVZJ7G Strong Biomarker [224]
CCK TT90CMU Strong Biomarker [225]
CCKAR TTCG0AL Strong Biomarker [226]
CCKBR TTVFO0U Strong Biomarker [227]
CCL17 TTMPHAE Strong Biomarker [228]
CCL21 TTLZK1U Strong Biomarker [229]
CCNA2 TTAMQ62 Strong Altered Expression [230]
CCNB1 TT9P6OW Strong Altered Expression [231]
CCNE2 TTLDRGX Strong Biomarker [232]
CCR1 TTC24WT Strong Biomarker [233]
CCR7 TT2GIDQ Strong Altered Expression [234]
CD160 TTOFEAS Strong Altered Expression [235]
CD248 TTYJWT7 Strong Altered Expression [236]
CD274 TT8ZLTI Strong Biomarker [237]
CD276 TT6CQUM Strong Biomarker [238]
CD80 TT89Z17 Strong Biomarker [239]
CDC25A TTLZS4Q Strong Biomarker [240]
CDC25C TTESBNC Strong Biomarker [241]
CDC42BPA TT5Z0EF Strong Altered Expression [242]
CDH11 TTRGWZC Strong Biomarker [243]
CDK2 TT7HF4W Strong Altered Expression [244]
CDK5 TTL4Q97 Strong Biomarker [245]
CDK8 TTBJR4L Strong Biomarker [246]
CDK9 TT1LVF2 Strong Biomarker [247]
CEACAM1 TTA9CK4 Strong Biomarker [248]
CEACAM3 TTPX7I5 Strong Altered Expression [249]
CEBPA TT5LWG1 Strong Altered Expression [250]
CFLAR TTJZQYH Strong Biomarker [251]
CHAT TTKYFSB Strong Biomarker [252]
CHKA TT10AWB Strong Biomarker [253]
CHM TTOA18V Strong Biomarker [254]
CIT TT3BKTU Strong Altered Expression [255]
CLCA1 TT3AF4R Strong Biomarker [256]
CLDN4 TTMTS9H Strong Altered Expression [257]
CLIC1 TT8KZG6 Strong Biomarker [258]
CLN3 TTORF9W Strong Altered Expression [259]
COL18A1 TT63DI9 Strong Biomarker [260]
COL1A2 TTUABC1 Strong Altered Expression [100]
COPS5 TTSTNJR Strong Altered Expression [261]
CRAT TTC8M31 Strong Biomarker [262]
CRHR2 TTIY658 Strong Altered Expression [263]
CRK TTFEUYR Strong Biomarker [179]
CRY2 TTAO58M Strong Altered Expression [264]
CSK TTX6F0Q Strong Biomarker [265]
CSNK1A1 TTFQEMX Strong Biomarker [266]
CSNK2A1 TTER6YH Strong Biomarker [267]
CTCFL TTY0RZT Strong Biomarker [268]
CTH TTLQUZS Strong Altered Expression [269]
CTSD TTPT2QI Strong Altered Expression [270]
CTSE TTLXC4Q Strong Altered Expression [271]
CXCL13 TT0NIZ1 Strong Biomarker [272]
CXCR2 TT30C9G Strong Altered Expression [273]
CXCR3 TT1UCIJ Strong Biomarker [274]
CXCR4 TTBID49 Strong Altered Expression [275]
CXCR5 TTIW59R Strong Biomarker [272]
CXCR6 TT2BVUA Strong Biomarker [169]
CYP2A6 TTAQ6ZW Strong Genetic Variation [276]
CYP3A4 TTWP7HQ Strong Altered Expression [277]
CYSLTR1 TTGKOY9 Strong Biomarker [278]
CYSLTR2 TT0PZR5 Strong Biomarker [279]
DCK TTJOCE4 Strong Biomarker [280]
DCN TTB3XAN Strong Biomarker [281]
DDR2 TTU98HG Strong Altered Expression [282]
DDX58 TTVB0O3 Strong Biomarker [283]
DEFB4A TTIVY12 Strong Altered Expression [284]
DEK TT1NMGV Strong Altered Expression [285]
DHCR24 TTTK0NH Strong Biomarker [286]
DHFR TTYZVDJ Strong Biomarker [287]
DIABLO TTN74LE Strong Biomarker [207]
DKK2 TTST5KX Strong Biomarker [288]
DLL1 TT9CFQD Strong Posttranslational Modification [289]
DLL4 TTV23LH Strong Biomarker [290]
DNASE1 TTYWGOJ Strong Biomarker [291]
DNM2 TTVRA5G Strong Altered Expression [292]
DPP4 TTDIGC1 Strong Biomarker [293]
DPYD TTZPS91 Strong Biomarker [294]
DPYSL2 TTZCW3T Strong Genetic Variation [295]
DTL TT8396I Strong Altered Expression [296]
DUSP10 TTF3RJ0 Strong Altered Expression [297]
DYRK1B TTYGQ8A Strong Biomarker [298]
E2F1 TTASI04 Strong Altered Expression [299]
EBP TT4VQZX Strong Biomarker [300]
EDN2 TTMR0OP Strong Posttranslational Modification [301]
EEF2K TT1QFLA Strong Altered Expression [302]
EGF TTED8JB Strong Biomarker [303]
EGR1 TTE8LGD Strong Biomarker [304]
EIF5A TTIVCNR Strong Biomarker [305]
ENPP3 TTD4TKP Strong Biomarker [306]
EPCAM TTZ8WH4 Strong Altered Expression [307]
EPHA1 TTLFZVU Strong Altered Expression [308]
EPHA2 TTRJB2G Strong Altered Expression [308]
EPHA3 TTHS2LR Strong Altered Expression [309]
EPHA8 TTHZ2LW Strong Altered Expression [310]
EPHB2 TTKPV6O Strong Biomarker [311]
EPHB4 TTI4ZX2 Strong Altered Expression [312]
EPX TTCIO0M Strong Genetic Variation [313]
ERBB3 TTSINU2 Strong Biomarker [314]
ESRRA TTPNQAC Strong Altered Expression [315]
ETS2 TT9AH0M Strong Biomarker [316]
EZR TTE47YC Strong Altered Expression [317]
F2RL1 TTQR74A Strong Biomarker [318]
F2RL3 TTD0652 Strong Altered Expression [319]
F7 TTF0EGX Strong Biomarker [320]
FABP1 TTIV96N Strong Altered Expression [269]
FAP TTGPQ0F Strong Biomarker [321]
FCGRT TTKLPHO Strong Biomarker [322]
FDXR TT3W4IX Strong Biomarker [323]
FECH TTQ6VF4 Strong Biomarker [324]
FFAR1 TTB8FUC Strong Biomarker [325]
FFAR2 TT0FYAN Strong Biomarker [326]
FGF1 TTMY81X Strong Biomarker [33]
FGF18 TT6ICRA Strong Altered Expression [327]
FGF19 TTGCH11 Strong Altered Expression [328]
FGF4 TTCEKVZ Strong Altered Expression [329]
FGF7 TTFY134 Strong Biomarker [330]
FHL1 TTI7ENL Strong Posttranslational Modification [331]
FKBP4 TTHY0FT Strong Altered Expression [332]
FLT4 TTDCBX5 Strong Biomarker [333]
FOLR1 TTVC37M Strong Biomarker [334]
FOSL2 TT689IR Strong Biomarker [335]
FOXO1 TTLRVIA Strong Biomarker [336]
FOXP3 TT1X3QF Strong Biomarker [337]
FPR2 TTOJ1NF Strong Biomarker [338]
FPR3 TT16TM5 Strong Altered Expression [339]
FSHR TTZFDBT Strong Biomarker [340]
FUT3 TTUPAD7 Strong Biomarker [341]
FUT4 TTNV1KZ Strong Biomarker [342]
FZD10 TTP1S2F Strong Altered Expression [343]
FZD7 TTUQMO5 Strong Altered Expression [344]
G3BP1 TTG0R8Z Strong Altered Expression [345]
GAL TTXZAJ5 Strong Biomarker [346]
GALR2 TTBPW3J Strong Biomarker [347]
GCGR TT9O6WS Strong Biomarker [348]
GCLM TTNFESW Strong Altered Expression [349]
GHR TTHJWYD Strong Biomarker [350]
GHSR TTWDC17 Strong Biomarker [351]
GLI2 TT045OH Strong Biomarker [352]
GLO1 TTV9A7R Strong Biomarker [353]
GMNN TT390KA Strong Altered Expression [354]
GNAO1 TTAXD8Z Strong Biomarker [355]
GPI TT19JIZ Strong Biomarker [356]
GPR137 TTATO6X Strong Biomarker [357]
GPR35 TT254XD Strong Altered Expression [358]
GPR55 TTNET8J Strong Biomarker [359]
GRM3 TT8A9EF Strong Biomarker [360]
GSS TTVEWR4 Strong Altered Expression [361]
GSTO1 TTWO3SH Strong Biomarker [362]
GUSB TTHS7CM Strong Altered Expression [363]
GZMB TTKEPHX Strong Altered Expression [364]
HCAR1 TTVK4ZO Strong Biomarker [365]
HCK TT42OGM Strong Biomarker [366]
HCRTR1 TT60Q8D Strong Altered Expression [367]
HDAC10 TTYHPU6 Strong Altered Expression [368]
HDAC3 TT4YWTO Strong Biomarker [369]
HDAC6 TT5ZKDI Strong Altered Expression [370]
HDC TTV9GOF Strong Biomarker [371]
HEXB TTKIBKM Strong Genetic Variation [372]
HGF TT4V2JM Strong Biomarker [373]
HIPK2 TTOB49C Strong Biomarker [374]
HLA-G TTLKFB3 Strong Altered Expression [375]
HMGA1 TTBA219 Strong Biomarker [376]
HMGB1 TTWQYB7 Strong Altered Expression [377]
HMGCS2 TTS0EZJ Strong Altered Expression [378]
HNF1A TT01M3K Strong Altered Expression [379]
HNF4A TT2F3CD Strong Altered Expression [380]
HNRNPA1 TTPJ9XK Strong Biomarker [381]
HOXA5 TTXSVQP Strong Altered Expression [382]
HOXB13 TTZ6I58 Strong Biomarker [383]
HSD11B2 TT9H85R Strong Altered Expression [384]
HSD17B4 TTL1WGS Strong Biomarker [385]
HSP90AA1 TT78R5H Strong Biomarker [386]
HSP90B1 TTFPKXQ Strong Altered Expression [387]
HSPA5 TTW26OG Strong Biomarker [388]
HSPA8 TTMQL3K Strong Biomarker [389]
HSPB1 TT9AZWY Strong Biomarker [390]
HSPB3 TTLH8WG Strong Biomarker [390]
HSPG2 TT5UM29 Strong Biomarker [391]
ICOS TTE5VP6 Strong Biomarker [392]
ICOSLG TTB9Z8R Strong Biomarker [393]
IDUA TT0IUKX Strong Biomarker [394]
IGFBP5 TTDWEA8 Strong Altered Expression [395]
IKBKB TTJ3E9X Strong Genetic Variation [396]
IL15RA TTGN89I Strong Biomarker [45]
IL17A TTG0MT6 Strong Biomarker [397]
IL17F TT2B6PS Strong Genetic Variation [398]
IL1R1 TTWOTEA Strong Altered Expression [399]
IL1R2 TT51DEV Strong Altered Expression [400]
IL2 TTF89GD Strong Altered Expression [401]
IL21 TT9QEJ6 Strong Altered Expression [402]
IL23R TT6H4QR Strong Biomarker [398]
IL24 TT1EPXZ Strong Biomarker [403]
IL33 TT5MD4P Strong Biomarker [404]
IL4R TTDWHC3 Strong Biomarker [405]
INPP5D TTTP2Z1 Strong Biomarker [406]
IRF8 TTHUBNK Strong Biomarker [407]
IRS1 TTAJSQ0 Strong Biomarker [408]
ITGA4 TTJMF9P Strong Biomarker [409]
ITGA5 TTHIZP9 Strong Altered Expression [410]
ITGB3 TTJA1ZO Strong Biomarker [411]
ITGB6 TTKQSXZ Strong Biomarker [412]
JAG2 TTOJY1B Strong Biomarker [413]
JMJD1C TTBISK4 Strong Biomarker [414]
JUN TTS7IR5 Strong Biomarker [415]
KCNA5 TTW0CMT Strong Biomarker [416]
KCND3 TTPLQO0 Strong Biomarker [417]
KCNH2 TTQ6VDM Strong Biomarker [418]
KDM3A TTKXS4A Strong Altered Expression [419]
KDM4A TTZHPB8 Strong Biomarker [420]
KDM5C TT94UCF Strong Altered Expression [421]
KISS1R TT3KBZY Strong Altered Expression [422]
KITLG TTDJ51N Strong Altered Expression [423]
KLF4 TTTI53X Strong Biomarker [377]
KLK14 TTDA81R Strong Biomarker [424]
KLK2 TTJLNAW Strong Biomarker [416]
KLK6 TTLPF4X Strong Biomarker [425]
KLK7 TTE6GTB Strong Altered Expression [426]
KLRK1 TTLRN4A Strong Biomarker [427]
LAPTM4B TTEJQT0 Strong Biomarker [428]
LBP TTVQJLY Strong Biomarker [429]
LCK TT860QF Strong Altered Expression [430]
LDHA TTW76JE Strong Altered Expression [431]
LDLR TTH0DUS Strong Biomarker [112]
LEP TTBJEZ5 Strong Altered Expression [432]
LGR5 TTTSGRH Strong Altered Expression [433]
LIFR TTID542 Strong Altered Expression [434]
LILRB1 TTC0QRJ Strong Altered Expression [435]
LIMK1 TTWL9TY Strong Biomarker [436]
LNPEP TTY2KP7 Strong Biomarker [437]
LONP1 TTM1VPZ Strong Biomarker [438]
LOXL2 TTFSUHX Strong Biomarker [439]
LPA TTU9LGY Strong Biomarker [440]
LPAR1 TTQ6S1K Strong Biomarker [441]
LPAR2 TTB7Y8I Strong Biomarker [169]
LPAR3 TTE2YJR Strong Biomarker [442]
LRRC32 TT0FAYT Strong Genetic Variation [443]
LTB4R TTN53ZF Strong Biomarker [444]
LTF TTSZDQU Strong Biomarker [445]
MAD1L1 TTNE9U7 Strong Altered Expression [446]
MAP2K5 TTV3O87 Strong Biomarker [56]
MAP2K7 TT6QY3J Strong Biomarker [119]
MAP3K10 TT9FN4J Strong Biomarker [224]
MAP3K20 TTTUZ3O Strong Biomarker [447]
MAP3K21 TTSW9YL Strong Biomarker [448]
MAP3K5 TTOQCD8 Strong Altered Expression [449]
MAP3K7 TTJQT60 Strong Biomarker [450]
MAP4K1 TTSHWUP Strong Altered Expression [451]
MAPK14 TTQBR95 Strong Biomarker [179]
MAPK3 TT1MG9E Strong Biomarker [149]
MAPK8 TT0K6EO Strong Biomarker [452]
MAPK9 TT3IVG2 Strong Altered Expression [453]
MARCKS TTHRM39 Strong Biomarker [454]
MARK2 TTAJ45Y Strong Biomarker [455]
MAT2A TTSMPXQ Strong Altered Expression [456]
MAZ TT059DA Strong Altered Expression [457]
MBTPS1 TTNSM2I Strong Altered Expression [458]
MC4R TTD0CIQ Strong Altered Expression [459]
MDK TTV8UE7 Strong Biomarker [460]
MDM2 TT9TE0O Strong Biomarker [461]
MDM4 TT9OUDQ Strong Biomarker [462]
MGLL TTZ963I Strong Biomarker [463]
MMP1 TTMX39J Strong Biomarker [464]
MMP11 TTZW4MV Strong Altered Expression [465]
MMP7 TTMTWOS Strong Biomarker [466]
MRC1 TTKV8W5 Strong Genetic Variation [467]
MSI2 TTTXQF6 Strong Biomarker [164]
MST1R TTBQ3OC Strong Altered Expression [468]
MTAP TTDBX7N Strong Altered Expression [469]
MTR TTUTO39 Strong Genetic Variation [470]
MUC15 TTGQ6MI Strong Biomarker [471]
MUC17 TTVO0JU Strong Altered Expression [472]
MUC5AC TTEL90S Strong Biomarker [473]
MYB TT8V13P Strong Biomarker [474]
MYCBP TTVW4XU Strong Altered Expression [475]
MYLK TT18ETS Strong Altered Expression [476]
NAPEPLD TTFMCB6 Strong Biomarker [359]
NCF1 TTZ4JC3 Strong Biomarker [477]
NCL TTK1V5Q Strong Biomarker [478]
NCOA4 TT8OY02 Strong Genetic Variation [479]
NECTIN4 TTPO9EG Strong Biomarker [480]
NEDD8 TTNDC4K Strong Biomarker [481]
NEK8 TT8AH9I Strong Biomarker [482]
NFKB2 TTKLNRV Strong Altered Expression [332]
NLRP1 TTQX29T Strong Biomarker [483]
NLRX1 TTKT026 Strong Altered Expression [484]
NME1 TTDY8JH Strong Altered Expression [485]
NME9 TTHSVK0 Strong Altered Expression [486]
NOX4 TTQRBSJ Strong Biomarker [487]
NPSR1 TTV1C0Z Strong Genetic Variation [488]
NR0B2 TT25A9Q Strong Altered Expression [489]
NR1H2 TTXA6PH Strong Biomarker [490]
NR1H4 TTS4UGC Strong Biomarker [491]
NR1I2 TT7LCTF Strong Biomarker [492]
NR4A2 TT9HKN3 Strong Biomarker [493]
NR5A2 TTAU3SY Strong Altered Expression [494]
NRP2 TTRXUVC Strong Altered Expression [495]
NTF4 TTIM2WO Strong Biomarker [496]
NTN1 TT0AH4L Strong Genetic Variation [497]
NTSR1 TTTUMEP Strong Biomarker [498]
NUAK1 TT65FL0 Strong Altered Expression [499]
NUF2 TTIXBFP Strong Biomarker [500]
ODC1 TTUMGNO Strong Biomarker [501]
OLFM4 TTK1CX7 Strong Biomarker [502]
OLR1 TTKSND3 Strong Biomarker [503]
ORAI1 TTE76YK Strong Biomarker [504]
OSM TTIVXSE Strong Biomarker [505]
P2RY12 TTZ1DT0 Strong Altered Expression [506]
PADI3 TTSCHFW Strong Biomarker [507]
PAK4 TT7Y3BZ Strong Biomarker [508]
PAM TTF4ZPC Strong Biomarker [509]
PARG TT39J16 Strong Biomarker [99]
PAWR TT3I4WV Strong Biomarker [510]
PBRM1 TTH8ZRL Strong Biomarker [511]
PCSK9 TTNIZ2B Strong Biomarker [512]
PCYT1B TTUAIKM Strong Biomarker [513]
PDE4B TTVIAT9 Strong Altered Expression [514]
PDE5A TTJ0IQB Strong Altered Expression [515]
PDK1 TTCZOF2 Strong Biomarker [516]
PF4 TTSG7Q5 Strong Biomarker [274]
PFKFB3 TTTHMQJ Strong Biomarker [517]
PGF TT48I1Y Strong Altered Expression [518]
PGGT1B TTX20QP Strong Biomarker [519]
PHLDB3 TT1KS9D Strong Biomarker [520]
PIK3CB TT9H4P3 Strong Biomarker [521]
PIM3 TTCGOIN Strong Altered Expression [522]
PIP5K1A TTA7DU1 Strong Biomarker [523]
PKM TT4LOT8 Strong Altered Expression [165]
PKN2 TTTHO0M Strong Altered Expression [524]
PLA2G1B TT9V5JH Strong Altered Expression [139]
PLA2G4A TTT1JVS Strong Biomarker [525]
PLAUR TTNOSTX Strong Biomarker [526]
PLCG1 TT6T4JI Strong Biomarker [527]
PLK4 TTGPNZQ Strong Biomarker [528]
PNKP TTHR3IE Strong Altered Expression [89]
PNP TTMCF1Y Strong Biomarker [529]
PPARD TT2JWF6 Strong Biomarker [530]
PPARGC1B TTKSQ3W Strong Biomarker [531]
PPIB TT6ZFQ4 Strong Biomarker [532]
PPID TTNAFOU Strong Biomarker [533]
PPIF TTRFQTB Strong Biomarker [533]
PPM1D TTENJAB Strong Biomarker [534]
PPOX TTNFMS9 Strong Biomarker [535]
PRDX5 TTLPJWH Strong Biomarker [536]
PREP TTNGKET Strong Biomarker [537]
PRKCA TTFJ8Q1 Strong Biomarker [538]
PRKCB TTYPXQF Strong Biomarker [539]
PRKD1 TTSLUMT Strong Biomarker [540]
PRKG1 TT7IZSA Strong Biomarker [541]
PRKG2 TTDWFCQ Strong Altered Expression [542]
PRMT5 TTR1D7X Strong Altered Expression [543]
PROKR1 TTB9CIL Strong Altered Expression [544]
PROKR2 TTM67AX Strong Biomarker [544]
PRSS1 TT2WR1T Strong Altered Expression [545]
PSIP1 TTH9LDP Strong Altered Expression [332]
PSMB6 TT8EPLT Strong Genetic Variation [546]
PSMB8 TTEAD9J Strong Altered Expression [547]
PSMD10 TT2H4LN Strong Biomarker [548]
PTGER3 TTPNGDE Strong Biomarker [549]
PTGIS TTLXKZR Strong Biomarker [550]
PTK2 TTON5IT Strong Biomarker [435]
PTP4A3 TT7YM8D Strong Altered Expression [551]
PTPN1 TTELIN2 Strong Biomarker [552]
PTPN13 TT405FP Strong Altered Expression [553]
PYY TTVFJLX Strong Biomarker [554]
RAB22A TTAJ746 Strong Biomarker [555]
RAC3 TT9BQ50 Strong Altered Expression [556]
RALBP1 TTVSRUA Strong Biomarker [557]
RECK TTRZBW7 Strong Posttranslational Modification [558]
REG3A TTL4H8N Strong Biomarker [172]
REG4 TTVZEHU Strong Altered Expression [559]
RENBP TTZCG0Q Strong Genetic Variation [560]
RIPK1 TTVJHX8 Strong Altered Expression [561]
ROCK2 TTGWKQJ Strong Biomarker [295]
ROR1 TTDEJAU Strong Altered Expression [562]
ROS1 TTSZ6Y3 Strong Biomarker [563]
RPS6KA6 TT3KYWB Strong Altered Expression [564]
RPS6KB1 TTG0U4H Strong Altered Expression [565]
RRM1 TTWP0NS Strong Biomarker [566]
RSF1 TTMP86V Strong Biomarker [567]
RSPO1 TTI9HL4 Strong Biomarker [568]
RUNX3 TTKCVO7 Strong Genetic Variation [569]
RXRA TT6PEUO Strong Biomarker [570]
RXRG TTH029C Strong Biomarker [571]
S100A6 TT716MY Strong Biomarker [572]
SCD TT6RIOV Strong Biomarker [573]
SCN5A TTZOVE0 Strong Biomarker [574]
SDC2 TT5H2F0 Strong Altered Expression [575]
SEMA4D TT5UT28 Strong Biomarker [576]
SENP1 TTW9HY5 Strong Biomarker [577]
SERPINB3 TT6QLPX Strong Biomarker [578]
SERPINB5 TT1KW50 Strong Altered Expression [579]
SETD2 TTPC3H4 Strong Altered Expression [580]
SFRP4 TTX8I1Y Strong Genetic Variation [581]
SGO1 TTBPKGD Strong Biomarker [582]
SGPL1 TT618Q2 Strong Biomarker [583]
SHCBP1 TTZ9WGL Strong Biomarker [509]
SIRT2 TTLKF5M Strong Biomarker [584]
SIRT3 TTVZLIJ Strong Altered Expression [585]
SIRT6 TTUXYWF Strong Biomarker [141]
SLC10A2 TTPI1M5 Strong Biomarker [586]
SLC12A5 TTH6UZY Strong Genetic Variation [587]
SLC17A5 TTFSUIA Strong Biomarker [588]
SLC19A3 TT9BTWM Strong Posttranslational Modification [589]
SLC1A2 TT2F078 Strong Biomarker [590]
SLC22A1 TTM5Q4V Strong Biomarker [591]
SLC22A3 TTG2UMS Strong Altered Expression [592]
SLC23A2 TTOP832 Strong Altered Expression [593]
SLC29A1 TTLXAKE Strong Altered Expression [594]
SLC3A2 TT5CZSM Strong Biomarker [595]
SLC5A5 TTW7HI9 Strong Biomarker [596]
SLC7A1 TT4S150 Strong Biomarker [262]
SLC7A5 TTPH2JB Strong Biomarker [595]
SLCO1B1 TTFGXEB Strong Altered Expression [597]
SLCO1B3 TTU86P0 Strong Altered Expression [598]
SLCO2A1 TTKVTQO Strong Biomarker [599]
SLK TT8K4DE Strong Biomarker [600]
SMAD7 TT0J32Z Strong Genetic Variation [601]
SMARCA4 TTVQEZS Strong Altered Expression [602]
SMPD1 TTJTM88 Strong Biomarker [603]
SMYD2 TT7YJFO Strong Biomarker [604]
SNCG TT5TQNZ Strong Biomarker [605]
SP1 TTZEP6S Strong Altered Expression [606]
SPDEF TT2ZUPY Strong Altered Expression [607]
SPHK1 TTOHFIY Strong Biomarker [608]
SPHK2 TTCN0M9 Strong Altered Expression [609]
SPN TTOZAX0 Strong Biomarker [610]
SPRY1 TT0PSN6 Strong Biomarker [611]
SPTBN1 TTS9BDA Strong Biomarker [612]
SRGN TTCHB06 Strong Biomarker [613]
SRPK1 TTU3WV6 Strong Biomarker [614]
SRPK2 TTCZEJ9 Strong Biomarker [615]
SSTR1 TTIND6G Strong Biomarker [616]
SSTR4 TTAE1BR Strong Biomarker [169]
ST14 TTPRO7W Strong Altered Expression [617]
STAT6 TTWOE1T Strong Biomarker [618]
SYK TT2HUPM Strong Biomarker [619]
SYVN1 TT8XKYM Strong Biomarker [620]
TACSTD2 TTP2HE5 Strong Altered Expression [621]
TAGLN TTDRZ9H Strong Altered Expression [622]
TAP1 TT7JZI8 Strong Biomarker [623]
TDG TTEXRQD Strong Altered Expression [624]
TEK TT9VGXW Strong Biomarker [625]
TERF2 TT5XSLT Strong Altered Expression [626]
TFAP2A TTDY4BS Strong Genetic Variation [627]
TFF1 TTNOJIZ Strong Altered Expression [628]
TFPI TT068JH Strong Genetic Variation [629]
TGFA TTTLQFR Strong Biomarker [630]
TGFB3 TTWOMY8 Strong Biomarker [631]
TGFBR1 TTP4520 Strong Altered Expression [632]
THBS1 TTKI0H1 Strong Biomarker [633]
TIAM1 TTNU6I5 Strong Altered Expression [634]
TKT TT04R7I Strong Altered Expression [635]
TKTL1 TTNQ1J3 Strong Altered Expression [635]
TLR5 TTCXP8J Strong Altered Expression [636]
TLR6 TTWRI8V Strong Altered Expression [637]
TLR9 TTSHG0T Strong Altered Expression [638]
TMEM97 TT9NXW4 Strong Altered Expression [639]
TMPRSS11D TTWHYC8 Strong Biomarker [640]
TMSB4X TTMVAIU Strong Biomarker [641]
TNFRSF1A TTG043C Strong Biomarker [642]
TNFRSF25 TTDV6BQ Strong Altered Expression [643]
TNFSF10 TTA5MS9 Strong Biomarker [159]
TNFSF12 TTBTDM1 Strong Biomarker [644]
TNFSF13 TTOI1RM Strong Altered Expression [645]
TNFSF15 TTEST6I Strong Altered Expression [643]
TNIK TTPB1W3 Strong Biomarker [646]
TNKS TTVUSO7 Strong Biomarker [647]
TNS4 TT1K65C Strong Altered Expression [648]
TOP1 TTGTQHC Strong Biomarker [649]
TOP2A TTCGY2K Strong Biomarker [650]
TPBG TT70MLA Strong Biomarker [651]
TPX2 TT0PHL4 Strong Altered Expression [652]
TRIM27 TTTO3QN Strong Biomarker [338]
TRPC1 TTA76X0 Strong Altered Expression [504]
TRPM6 TTV76RD Strong Altered Expression [653]
TRPM7 TTFPVZO Strong Altered Expression [654]
TRPV6 TTBK14N Strong Biomarker [262]
TYMP TTO0IB8 Strong Biomarker [655]
TYRO3 TTIEMFN Strong Altered Expression [656]
TYRP1 TTFRV98 Strong Altered Expression [545]
UCHL5 TTSX29Z Strong Biomarker [657]
UCP2 TTSC2YM Strong Biomarker [658]
UGT1A1 TT34ZAF Strong Altered Expression [177]
USP14 TTVSYP9 Strong Biomarker [657]
UTS2R TTW5UDX Strong Altered Expression [659]
VANGL1 TT18WJB Strong Biomarker [660]
VDAC1 TTAMKGB Strong Biomarker [661]
VDAC2 TTM1I7L Strong Biomarker [661]
VDR TTK59TV Strong Altered Expression [662]
VEGFC TT0QUFV Strong Altered Expression [663]
VEGFD TTOM5H4 Strong Altered Expression [664]
VIPR1 TTCL30I Strong Altered Expression [665]
VSIR TT51SK8 Strong Biomarker [666]
WAS TTE8T73 Strong Biomarker [667]
WDR5 TT7OFWB Strong Altered Expression [668]
YAP1 TT8UN2D Strong Biomarker [669]
YES1 TT0SQ8J Strong Altered Expression [670]
ZEB2 TTT2WK4 Strong Biomarker [671]
ZNF217 TTY3BRA Strong Biomarker [672]
CCR8 TTE836A Definitive Biomarker [673]
CSE1L TTTRULD Definitive Altered Expression [674]
CXCL1 TTLK1RW Definitive Altered Expression [22]
DGKZ TTSBBXL Definitive Altered Expression [675]
F3 TT38MDJ Definitive Biomarker [320]
GABRA1 TT1MPAY Definitive Altered Expression [676]
GRK3 TT5A4DX Definitive Biomarker [677]
MSRB1 TT1QUZV Definitive Biomarker [678]
NOP2 TTBLG3H Definitive Altered Expression [146]
PTPRJ TTWMKXP Definitive Genetic Variation [679]
TNFRSF17 TTZ3P4W Definitive Biomarker [680]
------------------------------------------------------------------------------------
⏷ Show the Full List of 743 DTT(s)
This Disease Is Related to 19 DTP Molecule(s)
Gene Name DTP ID Evidence Level Mode of Inheritance REF
SLC2A2 DTUJPOL Limited Altered Expression [80]
SLCO6A1 DTIFXNS Limited Biomarker [681]
SLC2A3 DT9SQ3L moderate Genetic Variation [682]
ABCB5 DTKVEXO Strong Biomarker [683]
ABCC5 DTYVM24 Strong Biomarker [684]
ATP7A DT0LT17 Strong Altered Expression [685]
SLC14A2 DT8QC7K Strong Altered Expression [659]
SLC16A12 DTZOKFJ Strong Biomarker [347]
SLC22A5 DT3HUVD Strong Biomarker [686]
SLC25A3 DTCRIWV Strong Biomarker [687]
SLC25A37 DTLBGTZ Strong Altered Expression [688]
SLC26A2 DTFSLX5 Strong Altered Expression [689]
SLC29A2 DTW78DQ Strong Altered Expression [594]
SLC2A5 DTOR02F Strong Biomarker [690]
SLC35A2 DT0567K Strong Altered Expression [691]
SLC44A1 DT3I2SU Strong Biomarker [264]
SLC4A2 DTF7GAL Strong Altered Expression [692]
SLC52A1 DT7NOKR Strong Biomarker [318]
SLC5A8 DTE3TAW Strong Altered Expression [39]
------------------------------------------------------------------------------------
⏷ Show the Full List of 19 DTP(s)
This Disease Is Related to 48 DME Molecule(s)
Gene Name DME ID Evidence Level Mode of Inheritance REF
CES2 DETHCPD Limited Altered Expression [693]
ACSS2 DEE76VW moderate Biomarker [694]
CMPK1 DEMPH4I moderate Altered Expression [695]
FADS1 DE05S8C moderate Altered Expression [696]
GCLC DESYL1F moderate Altered Expression [697]
GSTT1 DE3PKUG moderate Genetic Variation [698]
ADH1C DEM1HNL Strong Genetic Variation [699]
AKR1B10 DEP6GT1 Strong Altered Expression [700]
ALDH1A1 DE2JP1Y Strong Altered Expression [701]
ALDH1B1 DEXI4UQ Strong Biomarker [702]
BAAT DERA3OF Strong Altered Expression [703]
CHDH DEAHED0 Strong Genetic Variation [704]
CYP1A1 DE6OQ3W Strong Altered Expression [705]
CYP27B1 DE3FYEM Strong Biomarker [706]
CYP2R1 DEBIHM3 Strong Genetic Variation [707]
CYP4F3 DEFCMPI Strong Genetic Variation [708]
CYP7A1 DEDZRQ1 Strong Genetic Variation [709]
CYP7B1 DE36TMY Strong Altered Expression [710]
DHCR7 DEL7GFA Strong Genetic Variation [707]
DTYMK DEOTVYU Strong Biomarker [711]
EGLN3 DEMQTKH Strong Genetic Variation [712]
FMO5 DEBMX7C Strong Altered Expression [713]
FPGS DECWT2V Strong Altered Expression [714]
GLS DE3E0VT Strong Biomarker [715]
GMDS DE8K7F3 Strong Genetic Variation [716]
HPGD DEHKSC6 Strong Biomarker [717]
HPRT1 DEVXTP5 Strong Genetic Variation [718]
HSD17B7 DEDMWFX Strong Biomarker [719]
ME1 DE97WM8 Strong Biomarker [720]
MT2A DEFKGT7 Strong Altered Expression [721]
MTARC2 DE6QH2D Strong Biomarker [722]
MTRR DE6NIY9 Strong Genetic Variation [723]
NAT1 DE7OAB3 Strong Genetic Variation [724]
NAT10 DEZV4AP Strong Altered Expression [194]
NAT2 DER7TA0 Strong Altered Expression [725]
NT5C DE4E31Z Strong Altered Expression [726]
PARK7 DEPOVCH Strong Altered Expression [727]
PCYT1A DEQYXD4 Strong Biomarker [728]
PER1 DE9HF0I Strong Altered Expression [729]
PRODH DEVJIHS Strong Altered Expression [730]
PTGDS DER3H9C Strong Biomarker [731]
SAT1 DEMWO83 Strong Biomarker [732]
SULT1A1 DEYWLRK Strong Genetic Variation [276]
SULT1E1 DESTKG6 Strong Altered Expression [733]
SULT2A1 DE0P6LK Strong Altered Expression [329]
TPMT DEFQ8VO Strong Biomarker [734]
UGT1A7 DEZO4N3 Strong Genetic Variation [735]
UGT2B17 DEAZDL8 Strong Biomarker [736]
------------------------------------------------------------------------------------
⏷ Show the Full List of 48 DME(s)
This Disease Is Related to 1130 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
ACAD8 OT3JI5GB Limited Biomarker [46]
ACTL6A OT0EC5BQ Limited Altered Expression [737]
ANXA6 OT9KIQ0Y Limited Biomarker [26]
ARHGEF2 OTBQTFRT Limited Altered Expression [738]
ARPC2 OTSOKOMY Limited Biomarker [739]
ART1 OT7FBG5W Limited Biomarker [740]
B3GALT5 OTWXPEMU Limited Posttranslational Modification [741]
B3GNT7 OT8UTTXF Limited Genetic Variation [742]
BBS2 OTPF9JIB Limited Biomarker [743]
CA8 OT9Y8GA8 Limited Biomarker [744]
CACYBP OTJMZD2T Limited Biomarker [572]
CDX1 OTOHTMJE Limited Biomarker [745]
CLEC4D OTT7X1UC Limited Genetic Variation [746]
CLPTM1L OTDJWQXI Limited Genetic Variation [747]
CNIH4 OT1TFJK0 Limited Biomarker [748]
CTTN OTJRG4ES Limited Altered Expression [749]
CUEDC2 OTWMOLAJ Limited Altered Expression [750]
CXCL17 OTRCEVIZ Limited Altered Expression [751]
DCTN6 OTI8PIN9 Limited Biomarker [752]
DDB2 OTO8HVVB Limited Altered Expression [753]
DDIT3 OTI8YKKE Limited Biomarker [754]
DIAPH1 OTZBYPLH Limited Biomarker [755]
DLEC1 OTMKKBUW Limited Biomarker [756]
EIF3G OT5L1SRY Limited Biomarker [757]
ERCC1 OTNPYQHI Limited Biomarker [758]
ERCC2 OT1C8HQ4 Limited Altered Expression [759]
FBLN1 OT5MHHOP Limited Genetic Variation [760]
FBP1 OTQBANEP Limited Altered Expression [761]
FH OTEQWU6Q Limited Genetic Variation [746]
FHL2 OT0OAYWT Limited Altered Expression [762]
FUT1 OTODG57A Limited Genetic Variation [763]
GATA6 OTO2BC0F Limited Altered Expression [764]
GATAD2B OTJL128N Limited Biomarker [26]
GORASP1 OTQS91S7 Limited Altered Expression [87]
GPRC5A OTPOCWR7 Limited Biomarker [765]
GPX2 OTXI2NTI Limited Altered Expression [766]
GSTK1 OTDNGWAF Limited Biomarker [681]
HNRNPF OTSMBXMF Limited Biomarker [767]
HOXB9 OTMVHQOU Limited Altered Expression [768]
IARS2 OTDX4SCA Limited Altered Expression [769]
IFI27 OTI2XGIT Limited Biomarker [752]
IFNGR1 OTCTQBWW Limited Genetic Variation [47]
IGFBP4 OT2HZRBD Limited Biomarker [770]
IL6ST OT1N9C70 Limited Biomarker [771]
INPP4B OTLROA7G Limited Biomarker [772]
IRF2 OTAZRUW3 Limited Genetic Variation [47]
ISYNA1 OT49ONSE Limited Altered Expression [773]
LPIN1 OTQ75KF2 Limited Altered Expression [22]
LRPPRC OTXSK5LP Limited Biomarker [771]
LRRC8A OT23OE7H Limited Biomarker [774]
LUM OTSRC874 Limited Altered Expression [775]
MAX OTKZ0YKM Limited Genetic Variation [776]
MBD2 OTUQPP0R Limited Biomarker [777]
MEST OT8Q4U8Y Limited Biomarker [778]
MFAP1 OTZN4FT3 Limited Biomarker [779]
MINDY4 OTBZ2SZB Limited Biomarker [780]
MMRN1 OT7ZNYHT Limited Biomarker [781]
MYEOV OTDC7UHL Limited Biomarker [782]
NAA40 OTFLRVQO Limited Biomarker [783]
NDRG2 OT5L6KD7 Limited Altered Expression [784]
NFATC2 OTK5T6HZ Limited Biomarker [785]
NFE2L3 OT1MGXT0 Limited Biomarker [786]
NKAP OT7K7I8Q Limited Biomarker [787]
NR2F6 OTNVO2B6 Limited Biomarker [788]
PCBD1 OTDSRUD5 Limited Biomarker [789]
PEAK1 OTVVM637 Limited Altered Expression [790]
PHF20 OTCBVH5P Limited Biomarker [791]
PIK3R1 OT5BZ1J9 Limited Biomarker [792]
PLA2G10 OTRZ2L5A Limited Biomarker [92]
PLA2G2D OTU604XM Limited Biomarker [92]
POLD3 OTEQEFQ2 Limited Biomarker [26]
PPM1H OTKSVU7S Limited Altered Expression [793]
PRDX2 OTLWCY9T Limited Biomarker [794]
PRKAA1 OT7TNF0L Limited Altered Expression [795]
PRKAB1 OT1OG4QZ Limited Altered Expression [795]
PRKAG2 OTHTAM54 Limited Genetic Variation [796]
PSMD9 OT6Y5CC3 Limited Biomarker [752]
PTOV1 OT94WT5X Limited Altered Expression [701]
PTPA OTRGFOI7 Limited Biomarker [797]
PTPN3 OTSLZBVY Limited Genetic Variation [798]
PYROXD1 OTPGO23E Limited Biomarker [799]
RAD21 OTQS84ZF Limited Genetic Variation [679]
RAD54B OTMWB2P2 Limited Biomarker [800]
RASSF1 OTEZIPB7 Limited Biomarker [111]
RBM15B OTRJ9DT7 Limited Biomarker [801]
RBM3 OTAJ7R31 Limited Altered Expression [802]
RSPO2 OT3HHXU0 Limited Biomarker [803]
SASH1 OTQA8BD4 Limited Biomarker [804]
SCAF1 OT16TM3N Limited Altered Expression [805]
SNAI2 OT7Y8EJ2 Limited Biomarker [806]
SPINK4 OTHTCW94 Limited Altered Expression [807]
SRF OTW18FQN Limited Altered Expression [808]
ST6GAL1 OT7US3NO Limited Altered Expression [809]
STRA6 OT2IDF27 Limited Biomarker [810]
SYNE1 OTSBSLUH Limited Biomarker [811]
SYT1 OTVTPOI6 Limited Altered Expression [87]
TENM4 OT91K3FC Limited Biomarker [192]
TFG OT2KJENI Limited Genetic Variation [812]
TICAM2 OTK7GIJ5 Limited Biomarker [752]
TMED7 OTONO8E6 Limited Biomarker [752]
TMED9 OTYGAQS0 Limited Biomarker [748]
TNS2 OTP72P0F Limited Altered Expression [813]
TRIM72 OTFAFXPC Limited Altered Expression [814]
CEP85L OTSHJFOT Disputed Biomarker [815]
DBF4B OTARSHZM Disputed Altered Expression [816]
KRT23 OTQW6UAG Disputed Biomarker [817]
AADAC OT8VACT2 moderate Biomarker [818]
ACCS OTHIHI9D moderate Biomarker [694]
ALX4 OTNS9A29 moderate Posttranslational Modification [819]
ARHGEF1 OTXU4HBW moderate Biomarker [820]
ATN1 OTNZFLKY moderate Biomarker [821]
ATP2A3 OTFYDEES moderate Altered Expression [822]
BRINP1 OTEUVSCP moderate Biomarker [823]
BTF3 OT5ZZFJL moderate Biomarker [824]
CCAR2 OTLUDG5T moderate Biomarker [823]
CCL18 OT7JYSK9 moderate Altered Expression [825]
CD99 OTPUZ5DE moderate Biomarker [826]
CFHR1 OT72R16T moderate Biomarker [827]
CIP2A OTVS2GXA moderate Altered Expression [828]
CMPK2 OTOG90R0 moderate Altered Expression [695]
DBN1 OTZVKG8A moderate Altered Expression [829]
DCDC2 OTSUFH1H moderate Biomarker [830]
FBXW4 OTEGSZOX moderate Biomarker [818]
FOXA2 OTJOCVOY moderate Altered Expression [831]
FOXO3 OTHXQG4P moderate Biomarker [832]
FSTL1 OT6KEZUD moderate Biomarker [833]
GLTP OTM78ZFI moderate Altered Expression [834]
GRP OT8JDFNI moderate Biomarker [835]
H4C1 OTB71W46 moderate Biomarker [836]
HAVCR2 OTOL603T moderate Biomarker [837]
HCP5 OTV0YRI8 moderate Altered Expression [838]
HOXB3 OT9UC5PE moderate Biomarker [839]
HOXC13 OT52AVNA moderate Biomarker [840]
HSPA4 OT5HR0AR moderate Biomarker [841]
ISM1 OTZTK2TV moderate Altered Expression [842]
ITGB4 OT28UK84 moderate Altered Expression [843]
JUND OTNKACJD moderate Biomarker [844]
KATNB1 OT7CLZKS moderate Biomarker [110]
KCTD12 OTPYKT4Z moderate Biomarker [15]
KDM2B OTDMCVW7 moderate Altered Expression [845]
LMTK2 OT93MVIC moderate Biomarker [846]
LRIG1 OTY5HZN5 moderate Biomarker [847]
LYPD8 OT5B9NNM moderate Biomarker [848]
MAP6 OTPUI00F moderate Genetic Variation [849]
MAPK6 OTDDNF3Q moderate Genetic Variation [130]
MED25 OTDBY87B moderate Biomarker [850]
MPZ OTAR2YXH moderate Biomarker [135]
MSN OTZJ4J6G moderate Biomarker [851]
MTMR3 OTBIT23O moderate Biomarker [134]
MYL9 OT6B22JB moderate Altered Expression [852]
MYOM2 OTD2UOXW moderate Genetic Variation [853]
NLK OT2LETFS moderate Biomarker [854]
NOX1 OTZPJQCC moderate Biomarker [855]
NWD1 OT4JMFPH moderate Genetic Variation [856]
OXA1L OTS0BFRD moderate Biomarker [857]
P2RX5 OTLBR20R moderate Biomarker [858]
P4HB OTTYNYPF moderate Biomarker [859]
PA2G4 OT7IG7HT moderate Biomarker [656]
PHLDB2 OTDKMB2G moderate Biomarker [860]
PLA2G15 OT6VJTPA moderate Biomarker [694]
PLAAT4 OTI66SAJ moderate Biomarker [283]
PLEKHA8 OT03870U moderate Biomarker [861]
PMP22 OTXWYWCZ moderate Biomarker [135]
POTEF OTV3WXYE moderate Biomarker [862]
PRKAA2 OTU1KZPV moderate Biomarker [863]
PRPF6 OT3U0ABN moderate Biomarker [864]
PSD OTUZIXUZ moderate Genetic Variation [853]
RAB25 OTW0W6NP moderate Biomarker [865]
RAD51B OTCJVRMY moderate Genetic Variation [467]
RBBP4 OTG3BT3M moderate Altered Expression [866]
RCHY1 OTAE7504 moderate Biomarker [867]
RETREG1 OTYOSLZX moderate Posttranslational Modification [868]
RHOC OTOLE1FT moderate Altered Expression [869]
RPL28 OTEVRCBO moderate Biomarker [870]
RTKN OTSS8XR6 moderate Biomarker [871]
SATB2 OT2W80XC moderate Biomarker [872]
SHMT2 OT5NCAZN moderate Biomarker [873]
SMR3B OTL5HNM8 moderate Altered Expression [551]
SMURF1 OT5UIZR8 moderate Biomarker [874]
SMURF2 OT3TRVL7 moderate Biomarker [153]
SOX17 OT9H4WWE moderate Altered Expression [875]
STAT5A OTBSJGN3 moderate Altered Expression [423]
STT3A OTDPS6AV moderate Altered Expression [237]
TERF2IP OT3M5P3G moderate Altered Expression [876]
TIMP1 OTOXC51H moderate Altered Expression [877]
TM4SF5 OTPAV531 moderate Biomarker [878]
TMED3 OTNOPHHC moderate Biomarker [879]
TNFAIP8L1 OTVVKOTV moderate Biomarker [880]
TRAPPC9 OTF0CVMC moderate Biomarker [881]
TSPAN8 OT1F68WQ moderate Biomarker [882]
TTC22 OTFNNLI1 moderate Biomarker [883]
A2M OTFTX90K Strong Biomarker [42]
AATF OT1QOKLD Strong Altered Expression [884]
ABCE1 OTH19LOA Strong Biomarker [885]
ABHD5 OTY829Z3 Strong Biomarker [886]
ABI3 OTQTDSHP Strong Altered Expression [887]
ACAP2 OTYNZPC4 Strong Altered Expression [634]
ACSBG1 OTM040MW Strong Biomarker [888]
ACSL1 OTB06ESI Strong Genetic Variation [889]
ACSL4 OTI71MUJ Strong Biomarker [890]
ACTB OT1MCP2F Strong Biomarker [891]
ADA2 OTGCV24S Strong Biomarker [892]
ADAMTS12 OTG7HEA2 Strong Altered Expression [893]
ADAMTS15 OTYB6JS3 Strong Biomarker [894]
ADAMTS18 OTRMFI04 Strong Biomarker [895]
ADAMTSL3 OTMC2WFG Strong Altered Expression [896]
ADCY9 OT1IZT5K Strong Altered Expression [897]
ADIPOR1 OT65ZFZN Strong Genetic Variation [898]
ADIPOR2 OT2HDTL8 Strong Biomarker [899]
ADNP OTEGICWR Strong Altered Expression [900]
AFDN OTTRU341 Strong Biomarker [18]
AFMID OTFSM0TL Strong Altered Expression [901]
AGL OTWBM7WY Strong Biomarker [902]
AGO1 OTD3R434 Strong Biomarker [903]
AGO2 OT4JY32Q Strong Biomarker [904]
AHRR OTSJ12W6 Strong Altered Expression [905]
AHSA1 OTC7AFHT Strong Biomarker [179]
AIFM1 OTKPWB7Q Strong Biomarker [906]
AIM2 OT86QUI8 Strong Biomarker [907]
AIMP1 OTTA5C3U Strong Altered Expression [422]
AKAP10 OTPNFTOU Strong Altered Expression [908]
AKAP3 OT42QOFG Strong Altered Expression [909]
AKAP4 OTL4Z99V Strong Altered Expression [910]
ALDH1A3 OT1C9NKQ Strong Biomarker [911]
ALDH3A1 OTAYZZE6 Strong Altered Expression [269]
ALDH7A1 OTV57BZD Strong Biomarker [912]
ALPG OTCIM29R Strong Genetic Variation [913]
ALPP OTZU4G9W Strong Altered Expression [194]
ALX3 OTXZ25PZ Strong Biomarker [914]
AMOTL2 OTRCTKV9 Strong Altered Expression [915]
AMPD3 OT5SP1KJ Strong Biomarker [916]
ANGPTL2 OTB6JG41 Strong Altered Expression [183]
ANKRD36B OT3MW415 Strong Altered Expression [917]
ANOS1 OTZJT4KN Strong Altered Expression [918]
ANP32B OT3SQMLU Strong Altered Expression [919]
ANTXR1 OT5W1GPC Strong Biomarker [920]
APCDD1 OTV9AD0L Strong Biomarker [921]
APIP OT8ZABOU Strong Biomarker [590]
APOBEC1 OTY8QX2R Strong Altered Expression [922]
AQP5 OT77GBY8 Strong Biomarker [120]
ARC OTN2QQPG Strong Biomarker [923]
ARHGAP17 OTEABPLV Strong Biomarker [924]
ARHGEF17 OTUGS4FL Strong Biomarker [925]
ARHGEF28 OT3F32IU Strong Biomarker [926]
ARHGEF5 OTUVGFT9 Strong Biomarker [927]
ARHGEF7 OT9BPJCL Strong Biomarker [792]
ARID3A OTZZ4SFP Strong Biomarker [928]
ARNT OTMSIEZY Strong Altered Expression [929]
ASAH1 OT1DNGXL Strong Biomarker [930]
ASCC1 OTH4VAP9 Strong Altered Expression [931]
ASF1A OT4S44GP Strong Biomarker [932]
ASL OTI2NGQR Strong Altered Expression [933]
ASPRV1 OT8WVIBW Strong Altered Expression [84]
ATF6 OTAFHAVI Strong Altered Expression [828]
ATG3 OT28VBVK Strong Altered Expression [934]
ATG4B OTQ4RNRM Strong Biomarker [935]
ATOH1 OTBZYG2R Strong Biomarker [936]
ATP2B4 OTMWFDAC Strong Altered Expression [937]
ATP2C1 OTQN51T3 Strong Biomarker [938]
ATP5F1E OTMPLAIS Strong Altered Expression [939]
ATRNL1 OTY5JUX2 Strong Altered Expression [194]
AXIN1 OTRGZGZ5 Strong Biomarker [940]
AXIN2 OTRMGQNU Strong Biomarker [941]
B3GNT6 OTAX8BNJ Strong Altered Expression [942]
B3GNT8 OTDK2PQD Strong Biomarker [943]
B3GNTL1 OTYWGHF1 Strong Biomarker [943]
B4GALNT3 OT6BFB22 Strong Biomarker [944]
BAG1 OTRQNIA4 Strong Biomarker [945]
BAMBI OTCEJ8W5 Strong Altered Expression [946]
BARD1 OTTC0Z9Y Strong Biomarker [947]
BATF3 OTI61WXQ Strong Biomarker [948]
BCAM OTHZOPSD Strong Biomarker [949]
BCAR1 OTKT2C2N Strong Altered Expression [950]
BCL10 OT47MCLI Strong Altered Expression [951]
BCL2L12 OTS6IFZY Strong Posttranslational Modification [952]
BCL9 OTRBIPR4 Strong Biomarker [953]
BHLHE22 OTZUQY5L Strong Biomarker [954]
BHLHE40 OTITX14U Strong Biomarker [955]
BIN1 OTK8O0X8 Strong Altered Expression [956]
BIRC6 OTCQJAB0 Strong Biomarker [957]
BLNK OTSSPF6F Strong Biomarker [958]
BMP3 OTCTI0UW Strong Biomarker [959]
BMPR1A OTQOA4ZH Strong Genetic Variation [960]
BNIP3 OT4SO7J4 Strong Altered Expression [961]
BRCA1 OT5BN6VH Strong Biomarker [821]
BRI3 OT1RWIH7 Strong Biomarker [962]
BUB1B OT8KME51 Strong Altered Expression [963]
BVES OT4GT1WC Strong Biomarker [964]
C12orf75 OTFVI3EY Strong Altered Expression [965]
C1GALT1 OT2ZSZ6P Strong Altered Expression [966]
C1QL3 OT4TZH3J Strong Biomarker [967]
C2orf68 OTNNFK6R Strong Altered Expression [968]
CABLES1 OTMN4XSX Strong Biomarker [969]
CACNB1 OTV42SIT Strong Altered Expression [264]
CALB2 OTSNMCG9 Strong Altered Expression [970]
CALM2 OTNYA92F Strong Biomarker [971]
CALML3 OTM8DNQU Strong Biomarker [972]
CALU OTSYQN71 Strong Biomarker [243]
CAMKMT OTLJBRUW Strong Biomarker [971]
CAMTA2 OT6PIWF4 Strong Biomarker [973]
CAPN10 OTS9LJW4 Strong Genetic Variation [974]
CARD10 OT2RPM4I Strong Altered Expression [975]
CARD8 OTXXZYWU Strong Altered Expression [976]
CARD9 OTJ81AWD Strong Biomarker [977]
CASK OT8EF7ZF Strong Biomarker [978]
CASP14 OTKY93H9 Strong Altered Expression [979]
CASZ1 OTWJ2OR8 Strong Biomarker [980]
CAV2 OT1FGRQX Strong Altered Expression [981]
CBFA2T2 OTNOIB23 Strong Biomarker [792]
CBLL1 OTZUQBYX Strong Altered Expression [982]
CBX1 OT2L4XZX Strong Altered Expression [983]
CBX3 OTOP9RLD Strong Biomarker [984]
CBX5 OT8VYY84 Strong Biomarker [985]
CBX8 OT4U5V1T Strong Altered Expression [986]
CCAR1 OTUXLQZZ Strong Biomarker [987]
CCDC66 OTE8VSSO Strong Biomarker [988]
CCDC80 OTOZSYEM Strong Biomarker [989]
CCDC83 OTF1ETS6 Strong Altered Expression [990]
CCDC88A OT3SSYYC Strong Altered Expression [991]
CCL27 OTUZYC61 Strong Altered Expression [194]
CCN4 OT69BER9 Strong Biomarker [992]
CCNC OTMVK4K4 Strong Genetic Variation [993]
CCNDBP1 OTBWG1M0 Strong Altered Expression [994]
CCNH OTKDU3SR Strong Genetic Variation [89]
CCNL2 OT0NIKYM Strong Biomarker [995]
CCT4 OT5D452X Strong Biomarker [996]
CD151 OTF3UZS7 Strong Altered Expression [997]
CD200R1 OT65Q9M6 Strong Altered Expression [998]
CD226 OT4UG0KB Strong Biomarker [999]
CD63 OT2UGZA9 Strong Altered Expression [820]
CD81 OTQFXNAZ Strong Altered Expression [1000]
CDC42 OT5QBC5M Strong Biomarker [242]
CDC73 OT6JASZ1 Strong Altered Expression [1001]
CDCP1 OTD7RRWK Strong Altered Expression [14]
CDH17 OT9EV2XK Strong Altered Expression [1002]
CDHR2 OTTHEUPO Strong Altered Expression [1003]
CDHR5 OTTBWQMN Strong Altered Expression [1004]
CDK14 OT385ZH1 Strong Biomarker [1005]
CDKN3 OTBE3H07 Strong Biomarker [1006]
CDO1 OTLG1P77 Strong Biomarker [1007]
CEACAM4 OT0C7YUD Strong Altered Expression [1008]
CEACAM7 OTKFDTZY Strong Altered Expression [249]
CEMIP OTK80FYN Strong Biomarker [1009]
CEP131 OT6PF80T Strong Altered Expression [528]
CETN1 OTGQ8JOZ Strong Biomarker [1010]
CFL1 OTT6D5MH Strong Biomarker [1011]
CHAF1A OTXSSY4H Strong Altered Expression [1012]
CHFR OTRAD2TT Strong Posttranslational Modification [1013]
CHMP5 OTQWZL6R Strong Biomarker [1014]
CHP1 OTHTXN1A Strong Biomarker [1015]
CHPT1 OT4FJ0K3 Strong Biomarker [1016]
CHST4 OTESMIW5 Strong Biomarker [1017]
CHTF18 OTQK3FI4 Strong Biomarker [1018]
CIAPIN1 OTWS90F9 Strong Biomarker [1019]
CILK1 OTWOYEYP Strong Biomarker [447]
CIRBP OTXWTPBL Strong Biomarker [560]
CITED2 OT812TV7 Strong Biomarker [1020]
CIZ1 OT3UKHPI Strong Biomarker [1021]
CKB OTUCKOTT Strong Altered Expression [1022]
CKS1B OTNUPLUJ Strong Altered Expression [507]
CLCA2 OTF191LZ Strong Biomarker [256]
CLCN4 OT4A2UWF Strong Biomarker [1023]
CLDN1 OT27KV99 Strong Altered Expression [1024]
CLDN2 OTRF3D6Y Strong Altered Expression [1025]
CLDN3 OT71MN9S Strong Biomarker [257]
CLDN7 OTNE0XHQ Strong Altered Expression [1024]
CLEC3B OTFD29NF Strong Altered Expression [1026]
CLEC4M OT2WUIIP Strong Biomarker [1027]
CLUAP1 OTESP4WL Strong Altered Expression [1028]
CNDP2 OTJR9436 Strong Biomarker [1029]
CNN3 OTJTAXAP Strong Altered Expression [1030]
COL12A1 OTHLTV53 Strong Biomarker [722]
COL4A3 OT6SB8X5 Strong Biomarker [1031]
COL4A6 OTUREU5Z Strong Biomarker [1032]
COLCA1 OT8BP6UD Strong Altered Expression [1033]
COMP OTS2FPMI Strong Biomarker [1034]
COPS6 OTG9AAG0 Strong Biomarker [1035]
CORO1A OTVAZOHC Strong Altered Expression [1036]
CORO2A OTVK7PK3 Strong Altered Expression [1037]
COTL1 OT6YCNLF Strong Biomarker [972]
COX1 OTG3O9BN Strong Biomarker [149]
COX3 OTNNGBYJ Strong Biomarker [1038]
COX5A OTP0961M Strong Biomarker [1039]
COX8A OTU0NR39 Strong Biomarker [1039]
CPOX OTIAY121 Strong Biomarker [1039]
CPQ OTTNZNLD Strong Biomarker [1040]
CPSF4 OT53UK5L Strong Biomarker [1041]
CRB3 OTQKPTMU Strong Biomarker [1042]
CREM OTJIJ5AL Strong Biomarker [1043]
CRISP2 OT8HLTV5 Strong Biomarker [1044]
CRISPLD2 OTVSFHTL Strong Biomarker [1045]
CRKL OTOYSD1R Strong Biomarker [1046]
CRYGC OTYSTQWI Strong Biomarker [1047]
CSGALNACT1 OTBML9D9 Strong Altered Expression [1048]
CSN2 OT22C0PD Strong Altered Expression [1049]
CSRP1 OTUS7RM2 Strong Genetic Variation [1050]
CSRP3 OTECBJMV Strong Biomarker [972]
CST1 OTE4I83Q Strong Altered Expression [1051]
CST5 OTHJXNJG Strong Biomarker [1052]
CSTB OT3U0JF8 Strong Altered Expression [1053]
CTAGE1 OTWM7KSJ Strong Biomarker [1054]
CTBS OT135K92 Strong Biomarker [513]
CTHRC1 OTV88X2G Strong Altered Expression [1055]
CTNNA1 OTFC725Z Strong Genetic Variation [1056]
CTSZ OTSCX2LL Strong Biomarker [1057]
CUL1 OTXPE1UZ Strong Biomarker [481]
CUL4A OTTBV70J Strong Altered Expression [1058]
CUL4B OT2QX4DO Strong Biomarker [1059]
CXCL14 OTM189TA Strong Altered Expression [1060]
CXCL16 OTD49T9R Strong Altered Expression [1060]
CXCL3 OTSL94KH Strong Altered Expression [1061]
CXCL6 OTFTCQ4O Strong Altered Expression [1062]
CYB5D2 OTX10KKR Strong Genetic Variation [1063]
CYB5R1 OTMDHMLA Strong Altered Expression [1064]
CYFIP2 OTCAY35T Strong Biomarker [1065]
CYP2W1 OTXSB1AE Strong Biomarker [1066]
CYP4V2 OTQKNK0D Strong Genetic Variation [1067]
D2HGDH OTLHXW69 Strong Biomarker [1068]
DACT1 OT19Z704 Strong Biomarker [1069]
DACT2 OTNLCC0K Strong Altered Expression [1070]
DAPK2 OTWODUQG Strong Biomarker [1071]
DCAF1 OT3ZDVOE Strong Genetic Variation [1072]
DDA1 OTAZIAIH Strong Biomarker [1049]
DDHD1 OTWTHOWK Strong Biomarker [1073]
DDX17 OTXRMMBP Strong Biomarker [1074]
DDX3X OTDO4TRX Strong Biomarker [1075]
DDX53 OTHK3EGZ Strong Biomarker [184]
DEFB1 OT5SV0E4 Strong Altered Expression [1076]
DEFB103B OT8RWY64 Strong Altered Expression [284]
DEFB104A OTLQZR6K Strong Altered Expression [284]
DENR OTXP9HOY Strong Biomarker [1071]
DESI2 OTHUOKOC Strong Biomarker [1077]
DGKB OTTT9SZJ Strong Biomarker [1078]
DGKE OTWS86AS Strong Biomarker [1078]
DGUOK OT78HUZB Strong Biomarker [1078]
DHDDS OTVLYBUS Strong Biomarker [1016]
DHX36 OT8IGL9Y Strong Biomarker [1079]
DIXDC1 OT87DXEG Strong Altered Expression [1080]
DKK4 OTWCCVF6 Strong Biomarker [1081]
DLC1 OTP8LMCR Strong Biomarker [756]
DLX4 OTLWVCN4 Strong Altered Expression [1082]
DNAJA3 OT61924T Strong Altered Expression [1083]
DNLZ OT48CG1W Strong Biomarker [1084]
DNM1L OTXK1Q1G Strong Biomarker [1085]
DNM3 OTDMUGCR Strong Altered Expression [794]
DOK1 OTGVRLW6 Strong Biomarker [1086]
DPPA4 OTAEOACS Strong Altered Expression [1087]
DPYS OTLTUIVL Strong Biomarker [1088]
DRG1 OTIFYMI3 Strong Biomarker [1089]
DSC3 OTYG47F8 Strong Biomarker [1090]
DSCC1 OTPUVLZT Strong Altered Expression [1018]
DSG2 OTJPB2TO Strong Biomarker [1091]
DSP OTB2MOP8 Strong Biomarker [1092]
DST OTHZBM4X Strong Biomarker [135]
DSTN OTMXO4YB Strong Altered Expression [436]
DTD1 OT63V2KK Strong Altered Expression [689]
DUOX2 OTU14HCN Strong Biomarker [1093]
DUSP2 OTH54FMR Strong Altered Expression [1094]
DVL2 OTMNYNCM Strong Altered Expression [1095]
DYNLL1 OTR69LHT Strong Biomarker [756]
E2F4 OTB3JFH4 Strong Biomarker [1096]
ECM1 OT1K65VW Strong Altered Expression [1097]
EDIL3 OTDVVNS0 Strong Biomarker [1098]
EDN3 OTN7Q9BE Strong Posttranslational Modification [301]
EEF1A1 OT00THXS Strong Altered Expression [1099]
EFNA1 OTU2NUA2 Strong Biomarker [1100]
EFNB2 OT0DCUOM Strong Altered Expression [1101]
EIF3B OTF67VPH Strong Biomarker [1102]
EIF3C OTR8RF9X Strong Biomarker [1103]
EIF3D OTDOMP80 Strong Biomarker [1104]
EIF3E OTI0WG98 Strong Altered Expression [1105]
EIF3M OTVWEV60 Strong Biomarker [1106]
EIF4B OTE8TXA8 Strong Altered Expression [29]
ELK1 OTH9MXD6 Strong Biomarker [1107]
EME1 OTD9RKD9 Strong Biomarker [1108]
EMILIN1 OT94R6M1 Strong Altered Expression [1109]
ENDOG OT5IM7B3 Strong Biomarker [1110]
ENPP7 OTWOBMQ9 Strong Biomarker [1111]
ENTPD5 OTFH05B9 Strong Biomarker [722]
ERCC6 OT2QZKSF Strong Altered Expression [1112]
ETV4 OT8C98UZ Strong Biomarker [1113]
EVL OTZ8ZDNY Strong Biomarker [1114]
EXOC7 OT4YA137 Strong Biomarker [1115]
EYA4 OTINGR3Z Strong Biomarker [954]
FABP7 OTRE2H4G Strong Biomarker [1116]
FADD OTV7GFHH Strong Genetic Variation [1117]
FAM3B OTC2S91N Strong Biomarker [1118]
FANCB OTMZTXB5 Strong Altered Expression [269]
FANCM OTNJG99Z Strong Altered Expression [269]
FBXL20 OTVTR1KY Strong Altered Expression [1119]
FBXL5 OT93D50X Strong Biomarker [1120]
FBXO39 OTPRR6SK Strong Biomarker [1121]
FEM1B OTFE2ELA Strong Altered Expression [1122]
FEN1 OT6QGG7O Strong Altered Expression [1123]
FERMT1 OT626PBA Strong Altered Expression [1124]
FGF20 OTJIQ8YZ Strong Altered Expression [1125]
FGF3 OT9PK2SI Strong Altered Expression [1126]
FGF9 OT2SKDGM Strong Altered Expression [1127]
FKBP14 OT55W5WC Strong Biomarker [1128]
FLOT1 OT0JPPJZ Strong Altered Expression [1129]
FLT3LG OTU0YGC4 Strong Biomarker [1130]
FMOD OT9EJ5H8 Strong Biomarker [1131]
FOSB OTW6C05J Strong Altered Expression [1132]
FOXJ1 OT7LLBZ7 Strong Altered Expression [1133]
FOXK1 OTLZGS7J Strong Biomarker [1134]
FOXN3 OTOJYJZP Strong Biomarker [1135]
FUT2 OTLXM6WI Strong Altered Expression [1136]
FUT6 OTBZUQ7F Strong Altered Expression [1137]
FUT7 OTJF6BSN Strong Altered Expression [1137]
FZD1 OTZATHVS Strong Biomarker [1138]
FZD5 OTXFFY56 Strong Biomarker [1138]
FZR1 OT0WGWZS Strong Altered Expression [1139]
GABPA OT9YB2SA Strong Altered Expression [1140]
GADD45A OTDRV63V Strong Genetic Variation [1141]
GALNT4 OT6WKC13 Strong Biomarker [1142]
GALNT6 OTOQQVH1 Strong Biomarker [1143]
GC OTWS63BY Strong Biomarker [1144]
GCNT2 OTRUIMC4 Strong Biomarker [1145]
GCNT3 OTQ9ALTR Strong Biomarker [1146]
GEMIN2 OT4L6TLL Strong Biomarker [1147]
GFER OTVK43OK Strong Altered Expression [1148]
GINS1 OTVQZMMQ Strong Biomarker [623]
GINS3 OT8NVXTD Strong Biomarker [1149]
GIT1 OTHO92S5 Strong Biomarker [262]
GLRX3 OTUPAU1N Strong Altered Expression [486]
GLS2 OT08MSHL Strong Altered Expression [1150]
GNAI2 OTTLGRGH Strong Genetic Variation [1151]
GNB5 OT3ZSAXH Strong Biomarker [925]
GOLPH3 OTDLGYM3 Strong Biomarker [1152]
GPC1 OTQKRSSV Strong Biomarker [1153]
GPLD1 OTUUQOVY Strong Altered Expression [1154]
GPR42 OTEB0ROY Strong Biomarker [169]
GPX3 OT6PK94R Strong Biomarker [766]
GRAP2 OTS5NIZ3 Strong Biomarker [179]
GRHL1 OTZ4MNEW Strong Biomarker [429]
GSDME OT1ZWY32 Strong Altered Expression [1155]
GSTT2 OTANW3TJ Strong Altered Expression [1156]
GTF2H4 OTPD1DIU Strong Altered Expression [332]
GUCA2A OTUSF75G Strong Biomarker [1157]
GUCA2B OTZERX04 Strong Genetic Variation [1050]
H2AX OT18UX57 Strong Genetic Variation [1158]
HAND1 OTN4IPVV Strong Posttranslational Modification [1159]
HAND2 OTCXYW4Y Strong Biomarker [355]
HAPLN1 OTXWR9TJ Strong Biomarker [916]
HARS1 OTHOEOTS Strong Biomarker [1160]
HAS3 OTPM8IL8 Strong Altered Expression [1161]
HBD OTRQG4WA Strong Altered Expression [284]
HCFC1 OT0UCK62 Strong Biomarker [1162]
HES1 OT8P19W2 Strong Biomarker [1163]
HES6 OTWO5SCF Strong Altered Expression [1164]
HEY1 OTJQL0I3 Strong Altered Expression [1165]
HEY2 OTU4J3ZI Strong Genetic Variation [1166]
HGS OTCYYCAC Strong Biomarker [1160]
HHIP OT77RQYS Strong Altered Expression [1167]
HIC1 OTI9TWY4 Strong Biomarker [1168]
HIP1 OT7AKCFQ Strong Altered Expression [1169]
HLA-DOA OTZE5Q7R Strong Biomarker [1170]
HLA-E OTX1CTFB Strong Altered Expression [1171]
HLTF OTRX2OSF Strong Genetic Variation [1172]
HM13 OTGEO1LP Strong Biomarker [1065]
HMMR OT4M0JTZ Strong Altered Expression [1173]
HNRNPC OT47AK4C Strong Biomarker [1174]
HNRNPDL OTB3BFCV Strong Altered Expression [1175]
HNRNPK OTNPRM8U Strong Altered Expression [1176]
HNRNPL OT0DJX74 Strong Altered Expression [1177]
HNRNPLL OTA6Q5E0 Strong Altered Expression [1178]
HNRNPM OTFU3OEZ Strong Biomarker [1179]
HOOK2 OTPO4NQV Strong Biomarker [416]
HOXA3 OTIX5XFB Strong Altered Expression [1180]
HOXA4 OTNVTQDT Strong Altered Expression [1181]
HOXA6 OTHJP8M2 Strong Genetic Variation [382]
HOXD10 OT0NOWU2 Strong Posttranslational Modification [869]
HPS5 OTLO2374 Strong Biomarker [830]
HSFY2 OTG2O6S4 Strong Biomarker [1182]
HSPA1A OTKGIE76 Strong Biomarker [1183]
HSPB2 OTS01646 Strong Biomarker [390]
HSPH1 OTVRR73T Strong Altered Expression [1184]
HTN3 OTEUXA81 Strong Altered Expression [329]
HYAL2 OTTVINXW Strong Genetic Variation [1185]
IFITM2 OTAT6TI6 Strong Altered Expression [1186]
IFITM3 OT2QP8D3 Strong Altered Expression [1187]
IFRD1 OT4SQMLQ Strong Altered Expression [1188]
IGF2BP1 OT9G360P Strong Biomarker [1065]
IGF2BP2 OT4ZSEEE Strong Biomarker [1189]
IHH OT1DWGXC Strong Altered Expression [1190]
IL18BP OTW0LRYZ Strong Biomarker [1191]
IL22RA1 OTGVKLBR Strong Altered Expression [1192]
IL22RA2 OTGOFDCY Strong Biomarker [1193]
IL2RG OTRZ3OMY Strong Biomarker [1194]
IL34 OTZ15VVK Strong Biomarker [1195]
IL4I1 OTK54C63 Strong Altered Expression [1196]
IMMP1L OTA6LOLR Strong Biomarker [1065]
IMMP2L OT9WGAFD Strong Biomarker [1197]
IMPA1 OTBUVW1Z Strong Biomarker [1065]
ING2 OT6H0EWF Strong Altered Expression [1198]
ING4 OT0VVG4V Strong Biomarker [1199]
INHA OT7HWCO3 Strong Altered Expression [1200]
INO80 OTJBMS8T Strong Biomarker [1201]
INPPL1 OTCDAVBQ Strong Biomarker [1202]
INSIG2 OTX4VY51 Strong Biomarker [1203]
IPP OTCGBS3H Strong Biomarker [1204]
IQGAP1 OTZRWTGA Strong Biomarker [1205]
IRAK2 OT6Y1QZN Strong Biomarker [1206]
IRF9 OTK4MYQJ Strong Altered Expression [1207]
IRS4 OTTOL40K Strong Biomarker [1208]
IRX5 OT05J514 Strong Biomarker [1209]
ITGA2B OT4Y17PY Strong Altered Expression [1210]
ITGA3 OTBCH21D Strong Biomarker [487]
ITGAX OTOGIMHE Strong Biomarker [1211]
ITIH5 OTP46PZM Strong Altered Expression [1212]
ITPRID2 OTO3JDX5 Strong Biomarker [1213]
JADE3 OTEQR3MN Strong Biomarker [1214]
JAG1 OT3LGT6K Strong Altered Expression [289]
JAM2 OTHVJJRJ Strong Biomarker [902]
JARID2 OT14UM8H Strong Biomarker [1215]
JAZF1 OTXTYSYD Strong Genetic Variation [925]
JMJD6 OTILR7E4 Strong Biomarker [1158]
JUNB OTG2JXV5 Strong Altered Expression [1132]
KANK2 OT3SZIWM Strong Genetic Variation [572]
KARS1 OT0EU4SV Strong Biomarker [1216]
KAT5 OTL7257A Strong Altered Expression [1217]
KCMF1 OTVTKFAU Strong Biomarker [1218]
KDM4B OT5P1UPY Strong Biomarker [1219]
KDM8 OTCN5ST8 Strong Biomarker [1220]
KIF2A OT2WQ6QD Strong Biomarker [416]
KIF2C OTJ8G3NP Strong Altered Expression [1221]
KLF13 OTMIKHZ4 Strong Biomarker [264]
KLF2 OTIP1UFX Strong Biomarker [1222]
KLF5 OT1ABI9N Strong Biomarker [1223]
KLHL1 OTAX6SAD Strong Altered Expression [1224]
KLK13 OT8LOD2U Strong Biomarker [1225]
KMT2B OTMMAZQX Strong Altered Expression [986]
KPNA2 OTU7FOE6 Strong Biomarker [1226]
KRIT1 OT58AP1I Strong Biomarker [971]
KRT1 OTIOJWA4 Strong Biomarker [1227]
KRT18 OTVLQFIP Strong Altered Expression [1228]
L1TD1 OTB2W20Y Strong Altered Expression [1229]
LAT2 OTWJDKIH Strong Biomarker [1230]
LATS1 OTOOCG4R Strong Biomarker [1231]
LBR OT1HG3HG Strong Biomarker [1232]
LDHB OT9B1CT3 Strong Altered Expression [369]
LEF1 OTWS5I5H Strong Biomarker [1233]
LGALS3BP OT9AGQKH Strong Biomarker [1234]
LGALS4 OTKQCG0H Strong Altered Expression [1235]
LGALS7 OTMSVI7R Strong Altered Expression [1236]
LGALS9 OT7MF91K Strong Altered Expression [1237]
LIG4 OT40DNXU Strong Altered Expression [89]
LIMD2 OTSIFTD8 Strong Biomarker [1238]
LIMS1 OT729S0T Strong Biomarker [1204]
LIMS2 OTZ7IIPM Strong Altered Expression [1204]
LIMS3 OTTMS7V8 Strong Altered Expression [1204]
LIN28B OTVWP0FN Strong Altered Expression [1239]
LIPC OTZY5SC9 Strong Altered Expression [1240]
LLGL1 OTAIQSXZ Strong Biomarker [1241]
LMNB1 OT100T3P Strong Altered Expression [1242]
LNPK OTOBNX6G Strong Biomarker [1243]
LRATD1 OT65IL83 Strong Altered Expression [1244]
LRG1 OTLD0KWA Strong Biomarker [1245]
LRIT1 OTNEQPMZ Strong Biomarker [509]
LRP1B OT4YZG2N Strong Biomarker [1246]
LSR OTR8Y32X Strong Biomarker [1247]
LTBP3 OTME98V7 Strong Biomarker [1248]
LYNX1 OTK4103B Strong Biomarker [1249]
LYPD5 OTGP7UKA Strong Altered Expression [1250]
MACC1 OTV3DLX0 Strong Altered Expression [823]
MACROD2 OTNQCHC6 Strong Altered Expression [1251]
MACROH2A1 OTV2DQDD Strong Biomarker [1252]
MAD2L1 OTXNGZCG Strong Biomarker [1253]
MAD2L2 OT24ZO59 Strong Biomarker [1254]
MAEL OTZ2VU30 Strong Biomarker [1255]
MAGEE1 OTOQQO2X Strong Biomarker [365]
MAGT1 OTQSAV5C Strong Altered Expression [654]
MAK16 OTD546E5 Strong Biomarker [1256]
MALL OTKGZ89D Strong Altered Expression [176]
MAP1LC3B OTUYHB84 Strong Biomarker [1257]
MAP2K6 OTK13JKC Strong Genetic Variation [1258]
MARCHF2 OTADQ0OA Strong Biomarker [1259]
MARCKSL1 OT13J2FM Strong Altered Expression [1260]
MASTL OTQ7YKK5 Strong Altered Expression [1261]
MATN1 OTBRTCTQ Strong Biomarker [732]
MB OTYWYL2D Strong Biomarker [1262]
MBD4 OTWR9YXE Strong Biomarker [1263]
MCC OTQVI1EM Strong Altered Expression [269]
MCM2 OTGGORIQ Strong Altered Expression [1264]
MECOM OTP983W8 Strong Altered Expression [234]
MED12 OTQZ4D2X Strong Biomarker [1265]
MED13L OTSP1W0F Strong Altered Expression [1265]
MED15 OT0D0JVD Strong Biomarker [1266]
METAP1D OT144G80 Strong Altered Expression [1267]
MFAP5 OT46VXSG Strong Altered Expression [1268]
MIEN1 OTCQ8DAD Strong Altered Expression [1269]
MIP OTEBLU3E Strong Biomarker [1270]
MIXL1 OT584VOQ Strong Altered Expression [1271]
MLKL OTDSLC81 Strong Altered Expression [1272]
MMP25 OT3BG37V Strong Altered Expression [1273]
MMUT OTBBBV70 Strong Biomarker [1274]
MON1B OTJGDN94 Strong Altered Expression [1275]
MORC2 OT52A8BJ Strong Altered Expression [1276]
MPEG1 OT7DAO0F Strong Biomarker [394]
MPST OTCDPH5D Strong Biomarker [1277]
MRE11 OTGU8TZM Strong Genetic Variation [1278]
MRPL3 OT4WV1WL Strong Altered Expression [1279]
MRPL36 OTZ9QV3U Strong Genetic Variation [213]
MRPL41 OTG5URO4 Strong Biomarker [1280]
MRTFA OTCVXASM Strong Altered Expression [1281]
MS4A12 OTUCF3GW Strong Biomarker [1282]
MSC OTBRPZL5 Strong Biomarker [1283]
MSH3 OTD3YPVL Strong Altered Expression [1284]
MST1 OTOC4UNG Strong Altered Expression [1285]
MSTO1 OT37XCNP Strong Biomarker [224]
MSX2 OT1WDKE1 Strong Biomarker [1286]
MT1F OTZVUYG1 Strong Posttranslational Modification [721]
MTHFD1 OTMKHVWC Strong Genetic Variation [1287]
MTX1 OTLSDNZO Strong Biomarker [1288]
MUC13 OTWKS9MF Strong Altered Expression [1289]
MUC2 OT3X4QVX Strong Biomarker [936]
MUC4 OTLT11V1 Strong Altered Expression [1290]
MUS81 OTVZ4E60 Strong Biomarker [1291]
MVP OTJGHJRB Strong Biomarker [1292]
MXD1 OTS5CTHX Strong Altered Expression [446]
MXI1 OTUQ9E0D Strong Biomarker [1253]
MYCBP2 OTHODA1F Strong Biomarker [1293]
MYL2 OT78PC0C Strong Biomarker [1294]
MYOF OTRFC3IJ Strong Biomarker [1295]
NAA10 OTYB9R6I Strong Altered Expression [1296]
NAIP OTLA925F Strong Altered Expression [1297]
NANOG OTUEY1FM Strong Biomarker [1298]
NCAPH OTXOS97C Strong Biomarker [1299]
NDC80 OTS7D306 Strong Altered Expression [1300]
NDUFC2 OT9M119L Strong Biomarker [1301]
NEK4 OTOB8366 Strong Biomarker [600]
NELL2 OTS4MJZ7 Strong Altered Expression [495]
NEMF OT9DK06P Strong Biomarker [1302]
NEO1 OTGJ1997 Strong Biomarker [1303]
NEU3 OTQ5PQOW Strong Biomarker [1304]
NEUROD1 OTZQ7QJ2 Strong Biomarker [539]
NFATC1 OT4TMERS Strong Biomarker [1305]
NHLRC2 OTY4HPWB Strong Biomarker [1306]
NIBAN2 OTVDQSPI Strong Biomarker [1307]
NID1 OTKLBLS6 Strong Posttranslational Modification [1308]
NIT2 OTC1RAH3 Strong Biomarker [1309]
NLRP12 OTGR132Z Strong Biomarker [1310]
NLRP5 OTLU1YML Strong Altered Expression [1311]
NLRP6 OTEREN4W Strong Biomarker [1312]
NME4 OT2JTT42 Strong Biomarker [625]
NME6 OTJNKOFA Strong Biomarker [1313]
NME7 OTYMBK3Q Strong Biomarker [1313]
NOB1 OTW0YNSL Strong Biomarker [1314]
NOC2L OTNT7R33 Strong Biomarker [1315]
NOX5 OTHTH59G Strong Altered Expression [1316]
NOXO1 OTW29FB4 Strong Biomarker [1317]
NPDC1 OT788NC8 Strong Biomarker [1318]
NPHS1 OT21JD3P Strong Biomarker [17]
NPRL2 OTOB10MO Strong Altered Expression [1319]
NPTX1 OTKVHCV0 Strong Biomarker [230]
NR2C2 OTDZWVOJ Strong Biomarker [450]
NR5A1 OTOULYR4 Strong Altered Expression [1320]
NRCAM OT80HHQ2 Strong Altered Expression [1321]
NRDC OTWBBCXO Strong Biomarker [1322]
NRSN1 OT1KKXC8 Strong Biomarker [1015]
NTNG1 OTF48IID Strong Posttranslational Modification [1323]
NTS OTPGDNQS Strong Altered Expression [1324]
NUCB2 OTHO6JWN Strong Altered Expression [1325]
NUDT1 OTZSES3W Strong Genetic Variation [1326]
NUSAP1 OT85HIJ5 Strong Biomarker [1327]
OAZ2 OTV1XSWG Strong Biomarker [1328]
OGA OT7ZBWT1 Strong Altered Expression [1329]
ONECUT1 OTK1QUQT Strong Altered Expression [1330]
OPN1LW OTFNUZ7O Strong Biomarker [1331]
OR7C1 OTQKD84O Strong Biomarker [1332]
ORC6 OTKQN3KP Strong Altered Expression [1333]
OTUB1 OT8WWM9O Strong Biomarker [1334]
OTUD3 OTHUWQHP Strong Biomarker [1335]
PADI2 OTT40K94 Strong Altered Expression [1336]
PAEP OTQA0NV4 Strong Biomarker [1337]
PAF1 OTDDGUBQ Strong Biomarker [1338]
PAG1 OTFOJUIQ Strong Biomarker [1331]
PAK5 OT32WQGL Strong Altered Expression [1339]
PAK6 OTAHPZTT Strong Altered Expression [1340]
PALD1 OTLGUM8H Strong Biomarker [1341]
PALLD OTZ2MUJZ Strong Biomarker [1341]
PATZ1 OT0X9WGR Strong Altered Expression [1342]
PAX2 OTKP1N8F Strong Biomarker [1343]
PBX3 OT8WMVM4 Strong Posttranslational Modification [1344]
PCBD2 OTXV0ZD0 Strong Biomarker [789]
PCBP4 OTDLL4NB Strong Biomarker [1331]
PCLAF OTMVIOUU Strong Altered Expression [1345]
PDCD4 OTZ6NXUX Strong Biomarker [1346]
PDCD6 OT2YA5M8 Strong Biomarker [1347]
PDIK1L OTISF4KG Strong Biomarker [1348]
PDK4 OTCMHMBZ Strong Altered Expression [1349]
PDLIM3 OTVXQC81 Strong Altered Expression [194]
PDLIM4 OT23LZYY Strong Biomarker [1350]
PDLIM7 OTAZVODU Strong Altered Expression [1351]
PEG3 OTHQW98S Strong Biomarker [1352]
PER3 OTVKYVJA Strong Biomarker [1353]
PES1 OTMZK7XE Strong Genetic Variation [1354]
PEX5 OTK4LMG7 Strong Biomarker [1355]
PGK1 OT6V1ICH Strong Altered Expression [1356]
PHF14 OTZT3GV1 Strong Altered Expression [29]
PHF21B OTU5GLCQ Strong Altered Expression [1357]
PHF5A OTS94JFM Strong Altered Expression [419]
PHGR1 OTY3GTEP Strong Altered Expression [1358]
PHLPP1 OTIFXW8D Strong Biomarker [1359]
PHLPP2 OTXB1OUI Strong Altered Expression [1360]
PIAS4 OTB7SVMZ Strong Altered Expression [1361]
PIGR OT6GLSUL Strong Altered Expression [1362]
PIK3C3 OTLUM9L7 Strong Biomarker [1363]
PIK3R2 OTZSUQK5 Strong Biomarker [792]
PITX1 OTA0UN4C Strong Genetic Variation [1364]
PIWIL1 OT7CRGZ3 Strong Biomarker [1365]
PIWIL2 OT1PXQIF Strong Altered Expression [1366]
PIWIL4 OTDA9MY0 Strong Biomarker [1365]
PKHD1 OTAH8SMF Strong Genetic Variation [1367]
PKP2 OTJOVF68 Strong Biomarker [1368]
PLA2G3 OT3K7TMY Strong Biomarker [1369]
PLAA OTZ7NJGA Strong Biomarker [437]
PLB1 OTZ6TTYV Strong Altered Expression [139]
PLD4 OT5I74II Strong Altered Expression [1370]
PLS3 OTYBM4PK Strong Genetic Variation [1371]
PMEPA1 OTY8Z9UF Strong Biomarker [1372]
PMS2 OTNLWTMI Strong Altered Expression [1373]
PNO1 OT010GIS Strong Biomarker [1256]
PNPLA2 OTR3ERMR Strong Biomarker [886]
PODXL OTPNQXF3 Strong Biomarker [1374]
POGLUT1 OTDX7GZD Strong Biomarker [1375]
POLD1 OTWO4UCJ Strong Altered Expression [718]
POLDIP2 OT8SZSJ6 Strong Biomarker [179]
POLE OTFM3MMU Strong Genetic Variation [1376]
POU2F1 OTK7ELJ0 Strong Biomarker [591]
PPA1 OTHZK1QB Strong Biomarker [1377]
PPBP OT1FHGQS Strong Biomarker [273]
PPDPF OT4LO2GJ Strong Biomarker [1378]
PPL OTTM4WDO Strong Altered Expression [1379]
PPP1R11 OTSHYPPW Strong Biomarker [481]
PPP1R12C OT9Q86JO Strong Biomarker [792]
PPP1R13B OTC88VQO Strong Biomarker [792]
PPP1R13L OTNCPLWE Strong Biomarker [1380]
PPP1R8 OTH5KB2P Strong Altered Expression [1296]
PPP1R9B OTDCTHTT Strong Biomarker [1381]
PPP2R1B OTFIHQGD Strong Biomarker [1382]
PRAP1 OT48QD82 Strong Altered Expression [1383]
PRC1 OTHD0XS0 Strong Posttranslational Modification [1384]
PRDM1 OTQLSVBS Strong Altered Expression [1385]
PRDM2 OT8L7CGX Strong Genetic Variation [1386]
PRDX1 OTZ3BEC4 Strong Altered Expression [1387]
PRDX3 OTLB2WEU Strong Biomarker [1388]
PRF1 OTFVXD7H Strong Biomarker [1389]
PRM1 OT6HWA11 Strong Biomarker [1390]
PRMT8 OT3MRK62 Strong Altered Expression [1391]
PROK1 OT8S7RUG Strong Biomarker [544]
PROX1 OT68R6IO Strong Altered Expression [1392]
PRPF31 OTSJ0Z1Y Strong Altered Expression [1393]
PRR14 OTZMIMOK Strong Altered Expression [1394]
PRRT1 OTN0YIS3 Strong Biomarker [1395]
PRRT2 OTCJUBDO Strong Altered Expression [1396]
PRRX2 OT8UR4AU Strong Biomarker [1397]
PRSS22 OTANEFGM Strong Biomarker [1398]
PRSS55 OTXXWI5Y Strong Biomarker [1044]
PSD3 OTTN9B9O Strong Biomarker [1399]
PSG2 OT2EIXAI Strong Altered Expression [249]
PSMA7 OTPHI6ST Strong Biomarker [1400]
PSME3 OTSTC4YY Strong Altered Expression [1401]
PSMG1 OTZ5I6UM Strong Biomarker [172]
PTHLH OTI1JF13 Strong Altered Expression [1402]
PTPN12 OT5WA666 Strong Genetic Variation [1403]
PTPRG OT9N2WOF Strong Biomarker [1404]
PTPRM OTCEL6PN Strong Posttranslational Modification [1405]
PTPRT OTV5TXNN Strong Biomarker [1406]
PTPRU OTHDO0QG Strong Biomarker [687]
PTTG1 OTIMYS4W Strong Biomarker [1407]
PUF60 OTG90DYF Strong Biomarker [995]
PVR OT3N91T7 Strong Altered Expression [1408]
PXN OTVMMUOF Strong Altered Expression [1409]
QRSL1 OTJDU2UG Strong Biomarker [1410]
RAB11A OTC4FW0J Strong Biomarker [1411]
RAB43 OTVCSILI Strong Genetic Variation [1412]
RABGEF1 OTWC3Z3R Strong Altered Expression [876]
RAC2 OTAOHFNH Strong Altered Expression [1413]
RAD50 OTYMU9G1 Strong Altered Expression [1414]
RAG1 OTV131E4 Strong Biomarker [1194]
RAG2 OTG9UYTW Strong Biomarker [1415]
RAN OT2TER5M Strong Genetic Variation [1416]
RANBP2 OTFG5CVF Strong Altered Expression [545]
RANBP3 OTI8ESC3 Strong Altered Expression [1398]
RAP1A OT5RH6TI Strong Altered Expression [876]
RAPGEF5 OT53VS75 Strong Biomarker [1417]
RAPH1 OTMQXW7S Strong Biomarker [888]
RARRES1 OTETUPP5 Strong Biomarker [1266]
RASA2 OTL06RG2 Strong Biomarker [1418]
RASAL1 OTAHUNN7 Strong Biomarker [1419]
RASGRF2 OT67DAGF Strong Altered Expression [1420]
RASSF7 OT0V4EIZ Strong Genetic Variation [1421]
RBBP6 OTTVG4HU Strong Biomarker [1422]
RBFOX2 OTXY1WVH Strong Biomarker [1423]
RBM14 OTO9GMBD Strong Genetic Variation [572]
RBM38 OTPO8EXU Strong Altered Expression [1221]
RBMS3 OTFSC9MR Strong Biomarker [1256]
RBP7 OT0J3CPT Strong Biomarker [1424]
RCOR1 OTREADPC Strong Biomarker [1425]
RDX OTNSYUN6 Strong Biomarker [851]
RECQL5 OTVZMP1Q Strong Biomarker [1426]
REEP5 OTZU4TJI Strong Biomarker [1427]
REG1B OTSC2133 Strong Altered Expression [840]
REM1 OTUXL0HC Strong Biomarker [1428]
REV3L OT0OP8EJ Strong Altered Expression [1429]
RFC2 OTJ9N6BD Strong Biomarker [1430]
RGCC OTYJMLWM Strong Altered Expression [1431]
RGN OTD04KB1 Strong Biomarker [1432]
RGS19 OTBIELDO Strong Biomarker [1433]
RHBDF1 OTCQ7UDS Strong Biomarker [1434]
RHOBTB1 OTGE8K45 Strong Biomarker [1435]
RIN1 OTPBROUD Strong Genetic Variation [1436]
RIOK1 OT1OS3H3 Strong Altered Expression [1437]
RIOX2 OT2YFPI2 Strong Altered Expression [1438]
RIPK3 OTL1D484 Strong Altered Expression [1439]
RITA1 OTUH8IPS Strong Biomarker [461]
RMC1 OT7K8MTJ Strong Biomarker [1440]
RMDN1 OTE1NB6U Strong Altered Expression [652]
RMDN2 OTK5WSFI Strong Altered Expression [652]
RMDN3 OTKO7AUM Strong Altered Expression [652]
RNF14 OTWX0D0H Strong Biomarker [1441]
RNF19A OTKWCV80 Strong Biomarker [179]
ROBO3 OTPVG40S Strong Biomarker [283]
RPIA OT805SMH Strong Altered Expression [1442]
RPL29 OTUFIBJL Strong Altered Expression [1443]
RPL3 OTX6VXLB Strong Altered Expression [1444]
RPL30 OTLQVY1Z Strong Biomarker [1423]
RPL37 OTB6SDZ1 Strong Altered Expression [1445]
RPLP0 OT3XKD6Y Strong Altered Expression [1446]
RPLP1 OT7B0SIB Strong Altered Expression [1447]
RPN2 OTJ1SKOA Strong Altered Expression [1448]
RPRD1B OTB41D5K Strong Altered Expression [1449]
RPS18 OTFO45UM Strong Biomarker [1450]
RPS20 OTI8052R Strong Genetic Variation [1451]
RPS24 OTSNKIL5 Strong Biomarker [1452]
RPS27 OTFXKY7P Strong Biomarker [394]
RPS27A OTIIGGZ2 Strong Altered Expression [1453]
RPS29 OTCC1872 Strong Altered Expression [1454]
RPS6 OTT4D1LN Strong Altered Expression [29]
RRS1 OTTNCZN6 Strong Biomarker [1455]
RTKN2 OTV2AXQM Strong Biomarker [1456]
RUNX1T1 OT30DED5 Strong Biomarker [1457]
RUVBL1 OTWV19L7 Strong Altered Expression [1458]
RUVBL2 OTGWJ4T4 Strong Biomarker [316]
RYR3 OT4EHIP4 Strong Genetic Variation [1459]
SAA2 OTYAVJWG Strong Biomarker [77]
SALL1 OTYYZGLH Strong Biomarker [1395]
SALL4 OTC08PR5 Strong Biomarker [1460]
SAMD9 OTDG48P0 Strong Altered Expression [1461]
SAMHD1 OTBCIBC7 Strong Genetic Variation [1462]
SARS1 OTFKXQ1O Strong Biomarker [1463]
SARS2 OTU4T99W Strong Biomarker [1463]
SASS6 OT1V8H40 Strong Altered Expression [1464]
SCAF11 OTX59D0X Strong Biomarker [1147]
SCGB2A1 OT9L87U9 Strong Altered Expression [1465]
SCO2 OTJQQDRS Strong Biomarker [655]
SCRN1 OTELM5C2 Strong Altered Expression [1466]
SDAD1 OTP4468N Strong Biomarker [1467]
SDC4 OTKUVUGZ Strong Altered Expression [1468]
SDCBP OTS3NCC5 Strong Biomarker [1469]
SDF4 OTQ7WFYW Strong Biomarker [1010]
SEC14L2 OTJST64D Strong Biomarker [1470]
SELENOF OT2JFB3S Strong Genetic Variation [678]
SELENOP OT02B8IR Strong Altered Expression [1471]
SEMA3F OTQFMS8S Strong Biomarker [1472]
SEMA5A OTUOIOJV Strong Biomarker [1473]
SERPINA3 OT9BP2S0 Strong Biomarker [1474]
SERPINB2 OT72QLZB Strong Biomarker [1475]
SERTAD1 OTBHKZQP Strong Posttranslational Modification [449]
SETBP1 OTKGCOSR Strong Biomarker [1476]
SFN OTLJCZ1U Strong Altered Expression [1477]
SFPQ OTLCIAPJ Strong Biomarker [1478]
SGK3 OTQ6QO99 Strong Biomarker [1479]
SGMS2 OT3NHO99 Strong Biomarker [1480]
SGSM3 OTIB1P8A Strong Biomarker [1481]
SH3PXD2B OTAOMCDJ Strong Biomarker [1482]
SHC1 OT1J5IRN Strong Altered Expression [1483]
SHMT1 OTIINA3J Strong Genetic Variation [1484]
SIAH1 OT29A838 Strong Biomarker [1485]
SIGLEC7 OTNDLURR Strong Biomarker [1486]
SIM2 OT0QWHK4 Strong Biomarker [1487]
SIVA1 OTDT0XZK Strong Altered Expression [1488]
SLC12A9 OTR7VRAK Strong Altered Expression [1489]
SLC2A4RG OTW3LX8D Strong Genetic Variation [1490]
SLC66A1 OTUM63MK Strong Biomarker [862]
SLFN12 OTTBXM25 Strong Biomarker [1491]
SLPI OTUNFUU8 Strong Altered Expression [194]
SMAD2 OTC6VB4K Strong Biomarker [1492]
SMARCA1 OT0Y6PTU Strong Biomarker [1172]
SMC3 OTWGFRHD Strong Altered Expression [1493]
SMG1 OTTS3SXE Strong Biomarker [1494]
SMOC2 OTK1EQ49 Strong Biomarker [1495]
SNAI1 OTDPYAMC Strong Altered Expression [1496]
SND1 OTT734JN Strong Altered Expression [1497]
SNED1 OTBQVXY5 Strong Altered Expression [1498]
SNRK OTX0OPHO Strong Biomarker [1499]
SNX1 OTXQSJ1J Strong Altered Expression [1500]
SNX9 OTLNQ0ZM Strong Altered Expression [1501]
SOCS2 OTBPNKJQ Strong Altered Expression [1502]
SOX12 OT93P8C9 Strong Biomarker [1503]
SOX30 OTGT38E3 Strong Altered Expression [1504]
SOX4 OTSS40SS Strong Biomarker [58]
SOX9 OTVDJFGN Strong Altered Expression [880]
SP4 OTWB30IZ Strong Altered Expression [1505]
SPINK1 OTSUVAL2 Strong Altered Expression [1506]
SPON2 OTE7JLNM Strong Biomarker [1507]
SPPL3 OT2HLJF6 Strong Biomarker [1197]
SPRY2 OTH0CRCZ Strong Biomarker [1508]
SPTAN1 OT6VY3A3 Strong Altered Expression [1509]
SPZ1 OTQH8HJ5 Strong Biomarker [1044]
SRPRB OTUUFHQS Strong Altered Expression [1413]
SRPX2 OT6A63TX Strong Biomarker [1510]
SRRM2 OTSIMMC9 Strong Biomarker [1256]
SRSF1 OTF61HOV Strong Altered Expression [816]
SRSF3 OTOFT707 Strong Altered Expression [1511]
SRSF5 OTC5WP98 Strong Biomarker [1160]
SRSF6 OTGLOSYE Strong Biomarker [1512]
SSBP1 OTH2PZWH Strong Biomarker [1513]
ST13 OTNML6UP Strong Biomarker [172]
ST3GAL4 OTNENJZQ Strong Biomarker [732]
ST6GALNAC1 OT3JQD99 Strong Altered Expression [60]
ST7 OTZG8RC6 Strong Genetic Variation [1514]
STARD13 OTB4U1HY Strong Biomarker [1515]
STARD3 OTSTC5B5 Strong Biomarker [1318]
STAT2 OTO9G2RZ Strong Biomarker [1516]
STEAP4 OTFTLAEZ Strong Biomarker [1517]
STING1 OTDAP4G0 Strong Biomarker [948]
STK3 OTLNSCQD Strong Altered Expression [1518]
STX1A OTSBUZB4 Strong Biomarker [1519]
SUFU OT0IRYG1 Strong Biomarker [1520]
SUGP1 OT7W0EB8 Strong Altered Expression [1521]
SUMO1 OTJFD4P5 Strong Biomarker [1522]
SUZ12 OT655XF8 Strong Altered Expression [1523]
SYBU OT3FQV7N Strong Altered Expression [652]
SYCE1L OTXU44F3 Strong Altered Expression [1224]
SYMPK OTYAUDXV Strong Genetic Variation [1524]
SYNJ2 OTLRHXP1 Strong Biomarker [1525]
TADA2A OTXUMEL9 Strong Biomarker [892]
TAPBP OTL81AVZ Strong Biomarker [1526]
TAS2R16 OT67HLNS Strong Genetic Variation [1527]
TBPL1 OT4I143E Strong Altered Expression [626]
TBX5 OT70PISV Strong Biomarker [1528]
TCERG1L OTSBSCLF Strong Biomarker [1529]
TCF4 OTB9ASTK Strong Biomarker [1530]
TCF7 OT1ID822 Strong Biomarker [1531]
TCHP OTVDMHSY Strong Biomarker [1532]
TCIM OTARUXQF Strong Biomarker [1533]
TCTN1 OTG5KEV8 Strong Biomarker [1534]
TDRD6 OTW2UL4V Strong Altered Expression [1221]
TEKT5 OTZ5OUHY Strong Altered Expression [1535]
TENM1 OTSKSU4V Strong Biomarker [1536]
TENM3 OTWY13GR Strong Biomarker [428]
TET1 OTZDHT1D Strong Biomarker [1537]
TFAM OTXXV5V7 Strong Biomarker [1538]
TFEB OTJUJJQY Strong Biomarker [1539]
TFF2 OTRXB19X Strong Genetic Variation [1540]
TFF3 OTJJDRTU Strong Altered Expression [628]
TFPI2 OTZCRWOR Strong Biomarker [409]
TGFBR3 OTQOOUC4 Strong Biomarker [1541]
THAP11 OTEMWLZ0 Strong Biomarker [1162]
THBS2 OTXET551 Strong Genetic Variation [1542]
TIA1 OTGPN3P8 Strong Altered Expression [1543]
TIMELESS OTD8DCBJ Strong Biomarker [927]
TIMM8A OTDX9687 Strong Biomarker [1544]
TKTL2 OTULV5TA Strong Biomarker [635]
TLE5 OTEH0BFG Strong Biomarker [1545]
TM7SF2 OTILU5S7 Strong Biomarker [1546]
TMED2 OTBLO7RW Strong Biomarker [1015]
TMEFF2 OT1WZ2QO Strong Posttranslational Modification [1547]
TMEM147 OTMKZ4PV Strong Biomarker [1548]
TMEM208 OTMGH9OA Strong Biomarker [862]
TMEM37 OT317PEL Strong Biomarker [835]
TMEM69 OTXBBENK Strong Altered Expression [1398]
TMEM8B OTJZWPS6 Strong Biomarker [1549]
TMIGD2 OTWWAHTV Strong Biomarker [1550]
TMPRSS4 OTCCGY2K Strong Altered Expression [1551]
TNFAIP8 OT1G9297 Strong Biomarker [1552]
TNFAIP8L2 OTII0RM0 Strong Altered Expression [1553]
TNFRSF10D OTOSRDJT Strong Altered Expression [1554]
TNFRSF6B OTKAN9G7 Strong Altered Expression [1555]
TNFSF9 OTV9L89D Strong Biomarker [1556]
TOB1 OTNW949D Strong Biomarker [1557]
TOP1MT OT2H77ID Strong Biomarker [1558]
TP53I3 OTSCM68G Strong Biomarker [1280]
TP53INP1 OT2363Z9 Strong Genetic Variation [572]
TP53RK OTARRZAB Strong Altered Expression [1559]
TP73 OT0LUO47 Strong Altered Expression [1560]
TPM2 OTA1L0P8 Strong Posttranslational Modification [1561]
TPM3 OT5RU5G6 Strong Genetic Variation [1562]
TPM4 OTN4YLYR Strong Biomarker [1563]
TPPP OTCFMSUF Strong Biomarker [1015]
TRAF2 OT1MEZZN Strong Biomarker [1564]
TRERF1 OTA7UQF1 Strong Biomarker [1565]
TRIM11 OTMD6IM2 Strong Biomarker [1566]
TRIM15 OTNYAKP6 Strong Biomarker [1567]
TRIM21 OTA4UJCF Strong Biomarker [1568]
TRIM23 OTVIGJ4T Strong Altered Expression [1296]
TRIM25 OT35SG1R Strong Biomarker [13]
TRPS1 OT7XPPEL Strong Biomarker [1569]
TRRAP OT68OI2Y Strong Biomarker [1570]
TSACC OT3QW6PH Strong Genetic Variation [572]
TSPAN1 OTZQPIYK Strong Biomarker [1571]
TSTD1 OT5DMKFX Strong Biomarker [110]
ARMC8 OTNAXGM7 Definitive Biomarker [1572]
BRD8 OTIKS3PC Definitive Altered Expression [146]
CALD1 OTNJKJ6Q Definitive Altered Expression [1573]
CDK5RAP3 OTC0Q2QS Definitive Genetic Variation [1574]
CNNM4 OTUXJRM1 Definitive Altered Expression [1575]
CRIP1 OT0EICG3 Definitive Altered Expression [1576]
CTNND1 OTUMPSHR Definitive Biomarker [1577]
EPS8 OTZ6ES6V Definitive Altered Expression [1578]
ESM1 OT331Y8V Definitive Altered Expression [1579]
FBN2 OT3KYJQL Definitive Biomarker [1580]
FOXD3 OTXYV6GO Definitive Biomarker [1581]
GATA5 OTO81B63 Definitive Biomarker [1582]
HECW2 OTP2IN12 Definitive Altered Expression [1583]
HNRNPU OTLQN1E2 Definitive Altered Expression [146]
IGSF1 OT3XD6U2 Definitive Altered Expression [146]
MUC3A OTI4XUDY Definitive Altered Expression [1584]
MYO1A OTS80FOD Definitive Posttranslational Modification [1585]
NAA25 OTS3QVF1 Definitive Altered Expression [146]
NRIP1 OTIZOJQV Definitive Biomarker [1586]
NSUN5 OTBN7RS8 Definitive Altered Expression [146]
PRPF40A OT6EXJZN Definitive Genetic Variation [1587]
REEP6 OTY4FPO8 Definitive Genetic Variation [1588]
SPAG9 OT45AHMB Definitive Biomarker [1589]
STIM2 OTYNXAW0 Definitive Altered Expression [1590]
TMEM132D OTV6I4Z0 Definitive Biomarker [1591]
TRA2B OTZYQW52 Definitive Biomarker [1592]
------------------------------------------------------------------------------------
⏷ Show the Full List of 1130 DOT(s)

References

1 Novel association between heterozygous genotype of single nucleotide polymorphism C218T in drug transporter ABCC1 gene and increased risk of colon cancer.Saudi Med J. 2019 Mar;40(3):224-229. doi: 10.15537/smj.2019.3.23650.
2 Prognostic implication of ABC transporters and cancer stem cell markers in patients with stage III colon cancer receiving adjuvant FOLFOX-4 chemotherapy.Oncol Lett. 2019 Jun;17(6):5572-5580. doi: 10.3892/ol.2019.10234. Epub 2019 Apr 9.
3 Effect of overexpression of - and -actin isoforms on actin cytoskeleton organization and migration of human colon cancer cells.Histochem Cell Biol. 2014 Sep;142(3):307-22. doi: 10.1007/s00418-014-1199-9. Epub 2014 Feb 28.
4 Downregulation of Activin A Receptor Type 2A Is Associated with Metastatic Potential and Poor Prognosis of Colon Cancer.J Cancer. 2018 Sep 8;9(19):3626-3633. doi: 10.7150/jca.26790. eCollection 2018.
5 Hypoxia-inducible adenosine A2B receptor modulates proliferation of colon carcinoma cells.Hum Pathol. 2010 Nov;41(11):1550-7. doi: 10.1016/j.humpath.2010.04.008.
6 Aldo-Keto Reductases: Multifunctional Proteins as Therapeutic Targets in Diabetes and Inflammatory Disease.Adv Exp Med Biol. 2018;1032:173-202. doi: 10.1007/978-3-319-98788-0_13.
7 AKT2 phosphorylation of hexokinase 2 at T473 promotes tumorigenesis and metastasis in colon cancer cells via NF-B, HIF1, MMP2, and MMP9 upregulation.Cell Signal. 2019 Jun;58:99-110. doi: 10.1016/j.cellsig.2019.03.011. Epub 2019 Mar 12.
8 Immunohistochemistry for annexin A10 can distinguish sporadic from Lynch syndrome-associated microsatellite-unstable colorectal carcinoma.Am J Surg Pathol. 2014 Apr;38(4):518-25. doi: 10.1097/PAS.0000000000000148.
9 Combined pharmacological administration of AQP1 ion channel blocker AqB011 and water channel blocker Bacopaside II amplifies inhibition of colon cancer cell migration.Sci Rep. 2019 Sep 2;9(1):12635. doi: 10.1038/s41598-019-49045-9.
10 Inhibition of AURKA Reduces Proliferation and Survival of Gastrointestinal Cancer Cells With Activated KRAS by Preventing Activation of RPS6KB1.Gastroenterology. 2019 Feb;156(3):662-675.e7. doi: 10.1053/j.gastro.2018.10.030. Epub 2018 Oct 17.
11 Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer: results of the FOGT-4 trial.Br J Cancer. 2012 Mar 13;106(6):1239-45. doi: 10.1038/bjc.2012.53. Epub 2012 Feb 21.
12 Biglycan promotes the chemotherapy resistance of colon cancer by activating NF-B signal transduction.Mol Cell Biochem. 2018 Dec;449(1-2):285-294. doi: 10.1007/s11010-018-3365-1. Epub 2018 May 14.
13 Identification of TRIM25 as a Negative Regulator of Caspase-2 Expression Reveals a Novel Target for Sensitizing Colon Carcinoma Cells to Intrinsic Apoptosis.Cells. 2019 Dec 12;8(12):1622. doi: 10.3390/cells8121622.
14 CUB domain containing protein 1 (CDCP1) modulates adhesion and motility in colon cancer cells.BMC Cancer. 2014 Oct 9;14:754. doi: 10.1186/1471-2407-14-754.
15 Adefovir dipivoxil sensitizes colon cancer cells to vemurafenib by disrupting the KCTD12-CDK1 interaction.Cancer Lett. 2019 Jun 1;451:79-91. doi: 10.1016/j.canlet.2019.02.050. Epub 2019 Mar 11.
16 NEAT1 promotes colon cancer progression through sponging miR-495-3p and activating CDK6 in vitro and in vivo.J Cell Physiol. 2019 Nov;234(11):19582-19591. doi: 10.1002/jcp.28557. Epub 2019 Jun 7.
17 Colon cancer-associated B2 Escherichia coli colonize gut mucosa and promote cell proliferation.World J Gastroenterol. 2014 Jun 7;20(21):6560-72. doi: 10.3748/wjg.v20.i21.6560.
18 Disrupted interaction between CFTR and AF-6/afadin aggravates malignant phenotypes of colon cancer.Biochim Biophys Acta. 2014 Mar;1843(3):618-28. doi: 10.1016/j.bbamcr.2013.12.013.
19 Chk1 Inhibitor SCH900776 Effectively Potentiates the Cytotoxic Effects of Platinum-Based Chemotherapeutic Drugs in Human Colon Cancer Cells.Neoplasia. 2017 Oct;19(10):830-841. doi: 10.1016/j.neo.2017.08.002. Epub 2017 Sep 6.
20 The Role of M3 Muscarinic Receptor Ligand-Induced Kinase Signaling in Colon Cancer Progression.Cancers (Basel). 2019 Mar 5;11(3):308. doi: 10.3390/cancers11030308.
21 Genetic polymorphism 609C>T in NAD(P)H:quinone oxidoreductase 1 enhances the risk of proximal colon cancer.J Hum Genet. 2014 Jul;59(7):381-6. doi: 10.1038/jhg.2014.38. Epub 2014 May 15.
22 The phosphatidic acid phosphatase lipin-1 facilitates inflammation-driven colon carcinogenesis.JCI Insight. 2018 Sep 20;3(18):e97506. doi: 10.1172/jci.insight.97506. eCollection 2018 Sep 20.
23 Interleukin genes and associations with colon and rectal cancer risk and overall survival.Int J Cancer. 2013 Feb 15;132(4):905-15. doi: 10.1002/ijc.27660. Epub 2012 Jun 26.
24 Colonic vitamin D metabolism: implications for the pathogenesis of inflammatory bowel disease and colorectal cancer.Mol Cell Endocrinol. 2011 Dec 5;347(1-2):70-9. doi: 10.1016/j.mce.2011.07.022. Epub 2011 Jul 27.
25 DCLK1 integrates induction of TRIB3, EMT, drug resistance and poor prognosis in colorectal cancer.Carcinogenesis. 2020 May 14;41(3):303-312. doi: 10.1093/carcin/bgz157.
26 The DEAD box protein p68: a novel coactivator of Stat3 in mediating oncogenesis.Oncogene. 2017 Jun 1;36(22):3080-3093. doi: 10.1038/onc.2016.449. Epub 2016 Dec 12.
27 Dicer regulates non-homologous end joining and is associated with chemosensitivity in colon cancer patients.Carcinogenesis. 2017 Sep 1;38(9):873-882. doi: 10.1093/carcin/bgx059.
28 Activation of the PERK-ATF4 pathway promotes chemo-resistance in colon cancer cells.Sci Rep. 2019 Mar 1;9(1):3210. doi: 10.1038/s41598-019-39547-x.
29 Pulsed SILAC-based proteomic analysis unveils hypoxia- and serum starvation-induced de novo protein synthesis with PHD finger protein 14 (PHF14) as a hypoxia sensitive epigenetic regulator in cell cycle progression.Oncotarget. 2019 Mar 15;10(22):2136-2150. doi: 10.18632/oncotarget.26669. eCollection 2019 Mar 15.
30 The Diagnostic Significance of PDGF, EphA7, CCR5, and CCL5 Levels in Colorectal Cancer.Biomolecules. 2019 Sep 9;9(9):464. doi: 10.3390/biom9090464.
31 Loss-of-function uORF mutations in human malignancies.Sci Rep. 2018 Feb 5;8(1):2395. doi: 10.1038/s41598-018-19201-8.
32 5-HT(2A) and 5-HT(3) receptors contribute to the exacerbation of targeted and non-targeted effects of ionizing radiation-induced cell death in human colon carcinoma cells.Int J Radiat Biol. 2020 Apr;96(4):482-490. doi: 10.1080/09553002.2020.1704911. Epub 2020 Jan 8.
33 FGF-1/-3/FGFR4 signaling in cancer-associated fibroblasts promotes tumor progression in colon cancer through Erk and MMP-7.Cancer Sci. 2015 Oct;106(10):1278-87. doi: 10.1111/cas.12745. Epub 2015 Sep 4.
34 Down-regulation of growth arrest DNA damage-inducible gene 45beta expression is associated with human hepatocellular carcinoma. Am J Pathol. 2003 Jun;162(6):1961-74.
35 A review of gigaxonin mutations in giant axonal neuropathy (GAN) and cancer.Hum Genet. 2016 Jul;135(7):675-84. doi: 10.1007/s00439-016-1659-5. Epub 2016 Mar 29.
36 Apoptotic Effects of Drug Targeting Conjugates Containing Different GnRH Analogs on Colon Carcinoma Cells.Int J Mol Sci. 2019 Sep 8;20(18):4421. doi: 10.3390/ijms20184421.
37 Increased frequency of gastrin-releasing peptide receptor gene mutations during colon-adenocarcinoma progression.Mol Carcinog. 2003 May;37(1):5-15. doi: 10.1002/mc.10117.
38 Split tolerance permits safe Ad5-GUCY2C-PADRE vaccine-induced T-cell responses in colon cancer patients.J Immunother Cancer. 2019 Apr 23;7(1):104. doi: 10.1186/s40425-019-0576-2.
39 Effect of butyrate and Lactobacillus GG on a butyrate receptor and transporter during Campylobacter jejuni exposure.FEMS Microbiol Lett. 2017 Mar 1;364(6):fnx046. doi: 10.1093/femsle/fnx046.
40 Salmonella-mediated therapy targeting indoleamine 2, 3-dioxygenase 1 (IDO) activates innate immunity and mitigates colorectal cancer growth.Cancer Gene Ther. 2020 Apr;27(3-4):235-245. doi: 10.1038/s41417-019-0089-7. Epub 2019 Mar 1.
41 Cancer therapy with major histocompatibility complex-deficient and interferon -producing myeloid cells derived from allogeneic embryonic stem cells.Cancer Sci. 2019 Oct;110(10):3027-3037. doi: 10.1111/cas.14144. Epub 2019 Aug 7.
42 Changes Due to Ageing in the Glycan Structure of Alpha-2-Macroglobulin and Its Reactivity with Ligands.Protein J. 2019 Feb;38(1):23-29. doi: 10.1007/s10930-018-9806-6.
43 Genetic variants in IGF-I, IGF-II, IGFBP-3, and adiponectin genes and colon cancer risk in African Americans and Whites.Cancer Causes Control. 2012 Jul;23(7):1127-38. doi: 10.1007/s10552-012-9981-2. Epub 2012 May 8.
44 Downregulated IGFBP7 facilitates liver metastasis by modulating epithelialmesenchymal transition in colon cancer.Oncol Rep. 2019 Nov;42(5):1935-1945. doi: 10.3892/or.2019.7303. Epub 2019 Sep 6.
45 Cell-Based IL-15:IL-15R Secreting Vaccine as an Effective Therapy for CT26 Colon Cancer in Mice.Mol Cells. 2019 Dec 31;42(12):869-883. doi: 10.14348/molcells.2019.0188.
46 IL-23 in inflammatory bowel diseases and colon cancer.Cytokine Growth Factor Rev. 2019 Feb;45:1-8. doi: 10.1016/j.cytogfr.2018.12.002. Epub 2018 Dec 12.
47 Interferon-signaling pathway: associations with colon and rectal cancer risk and subsequent survival.Carcinogenesis. 2011 Nov;32(11):1660-7. doi: 10.1093/carcin/bgr189. Epub 2011 Aug 22.
48 Role of microRNA 30a targeting insulin receptor substrate 2 in colorectal tumorigenesis.Mol Cell Biol. 2015 Mar;35(6):988-1000. doi: 10.1128/MCB.01242-14. Epub 2015 Jan 12.
49 Haplotype CGC from XPD, hOGG1 and ITGA2 polymorphisms increases the risk of nasopharyngeal carcinoma in Malaysia.PLoS One. 2017 Nov 9;12(11):e0187200. doi: 10.1371/journal.pone.0187200. eCollection 2017.
50 p27Kip1, PCAF and PAX5 cooperate in the transcriptional regulation of specific target genes.Nucleic Acids Res. 2017 May 19;45(9):5086-5099. doi: 10.1093/nar/gkx075.
51 Co-inhibitory T cell receptor KLRG1: human cancer expression and efficacy of neutralization in murine cancer models.Oncotarget. 2019 Feb 15;10(14):1399-1406. doi: 10.18632/oncotarget.26659. eCollection 2019 Feb 15.
52 Cachexia-associated adipose loss induced by tumor-secreted leukemia inhibitory factor is counterbalanced by decreased leptin.JCI Insight. 2018 Jul 26;3(14):e121221. doi: 10.1172/jci.insight.121221. eCollection 2018 Jul 26.
53 Single nucleotide polymorphisms within MicroRNAs, MicroRNA targets, and MicroRNA biogenesis genes and their impact on colorectal cancer survival.Genes Chromosomes Cancer. 2017 Apr;56(4):285-295. doi: 10.1002/gcc.22434. Epub 2017 Jan 25.
54 Activation of MEK1 or MEK2 isoform is sufficient to fully transform intestinal epithelial cells and induce the formation of metastatic tumors.BMC Cancer. 2008 Nov 17;8:337. doi: 10.1186/1471-2407-8-337.
55 MAP kinase genes and colon and rectal cancer.Carcinogenesis. 2012 Dec;33(12):2398-408. doi: 10.1093/carcin/bgs305. Epub 2012 Oct 1.
56 MEK5/ERK5 signaling inhibition increases colon cancer cell sensitivity to 5-fluorouracil through a p53-dependent mechanism.Oncotarget. 2016 Jun 7;7(23):34322-40. doi: 10.18632/oncotarget.9107.
57 Natural product derivative Gossypolone inhibits Musashi family of RNA-binding proteins.BMC Cancer. 2018 Aug 10;18(1):809. doi: 10.1186/s12885-018-4704-z.
58 A TGF--MTA1-SOX4-EZH2 signaling axis drives epithelial-mesenchymal transition in tumor metastasis.Oncogene. 2020 Mar;39(10):2125-2139. doi: 10.1038/s41388-019-1132-8. Epub 2019 Dec 6.
59 AEG-1 knockdown in colon cancer cell lines inhibits radiation-enhanced migration and invasion in vitro and in a novel in vivo zebrafish model.Oncotarget. 2016 Dec 6;7(49):81634-81644. doi: 10.18632/oncotarget.13155.
60 Cross-talk between Colon Cells and Macrophages Increases ST6GALNAC1 and MUC1-sTn Expression in Ulcerative Colitis and Colitis-Associated Colon Cancer.Cancer Immunol Res. 2020 Feb;8(2):167-178. doi: 10.1158/2326-6066.CIR-19-0514. Epub 2019 Dec 12.
61 A human MUTYH variant linking colonic polyposis to redox degradation of the [4Fe4S](2+) cluster.Nat Chem. 2018 Aug;10(8):873-880. doi: 10.1038/s41557-018-0068-x. Epub 2018 Jun 18.
62 Contribution of drugs acting on the TLRs/MyD88 signaling pathway on colitis-associated cancer.Pharmazie. 2018 Jul 1;73(7):363-368. doi: 10.1691/ph.2018.8388.
63 Butyrate suppresses expression of neuropilin I in colorectal cell lines through inhibition of Sp1 transactivation.Mol Cancer. 2010 Oct 15;9:276. doi: 10.1186/1476-4598-9-276.
64 Knockdown of PAK4 or PAK1 inhibits the proliferation of mutant KRAS colon cancer cells independently of RAF/MEK/ERK and PI3K/AKT signaling.Mol Cancer Res. 2013 Feb;11(2):109-21. doi: 10.1158/1541-7786.MCR-12-0466. Epub 2012 Dec 10.
65 Eupafolin Suppresses Esophagus Cancer Growth by Targeting T-LAK Cell-Originated Protein Kinase.Front Pharmacol. 2019 Oct 22;10:1248. doi: 10.3389/fphar.2019.01248. eCollection 2019.
66 Combination of attenuated Salmonella carrying PD-1 siRNA with nifuroxazide for colon cancer therapy.J Cell Biochem. 2020 Feb;121(2):1973-1985. doi: 10.1002/jcb.29432. Epub 2019 Nov 6.
67 The plasminogen activator inhibitor system in colon cancer cell lines is influenced by the CO2 pneumoperitoneum.Int J Colorectal Dis. 2011 Jan;26(1):37-43. doi: 10.1007/s00384-010-1062-y. Epub 2010 Oct 8.
68 Colon cancer-associated DNA polymerase variant induces genomic instability and cellular transformation.J Biol Chem. 2012 Jul 6;287(28):23840-9. doi: 10.1074/jbc.M112.362111. Epub 2012 May 9.
69 Chiral phenoxyacetic acid analogues inhibit colon cancer cell proliferation acting as PPAR partial agonists.Sci Rep. 2019 Apr 1;9(1):5434. doi: 10.1038/s41598-019-41765-2.
70 Loss of MLH1 sensitizes colon cancer cells to DNA-PKcs inhibitor KU60648.Mol Carcinog. 2017 Jul;56(7):1816-1824. doi: 10.1002/mc.22640. Epub 2017 Mar 10.
71 The Roles of EP4 Prostanoid Receptors in Cancer Malignancy Signaling.Biol Pharm Bull. 2016;39(2):149-55. doi: 10.1248/bpb.b15-00840.
72 Upregulation of C-C chemokine receptor type 7 expression by membrane-associated prostaglandin E synthase-1/prostaglandin E2 requires glycogen synthase kinase 3-mediated signal transduction in colon cancer cells.Mol Med Rep. 2015 Nov;12(5):7169-75. doi: 10.3892/mmr.2015.4290. Epub 2015 Sep 3.
73 Kinase-Dependent and -Independent Roles for PTK6 in Colon Cancer.Mol Cancer Res. 2016 Jun;14(6):563-73. doi: 10.1158/1541-7786.MCR-15-0450. Epub 2016 Mar 16.
74 Therapeutic silence of pleiotrophin by targeted delivery of siRNA and its effect on the inhibition of tumor growth and metastasis.PLoS One. 2017 May 31;12(5):e0177964. doi: 10.1371/journal.pone.0177964. eCollection 2017.
75 ROBO1 Expression in Metastasizing Breast and Ovarian Cancer: SLIT2-induced Chemotaxis Requires Heparan Sulfates (Heparin).Anticancer Res. 2019 Mar;39(3):1267-1273. doi: 10.21873/anticanres.13237.
76 Granulocytic Myeloid-Derived Suppressor Cells Promote the Stemness of Colorectal Cancer Cells through Exosomal S100A9.Adv Sci (Weinh). 2019 Jul 22;6(18):1901278. doi: 10.1002/advs.201901278. eCollection 2019 Sep 18.
77 Stability of the N-Terminal Helix and Its Role in Amyloid Formation of Serum Amyloid A.ACS Omega. 2018 Nov 30;3(11):16184-16190. doi: 10.1021/acsomega.8b02377. Epub 2018 Nov 29.
78 Syndecan-1 deficiency promotes tumor growth in a murine model of colitis-induced colon carcinoma.PLoS One. 2017 Mar 28;12(3):e0174343. doi: 10.1371/journal.pone.0174343. eCollection 2017.
79 Dynamic biochemical tissue analysis detects functional L-selectin ligands on colon cancer tissues.PLoS One. 2017 Mar 10;12(3):e0173747. doi: 10.1371/journal.pone.0173747. eCollection 2017.
80 Expression of facilitative glucose transporter 1 mRNA in colon cancer was not regulated by k-ras.Cancer Lett. 2000 Jun 30;154(2):137-42. doi: 10.1016/s0304-3835(00)00354-2.
81 SREBP1 promotes the invasion of colorectal cancer accompanied upregulation of MMP7 expression and NF-B pathway activation.BMC Cancer. 2019 Jul 12;19(1):685. doi: 10.1186/s12885-019-5904-x.
82 TGF-2, catalase activity, H(2)O(2) output and metastatic potential of diverse types of tumour.Free Radic Biol Med. 2019 Apr;134:282-287. doi: 10.1016/j.freeradbiomed.2019.01.010. Epub 2019 Jan 9.
83 Translationally controlled tumor protein affects colorectal cancer metastasis through the high mobility group box 1-dependent pathway.Int J Oncol. 2018 Oct;53(4):1481-1492. doi: 10.3892/ijo.2018.4502. Epub 2018 Jul 25.
84 Tumor cell-secreted PLD increases tumor stemness by senescence-mediated communication with microenvironment.Oncogene. 2019 Feb;38(8):1309-1323. doi: 10.1038/s41388-018-0527-2. Epub 2018 Oct 10.
85 Costunolide specifically binds and inhibits thioredoxin reductase 1 to induce apoptosis in colon cancer.Cancer Lett. 2018 Jan 1;412:46-58. doi: 10.1016/j.canlet.2017.10.006. Epub 2017 Oct 13.
86 Pharmacological inhibition of USP7 promotes antitumor immunity and contributes to colon cancer therapy.Onco Targets Ther. 2019 Jan 15;12:609-617. doi: 10.2147/OTT.S182806. eCollection 2019.
87 PHD2 exerts anti-cancer and anti-inflammatory effects in colon cancer xenografts mice via attenuating NF-B activity.Life Sci. 2020 Feb 1;242:117167. doi: 10.1016/j.lfs.2019.117167. Epub 2019 Dec 12.
88 DNA repair protein XPA is differentially expressed in colorectal cancer and predicts better prognosis.Cancer Med. 2018 Jun;7(6):2339-2349. doi: 10.1002/cam4.1480. Epub 2018 Apr 19.
89 Traditional Chinese Medicine Curcumin Sensitizes Human Colon Cancer to Radiation by Altering the Expression of DNA Repair-related Genes.Anticancer Res. 2018 Jan;38(1):131-136. doi: 10.21873/anticanres.12200.
90 Insulin promotes progression of colon cancer by upregulation of ACAT1.Lipids Health Dis. 2018 May 24;17(1):122. doi: 10.1186/s12944-018-0773-x.
91 Graphene OxidePEGProtocatechuic Acid Nanocomposite Formulation with Improved Anticancer Properties.Nanomaterials (Basel). 2018 Oct 11;8(10):820. doi: 10.3390/nano8100820.
92 Distinct expression pattern of the full set of secreted phospholipases A2 in human colorectal adenocarcinomas: sPLA2-III as a biomarker candidate.Br J Cancer. 2008 Feb 12;98(3):587-95. doi: 10.1038/sj.bjc.6604184. Epub 2008 Jan 22.
93 Silencing of PTK7 in colon cancer cells: caspase-10-dependent apoptosis via mitochondrial pathway.PLoS One. 2010 Nov 16;5(11):e14018. doi: 10.1371/journal.pone.0014018.
94 Systematic Analysis of Gene Expression Alterations and Clinical Outcomes for Long-Chain Acyl-Coenzyme A Synthetase Family in Cancer.PLoS One. 2016 May 12;11(5):e0155660. doi: 10.1371/journal.pone.0155660. eCollection 2016.
95 ACLY facilitates colon cancer cell metastasis by CTNNB1.J Exp Clin Cancer Res. 2019 Sep 12;38(1):401. doi: 10.1186/s13046-019-1391-9.
96 Functional Characterization of Colon Cancer-Associated Mutations in ADAM17: Modifications in the Pro-Domain Interfere with Trafficking and Maturation.Int J Mol Sci. 2019 May 4;20(9):2198. doi: 10.3390/ijms20092198.
97 ALKBH5 Holds Prognostic Values and Inhibits the Metastasis of Colon Cancer.Pathol Oncol Res. 2020 Jul;26(3):1615-1623. doi: 10.1007/s12253-019-00737-7. Epub 2019 Sep 10.
98 MicroRNA?5/ATXN3 interaction regulates human colon cancer cell growth and migration.Mol Med Rep. 2019 May;19(5):4213-4221. doi: 10.3892/mmr.2019.10090. Epub 2019 Mar 27.
99 PARG regulates the proliferation and differentiation of DCs and Tcells via PARP/NFB in tumour metastases of colon carcinoma.Oncol Rep. 2019 May;41(5):2657-2666. doi: 10.3892/or.2019.7051. Epub 2019 Mar 7.
100 Bone Morphogenetic Protein 1 Targeting COL1A1 and COL1A2 to Regulate the Epithelial-Mesenchymal Transition Process of Colon Cancer SW620 Cells.J Nanosci Nanotechnol. 2020 Mar 1;20(3):1366-1374. doi: 10.1166/jnn.2020.17362.
101 Resveratrol displays converse dose-related effects on 5-fluorouracil-evoked colon cancer cell apoptosis: the roles of caspase-6 and p53. Cancer Biol Ther. 2008 Aug;7(8):1305-12. doi: 10.4161/cbt.7.8.6302. Epub 2008 Aug 16.
102 miR-155 is positively regulated by CBX7 in mouse embryonic fibroblasts and colon carcinomas, and targets the KRAS oncogene.BMC Cancer. 2017 Mar 4;17(1):170. doi: 10.1186/s12885-017-3158-z.
103 The Prognostic Role of Cancer Stem Cell Markers for Long-term Outcome After Resection of Colonic Liver Metastases.Anticancer Res. 2018 Jan;38(1):313-320. doi: 10.21873/anticanres.12224.
104 Clusterin, a gene enriched in intestinal stem cells, is required for L1-mediated colon cancer metastasis.Oncotarget. 2015 Oct 27;6(33):34389-401. doi: 10.18632/oncotarget.5360.
105 miR-590-3p promotes colon cancer cell proliferation via Wnt/-catenin signaling pathway by inhibiting WIF1 and DKK1.Eur Rev Med Pharmacol Sci. 2017 Nov;21(21):4844-4852.
106 FOXO1 degradation via G9a-mediated methylation promotes cell proliferation in colon cancer.Nucleic Acids Res. 2019 Feb 28;47(4):1692-1705. doi: 10.1093/nar/gky1230.
107 MiR-155-5p controls colon cancer cell migration via post-transcriptional regulation of Human Antigen R (HuR).Cancer Lett. 2018 May 1;421:145-151. doi: 10.1016/j.canlet.2018.02.026. Epub 2018 Feb 20.
108 Functional Interaction of Hypoxia-Inducible Factor 2-Alpha and Autophagy Mediates Drug Resistance in Colon Cancer Cells.Cancers (Basel). 2019 May 30;11(6):755. doi: 10.3390/cancers11060755.
109 Knockdown of IRE1 suppresses metastatic potential of colon cancer cells through inhibiting FN1-Src/FAK-GTPases signaling.Int J Biochem Cell Biol. 2019 Sep;114:105572. doi: 10.1016/j.biocel.2019.105572. Epub 2019 Jul 18.
110 KAT3B-p300 and H3AcK18/H3AcK14 levels are prognostic markers for kidney ccRCC tumor aggressiveness and target of KAT inhibitor CPTH2.Clin Epigenetics. 2018 Apr 4;10:44. doi: 10.1186/s13148-018-0473-4. eCollection 2018.
111 Identification of Cross Talk between FoxM1 and RASSF1A as a Therapeutic Target of Colon Cancer.Cancers (Basel). 2019 Feb 8;11(2):199. doi: 10.3390/cancers11020199.
112 MicroRNA (miR)-597-5p Inhibits Colon Cancer Cell Migration and Invasion by Targeting FOS-Like Antigen 2 (FOSL2).Front Oncol. 2019 Jun 12;9:495. doi: 10.3389/fonc.2019.00495. eCollection 2019.
113 Targeting GLI by GANT61 involves mechanisms dependent on inhibition of both transcription and DNA licensing.Oncotarget. 2016 Dec 6;7(49):80190-80207. doi: 10.18632/oncotarget.13376.
114 Knockdown GREM1 suppresses cell growth, angiogenesis, and epithelial-mesenchymal transition in colon cancer.J Cell Biochem. 2019 Apr;120(4):5583-5596. doi: 10.1002/jcb.27842. Epub 2018 Nov 13.
115 Resveratrol inhibits the invasion and metastasis of colon cancer through reversal of epithelial?mesenchymal transition via the AKT/GSK?/Snail signaling pathway.Mol Med Rep. 2019 Sep;20(3):2783-2795. doi: 10.3892/mmr.2019.10528. Epub 2019 Jul 25.
116 Lower Expression of Gelsolin in Colon Cancer and Its Diagnostic Value in Colon Cancer Patients.J Cancer. 2019 Jan 30;10(5):1288-1296. doi: 10.7150/jca.28529. eCollection 2019.
117 Sumoylation of HDAC2 promotes NF-B-dependent gene expression.Oncotarget. 2015 Mar 30;6(9):7123-35. doi: 10.18632/oncotarget.3344.
118 HDAC inhibitors show differential epigenetic regulation and cell survival strategies on p53 mutant colon cancer cells.J Biomol Struct Dyn. 2018 Mar;36(4):938-955. doi: 10.1080/07391102.2017.1302820. Epub 2017 Mar 28.
119 Dipyridamole Enhances the Cytotoxicities of Trametinib against Colon Cancer Cells through Combined Targeting of HMGCS1 and MEK Pathway.Mol Cancer Ther. 2020 Jan;19(1):135-146. doi: 10.1158/1535-7163.MCT-19-0413. Epub 2019 Sep 25.
120 AQP5 silencing suppresses p38 MAPK signaling and improves drug resistance in colon cancer cells.Tumour Biol. 2014 Jul;35(7):7035-45. doi: 10.1007/s13277-014-1956-3. Epub 2014 Apr 23.
121 BAG3-dependent expression of Mcl-1 confers resistance of mutant KRAS colon cancer cells to the HSP90 inhibitor AUY922.Mol Carcinog. 2018 Feb;57(2):284-294. doi: 10.1002/mc.22755. Epub 2017 Nov 14.
122 A study of the impact of inhibitors of DNA binding-1 on proliferation and migration in human colon carcinoma cells.Kaohsiung J Med Sci. 2019 Apr;35(4):209-213. doi: 10.1002/kjm2.12037. Epub 2019 Mar 19.
123 IL-32 expression indicates unfavorable prognosis in patients with colon cancer.Oncol Lett. 2019 May;17(5):4655-4660. doi: 10.3892/ol.2019.10136. Epub 2019 Mar 12.
124 Integrated bioinformatics analysis of key genes involved in progress of colon cancer.Mol Genet Genomic Med. 2019 Apr;7(4):e00588. doi: 10.1002/mgg3.588. Epub 2019 Feb 11.
125 A Transcriptomic Insight into the Impact of Colon Cancer Cells on Mast Cells.Int J Mol Sci. 2019 Apr 4;20(7):1689. doi: 10.3390/ijms20071689.
126 Has_circ_0055625 from circRNA profile increases colon cancer cell growth by sponging miR-106b-5p.J Cell Biochem. 2019 Mar;120(3):3027-3037. doi: 10.1002/jcb.27355. Epub 2018 Dec 5.
127 V211D Mutation in MEK1 Causes Resistance to MEK Inhibitors in Colon Cancer.Cancer Discov. 2019 Sep;9(9):1182-1191. doi: 10.1158/2159-8290.CD-19-0356. Epub 2019 Jun 21.
128 MLK3 phosphorylation by ERK1/2 is required for oxidative stress-induced invasion of colorectal cancer cells.Oncogene. 2018 Feb 22;37(8):1031-1040. doi: 10.1038/onc.2017.396. Epub 2017 Oct 30.
129 Verification of predicted alternatively spliced Wnt genes reveals two new splice variants (CTNNB1 and LRP5) and altered Axin-1 expression during tumour progression.BMC Genomics. 2006 Jun 13;7:148. doi: 10.1186/1471-2164-7-148.
130 L290P/V mutations increase ERK3's cytoplasmic localization and migration/invasion-promoting capability in cancer cells.Sci Rep. 2017 Nov 3;7(1):14979. doi: 10.1038/s41598-017-15135-9.
131 Cloning, expression of the truncation of recombinant peroxidase derived from millet bran and its reversal effects on 5-Fu resistance in colorectal cancer.Int J Biol Macromol. 2019 Jul 1;132:871-879. doi: 10.1016/j.ijbiomac.2019.03.111. Epub 2019 Mar 19.
132 Conjugate of Doxorubicin to Albumin-Binding Peptide Outperforms Aldoxorubicin.Small. 2019 Mar;15(12):e1804452. doi: 10.1002/smll.201804452. Epub 2019 Feb 13.
133 Design, synthesis and biological evaluation of pyridone-aminal derivatives as MNK1/2 inhibitors.Bioorg Med Chem. 2019 Apr 1;27(7):1211-1225. doi: 10.1016/j.bmc.2019.02.007. Epub 2019 Feb 2.
134 MTMR3 is upregulated in patients with breast cancer and regulates proliferation, cell cycle progression and autophagy in breast cancer cells.Oncol Rep. 2019 Nov;42(5):1915-1923. doi: 10.3892/or.2019.7292. Epub 2019 Aug 23.
135 Construing the Biochemical and Molecular Mechanism Underlying the In Vivo and In Vitro Chemotherapeutic Efficacy of Ruthenium-Baicalein Complex in Colon Cancer.Int J Biol Sci. 2019 Apr 22;15(5):1052-1071. doi: 10.7150/ijbs.31143. eCollection 2019.
136 The nuclear orphan receptor NR4A1 regulates 1-integrin expression in pancreatic and colon cancer cells and can be targeted by NR4A1 antagonists.Mol Carcinog. 2017 Sep;56(9):2066-2075. doi: 10.1002/mc.22662. Epub 2017 May 9.
137 Methylation of OSMR gene is frequently observed in non-invasive colorectal cancer.Anticancer Res. 2011 Apr;31(4):1293-5.
138 Hypoxia-Inducible PIM Kinase Expression Promotes Resistance to Antiangiogenic Agents.Clin Cancer Res. 2018 Jan 1;24(1):169-180. doi: 10.1158/1078-0432.CCR-17-1318. Epub 2017 Oct 30.
139 Deficiency of phospholipase A2 group 7 decreases intestinal polyposis and colon tumorigenesis in Apc(Min/+) mice.Cancer Res. 2013 May 1;73(9):2806-16. doi: 10.1158/0008-5472.CAN-12-2374. Epub 2013 Jan 29.
140 PLK1 has tumor-suppressive potential in APC-truncated colon cancer cells.Nat Commun. 2018 Mar 16;9(1):1106. doi: 10.1038/s41467-018-03494-4.
141 PKC Phosphorylates SIRT6 to Mediate Fatty Acid -Oxidation in Colon Cancer Cells.Neoplasia. 2019 Jan;21(1):61-73. doi: 10.1016/j.neo.2018.11.008. Epub 2018 Nov 30.
142 Downregulation of PRMT1, a histone arginine methyltransferase, by sodium propionate induces cell apoptosis in colon cancer.Oncol Rep. 2019 Mar;41(3):1691-1699. doi: 10.3892/or.2018.6938. Epub 2018 Dec 18.
143 PTBP1 knockdown overcomes the resistance to vincristine and oxaliplatin in drug-resistant colon cancer cells through regulation of glycolysis.Biomed Pharmacother. 2018 Dec;108:194-200. doi: 10.1016/j.biopha.2018.09.031. Epub 2018 Sep 13.
144 Diallyl disulfide inhibits colon cancer metastasis by suppressing Rac1-mediated epithelial-mesenchymal transition.Onco Targets Ther. 2019 Jul 16;12:5713-5728. doi: 10.2147/OTT.S208738. eCollection 2019.
145 RACK1 promotes tumorigenicity of colon cancer by inducing cell autophagy.Cell Death Dis. 2018 Nov 19;9(12):1148. doi: 10.1038/s41419-018-1113-9.
146 miR-223 promotes colon cancer by directly targeting p120 catenin.Oncotarget. 2017 Jul 25;8(38):63764-63779. doi: 10.18632/oncotarget.19541. eCollection 2017 Sep 8.
147 The most common RNF43 mutant G659Vfs*41 is fully functional in inhibiting Wnt signaling and unlikely to play a role in tumorigenesis.Sci Rep. 2019 Dec 6;9(1):18557. doi: 10.1038/s41598-019-54931-3.
148 Ribosomal Protein L15 is involved in Colon Carcinogenesis.Int J Med Sci. 2019 Aug 6;16(8):1132-1141. doi: 10.7150/ijms.34386. eCollection 2019.
149 3,3'-Diindolylmethane inhibits patient-derived xenograft colon tumor growth by targeting COX1/2 and ERK1/2.Cancer Lett. 2019 Apr 28;448:20-30. doi: 10.1016/j.canlet.2019.01.031. Epub 2019 Feb 1.
150 Overexpression of Chimeric RNA by Retroviral Transduction.Methods Mol Biol. 2020;2079:155-166. doi: 10.1007/978-1-4939-9904-0_12.
151 Dentatin exerts anticancer effects on human colon cancer cell lines via cell cycle arrest, autophagy, inhibition of cell migration and JAK/STAT signalling pathway.J BUON. 2019 Jul-Aug;24(4):1488-1493.
152 S100A4 May Be a Good Prognostic Marker and a Therapeutic Target for Colon Cancer.J Oncol. 2018 Jul 9;2018:1828791. doi: 10.1155/2018/1828791. eCollection 2018.
153 Reversible regulation of SATB1 ubiquitination by USP47 and SMURF2 mediates colon cancer cell proliferation and tumor progression.Cancer Lett. 2019 Apr 28;448:40-51. doi: 10.1016/j.canlet.2019.01.039. Epub 2019 Feb 8.
154 Deficiency in STAT1 Signaling Predisposes Gut Inflammation and Prompts Colorectal Cancer Development.Cancers (Basel). 2018 Sep 19;10(9):341. doi: 10.3390/cancers10090341.
155 SUV39H1 Represses the Expression of Cytotoxic T-Lymphocyte Effector Genes to Promote Colon Tumor Immune Evasion.Cancer Immunol Res. 2019 Mar;7(3):414-427. doi: 10.1158/2326-6066.CIR-18-0126. Epub 2019 Jan 4.
156 -Catenin/Tcf7l2-dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer.Sci Adv. 2019 Jul 31;5(7):eaax0698. doi: 10.1126/sciadv.aax0698. eCollection 2019 Jul.
157 Toll-like receptor 3 agonist poly I:C reinforces the potency of cytotoxic chemotherapy via the TLR3-UNC93B1-IFN- signaling axis in paclitaxel-resistant colon cancer.J Cell Physiol. 2019 May;234(5):7051-7061. doi: 10.1002/jcp.27459. Epub 2018 Nov 1.
158 Glucocorticoids indirectly decrease colon cancer cell proliferation and invasion via effects on cancer-associated fibroblasts.Exp Cell Res. 2018 Jan 15;362(2):332-342. doi: 10.1016/j.yexcr.2017.11.034. Epub 2017 Nov 28.
159 Impact of p53 status on TRAIL-mediated apoptotic and non-apoptotic signaling in cancer cells.PLoS One. 2019 Apr 4;14(4):e0214847. doi: 10.1371/journal.pone.0214847. eCollection 2019.
160 Expression of Tumor-mediated CD137 ligand in human colon cancer indicates dual signaling effects.Oncoimmunology. 2019 Sep 6;8(12):e1651622. doi: 10.1080/2162402X.2019.1651622. eCollection 2019.
161 LIGHT Elevation Enhances Immune Eradication of Colon Cancer Metastases.Cancer Res. 2017 Apr 15;77(8):1880-1891. doi: 10.1158/0008-5472.CAN-16-1655. Epub 2017 Mar 1.
162 Overexpression of TrpC5 promotes tumor metastasis via the HIF-1-Twist signaling pathway in colon cancer.Clin Sci (Lond). 2017 Sep 22;131(19):2439-2450. doi: 10.1042/CS20171069. Print 2017 Oct 1.
163 Microarraybased analysis of COL11A1 and TWIST1 as important differentiallyexpressed pathogenic genes between left and rightsided colon cancer.Mol Med Rep. 2019 Nov;20(5):4202-4214. doi: 10.3892/mmr.2019.10667. Epub 2019 Sep 10.
164 USP10 regulates Musashi-2 stability via deubiquitination and promotes tumour proliferation in colon cancer.FEBS Lett. 2019 Feb;593(4):406-413. doi: 10.1002/1873-3468.13323. Epub 2019 Jan 16.
165 Succinylation-dependent mitochondrial translocation of PKM2 promotes cell survival in response to nutritional stress.Cell Death Dis. 2019 Feb 20;10(3):170. doi: 10.1038/s41419-018-1271-9.
166 EZH2 is involved in silencing of WNT5A during epithelial-mesenchymal transition of colon cancer cell line.J Cancer Res Clin Oncol. 2017 Nov;143(11):2211-2219. doi: 10.1007/s00432-017-2479-2. Epub 2017 Jul 26.
167 XIAP facilitates breast and colon carcinoma growth via promotion of p62 depletion through ubiquitination-dependent proteasomal degradation.Oncogene. 2019 Feb;38(9):1448-1460. doi: 10.1038/s41388-018-0513-8. Epub 2018 Oct 1.
168 Regorafenib antagonizes BCRP-mediated multidrug resistance in colon cancer.Cancer Lett. 2019 Feb 1;442:104-112. doi: 10.1016/j.canlet.2018.10.032. Epub 2018 Oct 28.
169 G protein-coupled receptor LGR6 is an independent risk factor for colon adenocarcinoma.Front Med. 2019 Aug;13(4):482-491. doi: 10.1007/s11684-018-0633-0. Epub 2018 Jul 4.
170 Recent studies on the identification of proliferative abnormalities and of oncogenic potential of cutaneous cells in individuals at increased risk of colon cancer.Semin Oncol. 1976 Dec;3(4):369-72.
171 miR-20b reduces 5-FU resistance by suppressing the ADAM9/EGFR signaling pathway in colon cancer.Oncol Rep. 2017 Jan;37(1):123-130. doi: 10.3892/or.2016.5259. Epub 2016 Nov 18.
172 Differential coupling of the PAC1 SV1 splice variant on human colonic tumors to the activation of intracellular cAMP but not intracellular Ca2+ does not activate tumor proliferation.J Mol Neurosci. 2004;22(1-2):83-92. doi: 10.1385/JMN:22:1-2:83.
173 Adiponectin and colon cancer: evidence for inhibitory effects on viability and migration of human colorectal cell lines.Mol Cell Biochem. 2018 Nov;448(1-2):125-135. doi: 10.1007/s11010-018-3319-7. Epub 2018 Feb 14.
174 Small molecules related to adrenomedullin reduce tumor burden in a mouse model of colitis-associated colon cancer.Sci Rep. 2017 Dec 13;7(1):17488. doi: 10.1038/s41598-017-17573-x.
175 AGR2 is a target of canonical Wnt/-catenin signaling and is important for stemness maintenance in colorectal cancer stem cells.Biochem Biophys Res Commun. 2019 Aug 6;515(4):600-606. doi: 10.1016/j.bbrc.2019.05.154. Epub 2019 Jun 6.
176 Digital transcript profile analysis with aRNA-LongSAGE validates FERMT1 as a potential novel prognostic marker for colon cancer.Clin Cancer Res. 2011 May 1;17(9):2908-18. doi: 10.1158/1078-0432.CCR-10-2552. Epub 2011 Jan 10.
177 Isoflavones as Ah Receptor Agonists in Colon-Derived Cell Lines: Structure-Activity Relationships. Chem Res Toxicol. 2019 Nov 18;32(11):2353-2364. doi: 10.1021/acs.chemrestox.9b00352. Epub 2019 Oct 29.
178 Plasma fetuin-A concentration, genetic variation in the AHSG gene and risk of colorectal cancer.Int J Cancer. 2015 Aug 15;137(4):911-20. doi: 10.1002/ijc.29448. Epub 2015 Feb 5.
179 In Vitro and in Vivo antitumor activity and the mechanism of siphonodictyal B in human colon cancer cells.Cancer Med. 2019 Sep;8(12):5662-5672. doi: 10.1002/cam4.2409. Epub 2019 Jul 31.
180 SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells.Gastroenterology. 2011 Jul;141(1):279-91, 291.e1-5. doi: 10.1053/j.gastro.2011.04.008. Epub 2011 Apr 16.
181 15-Lipoxygenase-1 suppression of colitis-associated colon cancer through inhibition of the IL-6/STAT3 signaling pathway.FASEB J. 2015 Jun;29(6):2359-70. doi: 10.1096/fj.14-264515. Epub 2015 Feb 24.
182 Synergistic cooperation between the beta-catenin signaling pathway and steroidogenic factor 1 in the activation of the Mullerian inhibiting substance type II receptor.J Biol Chem. 2003 Jul 18;278(29):26511-6. doi: 10.1074/jbc.M300804200. Epub 2003 Apr 30.
183 Colon cancer-derived myofibroblasts increase endothelial cell migration by glucocorticoid-sensitive secretion of a pro-migratory factor.Vascul Pharmacol. 2017 Feb;89:19-30. doi: 10.1016/j.vph.2016.10.004. Epub 2016 Oct 4.
184 3-O-Acetyloleanolic acid inhibits angiopoietin-1-induced angiogenesis and lymphangiogenesis via suppression of angiopoietin-1/Tie-2 signaling.Phytother Res. 2020 Feb;34(2):359-367. doi: 10.1002/ptr.6526. Epub 2019 Nov 3.
185 Mechanisms involved in biological behavior changes associated with Angptl4 expression in colon cancer cell lines.Oncol Rep. 2012 May;27(5):1541-7. doi: 10.3892/or.2012.1672. Epub 2012 Feb 3.
186 Fusobacterium nucleatum prevents apoptosis in colorectal cancer cells via the ANO1 pathway.Cancer Manag Res. 2019 Oct 29;11:9057-9066. doi: 10.2147/CMAR.S185766. eCollection 2019.
187 Antitumour effect of glucooligosaccharides obtained via hydrolysis of -(1?)-glucan from Fomitopsis betulina.Mol Biol Rep. 2019 Dec;46(6):5977-5982. doi: 10.1007/s11033-019-05032-x. Epub 2019 Aug 22.
188 Functional comparison of human adenomatous polyposis coli (APC) and APC-like in targeting beta-catenin for degradation.PLoS One. 2013 Jul 1;8(7):e68072. doi: 10.1371/journal.pone.0068072. Print 2013.
189 Association between single-nucleotide polymorphisms of selected genes involved in the response to DNA damage and risk of colon, head and neck, and breast cancers in a Polish population.J Appl Genet. 2010;51(3):343-52. doi: 10.1007/BF03208865.
190 Ferric citrate and ferric EDTA but not ferrous sulfate drive amphiregulin-mediated activation of the MAP kinase ERK in gut epithelial cancer cells.Oncotarget. 2018 Mar 30;9(24):17066-17077. doi: 10.18632/oncotarget.24899. eCollection 2018 Mar 30.
191 Colon Cancer Cell Secretes EGF to Promote M2 Polarization of TAM Through EGFR/PI3K/AKT/mTOR Pathway.Technol Cancer Res Treat. 2019 Jan 1;18:1533033819849068. doi: 10.1177/1533033819849068.
192 Predictors of readmission and reoperation in patients with colorectal cancer.Support Care Cancer. 2020 May;28(5):2339-2350. doi: 10.1007/s00520-019-05050-2. Epub 2019 Sep 4.
193 Prognostic value of humbug gene overexpression in stage II colon cancer.Hum Pathol. 2007 Jan;38(1):17-25. doi: 10.1016/j.humpath.2006.07.009. Epub 2006 Oct 3.
194 The intestinal epithelial cell differentiation marker intestinal alkaline phosphatase (ALPi) is selectively induced by histone deacetylase inhibitors (HDACi) in colon cancer cells in a Kruppel-like factor 5 (KLF5)-dependent manner.J Biol Chem. 2014 Sep 5;289(36):25306-16. doi: 10.1074/jbc.M114.557546. Epub 2014 Jul 18.
195 Genetic disruption of tubulin acetyltransferase, TAT1, inhibits proliferation and invasion of colon cancer cells through decreases in Wnt1/-catenin signaling.Biochem Biophys Res Commun. 2017 Jan 1;482(1):8-14. doi: 10.1016/j.bbrc.2016.11.039. Epub 2016 Nov 9.
196 Activating transcription factor 3 promotes colon cancer metastasis.Tumour Biol. 2014 Aug;35(8):8329-34. doi: 10.1007/s13277-014-2044-4. Epub 2014 May 24.
197 Aerobic Exercise and Pharmacological Treatments Counteract Cachexia by Modulating Autophagy in Colon Cancer.Sci Rep. 2016 May 31;6:26991. doi: 10.1038/srep26991.
198 Alterations in the ATP2A2 gene in correlation with colon and lung cancer.Cancer Genet Cytogenet. 2006 Dec;171(2):105-11. doi: 10.1016/j.cancergencyto.2006.06.016.
199 Survivin-induced Aurora-B kinase activation: A mechanism by which APC mutations contribute to increased mitoses during colon cancer development.Am J Pathol. 2010 Dec;177(6):2816-26. doi: 10.2353/ajpath.2010.100047. Epub 2010 Nov 5.
200 Zinc--2-glycoprotein: a candidate biomarker for colon cancer diagnosis in Chinese population.Int J Mol Sci. 2014 Dec 30;16(1):691-703. doi: 10.3390/ijms16010691.
201 Identification of a novel aspartic-like protease differentially expressed in human breast cancer cell lines.Biochim Biophys Acta. 2000 Jun 15;1501(2-3):125-37. doi: 10.1016/s0925-4439(00)00014-4.
202 BACH1 silencing by siRNA inhibits migration of HT-29 colon cancer cells through reduction of metastasis-related genes.Biomed Pharmacother. 2016 Dec;84:191-198. doi: 10.1016/j.biopha.2016.09.021. Epub 2016 Sep 19.
203 Cabozantinib induces PUMA-dependent apoptosis in colon cancer cells via AKT/GSK-3/NF-B signaling pathway.Cancer Gene Ther. 2020 May;27(5):368-377. doi: 10.1038/s41417-019-0098-6. Epub 2019 Jun 11.
204 Expression of a novel Bcl-2 related gene, Bfl-1, in various human cancers and cancer cell lines.Anticancer Res. 1997 Nov-Dec;17(6D):4619-22.
205 MicroRNA-195 chemosensitizes colon cancer cells to the chemotherapeutic drug doxorubicin by targeting the first binding site of BCL2L2 mRNA.J Cell Physiol. 2015 Mar;230(3):535-45. doi: 10.1002/jcp.24366.
206 Effects of Beclin 1 overexpression on aggressive phenotypes of colon cancer cells.Oncol Lett. 2019 Feb;17(2):2441-2450. doi: 10.3892/ol.2018.9817. Epub 2018 Dec 10.
207 An apoptosis-independent role of SMAC in tumor suppression.Oncogene. 2013 May 9;32(19):2380-9. doi: 10.1038/onc.2012.265. Epub 2012 Jul 2.
208 Effect of RNAi-mediated silencing of Livin gene on biological properties of colon cancer cell line LoVo.Genet Mol Res. 2014 May 16;13(2):3832-41. doi: 10.4238/2014.May.16.8.
209 Abrus agglutinin stimulates BMP-2-dependent differentiation through autophagic degradation of -catenin in colon cancer stem cells.Mol Carcinog. 2018 May;57(5):664-677. doi: 10.1002/mc.22791. Epub 2018 Mar 14.
210 Effects of airborne particulate matter on alternative pre-mRNA splicing in colon cancer cells.Environ Res. 2015 Jul;140:185-90. doi: 10.1016/j.envres.2015.04.001. Epub 2015 Apr 9.
211 Anticancer effects of oridonin on colon cancer are mediated via BMP7/p38 MAPK/p53 signaling.Int J Oncol. 2018 Nov;53(5):2091-2101. doi: 10.3892/ijo.2018.4527. Epub 2018 Aug 16.
212 A Candidate-Pathway Approach to Identify Gene-Environment Interactions: Analyses of Colon Cancer Risk and Survival.J Natl Cancer Inst. 2015 Jun 13;107(9):djv160. doi: 10.1093/jnci/djv160. Print 2015 Sep.
213 BRIP-1 germline mutation and its role in colon cancer: presentation of two case reports and review of literature.BMC Med Genet. 2019 May 7;20(1):75. doi: 10.1186/s12881-019-0812-0.
214 miR-27a-3p regulates proliferation and apoptosis of colon cancer cells by potentially targeting BTG1.Oncol Lett. 2019 Sep;18(3):2825-2834. doi: 10.3892/ol.2019.10629. Epub 2019 Jul 18.
215 C1QBP is upregulated in colon cancer and binds to apolipoprotein A-I.Exp Ther Med. 2017 May;13(5):2493-2500. doi: 10.3892/etm.2017.4249. Epub 2017 Mar 21.
216 Complement 5a stimulates macrophage polarization and contributes to tumor metastases of colon cancer.Exp Cell Res. 2018 May 15;366(2):127-138. doi: 10.1016/j.yexcr.2018.03.009. Epub 2018 Mar 15.
217 Mesalazine and thymoquinone attenuate intestinal tumour development in Msh2(loxP/loxP) Villin-Cre mice.Gut. 2015 Dec;64(12):1905-12. doi: 10.1136/gutjnl-2014-307663. Epub 2014 Nov 26.
218 Carbonic anhydrase IV inhibits colon cancer development by inhibiting the Wnt signalling pathway through targeting the WTAP-WT1-TBL1 axis.Gut. 2016 Sep;65(9):1482-93. doi: 10.1136/gutjnl-2014-308614. Epub 2015 Jun 12.
219 Suppressive effect of an analog of the antimicrobial peptide of LL?7 on colon cancer cells via exosomeencapsulated miRNAs.Int J Mol Med. 2018 Dec;42(6):3009-3016. doi: 10.3892/ijmm.2018.3875. Epub 2018 Sep 13.
220 Mutational analysis of CASP10 gene in colon, breast, lung and hepatocellular carcinomas.Pathology. 2010 Jan;42(1):73-6. doi: 10.3109/00313020903434371.
221 microRNA-139-5p exerts tumor suppressor function by targeting NOTCH1 in colorectal cancer.Mol Cancer. 2014 May 26;13:124. doi: 10.1186/1476-4598-13-124.
222 Vitamin D receptor and calcium-sensing receptor polymorphisms and colorectal cancer survival in the Newfoundland population.Br J Cancer. 2017 Sep 5;117(6):898-906. doi: 10.1038/bjc.2017.242. Epub 2017 Aug 1.
223 miR-21-mediated regulation of 15-hydroxyprostaglandin dehydrogenase in colon cancer.Sci Rep. 2019 Apr 1;9(1):5405. doi: 10.1038/s41598-019-41862-2.
224 Role of endogenous and exogenous nitric oxide, carbon monoxide and hydrogen sulfide in HCT116 colon cancer cell proliferation.Biochem Pharmacol. 2018 Mar;149:186-204. doi: 10.1016/j.bcp.2017.10.011. Epub 2017 Oct 23.
225 Curcumin Reverses 5-Fluorouracil Resistance by Promoting Human Colon Cancer HCT-8/5-FU Cell Apoptosis and Down-regulating Heat Shock Protein 27 and P-Glycoprotein.Chin J Integr Med. 2019 Jun;25(6):416-424. doi: 10.1007/s11655-018-2997-z. Epub 2018 Nov 27.
226 Dual-agonist occupancy of orexin receptor 1 and cholecystokinin A receptor heterodimers decreases G-protein-dependent signaling and migration in the human colon cancer cell line HT-29.Biochim Biophys Acta Mol Cell Res. 2017 Jul;1864(7):1153-1164. doi: 10.1016/j.bbamcr.2017.03.003. Epub 2017 Mar 10.
227 Enhanced expression of cholecystokinin-2 receptor promotes the progression of colon cancer through activation of focal adhesion kinase.Int J Cancer. 2006 Dec 15;119(12):2724-32. doi: 10.1002/ijc.22207.
228 MiR-155-5p positively regulates CCL17-induced colon cancer cell migration by targeting RhoA.Oncotarget. 2017 Feb 28;8(9):14887-14896. doi: 10.18632/oncotarget.14841.
229 The CCL21/CCR7 pathway plays a key role in human colon cancer metastasis through regulation of matrix metalloproteinase-9.Dig Liver Dis. 2011 Jan;43(1):40-7. doi: 10.1016/j.dld.2010.05.013. Epub 2010 Jul 6.
230 NPTX1 inhibits colon cancer cell proliferation through down-regulating cyclin A2 and CDK2 expression.Cell Biol Int. 2018 May;42(5):589-597. doi: 10.1002/cbin.10935. Epub 2018 Feb 6.
231 Aspirin, platelets, and cancer: The point of view of the internist.Eur J Intern Med. 2016 Oct;34:11-20. doi: 10.1016/j.ejim.2016.06.004. Epub 2016 Jun 22.
232 Adiponectin and metformin additively attenuate IL1-induced malignant potential of colon cancer.Endocr Relat Cancer. 2013 Oct 24;20(6):849-59. doi: 10.1530/ERC-13-0240. Print 2013 Dec.
233 CCR1-mediated accumulation of myeloid cells in the liver microenvironment promoting mouse colon cancer metastasis.Clin Exp Metastasis. 2014 Dec;31(8):977-89. doi: 10.1007/s10585-014-9684-z. Epub 2014 Oct 18.
234 Overexpression of Evi-1 oncoprotein represses TGF- signaling in colorectal cancer.Mol Carcinog. 2013 Apr;52(4):255-264. doi: 10.1002/mc.21852. Epub 2011 Dec 7.
235 A novel antiangiogenic and vascular normalization therapy targeted against human CD160 receptor. J Exp Med. 2011 May 9;208(5):973-86.
236 Endosialin/TEM 1/CD248 is a pericyte marker of embryonic and tumor neovascularization.Microvasc Res. 2008 Nov;76(3):180-8. doi: 10.1016/j.mvr.2008.07.008. Epub 2008 Aug 8.
237 RETRACTED: KYA1797K down-regulates PD-L1 in colon cancer stem cells to block immune evasion by suppressing the -catenin/STT3 signaling pathway.Int Immunopharmacol. 2020 Jan;78:106003. doi: 10.1016/j.intimp.2019.106003. Epub 2019 Dec 5.
238 Molecular imaging of T cell co-regulator factor B7-H3 with (89)Zr-DS-5573a.Theranostics. 2018 Jul 30;8(15):4199-4209. doi: 10.7150/thno.25575. eCollection 2018.
239 Epithelial CD80 promotes immune surveillance of colonic preneoplastic lesions and its expression is increased by oxidative stress through STAT3 in colon cancer cells.J Exp Clin Cancer Res. 2019 May 9;38(1):190. doi: 10.1186/s13046-019-1205-0.
240 microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells.Cancer Res. 2009 Oct 15;69(20):8157-65. doi: 10.1158/0008-5472.CAN-09-1996. Epub 2009 Oct 13.
241 Tyrosine phosphorylation translocates beta-catenin from cell-->cell interface to the cytoplasm, but does not significantly enhance the LEF-1-dependent transactivating function.Cell Biol Int. 2001;25(5):421-7. doi: 10.1006/cbir.2000.0650.
242 Comparative Proteomics Analysis Identifies Cdc42-Cdc42BPA Signaling as Prognostic Biomarker and Therapeutic Target for Colon Cancer Invasion.J Proteome Res. 2018 Jan 5;17(1):265-275. doi: 10.1021/acs.jproteome.7b00550. Epub 2017 Nov 7.
243 Proteome profiling of cancer-associated fibroblasts identifies novel proinflammatory signatures and prognostic markers for colorectal cancer.Clin Cancer Res. 2013 Nov 1;19(21):6006-19. doi: 10.1158/1078-0432.CCR-13-1130. Epub 2013 Sep 11.
244 Molecular profiling and combinatorial activity of CCT068127: a potent CDK2 and CDK9 inhibitor.Mol Oncol. 2018 Mar;12(3):287-304. doi: 10.1002/1878-0261.12148. Epub 2018 Jan 28.
245 Synthesis and biological evaluation of N9-cis-cyclobutylpurine derivatives for use as cyclin-dependent kinase (CDK) inhibitors.Bioorg Med Chem Lett. 2017 Sep 15;27(18):4399-4404. doi: 10.1016/j.bmcl.2017.08.018. Epub 2017 Aug 12.
246 CDK8 Selectively Promotes the Growth of Colon Cancer Metastases in the Liver by Regulating Gene Expression of TIMP3 and Matrix Metalloproteinases.Cancer Res. 2018 Dec 1;78(23):6594-6606. doi: 10.1158/0008-5472.CAN-18-1583. Epub 2018 Sep 5.
247 Cyclin-dependent kinase 9 expression and its association with CD8(+) T cell infiltration in microsatellite-stable colorectal cancer.Oncol Lett. 2019 Dec;18(6):6046-6056. doi: 10.3892/ol.2019.10970. Epub 2019 Oct 8.
248 Inhibition of cancer growth and induction of apoptosis by BGP-13 and BGP-15, new calcipotriene-derived vitamin D3 analogs, in-vitro and in-vivo studies.Invest New Drugs. 2013 Apr;31(2):247-55. doi: 10.1007/s10637-012-9839-1. Epub 2012 Jun 2.
249 Preoperative neutrophil-lymphocyte ratio and CEA is associated with poor prognosis in patients with synchronous colorectal cancer liver metastasis.Ann Surg Treat Res. 2019 Apr;96(4):191-200. doi: 10.4174/astr.2019.96.4.191. Epub 2019 Mar 28.
250 Association of the invasiveness of colon cancer with the expression of C/EBP.Oncol Lett. 2019 Feb;17(2):1974-1979. doi: 10.3892/ol.2018.9755. Epub 2018 Nov 23.
251 Critical role for c-FLIP(L) on Fas resistance in colon carcinoma cell line HT-29.Cell Biol Int. 2008 Mar;32(3):329-36. doi: 10.1016/j.cellbi.2007.12.002. Epub 2007 Dec 23.
252 Acetylcholine release by human colon cancer cells mediates autocrine stimulation of cell proliferation.Am J Physiol Gastrointest Liver Physiol. 2008 Sep;295(3):G591-7. doi: 10.1152/ajpgi.00055.2008. Epub 2008 Jul 24.
253 Combined 5-FU and ChoK inhibitors as a new alternative therapy of colorectal cancer: evidence in human tumor-derived cell lines and mouse xenografts.PLoS One. 2013 Jun 10;8(6):e64961. doi: 10.1371/journal.pone.0064961. Print 2013.
254 REP1 inhibits FOXO3-mediated apoptosis to promote cancer cell survival.Cell Death Dis. 2017 Jan 5;8(1):e2536. doi: 10.1038/cddis.2016.462.
255 Up-regulation of CIT promotes the growth of colon cancer cells.Oncotarget. 2017 Jun 27;8(42):71954-71964. doi: 10.18632/oncotarget.18615. eCollection 2017 Sep 22.
256 Prognostic value of chloride channel accessory mRNA expression in colon cancer.Oncol Lett. 2019 Sep;18(3):2967-2976. doi: 10.3892/ol.2019.10615. Epub 2019 Jul 15.
257 Rapid eradication of colon carcinoma by Clostridium perfringens Enterotoxin suicidal gene therapy.BMC Cancer. 2017 Feb 13;17(1):129. doi: 10.1186/s12885-017-3123-x.
258 CLIC1 overexpression is associated with poor prognosis in gallbladder cancer.Tumour Biol. 2015 Jan;36(1):193-8. doi: 10.1007/s13277-014-2606-5. Epub 2014 Sep 17.
259 The CLN3 gene is a novel molecular target for cancer drug discovery.Cancer Res. 2002 Feb 1;62(3):801-8.
260 Endostatin gene therapy delivered by attenuated Salmonella typhimurium in murine tumor models.Cancer Gene Ther. 2018 Aug;25(7-8):167-183. doi: 10.1038/s41417-018-0021-6. Epub 2018 May 14.
261 Stat3 contributes to cancer progression by regulating Jab1/Csn5 expression.Oncogene. 2017 Feb 23;36(8):1069-1079. doi: 10.1038/onc.2016.271. Epub 2016 Aug 15.
262 Overexpression of arginine transporter CAT-1 is associated with accumulation of L-arginine and cell growth in human colorectal cancer tissue.PLoS One. 2013 Sep 6;8(9):e73866. doi: 10.1371/journal.pone.0073866. eCollection 2013.
263 Involvement of CRF2 signaling in enterocyte differentiation.World J Gastroenterol. 2017 Jul 28;23(28):5127-5145. doi: 10.3748/wjg.v23.i28.5127.
264 Integrated analysis of gene expression signatures associated with colon cancer from three datasets.Gene. 2018 May 15;654:95-102. doi: 10.1016/j.gene.2018.02.007. Epub 2018 Feb 3.
265 Cross talk between receptor guanylyl cyclase C and c-src tyrosine kinase regulates colon cancer cell cytostasis.Mol Cell Biol. 2009 Oct;29(19):5277-89. doi: 10.1128/MCB.00001-09. Epub 2009 Jul 20.
266 Integral analysis of p53 and its value as prognostic factor in sporadic colon cancer.BMC Cancer. 2013 Jun 5;13:277. doi: 10.1186/1471-2407-13-277.
267 MiR-186, miR-216b, miR-337-3p, and miR-760 cooperatively induce cellular senescence by targeting subunit of protein kinase CKII in human colorectal cancer cells.Biochem Biophys Res Commun. 2012 Dec 14;429(3-4):173-9. doi: 10.1016/j.bbrc.2012.10.117. Epub 2012 Nov 5.
268 Investigation of fusion gene expression in HCT116 cells.Oncol Lett. 2017 Dec;14(6):6962-6968. doi: 10.3892/ol.2017.7055. Epub 2017 Sep 25.
269 Molecular Portrait of Metastasis-Competent Circulating Tumor Cells in Colon Cancer Reveals the Crucial Role of Genes Regulating Energy Metabolism and DNA Repair.Clin Chem. 2017 Mar;63(3):700-713. doi: 10.1373/clinchem.2016.263582. Epub 2016 Dec 22.
270 Increased expression of cathepsin D is required for L1-mediated colon cancer progression.Oncotarget. 2019 Aug 27;10(50):5217-5228. doi: 10.18632/oncotarget.27155. eCollection 2019 Aug 27.
271 High Expression of Cathepsin E in Tissues but Not Blood of Patients with Barrett's Esophagus and Adenocarcinoma.Ann Surg Oncol. 2015 Jul;22(7):2431-8. doi: 10.1245/s10434-014-4155-y. Epub 2014 Oct 28.
272 CXCL13-CXCR5 axis promotes the growth and invasion of colon cancer cells via PI3K/AKT pathway.Mol Cell Biochem. 2015 Feb;400(1-2):287-95. doi: 10.1007/s11010-014-2285-y. Epub 2014 Dec 5.
273 Overexpression of chemokine receptor CXCR2 and ligand CXCL7 in liver metastases from colon cancer is correlated to shorter disease-free and overall survival.Cancer Sci. 2015 Mar;106(3):262-9. doi: 10.1111/cas.12603. Epub 2015 Mar 5.
274 Non-platelet-derived CXCL4 differentially regulates cytotoxic and regulatory T cells through CXCR3 to suppress the immune response to colon cancer.Cancer Lett. 2019 Feb 28;443:1-12. doi: 10.1016/j.canlet.2018.11.017. Epub 2018 Nov 24.
275 CXCR4/TGF-1 mediated hepatic stellate cells differentiation into carcinoma-associated fibroblasts and promoted liver metastasis of colon cancer.Cancer Biol Ther. 2020;21(3):258-268. doi: 10.1080/15384047.2019.1685157. Epub 2019 Dec 11.
276 Analysis of total meat intake and exposure to individual heterocyclic amines in a case-control study of colorectal cancer: contribution of metabolic variation to risk.Mutat Res. 2002 Sep 30;506-507:175-85. doi: 10.1016/s0027-5107(02)00164-1.
277 Vitamin D enhances the efficacy of irinotecan through miR-627-mediated inhibition of intratumoral drug metabolism. Mol Cancer Ther. 2016 Sep;15(9):2086-95.
278 Cysteinyl leukotriene receptor 1 facilitates tumorigenesis in a mouse model of colitis-associated colon cancer.Oncotarget. 2017 May 23;8(21):34773-34786. doi: 10.18632/oncotarget.16718.
279 A potential anti-tumor effect of leukotriene C4 through the induction of 15-hydroxyprostaglandin dehydrogenase expression in colon cancer cells.Oncotarget. 2017 May 23;8(21):35033-35047. doi: 10.18632/oncotarget.16591.
280 Transduction of the human deoxycytidine kinase gene in rodent tumor cells induces in vivo growth retardation in syngeneic hosts.Cancer Lett. 2000 Aug 11;156(2):151-7. doi: 10.1016/s0304-3835(00)00454-7.
281 Identifying DCN and HSPD1 as Potential Biomarkers in Colon Cancer Using 2D-LC-MS/MS Combined with iTRAQ Technology.J Cancer. 2017 Feb 11;8(3):479-489. doi: 10.7150/jca.17192. eCollection 2017.
282 Downregulation of discoidin domain receptor 2 in A375 human melanoma cells reduces its experimental liver metastasis ability.Oncol Rep. 2011 Oct;26(4):971-8. doi: 10.3892/or.2011.1356. Epub 2011 Jun 23.
283 Fascin1 suppresses RIG-I-like receptor signaling and interferon- production by associating with IB kinase (IKK) in colon cancer.J Biol Chem. 2018 Apr 27;293(17):6326-6336. doi: 10.1074/jbc.M117.819201. Epub 2018 Mar 1.
284 Expression and new exon mutations of the human Beta defensins and their association on colon cancer development.PLoS One. 2015 Jun 3;10(6):e0126868. doi: 10.1371/journal.pone.0126868. eCollection 2015.
285 DEK Expression is controlled by E2F and deregulated in diverse tumor types.Cell Cycle. 2006 Jun;5(11):1202-7. doi: 10.4161/cc.5.11.2801. Epub 2006 Jun 1.
286 Early prediction of tumor response to bevacizumab treatment in murine colon cancer models using three-dimensional dynamic contrast-enhanced ultrasound imaging.Angiogenesis. 2017 Nov;20(4):547-555. doi: 10.1007/s10456-017-9566-5. Epub 2017 Jul 18.
287 Human dihydrofolate reductase and thymidylate synthase form a complex in vitro and co-localize in normal and cancer cells.J Biomol Struct Dyn. 2017 May;35(7):1474-1490. doi: 10.1080/07391102.2016.1186560. Epub 2016 Aug 5.
288 Dickkopf-Related Protein 2 is Epigenetically Inactivated and Suppresses Colorectal Cancer Growth and Tumor Metastasis by Antagonizing Wnt/-Catenin Signaling.Cell Physiol Biochem. 2017;41(5):1709-1724. doi: 10.1159/000471861. Epub 2017 Mar 30.
289 Kaiso differentially regulates components of the Notch signaling pathway in intestinal cells.Cell Commun Signal. 2017 Jun 21;15(1):24. doi: 10.1186/s12964-017-0178-x.
290 Anti-DLL4 inhibits growth and reduces tumor-initiating cell frequency in colorectal tumors with oncogenic KRAS mutations.Cancer Res. 2011 Mar 1;71(5):1520-5. doi: 10.1158/0008-5472.CAN-10-2817. Epub 2010 Dec 30.
291 Neutrophil extracellular traps promote peritoneal metastasis of colon cancer cells.Oncotarget. 2019 Feb 8;10(12):1238-1249. doi: 10.18632/oncotarget.26664. eCollection 2019 Feb 8.
292 Ionizing radiation-induced adenovirus infection is mediated by Dynamin 2.Cancer Res. 2005 Jul 1;65(13):5493-7. doi: 10.1158/0008-5472.CAN-04-4526.
293 Chemotherapeutic agents attenuate CXCL12-mediated migration of colon cancer cells by selecting for CXCR4-negative cells and increasing peptidase CD26.BMC Cancer. 2015 Nov 10;15:882. doi: 10.1186/s12885-015-1702-2.
294 Thymidilate synthase expression predicts longer survival in patients with stage II colon cancer treated with 5-flurouracil independently of microsatellite instability.J Cancer Res Clin Oncol. 2011 Feb;137(2):201-10. doi: 10.1007/s00432-010-0872-1. Epub 2010 Apr 13.
295 Phosphorylation and mRNA splicing of collapsin response mediator protein-2 determine inhibition of rho-associated protein kinase (ROCK) II function in carcinoma cell migration and invasion.J Biol Chem. 2013 Oct 25;288(43):31229-40. doi: 10.1074/jbc.M113.505602. Epub 2013 Sep 13.
296 Prognostic significance of miR-215 in colon cancer.Clin Colorectal Cancer. 2011 Dec;10(4):340-7. doi: 10.1016/j.clcc.2011.06.002. Epub 2011 Jul 12.
297 Novel function of MKP-5/DUSP10, a phosphatase of stress-activated kinases, on ERK-dependent gene expression, and upregulation of its gene expression in colon carcinomas.Oncol Rep. 2012 Sep;28(3):931-6. doi: 10.3892/or.2012.1862. Epub 2012 Jun 12.
298 Mirk/Dyrk1B, a novel therapeutic target, mediates cell survival in non-small cell lung cancer cells.Cancer Biol Ther. 2009 Sep;8(17):1671-9. doi: 10.4161/cbt.8.17.9322. Epub 2009 Sep 20.
299 E2F1 facilitates DNA break repair by localizing to break sites and enhancing the expression of homologous recombination factors.Exp Mol Med. 2019 Sep 18;51(9):1-12. doi: 10.1038/s12276-019-0307-2.
300 Systemic delivery of full-length C/EBP beta/liposome complex suppresses growth of human colon cancer in nude mice.Cell Res. 2005 Oct;15(10):770-6. doi: 10.1038/sj.cr.7290346.
301 Epigenetic inactivation of endothelin-2 and endothelin-3 in colon cancer.Int J Cancer. 2013 Mar 1;132(5):1004-12. doi: 10.1002/ijc.27762. Epub 2012 Aug 24.
302 Silencing of EEF2K (eukaryotic elongation factor-2 kinase) reveals AMPK-ULK1-dependent autophagy in colon cancer cells.Autophagy. 2014 Sep;10(9):1495-508. doi: 10.4161/auto.29164. Epub 2014 Jun 19.
303 Bufalin-Loaded CaP/DPPE-PEG-EGF Nanospheres: Preparation, Cellular Uptake, Distribution, and Anti-Tumor Effects.J Biomed Nanotechnol. 2019 Feb 1;15(2):329-339. doi: 10.1166/jbn.2019.2681.
304 The extracellular matrix protein mindin attenuates colon cancer progression by blocking angiogenesis via Egr-1-mediated regulation.Oncogene. 2018 Feb 1;37(5):601-615. doi: 10.1038/onc.2017.359. Epub 2017 Oct 9.
305 Eukaryotic translation initiation factor 5A induces apoptosis in colon cancer cells and associates with the nucleus in response to tumour necrosis factor alpha signalling.Exp Cell Res. 2007 Feb 1;313(3):437-49. doi: 10.1016/j.yexcr.2006.09.030. Epub 2006 Oct 28.
306 Expression and localization of ecto-nucleotide pyrophosphatase/phosphodiesterase I-3 (E-NPP3/CD203c/PD-I beta/B10/gp130RB13-6) in human colon carcinoma.Int J Mol Med. 2003 Nov;12(5):763-6.
307 Construction of chimeric antigen receptormodified T cells targeting EpCAM and assessment of their antitumor effect on cancer cells.Mol Med Rep. 2019 Sep;20(3):2355-2364. doi: 10.3892/mmr.2019.10460. Epub 2019 Jul 3.
308 Evaluation of EphA2 and EphB4 as Targets for Image-Guided Colorectal Cancer Surgery.Int J Mol Sci. 2017 Feb 3;18(2):307. doi: 10.3390/ijms18020307.
309 EphA3 Downregulation by Hypermethylation Associated with Lymph Node Metastasis and TNM Stage in Colorectal Cancer.Dig Dis Sci. 2019 Jun;64(6):1514-1522. doi: 10.1007/s10620-018-5421-9. Epub 2018 Dec 17.
310 Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers.Clin Chem. 2004 Mar;50(3):490-9. doi: 10.1373/clinchem.2003.026849. Epub 2004 Jan 15.
311 Anti-MEK and Anti-EGFR mAbs in RAS-Mutant Metastatic Colorectal Cancer: Case Series and Rationale.Adv Ther. 2019 Jun;36(6):1480-1484. doi: 10.1007/s12325-019-00949-y. Epub 2019 Apr 12.
312 EphB4 promotes the proliferation, invasion, and angiogenesis of human colorectal cancer.Exp Mol Pathol. 2016 Jun;100(3):402-8. doi: 10.1016/j.yexmp.2016.03.011. Epub 2016 Apr 9.
313 Oxidative balance and colon and rectal cancer: interaction of lifestyle factors and genes.Mutat Res. 2012 Jun 1;734(1-2):30-40. doi: 10.1016/j.mrfmmm.2012.04.002. Epub 2012 Apr 15.
314 Silencing of CD133 inhibits GLUT1-mediated glucose transport through downregulation of the HER3/Akt/mTOR pathway in colon cancer.FEBS Lett. 2020 Mar;594(6):1021-1035. doi: 10.1002/1873-3468.13686. Epub 2019 Nov 29.
315 ERR suppression enhances the cytotoxicity of the MEK inhibitor trametinib against colon cancer cells.J Exp Clin Cancer Res. 2018 Sep 5;37(1):218. doi: 10.1186/s13046-018-0862-8.
316 RuvBl2 cooperates with Ets2 to transcriptionally regulate hTERT in colon cancer.FEBS Lett. 2011 Aug 4;585(15):2537-44. doi: 10.1016/j.febslet.2011.07.005. Epub 2011 Jul 13.
317 Proteomic characterization of peroxisome proliferator-activated receptor- (PPAR) overexpressing or silenced colorectal cancer cells unveils a novel protein network associated with an aggressive phenotype.Mol Oncol. 2016 Oct;10(8):1344-62. doi: 10.1016/j.molonc.2016.07.006. Epub 2016 Jul 25.
318 Factor VIIa regulates the expression of caspase-3, MMP-9, and CD44 in SW620 colon cancer cells involving PAR2/MAPKs/NF-B signaling pathways.Cancer Invest. 2013 Jan;31(1):7-16. doi: 10.3109/07357907.2012.743556. Epub 2012 Nov 21.
319 Decreased expression of protease-activated receptor 4 in human gastric cancer.Int J Biochem Cell Biol. 2011 Sep;43(9):1277-83. doi: 10.1016/j.biocel.2011.05.008. Epub 2011 May 25.
320 A recombinant adenovirus vector encoding the light chain of human coagulation factor VII and IgG1 Fc fragment to targeting tissue factor for colorectal cancer immunotherapy in the mouse model.J Cancer Res Clin Oncol. 2013 Jun;139(6):1015-23. doi: 10.1007/s00432-013-1417-1. Epub 2013 Mar 15.
321 Challenge in the differentiation between attenuated familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer: case report with review of the literature.Am J Gastroenterol. 2002 Jul;97(7):1822-7. doi: 10.1111/j.1572-0241.2002.05850.x.
322 Downregulation of the neonatal Fc receptor expression in non-small cell lung cancer tissue is associated with a poor prognosis.Oncotarget. 2016 Aug 23;7(34):54415-54429. doi: 10.18632/oncotarget.10074.
323 Bufalin-loaded vitamin E succinate-grafted-chitosan oligosaccharide/RGD conjugated TPGS mixed micelles demonstrated improved antitumor activity against drug-resistant colon cancer.Int J Nanomedicine. 2018 Nov 15;13:7533-7548. doi: 10.2147/IJN.S170692. eCollection 2018.
324 Erythropoietic protoporphyria a clinical and molecular study from Lebanon: Ferrochelatase a potential tumor suppressor gene in colon cancer.Clin Genet. 2017 Nov;92(5):495-502. doi: 10.1111/cge.12968. Epub 2017 Aug 2.
325 Involvement of FFA1 and FFA4 in the regulation of cellular functions during tumor progression in colon cancer cells.Exp Cell Res. 2018 Aug 1;369(1):54-60. doi: 10.1016/j.yexcr.2018.05.005. Epub 2018 May 8.
326 Loss of FFAR2 promotes colon cancer by epigenetic dysregulation of inflammation suppressors.Int J Cancer. 2018 Aug 15;143(4):886-896. doi: 10.1002/ijc.31366. Epub 2018 Mar 30.
327 Fibroblast growth factor 18 promotes proliferation and migration of H460 cells via the ERK and p38 signaling pathways.Oncol Rep. 2017 Feb;37(2):1235-1242. doi: 10.3892/or.2016.5301. Epub 2016 Dec 7.
328 Upregulation of Fibroblast Growth Factor 19 Is Associated with the Initiation of Colorectal Adenoma.Dig Dis. 2019;37(3):214-225. doi: 10.1159/000494454. Epub 2018 Dec 5.
329 A transforming gene, hst, found in NIH 3T3 cells transformed with DNA from three stomach cancers and a colon cancer.Jpn J Cancer Res. 1987 Apr;78(4):325-8.
330 Keratinocyte Growth Factor Regulation of Aryl Hydrocarbon Receptor Activation in Colorectal Cancer Cells.Dig Dis Sci. 2016 Feb;61(2):444-52. doi: 10.1007/s10620-015-3908-1. Epub 2015 Oct 29.
331 FHL1 on chromosome X is a single-hit gastrointestinal tumor-suppressor gene and contributes to the formation of an epigenetic field defect.Oncogene. 2013 Apr 25;32(17):2140-9. doi: 10.1038/onc.2012.228. Epub 2012 Jun 11.
332 The NF-kappa B transcription factor and cancer: high expression of NF-kappa B- and I kappa B-related proteins in tumor cell lines.Biochem Pharmacol. 1994 Jan 13;47(1):145-9. doi: 10.1016/0006-2952(94)90448-0.
333 Downregulation of VEGF-C expression in lung and colon cancer cells decelerates tumor growth and inhibits metastasis via multiple mechanisms.Oncogene. 2012 Mar 15;31(11):1389-97. doi: 10.1038/onc.2011.330. Epub 2011 Aug 1.
334 Dual targeting system by supramolecular complex of folate-conjugated methyl--cyclodextrin with adamantane-grafted hyaluronic acid for the treatment of colorectal cancer.Int J Biol Macromol. 2018 Jul 1;113:386-394. doi: 10.1016/j.ijbiomac.2018.02.149. Epub 2018 Feb 24.
335 Fos-like antigen 2 (FOSL2) promotes metastasis in colon cancer. Exp Cell Res. 2018 Dec 15;373(1-2):57-61.
336 Quxie Capsule Inhibits Colon Tumor Growth Partially Through Foxo1-Mediated Apoptosis and Immune Modulation.Integr Cancer Ther. 2019 Jan-Dec;18:1534735419846377. doi: 10.1177/1534735419846377.
337 The role of lymph node size and FOXP3+ regulatory T cells in node-negative colon cancer.J Clin Pathol. 2017 May;70(5):443-447. doi: 10.1136/jclinpath-2016-203978. Epub 2016 Nov 22.
338 Color-coded Imaging Distinguishes Cancer Cells, Stromal Cells, and Recombinant Cancer-stromal Cells in the Tumor Microenvironment During Metastasis.Anticancer Res. 2018 Aug;38(8):4417-4423. doi: 10.21873/anticanres.12743.
339 Formyl peptide receptor 2 mediated chemotherapeutics drug resistance in colon cancer cells.Eur Rev Med Pharmacol Sci. 2018 Jan;22(1):95-100. doi: 10.26355/eurrev_201801_14105.
340 Studying human disease genes in Caenorhabditis elegans: a molecular genetics laboratory project.CBE Life Sci Educ. 2012 Summer;11(2):165-79. doi: 10.1187/cbe-11-06-0045.
341 Promoter analysis of the human alpha1,3/4-fucosyltransferase gene (FUT III).Biochim Biophys Acta. 2005 Oct 15;1731(1):66-73. doi: 10.1016/j.bbaexp.2005.08.009. Epub 2005 Sep 13.
342 Transfection of alpha(1,3)fucosyltransferase antisense sequences impairs the proliferative and tumorigenic ability of human colon carcinoma cells.Mol Carcinog. 2000 Apr;27(4):280-8.
343 Frizzled-10, up-regulated in primary colorectal cancer, is a positive regulator of the WNT - beta-catenin - TCF signaling pathway.Int J Mol Med. 2002 Feb;9(2):107-12.
344 Overexpression of FZD7 is associated with poor survival in patients with colon cancer.Pathol Res Pract. 2019 Aug;215(8):152478. doi: 10.1016/j.prp.2019.152478. Epub 2019 May 27.
345 The roles and mechanisms of G3BP1 in tumour promotion. J Drug Target. 2019 Mar;27(3):300-305.
346 Galanin is up-regulated in colon adenocarcinoma.Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2373-8. doi: 10.1158/1055-9965.EPI-06-0740.
347 Identification of novel tumor markers in prostate, colon and breast cancer by unbiased methylation profiling.PLoS One. 2008 Apr 30;3(4):e2079. doi: 10.1371/journal.pone.0002079.
348 Glucagon promotes colon cancer cell growth via regulating AMPK and MAPK pathways.Oncotarget. 2018 Jan 31;9(12):10650-10664. doi: 10.18632/oncotarget.24367. eCollection 2018 Feb 13.
349 Reversal of cisplatin and multidrug resistance by ribozyme-mediated glutathione suppression.Biochem Biophys Res Commun. 2001 Aug 17;286(2):406-13. doi: 10.1006/bbrc.2001.5399.
350 siRNA-targeted inhibition of growth hormone receptor in human colon cancer SW480 cells.World J Gastroenterol. 2013 Nov 28;19(44):8108-13. doi: 10.3748/wjg.v19.i44.8108.
351 Ghrelin induces colon cancer cell proliferation through the GHS-R, Ras, PI3K, Akt, and mTOR signaling pathways.Eur J Pharmacol. 2016 Apr 5;776:124-31. doi: 10.1016/j.ejphar.2016.02.044. Epub 2016 Feb 12.
352 Hedgehog signaling drives cellular survival in human colon carcinoma cells.Cancer Res. 2011 Feb 1;71(3):1092-102. doi: 10.1158/0008-5472.CAN-10-2315. Epub 2010 Dec 6.
353 Synergistic inhibition of colon cancer growth by the combination of methylglyoxal and silencing of glyoxalase I mediated by the STAT1 pathway.Oncotarget. 2017 Jun 22;8(33):54838-54857. doi: 10.18632/oncotarget.18601. eCollection 2017 Aug 15.
354 Geminin ablation in vivo enhances tumorigenesis through increased genomic instability.J Pathol. 2018 Oct;246(2):134-140. doi: 10.1002/path.5128. Epub 2018 Aug 21.
355 Identification of regulatory role of DNA methylation in colon cancer gene expression via systematic bioinformatics analysis.Medicine (Baltimore). 2017 Nov;96(47):e8487. doi: 10.1097/MD.0000000000008487.
356 Phosphoglucose isomerase enhances colorectal cancer metastasis.Int J Oncol. 2009 Nov;35(5):1117-21. doi: 10.3892/ijo_00000427.
357 Down-regulation of GPR137 expression inhibits proliferation of colon cancer cells. RETRACTED ARTICLESee: Retraction NoticeActa Biochim Biophys Sin (Shanghai). 2014 Nov;46(11):935-41.
358 Utility of G protein-coupled receptor 35 expression for predicting outcome in colon cancer.Tumour Biol. 2019 Jun;41(6):1010428319858885. doi: 10.1177/1010428319858885.
359 Extravirgin olive oil up-regulates CB?tumor suppressor gene in human colon cancer cells and in rat colon via epigenetic mechanisms.J Nutr Biochem. 2015 Mar;26(3):250-8. doi: 10.1016/j.jnutbio.2014.10.013. Epub 2014 Dec 3.
360 The miR-487b-3p/GRM3/TGF signaling axis is an important regulator of colon cancer tumorigenesis.Oncogene. 2017 Jun 15;36(24):3477-3489. doi: 10.1038/onc.2016.499. Epub 2017 Jan 23.
361 Overexpression of glutathione S-transferase and elevation of thiol pools in a multidrug-resistant human colon cancer cell line.Mol Pharmacol. 1992 Jan;41(1):69-75.
362 Mechanistic evaluation and transcriptional signature of a glutathione S-transferase omega 1 inhibitor. Nat Commun. 2016 Oct 5;7:13084.
363 Advances in In-Silico based Predictive In-Vivo Profiling of Novel Potent -Glucuronidase Inhibitors.Curr Cancer Drug Targets. 2019;19(11):906-918. doi: 10.2174/1568009619666190320102238.
364 Tumor-derived granzyme B-expressing neutrophils acquire antitumor potential after lipid A treatment.Oncotarget. 2018 Jun 19;9(47):28364-28378. doi: 10.18632/oncotarget.25342. eCollection 2018 Jun 19.
365 Enhancement of radiation-induced DNA double-strand breaks and micronuclei in human colon carcinoma cells by N-methylformamide.Radiat Res. 1989 Jul;119(1):166-75.
366 Inhibition of Hematopoietic Cell Kinase Activity Suppresses Myeloid Cell-Mediated Colon Cancer Progression.Cancer Cell. 2017 Apr 10;31(4):563-575.e5. doi: 10.1016/j.ccell.2017.03.006.
367 Ectopic expression of OX1R in ulcerative colitis mediates anti-inflammatory effect of orexin-A.Biochim Biophys Acta Mol Basis Dis. 2018 Nov;1864(11):3618-3628. doi: 10.1016/j.bbadis.2018.08.023. Epub 2018 Aug 18.
368 HDAC10 expression is associated with DNA mismatch repair gene and is a predictor of good prognosis in colon carcinoma.Oncol Lett. 2017 Oct;14(4):4923-4929. doi: 10.3892/ol.2017.6818. Epub 2017 Aug 24.
369 Colon cancer cells maintain low levels of pyruvate to avoid cell death caused by inhibition of HDAC1/HDAC3.Biochem J. 2009 Jan 1;417(1):379-89. doi: 10.1042/BJ20081132.
370 Histone deacetylase 6 is overexpressed and promotes tumor growth of colon cancer through regulation of the MAPK/ERK signal pathway.Onco Targets Ther. 2019 Apr 2;12:2409-2419. doi: 10.2147/OTT.S194986. eCollection 2019.
371 Histidine decarboxylase (HDC)-expressing granulocytic myeloid cells induce and recruit Foxp3(+) regulatory T cells in murine colon cancer.Oncoimmunology. 2017 Feb 10;6(3):e1290034. doi: 10.1080/2162402X.2017.1290034. eCollection 2017.
372 A strategy for disease gene identification through nonsense-mediated mRNA decay inhibition.Nat Biotechnol. 2001 May;19(5):434-9. doi: 10.1038/88099.
373 Correlation of ERK/MAPK signaling pathway with proliferation and apoptosis of colon cancer cells.Oncol Lett. 2019 Feb;17(2):2266-2270. doi: 10.3892/ol.2018.9857. Epub 2018 Dec 20.
374 Tissue microarray cytometry reveals positive impact of homeodomain interacting protein kinase 2 in colon cancer survival irrespective of p53 function.Am J Pathol. 2011 May;178(5):1986-98. doi: 10.1016/j.ajpath.2011.01.021.
375 Predictive value of different proportion of lesion HLA-G expression in colorectal cancer.Oncotarget. 2017 Nov 18;8(64):107441-107451. doi: 10.18632/oncotarget.22487. eCollection 2017 Dec 8.
376 H19 promotes the migration and invasion of colon cancer by sponging miR-138 to upregulate the expression of HMGA1.Int J Oncol. 2017 May;50(5):1801-1809. doi: 10.3892/ijo.2017.3941. Epub 2017 Mar 29.
377 KLF4 sensitizes the colon cancer cell HCT-15 to cisplatin by altering the expression of HMGB1 and hTERT.Life Sci. 2019 Mar 1;220:169-176. doi: 10.1016/j.lfs.2019.02.005. Epub 2019 Feb 2.
378 Ketogenic HMGCS2 Is a c-Myc target gene expressed in differentiated cells of human colonic epithelium and down-regulated in colon cancer.Mol Cancer Res. 2006 Sep;4(9):645-53. doi: 10.1158/1541-7786.MCR-05-0267. Epub 2006 Aug 28.
379 Mechanisms of confluence-dependent expression of CD26 in colon cancer cell lines.BMC Cancer. 2011 Feb 1;11:51. doi: 10.1186/1471-2407-11-51.
380 Novel screening system revealed that intracellular cholesterol trafficking can be a good target for colon cancer prevention.Sci Rep. 2019 Apr 17;9(1):6192. doi: 10.1038/s41598-019-42363-y.
381 microRNA-18a induces apoptosis in colon cancer cells via the autophagolysosomal degradation of oncogenic heterogeneous nuclear ribonucleoprotein A1.Oncogene. 2014 Oct 2;33(40):4847-56. doi: 10.1038/onc.2013.429. Epub 2013 Oct 28.
382 A novel long non-coding RNA from the HOXA6-HOXA5 locus facilitates colon cancer cell growth.BMC Cancer. 2019 Jun 3;19(1):532. doi: 10.1186/s12885-019-5715-0.
383 Tumor-suppressive function and mechanism of HOXB13 in right-sided colon cancer.Signal Transduct Target Ther. 2019 Nov 29;4:51. doi: 10.1038/s41392-019-0086-1. eCollection 2019.
384 Insulin, CCAAT/enhancer-binding proteins and lactate regulate the human 11-hydroxysteroid dehydrogenase type 2 gene expression in colon cancer cell lines.PLoS One. 2014 Aug 18;9(8):e105354. doi: 10.1371/journal.pone.0105354. eCollection 2014.
385 Developing antineoplastic agents that target peroxisomal enzymes: cytisine-linked isoflavonoids as inhibitors of hydroxysteroid 17-beta-dehydrogenase-4 (HSD17B4).Org Biomol Chem. 2017 Sep 20;15(36):7623-7629. doi: 10.1039/c7ob01584d.
386 Polymer mediated transport of the Hsp90 inhibitor LB76, a polar cyclic peptide, produces an Hsp90 cellular phenotype.Chem Commun (Camb). 2019 Apr 11;55(31):4515-4518. doi: 10.1039/c9cc00890j.
387 Clients and Oncogenic Roles of Molecular Chaperone gp96/grp94.Curr Top Med Chem. 2016;16(25):2765-78. doi: 10.2174/1568026616666160413141613.
388 A high throughput substrate binding assay reveals hexachlorophene as an inhibitor of the ER-resident HSP70 chaperone GRP78.Bioorg Med Chem Lett. 2019 Jul 15;29(14):1689-1693. doi: 10.1016/j.bmcl.2019.05.041. Epub 2019 May 20.
389 Heat shock cognate protein 70 encodes antigenic epitopes recognised by HLA-B4601-restricted cytotoxic T lymphocytes from cancer patients.Br J Cancer. 2003 Sep 15;89(6):1079-85. doi: 10.1038/sj.bjc.6601203.
390 MiR-214 sensitizes human colon cancer cells to 5-FU by targeting Hsp27.Cell Mol Biol Lett. 2019 Mar 14;24:22. doi: 10.1186/s11658-019-0143-3. eCollection 2019.
391 Proteoglycans as potential microenvironmental biomarkers for colon cancer.Cell Tissue Res. 2015 Sep;361(3):833-44. doi: 10.1007/s00441-015-2141-8. Epub 2015 Feb 26.
392 Associations of ICOS and PD.1 Gene Variants with Colon Cancer Risk in The Iranian Population.Asian Pac J Cancer Prev. 2018 Mar 27;19(3):693-698. doi: 10.22034/APJCP.2018.19.3.693.
393 Polymorphisms in the ICOS/CD28-ICOSL pathway are related to capecitabine-based chemotherapy response in advanced colon cancer patients.Mol Immunol. 2018 Apr;96:78-82. doi: 10.1016/j.molimm.2018.02.017. Epub 2018 Mar 5.
394 Insights into Resistance Mechanisms of Inhibitors to Mps1 C604Y Mutation via a Comprehensive Molecular Modeling Study.Molecules. 2018 Jun 20;23(6):1488. doi: 10.3390/molecules23061488.
395 The role of IGFBP-5 in mediating the anti-proliferation effect of tetrandrine in human colon cancer cells.Int J Oncol. 2015 Mar;46(3):1205-13. doi: 10.3892/ijo.2014.2800. Epub 2014 Dec 17.
396 Exploring multilocus associations of inflammation genes and colorectal cancer risk using hapConstructor.BMC Med Genet. 2010 Dec 3;11:170. doi: 10.1186/1471-2350-11-170.
397 Helminth-derived molecules inhibit colitis-associated colon cancer development through NF-B and STAT3 regulation.Int J Cancer. 2019 Dec 1;145(11):3126-3139. doi: 10.1002/ijc.32626. Epub 2019 Aug 30.
398 The immune microenvironment of the colorectal tumor: Involvement of immunity genes and microRNAs belonging to the TH17 pathway.Biochim Biophys Acta. 2015 Aug;1856(1):28-38. doi: 10.1016/j.bbcan.2015.04.001. Epub 2015 Apr 21.
399 Interleukin-1 receptor antagonist inhibits the expression of vascular endothelial growth factor in colorectal carcinoma.Oncology. 2005;68(2-3):138-45. doi: 10.1159/000086768. Epub 2005 Jul 4.
400 Interleukin-1 Receptor Type 2 Acts with c-Fos to Enhance the Expression of Interleukin-6 and Vascular Endothelial Growth Factor A in Colon Cancer Cells and Induce Angiogenesis.J Biol Chem. 2015 Sep 4;290(36):22212-24. doi: 10.1074/jbc.M115.644823. Epub 2015 Jul 24.
401 De novo design of potent and selective mimics of IL-2 and IL-15.Nature. 2019 Jan;565(7738):186-191. doi: 10.1038/s41586-018-0830-7. Epub 2019 Jan 9.
402 IL-21 Enhances the Development of Colitis-Associated Colon Cancer: Possible Involvement of Activation-Induced Cytidine Deaminase Expression.J Immunol. 2019 Jun 1;202(11):3326-3333. doi: 10.4049/jimmunol.1800550. Epub 2019 Apr 24.
403 Interleukin (IL)-22 from IL-20 Subfamily of Cytokines Induces Colonic Epithelial Cell Proliferation Predominantly through ERK1/2 Pathway.Int J Mol Sci. 2019 Jul 15;20(14):3468. doi: 10.3390/ijms20143468.
404 Endogenous IL-33 exerts CD8(+) T cell antitumor responses overcoming pro-tumor effects by regulatory T cells in a colon carcinoma model.Biochem Biophys Res Commun. 2019 Oct 15;518(2):331-336. doi: 10.1016/j.bbrc.2019.08.058. Epub 2019 Aug 14.
405 4PD Functionalized Dendrimers: A Flexible Tool for In Vivo Gene Silencing of Tumor-Educated Myeloid Cells.J Immunol. 2017 May 15;198(10):4166-4177. doi: 10.4049/jimmunol.1600833. Epub 2017 Apr 10.
406 Dual enhancement of T and NK cell function by pulsatile inhibition of SHIP1 improves antitumor immunity and survival.Sci Signal. 2017 Oct 10;10(500):eaam5353. doi: 10.1126/scisignal.aam5353.
407 Myeloid-Derived Suppressor Cells Produce IL-10 to Elicit DNMT3b-Dependent IRF8 Silencing to Promote Colitis-Associated Colon Tumorigenesis.Cell Rep. 2018 Dec 11;25(11):3036-3046.e6. doi: 10.1016/j.celrep.2018.11.050.
408 Selective inhibition of proprotein convertases represses the metastatic potential of human colorectal tumor cells.J Clin Invest. 2008 Jan;118(1):352-63. doi: 10.1172/JCI32040.
409 Hypermethylation of ITGA4, TFPI2 and VIMENTIN promoters is increased in inflamed colon tissue: putative risk markers for colitis-associated cancer.J Cancer Res Clin Oncol. 2015 Dec;141(12):2097-107. doi: 10.1007/s00432-015-1972-8. Epub 2015 Apr 23.
410 Targeting colon cancer cells using PEGylated liposomes modified with a fibronectin-mimetic peptide.Int J Pharm. 2009 Jan 21;366(1-2):201-10. doi: 10.1016/j.ijpharm.2008.09.016. Epub 2008 Sep 19.
411 MiR-30a-5p Suppresses Tumor Metastasis of Human Colorectal Cancer by Targeting ITGB3.Cell Physiol Biochem. 2016;39(3):1165-76. doi: 10.1159/000447823. Epub 2016 Aug 31.
412 Tumor specific delivery and therapy mediate by integrin 6-target immunoliposomes for 6-siRNA in colon carcinoma.Oncotarget. 2016 Dec 20;7(51):85163-85175. doi: 10.18632/oncotarget.13209.
413 Long noncoding RNA ENST00000455974 plays an oncogenic role through up-regulating JAG2 in human DNA mismatch repair-proficient colon cancer.Biochem Biophys Res Commun. 2019 Jan 8;508(2):339-347. doi: 10.1016/j.bbrc.2018.11.088. Epub 2018 Nov 23.
414 Downregulation of histone demethylase JMJD1C inhibits colorectal cancer metastasis through targeting ATF2.Am J Cancer Res. 2018 May 1;8(5):852-865. eCollection 2018.
415 A role for the unfolded protein response stress sensor ERN1 in regulating the response to MEK inhibitors in KRAS mutant colon cancers.Genome Med. 2018 Nov 27;10(1):90. doi: 10.1186/s13073-018-0600-z.
416 Downregulation of the hexokinase II gene sensitizes human colon cancer cells to 5-fluorouracil.Chemotherapy. 2008;54(5):357-63. doi: 10.1159/000153655. Epub 2008 Sep 5.
417 Activity of voltage-gated K+ channels is associated with cell proliferation and Ca2+ influx in carcinoma cells of colon cancer.Life Sci. 1999;65(1):55-62. doi: 10.1016/s0024-3205(99)00218-0.
418 HERG1 gene expression as a specific tumor marker in colorectal tissues.Eur J Surg Oncol. 2010 Jan;36(1):72-7. doi: 10.1016/j.ejso.2009.05.009. Epub 2009 Jul 4.
419 Acetylation of PHF5A Modulates Stress Responses and Colorectal Carcinogenesis through Alternative Splicing-Mediated Upregulation of KDM3A.Mol Cell. 2019 Jun 20;74(6):1250-1263.e6. doi: 10.1016/j.molcel.2019.04.009. Epub 2019 May 1.
420 The JMJD2A demethylase regulates apoptosis and proliferation in colon cancer cells.J Cell Biochem. 2012 Apr;113(4):1368-76. doi: 10.1002/jcb.24009.
421 KDM5c inhibits multidrug resistance of colon cancer cell line by down-regulating ABCC1.Biomed Pharmacother. 2018 Nov;107:1205-1209. doi: 10.1016/j.biopha.2018.08.041. Epub 2018 Aug 29.
422 Kisspeptin effect on endothelial monocyte activating polypeptide II (EMAP-II)-associated lymphocyte cell death and metastases in colorectal cancer patients.Mol Med. 2014 Mar 18;20(1):80-92. doi: 10.2119/molmed.2013.00151.
423 Mechano-growth Factor Expression in Colorectal Cancer Investigated With Fluorescent Gold Nanoparticles.Anticancer Res. 2019 Apr;39(4):1705-1710. doi: 10.21873/anticanres.13276.
424 Parallel overexpression and clinical significance of kallikrein-related peptidases 7 and 14 (KLK7KLK14) in colon cancer.Thromb Haemost. 2013 Apr;109(4):716-25. doi: 10.1160/TH12-07-0518. Epub 2012 Dec 6.
425 Kallikrein 6 protease advances colon tumorigenesis via induction of the high mobility group A2 protein.Oncotarget. 2019 Oct 22;10(58):6062-6078. doi: 10.18632/oncotarget.27153. eCollection 2019 Oct 22.
426 Kallikrein-related peptidase 7 (KLK7) is a proliferative factor that is aberrantly expressed in human colon cancer.Biol Chem. 2014 Sep;395(9):1075-86. doi: 10.1515/hsz-2014-0142.
427 Chitosan nanoparticle-based delivery of fused NKG2D-IL-21 gene suppresses colon cancer growth in mice.Int J Nanomedicine. 2017 Apr 13;12:3095-3107. doi: 10.2147/IJN.S128032. eCollection 2017.
428 Relationship between LAPTM4B Gene Polymorphism and Prognosis of Patients following Tumor Resection for Colorectal and Esophageal Cancers.PLoS One. 2016 Jul 8;11(7):e0158715. doi: 10.1371/journal.pone.0158715. eCollection 2016.
429 Anti-sense RNA of 32-kDa laminin-binding protein inhibits attachment and invasion of a human colon carcinoma cell line.J Surg Res. 1992 Apr;52(4):340-6. doi: 10.1016/0022-4804(92)90113-e.
430 An alternative pathway for expression of p56lck from type I promoter transcripts in colon carcinoma.Oncogene. 1997 Dec 11;15(24):2929-37. doi: 10.1038/sj.onc.1201474.
431 Mouse genetics suggests cell-context dependency for Myc-regulated metabolic enzymes during tumorigenesis.PLoS Genet. 2012;8(3):e1002573. doi: 10.1371/journal.pgen.1002573. Epub 2012 Mar 15.
432 Leptin induces SIRT1 expression through activation of NF-E2-related factor 2: Implications for obesity-associated colon carcinogenesis.Biochem Pharmacol. 2018 Jul;153:282-291. doi: 10.1016/j.bcp.2018.02.001. Epub 2018 Feb 7.
433 Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patients.BMC Cancer. 2019 Feb 15;19(1):155. doi: 10.1186/s12885-019-5327-8.
434 Promoter methylation of leukemia inhibitory factor receptor gene in colorectal carcinoma.Int J Oncol. 2011 Aug;39(2):337-44. doi: 10.3892/ijo.2011.1050. Epub 2011 May 23.
435 MicroRNA? suppresses human colon cancer invasion and proliferation by targeting the expression of focal adhesion kinase.Mol Med Rep. 2016 Feb;13(2):1297-303. doi: 10.3892/mmr.2015.4643. Epub 2015 Dec 4.
436 Downregulation of LIMK1-ADF/cofilin by DADS inhibits the migration and invasion of colon cancer.Sci Rep. 2017 Mar 30;7:45624. doi: 10.1038/srep45624.
437 Transcriptional regulation of the human placental-like alkaline phosphatase gene and mechanisms involved in its induction by sodium butyrate.Cancer Res. 1992 Jun 15;52(12):3378-83.
438 Functional role and therapeutic potential of the pim-1 kinase in colon carcinoma.Neoplasia. 2013 Jul;15(7):783-94. doi: 10.1593/neo.13172.
439 LOXL2 Is Highly Expressed in Cancer-Associated Fibroblasts and Associates to Poor Colon Cancer Survival.Clin Cancer Res. 2015 Nov 1;21(21):4892-902. doi: 10.1158/1078-0432.CCR-14-3096. Epub 2015 Jul 23.
440 MAGI-3 competes with NHERF-2 to negatively regulate LPA2 receptor signaling in colon cancer cells.Gastroenterology. 2011 Mar;140(3):924-34. doi: 10.1053/j.gastro.2010.11.054. Epub 2010 Dec 4.
441 Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1.Cancer Res. 2003 Apr 1;63(7):1706-11.
442 Negative regulation of cell motile and invasive activities by lysophosphatidic acid receptor-3 in colon cancer HCT116 cells.Tumour Biol. 2012 Dec;33(6):1899-905. doi: 10.1007/s13277-012-0450-z. Epub 2012 Jul 5.
443 Platelets subvert T cell immunity against cancer via GARP-TGF axis.Sci Immunol. 2017 May 5;2(11):eaai7911. doi: 10.1126/sciimmunol.aai7911.
444 Role of bacterial infection in the epigenetic regulation of Wnt antagonist WIF1 by PRC2 protein EZH2.Oncogene. 2015 Aug 20;34(34):4519-30. doi: 10.1038/onc.2014.386. Epub 2014 Dec 8.
445 Bovine lactoferrin and lactoferricin exert antitumor activities on human colorectal cancer cells (HT-29) by activating various signaling pathways.Biochem Cell Biol. 2017 Feb;95(1):99-109. doi: 10.1139/bcb-2016-0094. Epub 2016 Nov 30.
446 Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase gene.Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7859-64. doi: 10.1073/pnas.1332465100. Epub 2003 Jun 16.
447 Gamma-secretase inhibition attenuates oxaliplatin-induced apoptosis through increased Mcl-1 and/or Bcl-xL in human colon cancer cells.Apoptosis. 2013 Oct;18(10):1163-74. doi: 10.1007/s10495-013-0883-x.
448 Recurrent MLK4 Loss-of-Function Mutations Suppress JNK Signaling to Promote Colon Tumorigenesis.Cancer Res. 2016 Feb 1;76(3):724-35. doi: 10.1158/0008-5472.CAN-15-0701-T. Epub 2015 Dec 4.
449 p34 (SEI-1) inhibits ROS-induced cell death through suppression of ASK1.Cancer Biol Ther. 2011 Sep 1;12(5):421-6. doi: 10.4161/cbt.12.5.15972. Epub 2011 Sep 1.
450 MEK and TAK1 Regulate Apoptosis in Colon Cancer Cells with KRAS-Dependent Activation of Proinflammatory Signaling.Mol Cancer Res. 2016 Dec;14(12):1204-1216. doi: 10.1158/1541-7786.MCR-16-0173. Epub 2016 Sep 21.
451 Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion.Mol Cell Biol. 2006 Feb;26(4):1297-306. doi: 10.1128/MCB.26.4.1297-1306.2006.
452 The Level of TWIST1 expression determines the response of colon cancer cells to mitogen-activated protein kinases inhibitors.Saudi J Gastroenterol. 2018 Jan-Feb;24(1):37-45. doi: 10.4103/sjg.SJG_270_17.
453 Differential activation of JNK1 isoforms by TRAIL receptors modulate apoptosis of colon cancer cell lines.Br J Cancer. 2009 May 5;100(9):1415-24. doi: 10.1038/sj.bjc.6605021. Epub 2009 Apr 7.
454 Functional characterization of the tumor-suppressor MARCKS in colorectal cancer and its association with survival.Oncogene. 2015 Feb 26;34(9):1150-9. doi: 10.1038/onc.2014.40. Epub 2014 Mar 24.
455 Aberrant expression and activation of the thrombin receptor protease-activated receptor-1 induces cell proliferation and motility in human colon cancer cells.Am J Pathol. 2003 May;162(5):1503-13. doi: 10.1016/S0002-9440(10)64283-6.
456 Polyamine and methionine adenosyltransferase 2A crosstalk in human colon and liver cancer.Exp Cell Res. 2013 Jul 15;319(12):1902-1911. doi: 10.1016/j.yexcr.2013.04.005. Epub 2013 Apr 12.
457 Myc-Associated Zinc Finger Protein Regulates the Proinflammatory Response in Colitis and Colon Cancer via STAT3 Signaling.Mol Cell Biol. 2018 Oct 29;38(22):e00386-18. doi: 10.1128/MCB.00386-18. Print 2018 Nov 15.
458 Evidence Suggests Sphingosine 1-Phosphate Might Be Actively Generated, Degraded, and Transported to Extracellular Spaces With Increased S1P(2) and S1P(3) Expression in ColonCancer.Clin Colorectal Cancer. 2018 Jun;17(2):e171-e182. doi: 10.1016/j.clcc.2017.11.004. Epub 2017 Nov 21.
459 Correlations of MC4R and MSH2 expression with obesity in colon cancer patients.Eur Rev Med Pharmacol Sci. 2017 May;21(9):2108-2113.
460 Morpholino antisense oligomer targeting human midkine: its application for cancer therapy.Int J Cancer. 2005 Apr 10;114(3):490-7. doi: 10.1002/ijc.20781.
461 Mdm2-P53 Interaction Inhibitor with Cisplatin Enhances Apoptosis in Colon and Prostate Cancer Cells In-Vitro.Asian Pac J Cancer Prev. 2019 Nov 1;20(11):3341-3351. doi: 10.31557/APJCP.2019.20.11.3341.
462 miRNA-766 induces apoptosis of human colon cancer cells through the p53/Bax signaling pathway by MDM4.Exp Ther Med. 2019 May;17(5):4100-4108. doi: 10.3892/etm.2019.7436. Epub 2019 Mar 26.
463 Monoacylglycerol lipase regulates cannabinoid receptor 2-dependent macrophage activation and cancer progression.Nat Commun. 2018 Jul 3;9(1):2574. doi: 10.1038/s41467-018-04999-8.
464 Targeting M3 Muscarinic Receptors for Colon Cancer Therapy.Curr Mol Pharmacol. 2018;11(3):184-190. doi: 10.2174/1874467211666180119115828.
465 Stromelysin-3 (ST-3) mRNA expression in colorectal carcinomas. Localization and clinicopathologic correlations.Diagn Mol Pathol. 1996 Dec;5(4):284-90. doi: 10.1097/00019606-199612000-00010.
466 Farnesoid X receptor represses matrix metalloproteinase 7 expression, revealing this regulatory axis as a promising therapeutic target in colon cancer.J Biol Chem. 2019 May 24;294(21):8529-8542. doi: 10.1074/jbc.RA118.004361. Epub 2019 Apr 9.
467 DNA repair and cancer in colon and rectum: Novel players in genetic susceptibility.Int J Cancer. 2020 Jan 15;146(2):363-372. doi: 10.1002/ijc.32516. Epub 2019 Jul 4.
468 Overexpression and activation of the RON receptor tyrosine kinase in a panel of human colorectal carcinoma cell lines.Exp Cell Res. 2000 Nov 25;261(1):229-38. doi: 10.1006/excr.2000.5012.
469 Strong expression of methylthioadenosine phosphorylase (MTAP) in human colon carcinoma cells is regulated by TCF1/[beta]-catenin.Lab Invest. 2005 Jan;85(1):124-36. doi: 10.1038/labinvest.3700192.
470 Polymorphisms in methionine synthase, methionine synthase reductase and serine hydroxymethyltransferase, folate and alcohol intake, and colon cancer risk.J Nutrigenet Nutrigenomics. 2008;1(4):196-204. doi: 10.1159/000136651. Epub 2008 Jun 2.
471 Overexpression of MUC15 activates extracellular signal-regulated kinase 1/2 and promotes the oncogenic potential of human colon cancer cells.Carcinogenesis. 2009 Aug;30(8):1452-8. doi: 10.1093/carcin/bgp137. Epub 2009 Jun 11.
472 MUC17, a novel membrane-tethered mucin.Biochem Biophys Res Commun. 2002 Mar 1;291(3):466-75. doi: 10.1006/bbrc.2002.6475.
473 Abrogation of MUC5AC Expression Contributes to the Apoptosis and Cell Cycle Arrest of Colon Cancer Cells.Cancer Biother Radiopharm. 2016 Sep;31(7):261-7. doi: 10.1089/cbr.2016.2054.
474 Use of c-myb antisense oligonucleotides to increase the sensitivity of human colon cancer cells to cisplatin.Oncol Rep. 2001 Jul-Aug;8(4):807-10. doi: 10.3892/or.8.4.807.
475 Overexpression of MYC binding protein promotes invasion and migration in gastric cancer.Oncol Lett. 2018 Apr;15(4):5243-5249. doi: 10.3892/ol.2018.7944. Epub 2018 Feb 2.
476 Single nucleotide polymorphisms in the MYLKP1 pseudogene are associated with increased colon cancer risk in African Americans.PLoS One. 2018 Aug 30;13(8):e0200916. doi: 10.1371/journal.pone.0200916. eCollection 2018.
477 Defective IL-23/IL-17 Axis Protects p47phox-/- Mice from Colon Cancer.Front Immunol. 2017 Jan 27;8:44. doi: 10.3389/fimmu.2017.00044. eCollection 2017.
478 Nucleolin facilitates nuclear retention of an ultraconserved region containing TRA24 and accelerates colon cancer cell growth.Oncotarget. 2018 Jun 1;9(42):26817-26833. doi: 10.18632/oncotarget.25510. eCollection 2018 Jun 1.
479 NCOA4-RET fusion in colorectal cancer: Therapeutic challenge using patient-derived tumor cell lines.J Cancer. 2018 Jul 30;9(17):3032-3037. doi: 10.7150/jca.26256. eCollection 2018.
480 Measles Virus Enters Breast and Colon Cancer Cell Lines through a PVRL4-Mediated Macropinocytosis Pathway.J Virol. 2017 Apr 28;91(10):e02191-16. doi: 10.1128/JVI.02191-16. Print 2017 May 15.
481 The Nedd8-activating enzyme inhibitor MLN4924 suppresses colon cancer cell growth via triggering autophagy.Korean J Physiol Pharmacol. 2018 Nov;22(6):617-625. doi: 10.4196/kjpp.2018.22.6.617. Epub 2018 Oct 25.
482 Panitumumab interaction with TAS-102 leads to combinational anticancer effects via blocking of EGFR-mediated tumor response to trifluridine.Mol Oncol. 2017 Aug;11(8):1065-1077. doi: 10.1002/1878-0261.12074. Epub 2017 May 30.
483 The NLRP1 inflammasome attenuates colitis and colitis-associated tumorigenesis.J Immunol. 2015 Apr 1;194(7):3369-80. doi: 10.4049/jimmunol.1402098. Epub 2015 Feb 27.
484 The Innate Immune Receptor NLRX1 Functions as a Tumor Suppressor by Reducing Colon Tumorigenesis and Key Tumor-Promoting Signals.Cell Rep. 2016 Mar 22;14(11):2562-75. doi: 10.1016/j.celrep.2016.02.064. Epub 2016 Mar 10.
485 Dynamin controls extracellular level of Awd/Nme1 metastasis suppressor protein.Naunyn Schmiedebergs Arch Pharmacol. 2016 Nov;389(11):1171-1182. doi: 10.1007/s00210-016-1268-9. Epub 2016 Jul 22.
486 Thioredoxin-like protein 2 is overexpressed in colon cancer and promotes cancer cell metastasis by interaction with ran.Antioxid Redox Signal. 2013 Sep 20;19(9):899-911. doi: 10.1089/ars.2012.4736. Epub 2013 Mar 4.
487 Proteomic and functional investigation of the colon cancer relapse-associated genes NOX4 and ITGA3.J Proteome Res. 2014 Nov 7;13(11):4910-8. doi: 10.1021/pr500557n. Epub 2014 Aug 18.
488 Cancer-predicting transcriptomic and epigenetic signatures revealed for ulcerative colitis in patient-derived epithelial organoids.Oncotarget. 2018 Jun 19;9(47):28717-28730. doi: 10.18632/oncotarget.25617. eCollection 2018 Jun 19.
489 Inactivation of Adenomatous Polyposis Coli Reduces Bile Acid/Farnesoid X Receptor Expression through Fxr gene CpG Methylation in Mouse Colon Tumors and Human Colon Cancer Cells.J Nutr. 2016 Feb;146(2):236-42. doi: 10.3945/jn.115.216580. Epub 2015 Nov 25.
490 Decreased transcription-coupled nucleotide excision repair capacity is associated with increased p53- and MLH1-independent apoptosis in response to cisplatin.BMC Cancer. 2010 May 14;10:207. doi: 10.1186/1471-2407-10-207.
491 Repression of intestinal transporters and FXR-FGF15 signaling explains bile acids dysregulation in experimental colitis-associated colon cancer.Oncotarget. 2017 Jun 28;8(38):63665-63679. doi: 10.18632/oncotarget.18885. eCollection 2017 Sep 8.
492 Rifaximin, a non-absorbable antibiotic, inhibits the release of pro-angiogenic mediators in colon cancer cells through a pregnane X receptor-dependent pathway.Int J Oncol. 2016 Aug;49(2):639-45. doi: 10.3892/ijo.2016.3550. Epub 2016 Jun 1.
493 Nuclear orphan receptor NR4A2 confers chemoresistance and predicts unfavorable prognosis of colorectal carcinoma patients who received postoperative chemotherapy.Eur J Cancer. 2013 Nov;49(16):3420-30. doi: 10.1016/j.ejca.2013.06.001. Epub 2013 Jun 25.
494 MicroRNA-374b reduces the proliferation and invasion of colon cancer cells by regulation of LRH-1/Wnt signaling.Gene. 2018 Feb 5;642:354-361. doi: 10.1016/j.gene.2017.11.019. Epub 2017 Nov 8.
495 Lymphangiogenic Gene Expression Is Associated With Lymph Node Recurrence and Poor Prognosis After Partial Hepatectomy for Colorectal Liver Metastasis.Ann Surg. 2017 Nov;266(5):765-771. doi: 10.1097/SLA.0000000000002430.
496 Analysis of risk factors for colon cancer progression.Onco Targets Ther. 2019 May 22;12:3991-4000. doi: 10.2147/OTT.S207390. eCollection 2019.
497 Epigenetic and genetic alterations in Netrin-1 receptors UNC5C and DCC in human colon cancer.Gastroenterology. 2007 Dec;133(6):1849-57. doi: 10.1053/j.gastro.2007.08.074. Epub 2007 Sep 5.
498 Enhanced tumor retention of NTSR1-targeted agents by employing a hydrophilic cysteine cathepsin inhibitor.Eur J Med Chem. 2019 Sep 1;177:386-400. doi: 10.1016/j.ejmech.2019.05.068. Epub 2019 May 25.
499 ypoxia-inducible factor 1- promotes colon cell proliferation and migration by upregulating AMPK-related protein kinase 5 under hypoxic conditions.Oncol Lett. 2018 Mar;15(3):3639-3645. doi: 10.3892/ol.2018.7748. Epub 2018 Jan 8.
500 Heterogeneous nuclear ribonucleoprotein K upregulates the kinetochore complex component NUF2 and promotes the tumorigenicity of colon cancer cells.Biochem Biophys Res Commun. 2015 Mar 27;459(1):29-35. doi: 10.1016/j.bbrc.2015.02.043. Epub 2015 Feb 19.
501 Ornithine Decarboxylase in Macrophages Exacerbates Colitis and Promotes Colitis-Associated Colon Carcinogenesis by Impairing M1 Immune Responses.Cancer Res. 2018 Aug 1;78(15):4303-4315. doi: 10.1158/0008-5472.CAN-18-0116. Epub 2018 May 31.
502 Reduced hGC-1 protein expression is associated with malignant progression of colon carcinoma.Clin Cancer Res. 2008 Feb 15;14(4):1041-9. doi: 10.1158/1078-0432.CCR-07-4125.
503 Targeting LOX-1 Inhibits Colorectal Cancer Metastasis in an Animal Model.Front Oncol. 2019 Sep 19;9:927. doi: 10.3389/fonc.2019.00927. eCollection 2019.
504 TRPC1 and ORAI1 channels in colon cancer.Cell Calcium. 2019 Jul;81:59-66. doi: 10.1016/j.ceca.2019.06.003. Epub 2019 Jun 7.
505 Promoter DNA methylation of oncostatin m receptor-beta as a novel diagnostic and therapeutic marker in colon cancer.PLoS One. 2009 Aug 7;4(8):e6555. doi: 10.1371/journal.pone.0006555.
506 P2Y12 receptor inhibition augments cytotoxic effects of cisplatin in breast cancer.Med Oncol. 2013;30(2):567. doi: 10.1007/s12032-013-0567-y. Epub 2013 Apr 9.
507 PADI3 plays an antitumor role via the Hsp90/CKS1 pathway in colon cancer.Cancer Cell Int. 2019 Nov 5;19:277. doi: 10.1186/s12935-019-0999-3. eCollection 2019.
508 PAK4 regulates G6PD activity by p53 degradation involving colon cancer cell growth.Cell Death Dis. 2017 May 25;8(5):e2820. doi: 10.1038/cddis.2017.85.
509 Biophysical characterization and structural determination of the potent cytotoxic Psathyrella asperospora lectin.Proteins. 2017 May;85(5):969-975. doi: 10.1002/prot.25265. Epub 2017 Mar 7.
510 The pro-apoptotic protein Prostate Apoptosis Response Protein-4 (Par-4) can be activated in colon cancer cells by treatment with Src inhibitor and 5-FU.Apoptosis. 2011 Dec;16(12):1285-94. doi: 10.1007/s10495-011-0648-3.
511 The epigenetic modifier PBRM1 restricts the basal activity of the innate immune system by repressing retinoic acid-inducible gene-I-like receptor signalling and is a potential prognostic biomarker for colon cancer.J Pathol. 2018 Jan;244(1):36-48. doi: 10.1002/path.4986. Epub 2017 Nov 27.
512 Potential anti-tumor effect of a nanoliposomal antiPCSK9 vaccine in mice bearing colorectal cancer.Arch Med Sci. 2019 May;15(3):559-569. doi: 10.5114/aoms.2019.84732. Epub 2019 Apr 30.
513 Cinnamtannin B-1 inhibits cell survival molecules and induces apoptosis in colon cancer.Int J Oncol. 2018 Oct;53(4):1442-1454. doi: 10.3892/ijo.2018.4489. Epub 2018 Jul 19.
514 The conserved protective cyclic AMP-phosphodiesterase function PDE4B is expressed in the adenoma and adjacent normal colonic epithelium of mammals and silenced in colorectal cancer.PLoS Genet. 2018 Sep 6;14(9):e1007611. doi: 10.1371/journal.pgen.1007611. eCollection 2018 Sep.
515 Phosphodiesterase-5 inhibition suppresses colonic inflammation-induced tumorigenesis via blocking the recruitment of MDSC.Am J Cancer Res. 2017 Jan 1;7(1):41-52. eCollection 2017.
516 Diet and colorectal cancer: analysis of a candidate pathway using SNPS, haplotypes, and multi-gene assessment.Nutr Cancer. 2011 Nov;63(8):1226-34. doi: 10.1080/01635581.2011.607545. Epub 2011 Oct 14.
517 PFKFB3 Inhibition Attenuates Oxaliplatin-Induced Autophagy and Enhances Its Cytotoxicity in Colon Cancer Cells.Int J Mol Sci. 2019 Oct 30;20(21):5415. doi: 10.3390/ijms20215415.
518 VEGFR-1 Regulates EGF-R to Promote Proliferation in Colon Cancer Cells.Int J Mol Sci. 2019 Nov 9;20(22):5608. doi: 10.3390/ijms20225608.
519 CCR4 mediates CCL17 (TARC)-induced migration of human colon cancer cells via RhoA/Rho-kinase signaling.Int J Colorectal Dis. 2013 Nov;28(11):1479-87. doi: 10.1007/s00384-013-1712-y. Epub 2013 May 7.
520 Pleckstrin homology domain-containing protein PHLDB3 supports cancer growth via a negative feedback loop involving p53. Nat Commun. 2016 Dec 23;7:13755.
521 The effect of omentin-1 on the proliferation and apoptosis of colon cancer stem cells and the potential mechanism.J BUON. 2019 Jan-Feb;24(1):91-98.
522 Pathophysiological roles of Pim-3 kinase in pancreatic cancer development and progression.World J Gastroenterol. 2014 Jul 28;20(28):9392-404. doi: 10.3748/wjg.v20.i28.9392.
523 Circular RNA PIP5K1A promotes colon cancer development through inhibiting miR-1273a.World J Gastroenterol. 2019 Sep 21;25(35):5300-5309. doi: 10.3748/wjg.v25.i35.5300.
524 PKN2 in colon cancer cells inhibits M2 phenotype polarization of tumor-associated macrophages via regulating DUSP6-Erk1/2 pathway.Mol Cancer. 2018 Jan 24;17(1):13. doi: 10.1186/s12943-017-0747-z.
525 HT-29 human colon cancer cell proliferation is regulated by cytosolic phospholipase A(2) dependent PGE(2)via both PKA and PKB pathways.Biochim Biophys Acta. 2012 Sep;1821(9):1224-34. doi: 10.1016/j.bbalip.2012.06.005. Epub 2012 Jun 19.
526 Selective suicide gene therapy of colon cancer exploiting the urokinase plasminogen activator receptor promoter.BioDrugs. 2010 Apr 1;24(2):131-46. doi: 10.2165/11530840-000000000-00000.
527 Phosphoinositide-specific phospholipase C1 inhibition induces autophagy in human colon cancer and hepatocellular carcinoma cells.Sci Rep. 2017 Oct 24;7(1):13912. doi: 10.1038/s41598-017-13334-y.
528 Cep131 overexpression promotes centrosome amplification and colon cancer progression by regulating Plk4 stability.Cell Death Dis. 2019 Jul 29;10(8):570. doi: 10.1038/s41419-019-1778-8.
529 Rapid disappearance of deoxyribose-1-phosphate in platelet derived endothelial cell growth factor/thymidine phosphorylase overexpressing cells.Biochem Biophys Res Commun. 2003 Feb 14;301(3):675-9. doi: 10.1016/s0006-291x(03)00022-6.
530 Potentiation of colon cancer susceptibility in mice by colonic epithelial PPAR-/ overexpression.J Natl Cancer Inst. 2014 Apr;106(4):dju052. doi: 10.1093/jnci/dju052. Epub 2014 Mar 28.
531 Peroxisome proliferator-activated receptors (PPARs) and associated transcription factors in colon cancer: reduced expression of PPARgamma-coactivator 1 (PGC-1).Cancer Lett. 2004 Jan 8;203(1):25-33. doi: 10.1016/j.canlet.2003.08.024.
532 Role of cyclophilin B in tumorigenesis and cisplatin resistance in hepatocellular carcinoma in humans.Hepatology. 2011 Nov;54(5):1661-78. doi: 10.1002/hep.24539.
533 Effect of ganoderic acid D on colon cancer Warburg effect: Role of SIRT3/cyclophilin D.Eur J Pharmacol. 2018 Apr 5;824:72-77. doi: 10.1016/j.ejphar.2018.01.026. Epub 2018 Jan 31.
534 Silencing of PPMD1 inhibits proliferation of human colon cancer cells via induction of apoptosis and cell cycle arrest.J BUON. 2019 Jul-Aug;24(4):1464-1469.
535 Highly Expressed Genes in Rapidly Proliferating Tumor Cells as New Targets for Colorectal Cancer Treatment.Clin Cancer Res. 2015 Aug 15;21(16):3695-704. doi: 10.1158/1078-0432.CCR-14-2457. Epub 2015 May 5.
536 Shikonin-induced Apoptosis of Colon Cancer Cells Is Reduced by Peroxiredoxin V Expression.Anticancer Res. 2019 Nov;39(11):6115-6123. doi: 10.21873/anticanres.13819.
537 In vitro and in vivo inhibitory effects of a Pleurotus eryngii protein on colon cancer cells.Food Funct. 2017 Oct 18;8(10):3553-3562. doi: 10.1039/c7fo00895c.
538 Modulating PKC Activity to Target Wnt/-Catenin Signaling in Colon Cancer.Cancers (Basel). 2019 May 18;11(5):693. doi: 10.3390/cancers11050693.
539 Protein kinase C beta II suppresses colorectal cancer by regulating IGF-1 mediated cell survival.Oncotarget. 2016 Apr 12;7(15):20919-33. doi: 10.18632/oncotarget.8062.
540 Protein kinase D1 attenuates tumorigenesis in colon cancer by modulating -catenin/T cell factor activity.Oncotarget. 2014 Aug 30;5(16):6867-84. doi: 10.18632/oncotarget.2277.
541 Two proliferation-related proteins, TYMS and PGK1, could be new cytotoxic T lymphocyte-directed tumor-associated antigens of HLA-A2+ colon cancer.Clin Cancer Res. 2004 Sep 1;10(17):5828-36. doi: 10.1158/1078-0432.CCR-04-0350.
542 New dimeric cGMP analogues reduce proliferation in three colon cancer cell lines.Eur J Med Chem. 2017 Dec 1;141:61-72. doi: 10.1016/j.ejmech.2017.09.053. Epub 2017 Sep 27.
543 Protein arginine methyltransferase 5 is implicated in the aggressiveness of human hepatocellular carcinoma and controls the invasive activity of cancer cells.Oncol Rep. 2018 Jul;40(1):536-544. doi: 10.3892/or.2018.6402. Epub 2018 Apr 25.
544 Endocrine gland-derived vascular endothelial growth factor strengthens cell invasion ability via prokineticin receptor 2 in colon cancer cell lines.Oncol Rep. 2013 Feb;29(2):459-63. doi: 10.3892/or.2012.2124. Epub 2012 Nov 6.
545 Expression of a thioredoxin-related protein-1 is induced by prostaglandin E(2).Int J Cancer. 2006 Apr 1;118(7):1670-9. doi: 10.1002/ijc.21572.
546 Detection of mutations in the DNA polymerase delta gene of human sporadic colorectal cancers and colon cancer cell lines.Int J Cancer. 1999 Mar 15;80(6):919-29. doi: 10.1002/(sici)1097-0215(19990315)80:6<919::aid-ijc19>3.0.co;2-u.
547 The LMP7-K allele of the immunoproteasome exhibits reduced transcript stability and predicts high risk of colon cancer.Cancer Res. 2011 Dec 1;71(23):7145-54. doi: 10.1158/0008-5472.CAN-10-1883. Epub 2011 Oct 28.
548 MicroRNA-1254 inhibits the migration of colon adenocarcinoma cells by targeting PSMD10.J Dig Dis. 2017 Mar;18(3):169-178. doi: 10.1111/1751-2980.12463.
549 Prostaglandin E?regulates cellular migration via induction of vascular endothelial growth factor receptor-1 in HCA-7 human colon cancer cells.Biochem Pharmacol. 2011 Feb 1;81(3):379-87. doi: 10.1016/j.bcp.2010.11.001. Epub 2010 Nov 9.
550 Prostacyclin synthase and arachidonate 5-lipoxygenase polymorphisms and risk of colorectal polyps.Cancer Epidemiol Biomarkers Prev. 2006 Mar;15(3):502-8. doi: 10.1158/1055-9965.EPI-05-0804.
551 WiNTRLINC1/ASCL2/c-Myc Axis Characteristics of Colon Cancer with Differentiated Histology at Young Onset and Essential for Cell Viability.Ann Surg Oncol. 2019 Dec;26(13):4826-4834. doi: 10.1245/s10434-019-07780-3. Epub 2019 Sep 23.
552 pTyr421 cortactin is overexpressed in colon cancer and is dephosphorylated by curcumin: involvement of non-receptor type 1 protein tyrosine phosphatase (PTPN1).PLoS One. 2014 Jan 22;9(1):e85796. doi: 10.1371/journal.pone.0085796. eCollection 2014.
553 Silencing Fas-associated phosphatase 1 expression enhances efficiency of chemotherapy for colon carcinoma with oxaliplatin.World J Gastroenterol. 2010 Jan 7;16(1):112-8. doi: 10.3748/wjg.v16.i1.112.
554 B-cell leukemia protein-2 and peptide YY chemotherapy resistance in colon cancer.Am J Surg. 1999 Nov;178(5):411-4. doi: 10.1016/s0002-9610(99)00209-3.
555 MicroRNA-193b acts as a tumor suppressor in colon cancer progression via targeting RAB22A.Exp Ther Med. 2019 May;17(5):3921-3928. doi: 10.3892/etm.2019.7435. Epub 2019 Mar 26.
556 RAC3 influences the chemoresistance of colon cancer cells through autophagy and apoptosis inhibition.Cancer Cell Int. 2017 Nov 28;17:111. doi: 10.1186/s12935-017-0483-x. eCollection 2017.
557 Loss of caspase-3 sensitizes colon cancer cells to genotoxic stress via RIP1-dependent necrosis.Cell Death Dis. 2015 Apr 23;6(4):e1729. doi: 10.1038/cddis.2015.104.
558 Epigenetic inactivation of the metastasis suppressor RECK enhances invasion of human colon cancer cells.J Cell Physiol. 2007 Oct;213(1):65-9. doi: 10.1002/jcp.21089.
559 Overexpression of Reg4, alone or combined with MMP-7 overexpression, is predictive of poor prognosis in colorectal cancer.Oncol Rep. 2015 Jan;33(1):320-8. doi: 10.3892/or.2014.3559. Epub 2014 Oct 22.
560 Expression of RNA-binding Motif Protein 3 (RBM3) and Cold-inducible RNA-binding protein (CIRP) Is Associated with Improved Clinical Outcome in Patients with Colon Cancer.Anticancer Res. 2017 Apr;37(4):1779-1785. doi: 10.21873/anticanres.11511.
561 Differential roles of RIPK1 and RIPK3 in TNF-induced necroptosis and chemotherapeutic agent-induced cell death.Cell Death Dis. 2015 Feb 12;6(2):e1636. doi: 10.1038/cddis.2015.16.
562 Comparative genomics on ROR1 and ROR2 orthologs.Oncol Rep. 2005 Nov;14(5):1381-4. doi: 10.3892/or.14.5.1381.
563 In vivo pathogenesis of colon carcinoma and its suppression by hydrophilic fractions of Clematis flammula via activation of TRAIL death machinery (DRs) expression.Biomed Pharmacother. 2019 Jan;109:2182-2191. doi: 10.1016/j.biopha.2018.11.052. Epub 2018 Nov 27.
564 Regulation of replicative and stress-induced senescence by RSK4, which is down-regulated in human tumors.Clin Cancer Res. 2009 Jul 15;15(14):4546-53. doi: 10.1158/1078-0432.CCR-08-3159. Epub 2009 Jul 7.
565 Inositol Hexaphosphate Inhibits Proliferation and Induces Apoptosis of Colon Cancer Cells by Suppressing the AKT/mTOR Signaling Pathway.Molecules. 2017 Oct 3;22(10):1657. doi: 10.3390/molecules22101657.
566 Suppression of lung tumor formation by the regulatory subunit of ribonucleotide reductase.Cancer Res. 2006 Jul 1;66(13):6497-502. doi: 10.1158/0008-5472.CAN-05-4462.
567 Rsf-1 overexpression correlates with poor prognosis and cell proliferation in colon cancer.Tumour Biol. 2012 Oct;33(5):1485-91. doi: 10.1007/s13277-012-0399-y. Epub 2012 Apr 20.
568 R-Spondin1/LGR5 Activates TGF Signaling and Suppresses Colon Cancer Metastasis.Cancer Res. 2017 Dec 1;77(23):6589-6602. doi: 10.1158/0008-5472.CAN-17-0219. Epub 2017 Sep 22.
569 Molecular subtypes in stage II-III colon cancer defined by genomic instability: early recurrence-risk associated with a high copy-number variation and loss of RUNX3 and CDKN2A.PLoS One. 2015 Apr 16;10(4):e0122391. doi: 10.1371/journal.pone.0122391. eCollection 2015.
570 Oncogenic potential of truncated RXR during colitis-associated colorectal tumorigenesis by promoting IL-6-STAT3 signaling.Nat Commun. 2019 Apr 1;10(1):1463. doi: 10.1038/s41467-019-09375-8.
571 Modulation of NKG2D ligand expression and metastasis in tumors by spironolactone via RXR activation.J Exp Med. 2013 Nov 18;210(12):2675-92. doi: 10.1084/jem.20122292. Epub 2013 Nov 4.
572 The effect of S100A6 on nuclear translocation of CacyBP/SIP in colon cancer cells.PLoS One. 2018 Mar 13;13(3):e0192208. doi: 10.1371/journal.pone.0192208. eCollection 2018.
573 Trichothecin inhibits invasion and metastasis of colon carcinoma associating with SCD-1-mediated metabolite alteration.Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Feb;1865(2):158540. doi: 10.1016/j.bbalip.2019.158540. Epub 2019 Oct 31.
574 Voltage-gated Na+ Channel Activity Increases Colon Cancer Transcriptional Activity and Invasion Via Persistent MAPK Signaling.Sci Rep. 2015 Jun 22;5:11541. doi: 10.1038/srep11541.
575 Inflammatory hypoxia induces syndecan-2 expression through IL-1-mediated FOXO3a activation in colonic epithelia.FASEB J. 2017 Apr;31(4):1516-1530. doi: 10.1096/fj.201601098R. Epub 2016 Dec 28.
576 Semaphoring 4D is required for the induction of antioxidant stress and anti-inflammatory effects of dihydromyricetin in colon cancer.Int Immunopharmacol. 2019 Feb;67:220-230. doi: 10.1016/j.intimp.2018.12.025. Epub 2018 Dec 15.
577 SUMO-specific protease 1 regulates the in vitro and in vivo growth of colon cancer cells with the upregulated expression of CDK inhibitors.Cancer Lett. 2011 Oct 1;309(1):78-84. doi: 10.1016/j.canlet.2011.05.019. Epub 2011 Jun 12.
578 Fine mapping of colon tumor susceptibility (Scc) genes in the mouse, different from the genes known to be somatically mutated in colon cancer.Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1082-6. doi: 10.1073/pnas.93.3.1082.
579 Serpin B5 is a CEA-interacting biomarker for colorectal cancer.Int J Cancer. 2014 Apr 1;134(7):1595-604. doi: 10.1002/ijc.28494. Epub 2013 Oct 11.
580 Imperatorin suppresses proliferation and angiogenesis of human colon cancer cell by targeting HIF-1 via the mTOR/p70S6K/4E-BP1 and MAPK pathways.J Ethnopharmacol. 2017 May 5;203:27-38. doi: 10.1016/j.jep.2017.03.033. Epub 2017 Mar 21.
581 SFRP4 expression correlates with epithelial mesenchymal transition-linked genes and poor overall survival in colon cancer patients.World J Gastrointest Oncol. 2019 Aug 15;11(8):589-598. doi: 10.4251/wjgo.v11.i8.589.
582 Antagonizing pathways leading to differential dynamics in colon carcinogenesis in Shugoshin1 (Sgo1)-haploinsufficient chromosome instability model.Mol Carcinog. 2016 May;55(5):600-10. doi: 10.1002/mc.22306. Epub 2015 Mar 14.
583 Cancer-induced inflammation and inflammation-induced cancer in colon: a role for S1P lyase.Oncogene. 2019 Jun;38(24):4788-4803. doi: 10.1038/s41388-019-0758-x. Epub 2019 Feb 28.
584 Risk of gastrointestinal cancers in patients with cystic fibrosis: a systematic review and meta-analysis.Lancet Oncol. 2018 Jun;19(6):758-767. doi: 10.1016/S1470-2045(18)30188-8. Epub 2018 Apr 26.
585 Prognostic and clinicopathological value of SIRT3 expression in various cancers: a systematic review and meta-analysis.Onco Targets Ther. 2018 Apr 13;11:2157-2167. doi: 10.2147/OTT.S157836. eCollection 2018.
586 Slc10a2-null mice uncover colon cancer-promoting actions of endogenous fecal bile acids.Carcinogenesis. 2015 Oct;36(10):1193-200. doi: 10.1093/carcin/bgv107. Epub 2015 Jul 25.
587 Discovery of biclonal origin and a novel oncogene SLC12A5 in colon cancer by single-cell sequencing.Cell Res. 2014 Jun;24(6):701-12. doi: 10.1038/cr.2014.43. Epub 2014 Apr 4.
588 Astragalus saponins modulates colon cancer development by regulating calpain-mediated glucose-regulated protein expression.BMC Complement Altern Med. 2014 Oct 15;14:401. doi: 10.1186/1472-6882-14-401.
589 Different involvement of DNA methylation and histone deacetylation in the expression of solute-carrier transporters in 4 colon cancer cell lines. Biol Pharm Bull. 2012;35(3):301-7.
590 CD44-SLC1A2 fusion transcripts in primary colorectal cancer.Pathol Oncol Res. 2015 Jul;21(3):759-64. doi: 10.1007/s12253-014-9887-2. Epub 2015 Jan 10.
591 Oct1/Pou2f1 is selectively required for colon regeneration and regulates colon malignancy.PLoS Genet. 2019 May 6;15(5):e1007687. doi: 10.1371/journal.pgen.1007687. eCollection 2019 May.
592 Role and mechanism of organic cation transporter 3 in oxaliplatin treatment of colon cancer in vitro and in vivo.Oncol Rep. 2019 Oct;42(4):1355-1364. doi: 10.3892/or.2019.7267. Epub 2019 Aug 7.
593 L-Ascorbic acid can abrogate SVCT-2-dependent cetuximab resistance mediated by mutant KRAS in human colon cancer cells.Free Radic Biol Med. 2016 Jun;95:200-8. doi: 10.1016/j.freeradbiomed.2016.03.009. Epub 2016 Mar 22.
594 Differential expression of hENT1 and hENT2 in colon cancer cell lines.Genet Mol Res. 2017 Feb 16;16(1). doi: 10.4238/gmr16019549.
595 Silencing of Intestinal Glycoprotein CD98 by Orally Targeted Nanoparticles Enhances Chemosensitization of Colon Cancer.ACS Nano. 2018 Jun 26;12(6):5253-5265. doi: 10.1021/acsnano.7b08499. Epub 2018 Jun 8.
596 EGFR-targeted nonviral NIS gene transfer for bioimaging and therapy of disseminated colon cancer metastases.Oncotarget. 2017 Sep 16;8(54):92195-92208. doi: 10.18632/oncotarget.21028. eCollection 2017 Nov 3.
597 Expression of OATP family members in hormone-related cancers: potential markers of progression.PLoS One. 2011;6(5):e20372. doi: 10.1371/journal.pone.0020372. Epub 2011 May 19.
598 Overexpression of OATP1B3 confers apoptotic resistance in colon cancer.Cancer Res. 2008 Dec 15;68(24):10315-23. doi: 10.1158/0008-5472.CAN-08-1984.
599 A novel role for OATP2A1/SLCO2A1 in a murine model of colon cancer.Sci Rep. 2017 Nov 29;7(1):16567. doi: 10.1038/s41598-017-16738-y.
600 Possible role of nuclear -catenin in resistance to preoperative chemoradiotherapy in locally advanced rectal cancer.Histopathology. 2017 Aug;71(2):227-237. doi: 10.1111/his.13227. Epub 2017 May 22.
601 Are SMAD7 rs4939827 and CHI3L1 rs4950928 polymorphisms associated with colorectal cancer in Egyptian patients?.Tumour Biol. 2016 Jul;37(7):9387-97. doi: 10.1007/s13277-016-4813-8. Epub 2016 Jan 16.
602 The chromatin-remodeling enzyme BRG1 promotes colon cancer progression via positive regulation of WNT3A.Oncotarget. 2016 Dec 27;7(52):86051-86063. doi: 10.18632/oncotarget.13326.
603 Liver acid sphingomyelinase inhibits growth of metastatic colon cancer.J Clin Invest. 2013 Feb;123(2):834-43. doi: 10.1172/JCI65188. Epub 2013 Jan 9.
604 SMYD2-OE promotes oxaliplatin resistance in colon cancer through MDR1/P-glycoprotein via MEK/ERK/AP1 pathway.Onco Targets Ther. 2019 Apr 8;12:2585-2594. doi: 10.2147/OTT.S186806. eCollection 2019.
605 Effects of -synuclein on the tumorigenicity and metastasis of colon cancer SW1116 cells in vitro and in vivo.Oncol Rep. 2013 Nov;30(5):2161-70. doi: 10.3892/or.2013.2688. Epub 2013 Aug 22.
606 Baicalin induces apoptosis in SW480 cells through downregulation of the SP1 transcription factor.Anticancer Drugs. 2019 Feb;30(2):153-158. doi: 10.1097/CAD.0000000000000708.
607 PDEF is a negative regulator of colon cancer cell growth and migration.J Cell Biochem. 2009 Dec 15;108(6):1389-98. doi: 10.1002/jcb.22371.
608 Sphingosine kinase1 promotes the metastasis of colorectal cancer by inducing the epithelialmesenchymal transition mediated by the FAK/AKT/MMPs axis.Int J Oncol. 2019 Jan;54(1):41-52. doi: 10.3892/ijo.2018.4607. Epub 2018 Oct 25.
609 Overexpression of SphK2 contributes to ATRA resistance in colon cancer through rapid degradation of cytoplasmic RXR by K48/K63-linked polyubiquitination.Oncotarget. 2017 Jun 13;8(24):39605-39617. doi: 10.18632/oncotarget.17174.
610 Tumor cell MUC1 and CD43 are glycosylated differently with sialyl-Lewis a and x epitopes and show variable interactions with E-selectin under physiological flow conditions.Glycoconj J. 2001 Nov-Dec;18(11-12):925-30. doi: 10.1023/a:1022208727512.
611 Sprouty1, a new target of the angiostatic agent 16K prolactin, negatively regulates angiogenesis. Mol Cancer. 2010 Sep 2;9:231.
612 Transforming growth factor-beta suppresses nonmetastatic colon cancer through Smad4 and adaptor protein ELF at an early stage of tumorigenesis.Cancer Res. 2005 May 15;65(10):4228-37. doi: 10.1158/0008-5472.CAN-04-4585.
613 Increased Expression of Serglycin in Specific Carcinomas and Aggressive Cancer Cell Lines.Biomed Res Int. 2015;2015:690721. doi: 10.1155/2015/690721. Epub 2015 Oct 25.
614 The many faces of SRPK1.J Pathol. 2017 Mar;241(4):437-440. doi: 10.1002/path.4846. Epub 2017 Feb 1.
615 SRPK2 promotes the growth and migration of the colon cancer cells.Gene. 2016 Jul 15;586(1):41-7. doi: 10.1016/j.gene.2016.03.051. Epub 2016 Apr 12.
616 Somatostatin signaling via SSTR1 contributes to the quiescence of colon cancer stem cells.BMC Cancer. 2016 Dec 7;16(1):941. doi: 10.1186/s12885-016-2969-7.
617 Quantitation of membrane type serine protease 1 (MT-SP1) in transformed and normal cells.Biol Chem. 2003 Feb;384(2):257-66. doi: 10.1515/BC.2003.029.
618 Lack of STAT6 Attenuates Inflammation and Drives Protection against Early Steps of Colitis-Associated Colon Cancer. Cancer Immunol Res. 2017 May;5(5):385-396.
619 SYK-CARD9 Signaling Axis Promotes Gut Fungi-Mediated Inflammasome Activation to Restrict Colitis and Colon Cancer.Immunity. 2018 Sep 18;49(3):515-530.e5. doi: 10.1016/j.immuni.2018.08.024.
620 Upregulation of HRD1 promotes cell migration and invasion in colon cancer.Mol Cell Biochem. 2019 Apr;454(1-2):1-9. doi: 10.1007/s11010-018-3447-0. Epub 2018 Oct 10.
621 TNF- promotes colon cancer cell migration and invasion by upregulating TROP-2.Oncol Lett. 2018 Mar;15(3):3820-3827. doi: 10.3892/ol.2018.7735. Epub 2018 Jan 5.
622 Loss of transgelin in breast and colon tumors and in RIE-1 cells by Ras deregulation of gene expression through Raf-independent pathways.J Biol Chem. 2002 Mar 22;277(12):9790-9. doi: 10.1074/jbc.M110086200. Epub 2001 Dec 28.
623 PSF1, a DNA replication factor expressed widely in stem and progenitor cells, drives tumorigenic and metastatic properties.Cancer Res. 2010 Feb 1;70(3):1215-24. doi: 10.1158/0008-5472.CAN-09-3662. Epub 2010 Jan 26.
624 Thymine DNA glycosylase promotes transactivation of -catenin/TCFs by cooperating with CBP.J Mol Cell Biol. 2014 Jun;6(3):231-9. doi: 10.1093/jmcb/mju014. Epub 2014 Apr 18.
625 Impact of Phytolacca americana extracts on gene expression of colon cancer cells.Phytother Res. 2014 Feb;28(2):219-23. doi: 10.1002/ptr.4979. Epub 2013 Apr 4.
626 TRF2 inhibits a cell-extrinsic pathway through which natural killer cells eliminate cancer cells.Nat Cell Biol. 2013 Jul;15(7):818-28. doi: 10.1038/ncb2774. Epub 2013 Jun 23.
627 Screening Method for Anti-Colon Cancer Drugs Using Two Sensor Cell Lines with Human 4-Galactosyltransferase 4 Gene Promoters.Sensors (Basel). 2018 Aug 6;18(8):2573. doi: 10.3390/s18082573.
628 TFF3 and TFF1 expression levels are elevated in colorectal cancer and promote the malignant behavior of colon cancer by activating the EMT process.Int J Oncol. 2019 Oct;55(4):789-804. doi: 10.3892/ijo.2019.4854. Epub 2019 Aug 5.
629 Tissue Factor Pathway Inhibitor Gene Polymorphism -33TC Predicts Improved Disease-Free Survival in Colorectal Cancer.Ann Surg Oncol. 2016 Jul;23(7):2274-80. doi: 10.1245/s10434-016-5169-4. Epub 2016 Mar 11.
630 Transforming growth factor alpha promotes tumorigenesis and regulates epithelial-mesenchymal transition modulation in colon cancer.Biochem Biophys Res Commun. 2018 Dec 2;506(4):901-906. doi: 10.1016/j.bbrc.2018.10.137. Epub 2018 Nov 2.
631 Transforming growth factor beta1 suppresses nonmetastatic colon cancer at an early stage of tumorigenesis.Cancer Res. 1999 Jul 15;59(14):3379-86.
632 Allele-specific expression of TGFBR1 in colon cancer patients.Carcinogenesis. 2010 Oct;31(10):1800-4. doi: 10.1093/carcin/bgq165. Epub 2010 Aug 12.
633 Mechanisms of platelet-stimulated colon cancer invasion: role of clusterin and thrombospondin 1 in regulation of the P38MAPK-MMP-9 pathway.Carcinogenesis. 2014 Feb;35(2):324-32. doi: 10.1093/carcin/bgt332. Epub 2013 Oct 1.
634 The CircRNA-ACAP2/Hsa-miR-21-5p/ Tiam1 Regulatory Feedback Circuit Affects the Proliferation, Migration, and Invasion of Colon Cancer SW480 Cells.Cell Physiol Biochem. 2018;49(4):1539-1550. doi: 10.1159/000493457. Epub 2018 Sep 13.
635 The TKTL1 gene influences total transketolase activity and cell proliferation in human colon cancer LoVo cells.Anticancer Drugs. 2007 Apr;18(4):427-33. doi: 10.1097/CAD.0b013e328013d99e.
636 Toll-like receptor 5 engagement modulates tumor development and growth in a mouse xenograft model of human colon cancer.Gastroenterology. 2008 Aug;135(2):518-28. doi: 10.1053/j.gastro.2008.04.022. Epub 2008 Apr 23.
637 Toll-like receptor 6 expression, sequence variants, and their association with colorectal cancer risk.J Cancer. 2019 Jun 2;10(13):2969-2981. doi: 10.7150/jca.31011. eCollection 2019.
638 TLR9 signaling activation at different stages in colorectal cancer and NF-kappaB expression.Onco Targets Ther. 2018 Sep 18;11:5963-5971. doi: 10.2147/OTT.S174274. eCollection 2018.
639 Expression analysis of MAC30 in human pancreatic cancer and tumors of the gastrointestinal tract.Histol Histopathol. 2004 Oct;19(4):1021-31. doi: 10.14670/HH-19.1021.
640 Histone hypoacetylation contributes to CXCL12 downregulation in colon cancer: impact on tumor growth and cell migration.Oncotarget. 2017 Jun 13;8(24):38351-38366. doi: 10.18632/oncotarget.16323.
641 Thymosin beta 4 induces colon cancer cell migration and clinical metastasis via enhancing ILK/IQGAP1/Rac1 signal transduction pathway.Cancer Lett. 2011 Sep 28;308(2):162-71. doi: 10.1016/j.canlet.2011.05.001. Epub 2011 May 28.
642 IL-32 suppresses colorectal cancer development via TNFR1-mediated death signaling.Oncotarget. 2015 Apr 20;6(11):9061-72. doi: 10.18632/oncotarget.3197.
643 Distinct Expression Patterns of Two Tumor Necrosis Factor Superfamily Member 15 Gene Isoforms in Human Colon Cancer.Dig Dis Sci. 2019 Jul;64(7):1857-1867. doi: 10.1007/s10620-019-05507-8. Epub 2019 Feb 20.
644 Inhibitor of Apoptosis Protein-1 Regulates Tumor Necrosis Factor-Mediated Destruction of Intestinal Epithelial Cells.Gastroenterology. 2017 Mar;152(4):867-879. doi: 10.1053/j.gastro.2016.11.019. Epub 2016 Nov 24.
645 Simultaneous knockdown of APRIL via multiple shRNAs reduces the malignancy of SW480 cells.Oncol Rep. 2012 Nov;28(5):1613-8. doi: 10.3892/or.2012.1980. Epub 2012 Aug 22.
646 Enormous influence of TNIK knockdown on intracellular signals and cell survival.Hum Cell. 2011 Sep;24(3):121-6. doi: 10.1007/s13577-011-0023-2. Epub 2011 Jun 28.
647 Tankyrase 1 inhibitior XAV939 increases chemosensitivity in colon cancer cell lines via inhibition of the Wnt signaling pathway.Int J Oncol. 2016 Apr;48(4):1333-40. doi: 10.3892/ijo.2016.3360. Epub 2016 Jan 26.
648 Tensin-4-dependent MET stabilization is essential for survival and proliferation in carcinoma cells.Dev Cell. 2014 May 27;29(4):421-36. doi: 10.1016/j.devcel.2014.03.024. Epub 2014 May 8.
649 Characterization of DNA topoisomerase I in three SN-38 resistant human colon cancer cell lines reveals a new pair of resistance-associated mutations.J Exp Clin Cancer Res. 2016 Mar 31;35:56. doi: 10.1186/s13046-016-0335-x.
650 Proliferation and invasion of colon cancer cells are suppressed by knockdown of TOP2A.J Cell Biochem. 2018 Sep;119(9):7256-7263. doi: 10.1002/jcb.26916. Epub 2018 May 15.
651 Control of established colon cancer xenografts using a novel humanized single chain antibody-streptococcal superantigen fusion protein targeting the 5T4 oncofetal antigen.PLoS One. 2014 Apr 15;9(4):e95200. doi: 10.1371/journal.pone.0095200. eCollection 2014.
652 TPX2 is a novel prognostic marker for the growth and metastasis of colon cancer.J Transl Med. 2013 Dec 17;11:313. doi: 10.1186/1479-5876-11-313.
653 Identification of key tumorigenesisrelated genes and their microRNAs in colon cancer.Oncol Rep. 2018 Dec;40(6):3551-3560. doi: 10.3892/or.2018.6726. Epub 2018 Sep 21.
654 The different expression of TRPM7 and MagT1 impacts on the proliferation of colon carcinoma cells sensitive or resistant to doxorubicin.Sci Rep. 2017 Jan 17;7:40538. doi: 10.1038/srep40538.
655 Platelet-derived endothelial cell growth factor mediates Rho-associated coiled-coil domain kinase messenger RNA expression and promotes cell motility.Ann Surg Oncol. 2003 Jun;10(5):582-7. doi: 10.1245/aso.2003.08.020.
656 Ebp1 p48 promotes oncogenic activities in human colon cancer cells through regulation of TIF-90-mediated ribosomal RNA synthesis.J Cell Physiol. 2019 Aug;234(10):17612-17621. doi: 10.1002/jcp.28385. Epub 2019 Feb 22.
657 The deubiquitinase inhibitor b-AP15 induces strong proteotoxic stress and mitochondrial damage.Biochem Pharmacol. 2018 Oct;156:291-301. doi: 10.1016/j.bcp.2018.08.039. Epub 2018 Aug 25.
658 MiR-133a Is Functionally Involved in Doxorubicin-Resistance in Breast Cancer Cells MCF-7 via Its Regulation of the Expression of Uncoupling Protein 2.PLoS One. 2015 Jun 24;10(6):e0129843. doi: 10.1371/journal.pone.0129843. eCollection 2015.
659 Urotensin-II receptor is over-expressed in colon cancer cell lines and in colon carcinoma in humans.Eur J Clin Invest. 2014;44(3):285-94. doi: 10.1111/eci.12231. Epub 2014 Jan 22.
660 KITENIN increases invasion and migration of mouse squamous cancer cells and promotes pulmonary metastasis in a mouse squamous tumor model.FEBS Lett. 2009 Feb 18;583(4):711-7. doi: 10.1016/j.febslet.2009.01.014. Epub 2009 Jan 21.
661 Sulindac sulfone inhibits the mTORC1 pathway in colon cancer cells by directly targeting voltage-dependent anion channel 1 and 2.Biochem Biophys Res Commun. 2018 Nov 10;505(4):1203-1210. doi: 10.1016/j.bbrc.2018.10.050. Epub 2018 Oct 14.
662 A molecular sub-cluster of colon cancer cells with low VDR expression is sensitive to chemotherapy, BRAF inhibitors and PI3K-mTOR inhibitors treatment.Aging (Albany NY). 2019 Oct 9;11(19):8587-8603. doi: 10.18632/aging.102349. Epub 2019 Oct 9.
663 Long Noncoding RNA ASLNC07322 Functions in VEGF-C Expression Regulated by Smad4 during Colon Cancer Metastasis.Mol Ther Nucleic Acids. 2019 Dec 6;18:851-862. doi: 10.1016/j.omtn.2019.10.012. Epub 2019 Oct 18.
664 The relevance of cell type- and tumor zone-specific VEGFR-2 activation in locally advanced colon cancer.J Exp Clin Cancer Res. 2015 May 13;34(1):42. doi: 10.1186/s13046-015-0162-5.
665 VPAC1 overexpression is associated with poor differentiation in colon cancer.Tumour Biol. 2014 Jul;35(7):6397-404. doi: 10.1007/s13277-014-1852-x. Epub 2014 Mar 28.
666 Hypoxia-Induced VISTA Promotes the Suppressive Function of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment.Cancer Immunol Res. 2019 Jul;7(7):1079-1090. doi: 10.1158/2326-6066.CIR-18-0507. Epub 2019 May 14.
667 Colitis and colon cancer in WASP-deficient mice require helicobacter species.Inflamm Bowel Dis. 2013 Sep;19(10):2041-50. doi: 10.1097/MIB.0b013e318295fd8f.
668 WDR5 supports colon cancer cells by promoting methylation of H3K4 and suppressing DNA damage.BMC Cancer. 2018 Jun 20;18(1):673. doi: 10.1186/s12885-018-4580-6.
669 Suppression of YAP by DDP disrupts colon tumor progression.Oncol Rep. 2018 May;39(5):2114-2126. doi: 10.3892/or.2018.6297. Epub 2018 Mar 6.
670 Colon cancer cells escape 5FU chemotherapy-induced cell death by entering stemness and quiescence associated with the c-Yes/YAP axis.Clin Cancer Res. 2014 Feb 15;20(4):837-46. doi: 10.1158/1078-0432.CCR-13-1854. Epub 2013 Dec 9.
671 MiR-3653 inhibits the metastasis and epithelial-mesenchymal transition of colon cancer by targeting Zeb2.Pathol Res Pract. 2019 Oct;215(10):152577. doi: 10.1016/j.prp.2019.152577. Epub 2019 Aug 2.
672 The candidate oncogene ZNF217 is frequently amplified in colon cancer.J Pathol. 2004 Nov;204(3):282-8. doi: 10.1002/path.1632.
673 Targeting CCR8 Induces Protective Antitumor Immunity and Enhances Vaccine-Induced Responses in Colon Cancer.Cancer Res. 2018 Sep 15;78(18):5340-5348. doi: 10.1158/0008-5472.CAN-18-1119. Epub 2018 Jul 19.
674 Expression of cellular apoptosis susceptibility (CAS) in the human testis and testicular germ cell tumors.Med Oncol. 2019 May 29;36(7):61. doi: 10.1007/s12032-019-1281-1.
675 Increased diacylglycerol kinase expression in human metastatic colon cancer cells augments Rho GTPase activity and contributes to enhanced invasion.BMC Cancer. 2014 Mar 19;14:208. doi: 10.1186/1471-2407-14-208.
676 Identification of GABRA1 and LAMA2 as new DNA methylation markers in colorectal cancer.Int J Oncol. 2012 Mar;40(3):889-98. doi: 10.3892/ijo.2011.1245. Epub 2011 Oct 25.
677 Overexpression of GRK3, Promoting Tumor Proliferation, Is Predictive of Poor Prognosis in Colon Cancer.Dis Markers. 2017;2017:1202710. doi: 10.1155/2017/1202710. Epub 2017 Dec 28.
678 Genetic variation in selenoprotein genes, lifestyle, and risk of colon and rectal cancer.PLoS One. 2012;7(5):e37312. doi: 10.1371/journal.pone.0037312. Epub 2012 May 17.
679 Missense polymorphisms of PTPRJ and PTPN13 genes affect susceptibility to a variety of human cancers.J Cancer Res Clin Oncol. 2010 Feb;136(2):249-59. doi: 10.1007/s00432-009-0656-7. Epub 2009 Aug 12.
680 The haplotypes of TNFRSF17 polymorphisms are associated with colon cancer in a Korean population.Int J Colorectal Dis. 2012 Jun;27(6):701-7. doi: 10.1007/s00384-011-1364-8. Epub 2011 Nov 24.
681 Glutathione, an Antioxidant Tripeptide: Dual Roles in Carcinogenesis and Chemoprevention.Curr Protein Pept Sci. 2019;20(9):907-917. doi: 10.2174/1389203720666190206130003.
682 Metastatic Colorectal Cancer Rewrites Metabolic Program Through a Glut3-YAP-dependent Signaling Circuit.Theranostics. 2019 Apr 13;9(9):2526-2540. doi: 10.7150/thno.32915. eCollection 2019.
683 MicroRNA-522 reverses drug resistance of doxorubicin-induced HT29 colon cancer cell by targeting ABCB5. Mol Med Rep. 2015 Sep;12(3):3930-3936.
684 Gene expression of CYP3A4, ABC-transporters (MDR1 and MRP1-MRP5) and hPXR in three different human colon carcinoma cell lines.J Pharm Pharmacol. 2003 Jan;55(1):59-66. doi: 10.1111/j.2042-7158.2003.tb02434.x.
685 Copper-transporting P-type ATPase, ATP7A, confers multidrug resistance and its expression is related to resistance to SN-38 in clinical colon cancer. Cancer Res. 2007 May 15;67(10):4860-8. doi: 10.1158/0008-5472.CAN-06-3096.
686 Dual targeting of l-carnitine-conjugated nanoparticles to OCTN2 and ATB(0,+) to deliver chemotherapeutic agents for colon cancer therapy.Drug Deliv. 2017 Nov;24(1):1338-1349. doi: 10.1080/10717544.2017.1377316.
687 Apoptosis of estrogen-receptor negative breast cancer and colon cancer cell lines by PTP alpha and src RNAi.Int J Cancer. 2008 May 1;122(9):1999-2007. doi: 10.1002/ijc.23321.
688 Targeting delivery of lipocalin 2-engineered mesenchymal stem cells to colon cancer in order to inhibit liver metastasis in nude mice.Tumour Biol. 2015 Aug;36(8):6011-8. doi: 10.1007/s13277-015-3277-6. Epub 2015 Mar 5.
689 NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity.Cancer Res. 1992 Feb 15;52(4):797-802.
690 The Constituents of the Stems of Cissus assamica and Their Bioactivities.Molecules. 2018 Oct 28;23(11):2799. doi: 10.3390/molecules23112799.
691 Cooperative Regulation of Intestinal UDP-Glucuronosyltransferases 1A8, -1A9, and 1A10 by CDX2 and HNF4 Is Mediated by a Novel Composite Regulatory Element.Mol Pharmacol. 2018 May;93(5):541-552. doi: 10.1124/mol.117.110619. Epub 2018 Mar 8.
692 Gastrin inhibits a novel, pathological colon cancer signaling pathway involving EGR1, AE2, and P-ERK.J Mol Med (Berl). 2012 Jun;90(6):707-18. doi: 10.1007/s00109-011-0851-2. Epub 2012 Jan 7.
693 Transcriptional activation of the carboxylesterase 2 gene by the p53 pathway. Cancer Biol Ther. 2006 Nov;5(11):1450-6.
694 Association of Survival With Adherence to the American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Survivors After Colon Cancer Diagnosis: The CALGB 89803/Alliance Trial.JAMA Oncol. 2018 Jun 1;4(6):783-790. doi: 10.1001/jamaoncol.2018.0126.
695 Potential role of nucleoside diphosphate kinase in myricetin-induced selective apoptosis in colon cancer HCT-15?cells. Food Chem Toxicol. 2018 Jun;116(Pt B):315-322. doi: 10.1016/j.fct.2018.04.053. Epub 2018 Apr 24.
696 Specific delivery of delta-5-desaturase siRNA via RNA nanoparticles supplemented with dihomo--linolenic acid for colon cancer suppression.Redox Biol. 2019 Feb;21:101085. doi: 10.1016/j.redox.2018.101085. Epub 2018 Dec 18.
697 Anthocyanin Encapsulated by Ferulic Acid-Grafted-Maltodextrin (FA-g-MD) Microcapsules Potentially Improved its Free Radical Scavenging Capabilities Against H(2)O(2)-Induced Oxidative Stress.Molecules. 2019 Apr 23;24(8):1596. doi: 10.3390/molecules24081596.
698 The diagnostic potential of glutathione S-transferase (GST) polymorphisms in patients with colorectal cancer.Adv Clin Exp Med. 2018 Nov;27(11):1561-1566. doi: 10.17219/acem/74682.
699 Alcohol intake, ADH1B and ADH1C genotypes, and the risk of colorectal cancer by sex and subsite in the Netherlands Cohort Study.Carcinogenesis. 2018 Mar 8;39(3):375-388. doi: 10.1093/carcin/bgy011.
700 AKR1B10, a transcriptional target of p53, is downregulated in colorectal cancers associated with poor prognosis.Mol Cancer Res. 2013 Dec;11(12):1554-63. doi: 10.1158/1541-7786.MCR-13-0330-T. Epub 2013 Oct 18.
701 A novel DNA-binding motif in prostate tumor overexpressed-1 (PTOV1) required for the expression of ALDH1A1 and CCNG2 in cancer cells.Cancer Lett. 2019 Jun 28;452:158-167. doi: 10.1016/j.canlet.2019.03.019. Epub 2019 Mar 25.
702 ALDH1B1 Is Crucial for Colon Tumorigenesis by Modulating Wnt/-Catenin, Notch and PI3K/Akt Signaling Pathways.PLoS One. 2015 May 7;10(5):e0121648. doi: 10.1371/journal.pone.0121648. eCollection 2015.
703 Mutational inactivation of TGFBR2 in microsatellite unstable colon cancer arises from the cooperation of genomic instability and the clonal outgrowth of transforming growth factor beta resistant cells.Genes Chromosomes Cancer. 2008 Feb;47(2):95-106. doi: 10.1002/gcc.20511.
704 Genetic modification of the effect of alcohol consumption on CHD.Proc Nutr Soc. 2004 Feb;63(1):73-9. doi: 10.1079/PNS2003321.
705 Butyrate alters expression of cytochrome P450 1A1 and metabolism of benzo[a]pyrene via its histone deacetylase activity in colon epithelial cell models. Arch Toxicol. 2017 May;91(5):2135-2150. doi: 10.1007/s00204-016-1887-4. Epub 2016 Nov 9.
706 Vitamin D related genes, CYP24A1 and CYP27B1, and colon cancer risk.Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2540-8. doi: 10.1158/1055-9965.EPI-09-0228. Epub 2009 Aug 25.
707 Association of common gene variants in vitamin D modulating genes and colon cancer recurrence.J Cancer Res Clin Oncol. 2013 Sep;139(9):1457-64. doi: 10.1007/s00432-013-1461-x. Epub 2013 Jun 23.
708 Polymorphisms in drug-metabolizing enzymes as modifiers of cancer risk.Clin Chem. 1995 Dec;41(12 Pt 2):1864-9.
709 Genetic polymorphism of cholesterol 7alpha-hydroxylase (CYP7A1) and colorectal adenomas: Self Defense Forces Health Study.Cancer Sci. 2006 May;97(5):406-10. doi: 10.1111/j.1349-7006.2006.00182.x.
710 MicroRNA-17 induces epithelial-mesenchymal transition consistent with the cancer stem cell phenotype by regulating CYP7B1 expression in colon cancer. Int J Mol Med. 2016 Aug;38(2):499-506.
711 Synthetic lethality by lentiviral short hairpin RNA silencing of thymidylate kinase and doxorubicin in colon cancer cells regardless of the p53 status. Cancer Res. 2008 Apr 15;68(8):2831-40. doi: 10.1158/0008-5472.CAN-07-3069.
712 Prolyl hydroxylase 3 stabilizes the p53 tumor suppressor by inhibiting the p53-MDM2 interaction in a hydroxylase-independent manner.J Biol Chem. 2019 Jun 21;294(25):9949-9958. doi: 10.1074/jbc.RA118.007181. Epub 2019 May 15.
713 Overexpression of flavin-containing monooxygenase 5 predicts poor prognosis in patients with colorectal cancer.Oncol Lett. 2018 Mar;15(3):3923-3927. doi: 10.3892/ol.2018.7724. Epub 2018 Jan 4.
714 Altered gene expression of folate enzymes in adjacent mucosa is associated with outcome of colorectal cancer patients.Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):6012-9.
715 Inhibition of Glucose Transporters and Glutaminase Synergistically Impairs Tumor Cell Growth.Cell Chem Biol. 2019 Sep 19;26(9):1214-1228.e25. doi: 10.1016/j.chembiol.2019.06.005. Epub 2019 Jul 11.
716 Mutation of GDP-mannose-4,6-dehydratase in colorectal cancer metastasis.PLoS One. 2013 Jul 29;8(7):e70298. doi: 10.1371/journal.pone.0070298. Print 2013.
717 15-Keto prostaglandin E(2) induces heme oxygenase-1 expression through activation of Nrf2 in human colon epithelial CCD 841 CoN cells.Arch Biochem Biophys. 2020 Jan 15;679:108162. doi: 10.1016/j.abb.2019.108162. Epub 2019 Dec 24.
718 Effect of exogenous MSH6 and POLD1 expression on the mutation rate of the HPRT locus in a human colon cancer cell line with mutator phenotype, DLD-1.Int J Oncol. 2004 Mar;24(3):697-702.
719 17Beta-hydroxysteroid dehydrogenase type 2: independent prognostic significance and evidence of estrogen protection in female patients with colon cancer.J Steroid Biochem Mol Biol. 2003 Nov;87(2-3):133-40. doi: 10.1016/j.jsbmb.2003.08.008.
720 The HMGB1 protein induces a metabolic type of tumour cell death by blocking aerobic respiration.Nat Commun. 2016 Mar 7;7:10764. doi: 10.1038/ncomms10764.
721 Downregulation of metallothionein 1F, a putative oncosuppressor, by loss of heterozygosity in colon cancer tissue.Biochim Biophys Acta. 2012 Jun;1822(6):918-26. doi: 10.1016/j.bbadis.2012.02.021. Epub 2012 Mar 9.
722 Integrating proteomic and transcriptomic high-throughput surveys for search of new biomarkers of colon tumors.Funct Integr Genomics. 2011 Jun;11(2):215-24. doi: 10.1007/s10142-010-0200-5. Epub 2010 Nov 9.
723 Gene-diet-interactions in folate-mediated one-carbon metabolism modify colon cancer risk.Mol Nutr Food Res. 2013 Apr;57(4):721-34. doi: 10.1002/mnfr.201200180. Epub 2012 Sep 7.
724 Loss of human arylamine N-acetyltransferase I regulates mitochondrial function by inhibition of the pyruvate dehydrogenase complex.Int J Biochem Cell Biol. 2019 May;110:84-90. doi: 10.1016/j.biocel.2019.03.002. Epub 2019 Mar 2.
725 Butyrate interacts with benzo[a]pyrene to alter expression and activities of xenobiotic metabolizing enzymes involved in metabolism of carcinogens within colon epithelial cell models. Toxicology. 2019 Jan 15;412:1-11.
726 Quantitative analysis of thymidine kinase 1 and 5'(3')-deoxyribonucleotidase mRNA expression: the role of fluorothymidine uptake.Anticancer Res. 2011 Jun;31(6):2135-9.
727 DJ-1 promotes survival of human colon cancer cells under hypoxia by modulating HIF-1 expression through the PI3K-AKT pathway.Cancer Manag Res. 2018 Oct 16;10:4615-4629. doi: 10.2147/CMAR.S172008. eCollection 2018.
728 Three-dimensional computed tomographic angiography with computed tomographic colonography for laparoscopic colorectal surgery.Jpn J Radiol. 2018 Dec;36(12):698-705. doi: 10.1007/s11604-018-0775-7. Epub 2018 Sep 14.
729 Correlated downregulation of estrogen receptor beta and the circadian clock gene Per1 in human colorectal cancer.Mol Carcinog. 2009 Jul;48(7):642-7. doi: 10.1002/mc.20510.
730 Proline oxidase, encoded by p53-induced gene-6, catalyzes the generation of proline-dependent reactive oxygen species.Cancer Res. 2001 Mar 1;61(5):1810-5.
731 A novel indole compound, AWT-489, inhibits prostaglandin D2-induced CD55 expression by acting on DP prostanoid receptors as an antagonist in LS174T human colon cancer cells.Arch Biochem Biophys. 2014 Jan 1;541:21-9. doi: 10.1016/j.abb.2013.10.023. Epub 2013 Nov 12.
732 Characterization of two glycolipid: alpha 2-3sialyltransferases, SAT-3 (CMP-NeuAc:nLcOse4Cer alpha 2-3sialyltransferase) and SAT-4 (CMP-NeuAc:GgOse4Cer alpha 2-3sialyltransferase), from human colon carcinoma (Colo 205) cell line.Biochemistry. 1996 Apr 23;35(16):5166-74. doi: 10.1021/bi960239l.
733 Coffee reduces SULT1E1 expression in human colon carcinoma Caco-2 cells.Biol Pharm Bull. 2013;36(2):299-304. doi: 10.1248/bpb.b12-00902.
734 Human thiopurine methyltransferase: molecular cloning and expression of T84 colon carcinoma cell cDNA.Mol Pharmacol. 1993 Jun;43(6):878-87.
735 Joint effects between UDP-glucuronosyltransferase 1A7 genotype and dietary carcinogen exposure on risk of colon cancer.Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1626-32. doi: 10.1158/1055-9965.EPI-04-0682.
736 The effect of copy number variation in the phase II detoxification genes UGT2B17 and UGT2B28 on colorectal cancer risk.Cancer. 2013 Jul 1;119(13):2477-85. doi: 10.1002/cncr.28009. Epub 2013 Apr 10.
737 ACTL6A expression promotes invasion, metastasis and epithelial mesenchymal transition of colon cancer.BMC Cancer. 2018 Oct 22;18(1):1020. doi: 10.1186/s12885-018-4931-3.
738 Increased expression of GEF-H1 promotes colon cancer progression by RhoA signaling.Pathol Res Pract. 2019 May;215(5):1012-1019. doi: 10.1016/j.prp.2019.02.008. Epub 2019 Feb 27.
739 Pimozide suppresses cancer cell migration and tumor metastasis through binding to ARPC2, a subunit of the Arp2/3 complex.Cancer Sci. 2019 Dec;110(12):3788-3801. doi: 10.1111/cas.14205. Epub 2019 Nov 15.
740 Effect of ART1 on the proliferation and migration of mouse colon carcinoma CT26 cells invivo.Mol Med Rep. 2017 Mar;15(3):1222-1228. doi: 10.3892/mmr.2017.6152. Epub 2017 Jan 26.
741 Unexpected distribution of CA19.9 and other type 1 chain Lewis antigens in normal and cancer tissues of colon and pancreas: Importance of the detection method and role of glycosyltransferase regulation.Biochim Biophys Acta Gen Subj. 2017 Jan;1861(1 Pt A):3210-3220. doi: 10.1016/j.bbagen.2016.08.005. Epub 2016 Aug 14.
742 Suppression of B3GNT7 gene expression in colon adenocarcinoma and its potential effect in the metastasis of colon cancer cells.Glycobiology. 2014 Apr;24(4):359-67. doi: 10.1093/glycob/cwu002. Epub 2014 Jan 12.
743 Bombesin induces cyclooxygenase-2 expression through the activation of the nuclear factor of activated T cells and enhances cell migration in Caco-2 colon carcinoma cells.Oncogene. 2007 Feb 15;26(7):958-69. doi: 10.1038/sj.onc.1209856. Epub 2006 Aug 14.
744 Carbonic anhydrase-related protein VIII promotes colon cancer cell growth.Mol Carcinog. 2007 Mar;46(3):208-14. doi: 10.1002/mc.20264.
745 Autophagy of cancer stem cells is involved with chemoresistance of colon cancer cells.Biochem Biophys Res Commun. 2013 May 17;434(4):898-903. doi: 10.1016/j.bbrc.2013.04.053. Epub 2013 Apr 23.
746 Ingested nitrate, disinfection by-products, and risk of colon and rectal cancers in the Iowa Women's Health Study cohort.Environ Int. 2019 May;126:242-251. doi: 10.1016/j.envint.2019.02.010. Epub 2019 Feb 26.
747 TERT's role in colorectal carcinogenesis.Mol Carcinog. 2013 Jul;52(7):507-13. doi: 10.1002/mc.21885. Epub 2012 Feb 21.
748 The protein secretion modulator TMED9 drives CNIH4/TGF/GLI signaling opposing TMED3-WNT-TCF to promote colon cancer metastases.Oncogene. 2019 Jul;38(29):5817-5837. doi: 10.1038/s41388-019-0845-z. Epub 2019 Jun 28.
749 Cortactin promotes colon cancer progression by regulating ERK pathway.Int J Oncol. 2015 Sep;47(3):1034-42. doi: 10.3892/ijo.2015.3072. Epub 2015 Jul 6.
750 Expression of CUEDC2 in colorectal cancer with different invasion and migration abilities.J Int Med Res. 2019 Feb;47(2):905-914. doi: 10.1177/0300060518813072. Epub 2019 Jan 17.
751 Lymph node CXCL17 messenger RNA: A new prognostic biomarker for colon cancer.Tumour Biol. 2018 Sep;40(9):1010428318799251. doi: 10.1177/1010428318799251.
752 Construction and characterization of regulated cycle inhibiting factors induced upon Tet-On system in human colon cancer cell lines.Anticancer Drugs. 2018 Oct;29(9):854-860. doi: 10.1097/CAD.0000000000000654.
753 Expression of DDB2 Protein in the Initiation, Progression, and Prognosis of Colorectal Cancer.Dig Dis Sci. 2018 Nov;63(11):2959-2968. doi: 10.1007/s10620-018-5224-z. Epub 2018 Jul 27.
754 Loperamide overcomes the resistance of colon cancer cells to bortezomib by inducing CHOP-mediated paraptosis-like cell death.Biochem Pharmacol. 2019 Apr;162:41-54. doi: 10.1016/j.bcp.2018.12.006. Epub 2018 Dec 7.
755 Drosophila homologue of Diaphanous 1 (DIAPH1) controls the metastatic potential of colon cancer cells by regulating microtubule-dependent adhesion.Oncotarget. 2015 Jul 30;6(21):18577-89. doi: 10.18632/oncotarget.4094.
756 Tumor suppressor DLC-1 induces apoptosis and inhibits the growth and invasion of colon cancer cells through the Wnt/-catenin signaling pathway.Oncol Rep. 2014 May;31(5):2270-8. doi: 10.3892/or.2014.3057. Epub 2014 Mar 5.
757 Eukaryotic translation initiation factor 3 subunit G promotes human colorectal cancer.Am J Transl Res. 2019 Feb 15;11(2):612-623. eCollection 2019.
758 Unexpected Growth-Promoting Effect of Oxaliplatin in Excision Repair Cross-Complementation Group 1 Transfected Human Colon Cancer Cells.Pharmacology. 2018;102(3-4):161-168. doi: 10.1159/000491587. Epub 2018 Jul 26.
759 The Differential Expression of Core Genes in Nucleotide Excision Repair Pathway Indicates Colorectal Carcinogenesis and Prognosis.Biomed Res Int. 2018 Jan 15;2018:9651320. doi: 10.1155/2018/9651320. eCollection 2018.
760 GROalpha is highly expressed in adenocarcinoma of the colon and down-regulates fibulin-1.Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):5951-9. doi: 10.1158/1078-0432.CCR-06-0736.
761 Promoter hypermethylation mediated downregulation of FBP1 in human hepatocellular carcinoma and colon cancer. PLoS One. 2011;6(10):e25564. doi: 10.1371/journal.pone.0025564. Epub 2011 Oct 19.
762 ADAM-17/FHL2 colocalisation suggests interaction and role of these proteins in colorectal cancer.Tumour Biol. 2017 Mar;39(3):1010428317695024. doi: 10.1177/1010428317695024.
763 A retinoid responsive cytokine gene, MK, is preferentially expressed in the proximal tubules of the kidney and human tumor cell lines.Am J Pathol. 1993 Feb;142(2):425-31.
764 The miR-196b miRNA inhibits the GATA6 intestinal transcription factor and is upregulated in colon cancer patients.Oncotarget. 2017 Jan 17;8(3):4747-4759. doi: 10.18632/oncotarget.13580.
765 Elevation of GPRC5A expression in colorectal cancer promotes tumor progression through VNN-1 induced oxidative stress.Int J Cancer. 2017 Jun 15;140(12):2734-2747. doi: 10.1002/ijc.30698. Epub 2017 Apr 3.
766 Significance of Polymorphisms and Expression of Enzyme-Encoding Genes Related to Glutathione in Hematopoietic Cancers and Solid Tumors.Biomed Res Int. 2015;2015:853573. doi: 10.1155/2015/853573. Epub 2015 Nov 23.
767 Altered expression and localization of creatine kinase B, heterogeneous nuclear ribonucleoprotein F, and high mobility group box 1 protein in the nuclear matrix associated with colon cancer.Cancer Res. 2006 Jan 15;66(2):763-9. doi: 10.1158/0008-5472.CAN-05-3771.
768 Acetylated HOXB9 at lysine 27 is of differential diagnostic value in patients with pancreatic ductal adenocarcinoma.Front Med. 2020 Feb;14(1):91-100. doi: 10.1007/s11684-019-0696-6. Epub 2019 Aug 2.
769 Expression of IARS2 gene in colon cancer and effect of its knockdown on biological behavior of RKO cells.Int J Clin Exp Pathol. 2015 Oct 1;8(10):12151-9. eCollection 2015.
770 Insulin-like growth factor binding protein-4 gene therapy increases apoptosis by altering Bcl-2 and Bax proteins and decreases angiogenesis in colorectal cancer.Int J Oncol. 2007 Apr;30(4):883-8.
771 Bazedoxifene as a novel GP130 inhibitor for Colon Cancer therapy.J Exp Clin Cancer Res. 2019 Feb 8;38(1):63. doi: 10.1186/s13046-019-1072-8.
772 Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases.Biosci Rep. 2017 Feb 10;37(1):BSR20160432. doi: 10.1042/BSR20160432. Print 2017 Feb 28.
773 The expression of iNOS and nitrotyrosine in colitis and colon cancer in humans.Acta Histochem. 2012 Dec;114(8):827-35. doi: 10.1016/j.acthis.2012.02.004. Epub 2012 Mar 13.
774 High expression of leucinerich repeatcontaining8A is indicative of a worse outcome of colon cancer patients by enhancing cancer cell growth and metastasis.Oncol Rep. 2018 Sep;40(3):1275-1286. doi: 10.3892/or.2018.6556. Epub 2018 Jul 10.
775 Overexpression of lumican affects the migration of human colon cancer cells through up-regulation of gelsolin and filamentous actin reorganization.Exp Cell Res. 2012 Nov 1;318(18):2312-23. doi: 10.1016/j.yexcr.2012.07.005. Epub 2012 Jul 16.
776 c-Myc inactivation by mutant Max alters growth and morphology of NCI-H-630 colon cancer cells.J Cell Physiol. 1996 Oct;169(1):200-8. doi: 10.1002/(SICI)1097-4652(199610)169:1<200::AID-JCP20>3.0.CO;2-F.
777 A potential common role of the Jumonji C domain-containing 1A histone demethylase and chromatin remodeler ATRX in promoting colon cancer.Oncol Lett. 2018 Nov;16(5):6652-6662. doi: 10.3892/ol.2018.9487. Epub 2018 Sep 24.
778 Promoter switch: a novel mechanism causing biallelic PEG1/MEST expression in invasive breast cancer.Hum Mol Genet. 2002 Jun 1;11(12):1449-53. doi: 10.1093/hmg/11.12.1449.
779 Adenine Inhibits the Growth of Colon Cancer Cells via AMP-Activated Protein Kinase Mediated Autophagy.Evid Based Complement Alternat Med. 2019 Sep 12;2019:9151070. doi: 10.1155/2019/9151070. eCollection 2019.
780 FAM188B enhances cell survival via interaction with USP7.Cell Death Dis. 2018 May 24;9(6):633. doi: 10.1038/s41419-018-0650-6.
781 Colon cancer recurrenceassociated genes revealed by WGCNA coexpression network analysis.Mol Med Rep. 2017 Nov;16(5):6499-6505. doi: 10.3892/mmr.2017.7412. Epub 2017 Aug 31.
782 MYEOV (myeloma overexpressed gene) drives colon cancer cell migration and is regulated by PGE2.J Exp Clin Cancer Res. 2010 Jun 22;29(1):81. doi: 10.1186/1756-9966-29-81.
783 NAA40 contributes to colorectal cancer growth by controlling PRMT5 expression.Cell Death Dis. 2019 Mar 11;10(3):236. doi: 10.1038/s41419-019-1487-3.
784 Tumor suppressor candidate gene, NDRG2 is frequently inactivated in human glioblastoma multiforme.Mol Med Rep. 2014 Aug;10(2):891-6. doi: 10.3892/mmr.2014.2237. Epub 2014 May 14.
785 Transcription factor NFATc2 controls the emergence of colon cancer associated with IL-6-dependent colitis.Cancer Res. 2012 Sep 1;72(17):4340-50. doi: 10.1158/0008-5472.CAN-11-4155. Epub 2012 Jun 27.
786 NFE2L3 Controls Colon Cancer Cell Growth through Regulation of DUX4, a CDK1 Inhibitor.Cell Rep. 2019 Nov 5;29(6):1469-1481.e9. doi: 10.1016/j.celrep.2019.09.087.
787 The oncogenic role of NKAP in the growth and invasion of colon cancer cells.Oncol Rep. 2019 Nov;42(5):2130-2138. doi: 10.3892/or.2019.7322. Epub 2019 Sep 18.
788 The orphan nuclear receptor EAR2 is overexpressed in colorectal cancer and it regulates survivability of colon cancer cells.Cancer Lett. 2011 Oct 28;309(2):137-44. doi: 10.1016/j.canlet.2011.05.025. Epub 2011 Jun 22.
789 Expression of prostaglandin H synthase-2 in human brain tumors.Acta Neuropathol. 2001 Aug;102(2):181-7. doi: 10.1007/s004010100373.
790 PEAK1, acting as a tumor promoter in colorectal cancer, is regulated by the EGFR/KRas signaling axis and miR-181d.Cell Death Dis. 2018 Feb 15;9(3):271. doi: 10.1038/s41419-018-0320-8.
791 PKB-mediated PHF20 phosphorylation on Ser291 is required for p53 function in DNA damage.Cell Signal. 2013 Jan;25(1):74-84. doi: 10.1016/j.cellsig.2012.09.009. Epub 2012 Sep 11.
792 Inhibition of Growth and Metastasis of Colon Cancer by Delivering 5-Fluorouracil-loaded Pluronic P85 Copolymer Micelles.Sci Rep. 2016 Feb 11;6:20896. doi: 10.1038/srep20896.
793 Protein phosphatase 1H, overexpressed in colon adenocarcinoma, is associated with CSE1L.Cancer Biol Ther. 2008 Feb;7(2):285-92. doi: 10.4161/cbt.7.2.5302. Epub 2007 Nov 14.
794 siPRDX2-elevated DNM3 inhibits the proliferation and metastasis of colon cancer cells via AKT signaling pathway.Cancer Manag Res. 2019 Jun 28;11:5799-5811. doi: 10.2147/CMAR.S193805. eCollection 2019.
795 A Functional Signature Ontology (FUSION) screen detects an AMPK inhibitor with selective toxicity toward human colon tumor cells.Sci Rep. 2018 Feb 28;8(1):3770. doi: 10.1038/s41598-018-22090-6.
796 Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1.Carcinogenesis. 2010 Sep;31(9):1604-11. doi: 10.1093/carcin/bgq142. Epub 2010 Jul 9.
797 G9a governs colon cancer stem cell phenotype and chemoradioresistance through PP2A-RPA axis-mediated DNA damage response.Radiother Oncol. 2017 Sep;124(3):395-402. doi: 10.1016/j.radonc.2017.03.002. Epub 2017 Mar 25.
798 PTPH1 immunohistochemical expression and promoter methylation in breast cancer patients from India: A retrospective study.J Cell Physiol. 2019 Feb;234(2):1071-1079. doi: 10.1002/jcp.27211. Epub 2018 Sep 6.
799 A siRNA-based method for efficient silencing of PYROXD1 gene expression in the colon cancer cell line HCT116.J Cell Biochem. 2019 Dec;120(12):19310-19317. doi: 10.1002/jcb.26858. Epub 2019 Sep 10.
800 A role for RAD54B in homologous recombination in human cells.EMBO J. 2002 Jan 15;21(1-2):175-80. doi: 10.1093/emboj/21.1.175.
801 BAP1 expression is prognostic in breast and uveal melanoma but not colon cancer and is highly positively correlated with RBM15B and USP19.PLoS One. 2019 Feb 4;14(2):e0211507. doi: 10.1371/journal.pone.0211507. eCollection 2019.
802 High RNA-binding Motif Protein 3 Expression Is Associated with Improved Clinical Outcomes in Invasive Breast Cancer.J Breast Cancer. 2018 Sep;21(3):288-296. doi: 10.4048/jbc.2018.21.e34. Epub 2018 Aug 28.
803 R-spondin 2 promotes proliferation and migration via the Wnt/-catenin pathway in human hepatocellular carcinoma.Oncol Lett. 2017 Aug;14(2):1757-1765. doi: 10.3892/ol.2017.6339. Epub 2017 Jun 7.
804 SASH1 regulates proliferation, apoptosis, and invasion of osteosarcoma cell.Mol Cell Biochem. 2013 Jan;373(1-2):201-10. doi: 10.1007/s11010-012-1491-8. Epub 2012 Oct 29.
805 SR-A1, a member of the human pre-mRNA splicing factor family, and its expression in colon cancer progression.Biol Chem. 2004 Sep;385(9):785-90. doi: 10.1515/BC.2004.102.
806 Modulation of the colon cancer cell phenotype by pro-inflammatory macrophages: A preclinical model of surgery-associated inflammation and tumor recurrence.PLoS One. 2018 Feb 20;13(2):e0192958. doi: 10.1371/journal.pone.0192958. eCollection 2018.
807 Association and diagnostic value of serum SPINK4 in colorectal cancer.PeerJ. 2019 Apr 4;7:e6679. doi: 10.7717/peerj.6679. eCollection 2019.
808 Serum response factor is alternatively spliced in human colon cancer.J Surg Res. 2004 Sep;121(1):92-100. doi: 10.1016/j.jss.2004.02.031.
809 Modification of 2,6-sialylation mediates the invasiveness and tumorigenicity of non-small cell lung cancer cells in vitro and in vivo via Notch1/Hes1/MMPs pathway.Int J Cancer. 2018 Nov 1;143(9):2319-2330. doi: 10.1002/ijc.31737. Epub 2018 Sep 7.
810 RBP4-STRA6 Pathway Drives Cancer Stem Cell Maintenance and Mediates High-Fat Diet-Induced Colon Carcinogenesis.Stem Cell Reports. 2017 Aug 8;9(2):438-450. doi: 10.1016/j.stemcr.2017.06.002. Epub 2017 Jul 6.
811 Identification of new binding proteins of focal adhesion kinase using immunoprecipitation and mass spectrometry.Sci Rep. 2019 Sep 9;9(1):12908. doi: 10.1038/s41598-019-49145-6.
812 Association between interleukin-4R and TGF-1 gene polymorphisms and the risk of colorectal cancer in a Korean population.Colorectal Dis. 2010 Dec;12(12):1208-12. doi: 10.1111/j.1463-1318.2009.02080.x.
813 Down-regulation of tensin2 enhances tumorigenicity and is associated with a variety of cancers.Oncotarget. 2016 Jun 21;7(25):38143-38153. doi: 10.18632/oncotarget.9411.
814 TRIM72 Immunohistochemical Expression Can Predict Relapse in Colorectal Carcinoma.Pathol Oncol Res. 2020 Apr;26(2):861-865. doi: 10.1007/s12253-019-00629-w. Epub 2019 Mar 9.
815 Breakpoint analysis of transcriptional and genomic profiles uncovers novel gene fusions spanning multiple human cancer types.PLoS Genet. 2013 Apr;9(4):e1003464. doi: 10.1371/journal.pgen.1003464. Epub 2013 Apr 25.
816 SRSF1 Prevents DNA Damage and Promotes Tumorigenesis through Regulation of DBF4B Pre-mRNA Splicing.Cell Rep. 2017 Dec 19;21(12):3406-3413. doi: 10.1016/j.celrep.2017.11.091.
817 Keratin23 (KRT23) knockdown decreases proliferation and affects the DNA damage response of colon cancer cells.PLoS One. 2013 Sep 9;8(9):e73593. doi: 10.1371/journal.pone.0073593. eCollection 2013.
818 DAC can restore expression of NALP1 to suppress tumor growth in colon cancer.Cell Death Dis. 2015 Jan 22;6(1):e1602. doi: 10.1038/cddis.2014.532.
819 Aristaless-like homeobox-4 gene methylation is a potential marker for colorectal adenocarcinomas.Gastroenterology. 2006 Nov;131(5):1418-30. doi: 10.1053/j.gastro.2006.08.034. Epub 2006 Aug 18.
820 Disruption of Core 1-mediated O-glycosylation oppositely regulates CD44 expression in human colon cancer cells and tumor-derived exosomes.Biochem Biophys Res Commun. 2020 Jan 8;521(2):514-520. doi: 10.1016/j.bbrc.2019.10.149. Epub 2019 Oct 31.
821 Colorectal cancer-derived extracellular vesicles induce transformation of fibroblasts into colon carcinoma cells.J Exp Clin Cancer Res. 2019 Jun 14;38(1):257. doi: 10.1186/s13046-019-1248-2.
822 Epigenetic regulation of the human ATP2A3 gene promoter in gastric and colon cancer cell lines.Mol Carcinog. 2019 Jun;58(6):887-897. doi: 10.1002/mc.22978. Epub 2019 Jan 29.
823 DBC1 regulates Wnt/-catenin-mediated expression of MACC1, a key regulator of cancer progression, in colon cancer.Cell Death Dis. 2018 Aug 6;9(8):831. doi: 10.1038/s41419-018-0899-9.
824 Basic transcription factor 3 expression silencing attenuates colon cancer cell proliferation and migration in vitro.Oncol Lett. 2019 Jan;17(1):113-118. doi: 10.3892/ol.2018.9613. Epub 2018 Oct 24.
825 Surgical trauma-induced CCL18 promotes recruitment of regulatory T cells and colon cancer progression.J Cell Physiol. 2019 Apr;234(4):4608-4616. doi: 10.1002/jcp.27245. Epub 2018 Sep 14.
826 Targeting Tumor Vascular CD99 Inhibits Tumor Growth.Front Immunol. 2019 Apr 2;10:651. doi: 10.3389/fimmu.2019.00651. eCollection 2019.
827 Design and synthesis of substituted dihydropyrimidinone derivatives as cytotoxic and tubulin polymerization inhibitors.Bioorg Chem. 2019 Dec;93:103317. doi: 10.1016/j.bioorg.2019.103317. Epub 2019 Sep 26.
828 ER stress-related ATF6 upregulates CIP2A and contributes to poor prognosis of colon cancer.Mol Oncol. 2018 Oct;12(10):1706-1717. doi: 10.1002/1878-0261.12365. Epub 2018 Aug 20.
829 Downregulation of DBN1 is related to vincristine resistance in colon cancer cells.J Cancer Res Ther. 2019 Jan-Mar;15(1):38-41. doi: 10.4103/0973-1482.192766.
830 Ru(II)-thymine complex causes DNA damage and apoptotic cell death in human colon carcinoma HCT116 cells mediated by JNK/p38/ERK1/2 via a p53-independent signaling.Sci Rep. 2019 Jul 31;9(1):11094. doi: 10.1038/s41598-019-47539-0.
831 2-Amino-4-(1-piperidine) pyridine exhibits inhibitory effect on colon cancer through suppression of FOXA2 expression.3 Biotech. 2019 Nov;9(11):384. doi: 10.1007/s13205-019-1915-1. Epub 2019 Oct 4.
832 Forkhead box O3 promotes colon cancer proliferation and drug resistance by activating MDR1 expression.Mol Genet Genomic Med. 2019 Mar;7(3):e554. doi: 10.1002/mgg3.554. Epub 2019 Jan 8.
833 Follistatin-like protein 1 sustains colon cancer cell growth and survival.Oncotarget. 2018 Jul 27;9(58):31278-31290. doi: 10.18632/oncotarget.25811. eCollection 2018 Jul 27.
834 Upregulation of human glycolipid transfer protein (GLTP) induces necroptosis in colon carcinoma cells.Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Feb;1864(2):158-167. doi: 10.1016/j.bbalip.2018.11.002. Epub 2018 Nov 22.
835 Independent prognostic genes and mechanism investigation for colon cancer.Biol Res. 2018 Apr 13;51(1):10. doi: 10.1186/s40659-018-0158-7.
836 Plasma Histone H4 and H4K20 Trimethylation Levels Differ Between Colon Cancer and Precancerous Polyps.In Vivo. 2019 Sep-Oct;33(5):1653-1658. doi: 10.21873/invivo.11651.
837 Tim-3 suppresses the killing effect of V9V2T cells on colon cancer cells by reducing perforin and granzyme B expression.Exp Cell Res. 2020 Jan 1;386(1):111719. doi: 10.1016/j.yexcr.2019.111719. Epub 2019 Nov 11.
838 HCP5 promotes colon cancer development by activating AP1G1 via PI3K/AKT pathway.Eur Rev Med Pharmacol Sci. 2019 Apr;23(7):2786-2793. doi: 10.26355/eurrev_201904_17553.
839 LncRNA-UCA1 modulates progression of colon cancer through regulating the miR-28-5p/HOXB3 axis.J Cell Biochem. 2019 May;120(5):6926-6936. doi: 10.1002/jcb.27630. Epub 2019 Jan 16.
840 Candidate genes involved in metastasis of colon cancer identified by integrated analysis.Cancer Med. 2019 May;8(5):2338-2347. doi: 10.1002/cam4.2071. Epub 2019 Mar 18.
841 Pro-apoptotic effect of haem oxygenase-1 in human colorectal carcinoma cells via endoplasmic reticular stress.J Cell Mol Med. 2019 Aug;23(8):5692-5704. doi: 10.1111/jcmm.14482. Epub 2019 Jun 14.
842 miR-1307-3p overexpression inhibits cell proliferation and promotes cell apoptosis by targeting ISM1 in colon cancer.Mol Cell Probes. 2019 Dec;48:101445. doi: 10.1016/j.mcp.2019.101445. Epub 2019 Sep 9.
843 ITGB4 is a novel prognostic factor in colon cancer.J Cancer. 2019 Aug 28;10(21):5223-5233. doi: 10.7150/jca.29269. eCollection 2019.
844 MALAT1-miR663a negative feedback loop in colon cancer cell functions through direct miRNA-lncRNA binding.Cell Death Dis. 2018 Aug 28;9(9):857. doi: 10.1038/s41419-018-0925-y.
845 CBP-triggered KDM2B acetylation accelerates the carcinogenesis of colon cancer.J Cell Physiol. 2020 Mar;235(3):2901-2910. doi: 10.1002/jcp.29196. Epub 2019 Sep 17.
846 Lemur tyrosine kinase 2 acts as a positive regulator of NF-B activation and colon cancer cell proliferation.Cancer Lett. 2019 Jul 10;454:70-77. doi: 10.1016/j.canlet.2019.04.011. Epub 2019 Apr 10.
847 A Unique Nonsaccharide Mimetic of Heparin Hexasaccharide Inhibits Colon Cancer Stem Cells via p38 MAP Kinase Activation.Mol Cancer Ther. 2019 Jan;18(1):51-61. doi: 10.1158/1535-7163.MCT-18-0104. Epub 2018 Oct 18.
848 LYPD8 regulates the proliferation and migration of colorectal cancer cells through inhibiting the secretion of IL? and TNF?"Xu J. Zhang W
849 Factors Affecting Adherence in a Pragmatic Trial of Annual Fecal Immunochemical Testing for Colorectal Cancer.J Gen Intern Med. 2019 Jun;34(6):978-985. doi: 10.1007/s11606-018-4820-0. Epub 2019 Jan 25.
850 Pharmacologic doses of ascorbic acid repress specificity protein (Sp) transcription factors and Sp-regulated genes in colon cancer cells. Nutr Cancer. 2011;63(7):1133-42. doi: 10.1080/01635581.2011.605984. Epub 2011 Sep 15.
851 ZINC4085554 inhibits cancer cell adhesion by interfering with the interaction of Akt1 and FAK.Oncol Lett. 2019 Jun;17(6):5251-5260. doi: 10.3892/ol.2019.10192. Epub 2019 Mar 27.
852 Long non-coding RNA MBNL1-AS1 regulates proliferation, migration, and invasion of cancer stem cells in colon cancer by interacting with MYL9 via sponging microRNA-412-3p.Clin Res Hepatol Gastroenterol. 2020 Feb;44(1):101-114. doi: 10.1016/j.clinre.2019.05.001. Epub 2019 Jun 26.
853 Immune Effects of M51R Vesicular Stomatitis Virus Treatment of Carcinomatosis From Colon Cancer.J Surg Res. 2020 Jan;245:127-135. doi: 10.1016/j.jss.2019.07.032. Epub 2019 Aug 12.
854 Targeted disruption of Nemo-like kinase inhibits tumor cell growth by simultaneous suppression of cyclin D1 and CDK2 in human hepatocellular carcinoma.J Cell Biochem. 2010 Jun 1;110(3):687-96. doi: 10.1002/jcb.22579.
855 NOX1-Dependent mTORC1 Activation via S100A9 Oxidation in Cancer Stem-like Cells Leads to Colon Cancer Progression.Cell Rep. 2019 Jul 30;28(5):1282-1295.e8. doi: 10.1016/j.celrep.2019.06.085.
856 Vitamin D and the nutritional environment in functions of intestinal stem cells: Implications for tumorigenesis and prevention.J Steroid Biochem Mol Biol. 2020 Apr;198:105556. doi: 10.1016/j.jsbmb.2019.105556. Epub 2019 Nov 26.
857 Sequestration of 9-Hydroxystearic Acid in FAHFA (Fatty Acid Esters of Hydroxy Fatty Acids) as a Protective Mechanism for Colon Carcinoma Cells to Avoid Apoptotic Cell Death.Cancers (Basel). 2019 Apr 12;11(4):524. doi: 10.3390/cancers11040524.
858 Liver receptor homologue 1, a novel prognostic marker in colon cancer patients.Oncol Lett. 2018 Sep;16(3):2833-2838. doi: 10.3892/ol.2018.8988. Epub 2018 Jun 18.
859 P4HB knockdown induces human HT29 colon cancer cell apoptosis through the generation of reactive oxygen species and inactivation of STAT3 signaling.Mol Med Rep. 2019 Jan;19(1):231-237. doi: 10.3892/mmr.2018.9660. Epub 2018 Nov 15.
860 Oncogenic effect of PHLDB2 is associated with epithelial-mesenchymal transition and E-cadherin regulation in colorectal cancer.Cancer Cell Int. 2019 Jul 16;19:184. doi: 10.1186/s12935-019-0903-1. eCollection 2019.
861 FAPP2 promotes tumor cell growth in human colon cancer through activation of Wnt signaling.Exp Cell Res. 2019 Jan 1;374(1):12-18. doi: 10.1016/j.yexcr.2018.11.002. Epub 2018 Nov 5.
862 Identification of TMEM208 and PQLC2 as reference genes for normalizing mRNA expression in colorectal cancer treated with aspirin.Oncotarget. 2017 Apr 4;8(14):22759-22771. doi: 10.18632/oncotarget.15191.
863 AMPK2 knockout enhances tumour inflammation through exacerbated liver injury and energy deprivation-associated AMPK1 activation.J Cell Mol Med. 2019 Mar;23(3):1687-1697. doi: 10.1111/jcmm.13978. Epub 2019 Jan 12.
864 An integrative analysis of colon cancer identifies an essential function for PRPF6 in tumor growth.Genes Dev. 2014 May 15;28(10):1068-84. doi: 10.1101/gad.237206.113. Epub 2014 May 1.
865 Epidermal growth factor-mediated Rab25 pathway regulates integrin 1 trafficking in colon cancer.Cancer Cell Int. 2018 Mar 5;18:32. doi: 10.1186/s12935-018-0526-y. eCollection 2018.
866 Retinoblastoma binding protein 4 up-regulation is correlated with hepatic metastasis and poor prognosis in colon cancer patients.Hepatobiliary Pancreat Dis Int. 2019 Oct;18(5):446-451. doi: 10.1016/j.hbpd.2019.08.006. Epub 2019 Aug 24.
867 Avenanthramide A Induces Cellular Senescence via miR-129-3p/Pirh2/p53 Signaling Pathway To Suppress Colon Cancer Growth.J Agric Food Chem. 2019 May 1;67(17):4808-4816. doi: 10.1021/acs.jafc.9b00833. Epub 2019 Apr 17.
868 Promoter hypermethylation inactivate tumor suppressor FAM134B and is associated with poor prognosis in colorectal cancer.Genes Chromosomes Cancer. 2018 May;57(5):240-251. doi: 10.1002/gcc.22525. Epub 2018 Jan 30.
869 Epigenetic inactivation of HOXD10 is associated with human colon cancer via inhibiting the RHOC/AKT/MAPK signaling pathway.Cell Commun Signal. 2019 Jan 25;17(1):9. doi: 10.1186/s12964-018-0316-0.
870 Germline variability and tumor expression level of ribosomal protein gene RPL28 are associated with survival of metastatic colorectal cancer patients.Sci Rep. 2019 Sep 10;9(1):13008. doi: 10.1038/s41598-019-49477-3.
871 RETRACTED: Long non-coding RNA HULC interacts with miR-613 to regulate colon cancer growth and metastasis through targeting RTKN.Biomed Pharmacother. 2019 Jan;109:2035-2042. doi: 10.1016/j.biopha.2018.08.017. Epub 2018 Nov 26.
872 SATB2 and CDX2 are prognostic biomarkers in DNA mismatch repair protein deficient colon cancer.Mod Pathol. 2019 Jul;32(8):1217-1231. doi: 10.1038/s41379-019-0265-1. Epub 2019 Apr 8.
873 Long noncoding RNA LINC01234 promotes serine hydroxymethyltransferase 2 expression and proliferation by competitively binding miR-642a-5p in colon cancer.Cell Death Dis. 2019 Feb 12;10(2):137. doi: 10.1038/s41419-019-1352-4.
874 MicroRNA-125a inhibits tumorigenesis by targeting Smurf1 in colorectal carcinoma.FEBS Open Bio. 2019 Jul;9(7):1305-1314. doi: 10.1002/2211-5463.12680. Epub 2019 Jun 17.
875 Induction and down-regulation of Sox17 and its possible roles during the course of gastrointestinal tumorigenesis.Gastroenterology. 2009 Oct;137(4):1346-57. doi: 10.1053/j.gastro.2009.06.041. Epub 2009 Jun 21.
876 Rap1 regulates hematopoietic stem cell survival and affects oncogenesis and response to chemotherapy.Nat Commun. 2019 Dec 13;10(1):5349. doi: 10.1038/s41467-019-13082-9.
877 Ca(2+)/calmodulin-dependent protein kinase II regulates colon cancer proliferation and migration via ERK1/2 and p38 pathways.World J Gastroenterol. 2017 Sep 7;23(33):6111-6118. doi: 10.3748/wjg.v23.i33.6111.
878 Production of an anti-TM4SF5 monoclonal antibody and its application in the detection of TM4SF5 as a possible marker of a poor prognosis in colorectal cancer.Int J Oncol. 2018 Jul;53(1):275-285. doi: 10.3892/ijo.2018.4385. Epub 2018 Apr 26.
879 Prognostic Role of TMED3 in Clear Cell Renal Cell Carcinoma: A Retrospective Multi-Cohort Analysis.Front Genet. 2019 Apr 17;10:355. doi: 10.3389/fgene.2019.00355. eCollection 2019.
880 TIPE1 impairs stemness maintenance in colorectal cancer through directly targeting -catenin.Carcinogenesis. 2020 Mar 13;41(1):25-35. doi: 10.1093/carcin/bgz079.
881 TRAPPC9: Novel insights into its trafficking and signaling pathways in health and disease (Review).Int J Mol Med. 2018 Dec;42(6):2991-2997. doi: 10.3892/ijmm.2018.3889. Epub 2018 Sep 21.
882 Ultrasensitive NIR-SERRS Probes with Multiplexed Ratiometric Quantification for In Vivo Antibody Leads Validation.Adv Healthc Mater. 2018 Feb;7(4). doi: 10.1002/adhm.201700870. Epub 2017 Dec 1.
883 miR663aTTC22V1 axis inhibits colon cancer metastasis.Oncol Rep. 2019 Mar;41(3):1718-1728. doi: 10.3892/or.2019.6969. Epub 2019 Jan 16.
884 Che-1 arrests human colon carcinoma cell proliferation by displacing HDAC1 from the p21WAF1/CIP1 promoter.J Biol Chem. 2003 Sep 19;278(38):36496-504. doi: 10.1074/jbc.M306694200. Epub 2003 Jul 7.
885 ABCE1, a member of ATP-binding cassette transporter gene, encodes peptides capable of inducing HLA-A2-restricted and tumor-reactive cytotoxic T lymphocytes in colon cancer patients.Oncol Rep. 2005 May;13(5):907-13.
886 ABHD5 interacts with BECN1 to regulate autophagy and tumorigenesis of colon cancer independent of PNPLA2.Autophagy. 2016 Nov;12(11):2167-2182. doi: 10.1080/15548627.2016.1217380. Epub 2016 Aug 25.
887 ABI3 ectopic expression reduces in vitro and in vivo cell growth properties while inducing senescence.BMC Cancer. 2011 Jan 11;11:11. doi: 10.1186/1471-2407-11-11.
888 An N-, C-terminally truncated basic fibroblast growth factor and LPD (liposome-polycation-DNA) complexes elicits a protective immune response against murine colon carcinoma.Cancer Biol Ther. 2010 Aug 1;10(3):276-81. doi: 10.4161/cbt.10.3.12421. Epub 2010 Aug 20.
889 3'UTR Polymorphism in ACSL1 Gene Correlates with Expression Levels and Poor Clinical Outcome in Colon Cancer Patients.PLoS One. 2016 Dec 19;11(12):e0168423. doi: 10.1371/journal.pone.0168423. eCollection 2016.
890 Fatty acid CoA ligase 4 is up-regulated in colon adenocarcinoma.Cancer Res. 2001 Dec 1;61(23):8429-34.
891 PRP4 kinase induces actin rearrangement and epithelial-mesenchymal transition through modulation of the actin-binding protein cofilin.Exp Cell Res. 2018 Aug 1;369(1):158-165. doi: 10.1016/j.yexcr.2018.05.018. Epub 2018 May 19.
892 A study of three polymorphic sites of ADA gene in colon cancer.Cancer Invest. 2010 Dec;28(10):989-92. doi: 10.3109/07357907.2010.483501. Epub 2010 Jun 30.
893 The ADAMTS12 metalloprotease gene is epigenetically silenced in tumor cells and transcriptionally activated in the stroma during progression of colon cancer.J Cell Sci. 2009 Aug 15;122(Pt 16):2906-13. doi: 10.1242/jcs.050468. Epub 2009 Jul 28.
894 Genetic inactivation of ADAMTS15 metalloprotease in human colorectal cancer.Cancer Res. 2009 Jun 1;69(11):4926-34. doi: 10.1158/0008-5472.CAN-08-4155. Epub 2009 May 19.
895 Adamts18 deficiency promotes colon carcinogenesis by enhancing -catenin and p38MAPK/ERK1/2 signaling in the mouse model of AOM/DSS-induced colitis-associated colorectal cancer.Oncotarget. 2017 Mar 21;8(12):18979-18990. doi: 10.18632/oncotarget.14866.
896 ADAMTSL3/punctin-2, a gene frequently mutated in colorectal tumors, is widely expressed in normal and malignant epithelial cells, vascular endothelial cells and other cell types, and its mRNA is reduced in colon cancer.Int J Cancer. 2007 Oct 15;121(8):1710-6. doi: 10.1002/ijc.22882.
897 Elevated Adenylyl Cyclase 9 Expression Is a Potential Prognostic Biomarker for Patients with Colon Cancer.Med Sci Monit. 2018 Jan 2;24:19-25. doi: 10.12659/msm.906002.
898 Effects of genetic variations in the adiponectin pathway genes on the risk of colorectal cancer in the Chinese population.BMC Med Genet. 2011 Jul 12;12:94. doi: 10.1186/1471-2350-12-94.
899 Expression of adiponectin receptors, AdipoR1 and AdipoR2, in normal colon epithelium and colon cancer tissue.Oncol Rep. 2008 Sep;20(3):479-83.
900 ADNP Is a Therapeutically Inducible Repressor of WNT Signaling in Colorectal Cancer.Clin Cancer Res. 2017 Jun 1;23(11):2769-2780. doi: 10.1158/1078-0432.CCR-16-1604. Epub 2016 Nov 30.
901 MYC promotes tryptophan uptake and metabolism by the kynurenine pathway in colon cancer.Genes Dev. 2019 Sep 1;33(17-18):1236-1251. doi: 10.1101/gad.327056.119. Epub 2019 Aug 15.
902 Transcriptome profiling analysis reveals biomarkers in colon cancer samples of various differentiation.Oncol Lett. 2018 Jul;16(1):48-54. doi: 10.3892/ol.2018.8668. Epub 2018 May 8.
903 Screening for possible miRNA-mRNA associations in a colon cancer cell line.Gene. 2014 Jan 10;533(2):520-31. doi: 10.1016/j.gene.2013.08.005. Epub 2013 Aug 9.
904 Long non-coding RNA CASC7 inhibits the proliferation and migration of colon cancer cells via inhibiting microRNA-21.Biomed Pharmacother. 2017 Nov;95:1644-1653. doi: 10.1016/j.biopha.2017.09.052. Epub 2017 Oct 6.
905 Regulation of CD40 signaling in colon cancer cells and its implications in clinical tissues.Cancer Immunol Immunother. 2016 Aug;65(8):919-29. doi: 10.1007/s00262-016-1847-0. Epub 2016 Jun 4.
906 AIF suppresses chemical stress-induced apoptosis and maintains the transformed state of tumor cells.EMBO J. 2005 Aug 3;24(15):2815-26. doi: 10.1038/sj.emboj.7600746. Epub 2005 Jul 7.
907 Compensation of loss of protein function in microsatellite-unstable colon cancer cells (HCT116): a gene-dependent effect on the cell surface glycan profile.Glycobiology. 2009 Jul;19(7):726-34. doi: 10.1093/glycob/cwp040. Epub 2009 Mar 17.
908 PKA RI/A-kinase anchoring proteins 10 signaling pathway and the prognosis of colorectal cancer.J Gastroenterol Hepatol. 2015 Mar;30(3):496-503. doi: 10.1111/jgh.12689.
909 Identification of the cancer/testis antigens AKAP3 and CTp11 by SEREX in hepatocellular carcinoma.Oncol Rep. 2012 Nov;28(5):1792-8. doi: 10.3892/or.2012.2002. Epub 2012 Aug 30.
910 A-kinase anchor protein 4 (AKAP4) a promising therapeutic target of colorectal cancer.J Exp Clin Cancer Res. 2015 Nov 21;34:142. doi: 10.1186/s13046-015-0258-y.
911 ALDH1A3 affects colon cancer in vitro proliferation and invasion depending on CXCR4 status.Br J Cancer. 2018 Jan;118(2):224-232. doi: 10.1038/bjc.2017.363. Epub 2017 Dec 12.
912 Therapeutic opportunities in colon cancer: Focus on phosphodiesterase inhibitors.Life Sci. 2019 Aug 1;230:150-161. doi: 10.1016/j.lfs.2019.05.043. Epub 2019 May 21.
913 Molecular cloning of complementary DNAs encoding alkaline phosphatase in human colon cancer cells.Cancer Res. 1990 Feb 15;50(4):1085-91.
914 Induction of AMPK activation by N,N'-diarylurea FND-4b decreases growth and increases apoptosis in triple negative and estrogen-receptor positive breast cancers.PLoS One. 2019 Mar 15;14(3):e0209392. doi: 10.1371/journal.pone.0209392. eCollection 2019.
915 AmotL2 disrupts apical-basal cell polarity and promotes tumour invasion.Nat Commun. 2014 Aug 1;5:4557. doi: 10.1038/ncomms5557.
916 Gene expression profiling following constitutive activation of MEK1 and transformation of rat intestinal epithelial cells.Mol Cancer. 2006 Nov 17;5:63. doi: 10.1186/1476-4598-5-63.
917 The expression of MAGE and SSX, and correlation of COX2, VEGF, and survivin in colorectal cancer.Anticancer Res. 2012 Feb;32(2):559-64.
918 Anosmin-1 involved in neuronal cell migration is hypoxia inducible and cancer regulated.Cell Cycle. 2009 Nov 15;8(22):3770-6. doi: 10.4161/cc.8.22.10066. Epub 2009 Nov 14.
919 Reduced APRIL expression induces cellular senescence via a HSPG-dependent pathway.Pathol Oncol Res. 2009 Dec;15(4):693-701. doi: 10.1007/s12253-009-9172-y. Epub 2009 May 26.
920 TAZ expression as a prognostic indicator in colorectal cancer.PLoS One. 2013;8(1):e54211. doi: 10.1371/journal.pone.0054211. Epub 2013 Jan 23.
921 Isolation of a novel human gene, APCDD1, as a direct target of the beta-Catenin/T-cell factor 4 complex with probable involvement in colorectal carcinogenesis.Cancer Res. 2002 Oct 15;62(20):5651-6.
922 An alternatively spliced form of apobec-1 messenger RNA is overexpressed in human colon cancer.Gastroenterology. 1998 Nov;115(5):1096-103. doi: 10.1016/s0016-5085(98)70080-0.
923 Arctigenin blocks the unfolded protein response and shows therapeutic antitumor activity.J Cell Physiol. 2010 Jul;224(1):33-40. doi: 10.1002/jcp.22085.
924 Tumor Suppressive Role of ARHGAP17 in Colon Cancer Through Wnt/-Catenin Signaling.Cell Physiol Biochem. 2018;46(5):2138-2148. doi: 10.1159/000489543. Epub 2018 Apr 28.
925 Comprehensive genomic analyses of a metastatic colon cancer to the lung by whole exome sequencing and gene expression analysis.Int J Oncol. 2014 Jan;44(1):211-21. doi: 10.3892/ijo.2013.2150. Epub 2013 Oct 25.
926 p190RhoGEF (Rgnef) promotes colon carcinoma tumor progression via interaction with focal adhesion kinase.Cancer Res. 2011 Jan 15;71(2):360-70. doi: 10.1158/0008-5472.CAN-10-2894. Epub 2011 Jan 11.
927 Activation of TIM1 induces colon cancer cell apoptosis via modulating Fas ligand expression.Biochem Biophys Res Commun. 2016 Apr 29;473(2):377-81. doi: 10.1016/j.bbrc.2016.02.085. Epub 2016 Feb 26.
928 ARID3A Positivity Correlated With Favorable Prognosis in Patients With Residual Rectal Cancer After Neoadjuvant Chemoradiotherapy.Anticancer Res. 2019 Jun;39(6):2845-2853. doi: 10.21873/anticanres.13413.
929 P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis.Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6334-9. doi: 10.1073/pnas.0911082107. Epub 2010 Mar 22.
930 Acid ceramidase inhibition sensitizes human colon cancer cells to oxaliplatin through downregulation of transglutaminase 2 and 1 integrin/FAK-mediated signalling.Biochem Biophys Res Commun. 2018 Sep 5;503(2):843-848. doi: 10.1016/j.bbrc.2018.06.085. Epub 2018 Jun 21.
931 Inflexinol inhibits colon cancer cell growth through inhibition of nuclear factor-kappaB activity via direct interaction with p50.Mol Cancer Ther. 2009 Jun;8(6):1613-24. doi: 10.1158/1535-7163.MCT-08-0694. Epub 2009 Jun 9.
932 ASF1A regulates H4(Y72) phosphorylation and promotes autophagy in colon cancer cells via a kinase activity.Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):2754-2763. doi: 10.1080/21691401.2019.1617725.
933 Induction of Nitric-Oxide Metabolism in Enterocytes Alleviates Colitis and Inflammation-Associated Colon Cancer.Cell Rep. 2018 May 15;23(7):1962-1976. doi: 10.1016/j.celrep.2018.04.053.
934 ATG3, a Target of miR-431-5p, Promotes Proliferation and Invasion of Colon Cancer via Promoting Autophagy.Cancer Manag Res. 2019 Dec 9;11:10275-10285. doi: 10.2147/CMAR.S226828. eCollection 2019.
935 lncRNA KCNQ1OT1 enhances the chemoresistance of oxaliplatin in colon cancer by targeting the miR-34a/ATG4B pathway.Onco Targets Ther. 2019 Apr 9;12:2649-2660. doi: 10.2147/OTT.S188054. eCollection 2019.
936 MicroRNA-613 promotes colon cancer cell proliferation, invasion and migration by targeting ATOH1.Biochem Biophys Res Commun. 2018 Oct 12;504(4):827-833. doi: 10.1016/j.bbrc.2018.09.054. Epub 2018 Sep 13.
937 Plasma membrane calcium ATPase 4 and the remodeling of calcium homeostasis in human colon cancer cells.Carcinogenesis. 2009 Nov;30(11):1962-9. doi: 10.1093/carcin/bgp223. Epub 2009 Sep 15.
938 '1-8 interferon inducible gene family': putative colon carcinoma-associated antigens.Br J Cancer. 2007 Dec 17;97(12):1655-63. doi: 10.1038/sj.bjc.6604061. Epub 2007 Dec 11.
939 ATP Synthase Subunit Epsilon Overexpression Promotes Metastasis by Modulating AMPK Signaling to Induce Epithelial-to-Mesenchymal Transition and Is a Poor Prognostic Marker in Colorectal Cancer Patients.J Clin Med. 2019 Jul 21;8(7):1070. doi: 10.3390/jcm8071070.
940 Identification and characterization of functional single nucleotide polymorphisms (SNPs) in Axin 1 gene: a molecular dynamics approach.Cell Biochem Biophys. 2018 Jun;76(1-2):173-185. doi: 10.1007/s12013-017-0818-1. Epub 2017 Aug 2.
941 miR-3120-5p promotes colon cancer stem cell stemness and invasiveness through targeting Axin2.Biochem Biophys Res Commun. 2018 Feb 5;496(2):302-308. doi: 10.1016/j.bbrc.2018.01.021. Epub 2018 Jan 4.
942 Core 3 synthase is down-regulated in colon carcinoma and profoundly suppresses the metastatic potential of carcinoma cells.Proc Natl Acad Sci U S A. 2005 Mar 22;102(12):4572-7. doi: 10.1073/pnas.0407983102. Epub 2005 Mar 8.
943 A novel beta1,3-N-acetylglucosaminyltransferase (beta3Gn-T8), which synthesizes poly-N-acetyllactosamine, is dramatically upregulated in colon cancer.FEBS Lett. 2005 Jan 3;579(1):71-8. doi: 10.1016/j.febslet.2004.11.037.
944 1, 4-N-acetylgalactosaminyltransferase III modulates cancer stemness through EGFR signaling pathway in colon cancer cells.Oncotarget. 2014 Jun 15;5(11):3673-84. doi: 10.18632/oncotarget.1981.
945 Magnetic gold nanoparticle-mediated small interference RNA silencing Bag-1 gene for colon cancer therapy.Oncol Rep. 2016 Feb;35(2):978-84. doi: 10.3892/or.2015.4453. Epub 2015 Nov 26.
946 A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.Gastroenterology. 2009 Jul;137(1):165-75. doi: 10.1053/j.gastro.2009.03.041. Epub 2009 Mar 26.
947 Expression of an Oncogenic BARD1 Splice Variant Impairs Homologous Recombination and Predicts Response to PARP-1 Inhibitor Therapy in Colon Cancer.Sci Rep. 2016 May 20;6:26273. doi: 10.1038/srep26273.
948 Intratumoral delivery of inactivated modified vaccinia virus Ankara (iMVA) induces systemic antitumor immunity via STING and Batf3-dependent dendritic cells.Sci Immunol. 2017 May 19;2(11):eaal1713. doi: 10.1126/sciimmunol.aal1713.
949 A unique gene encodes spliceoforms of the B-cell adhesion molecule cell surface glycoprotein of epithelial cancer and of the Lutheran blood group glycoprotein.Blood. 1996 Sep 1;88(5):1865-72.
950 The tyrosine kinase substrate p120cas binds directly to E-cadherin but not to the adenomatous polyposis coli protein or alpha-catenin.Mol Cell Biol. 1995 Sep;15(9):4819-24. doi: 10.1128/MCB.15.9.4819.
951 Resistance of colon cancer cells to long-term 5-fluorouracil exposure is correlated to the relative level of Bcl-2 and Bcl-X(L) in addition to Bax and p53 status.Int J Cancer. 2002 Apr 1;98(4):498-504. doi: 10.1002/ijc.10146.
952 Quantitative expression analysis and prognostic significance of the novel apoptosis-related gene BCL2L12 in colon cancer.Biol Chem. 2008 Dec;389(12):1467-75. doi: 10.1515/BC.2008.173.
953 Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasion.Breast Cancer Res. 2015 Sep 17;17:128. doi: 10.1186/s13058-015-0630-z.
954 Novel method for high throughput DNA methylation marker evaluation using PNA-probe library hybridization and MALDI-TOF detection.Nucleic Acids Res. 2006 May 2;34(8):e59. doi: 10.1093/nar/gkl218.
955 Abundant expression of Dec1/stra13/sharp2 in colon carcinoma: its antagonizing role in serum deprivation-induced apoptosis and selective inhibition of procaspase activation.Biochem J. 2002 Oct 15;367(Pt 2):413-22. doi: 10.1042/BJ20020514.
956 The paradoxical patterns of expression of indoleamine 2,3-dioxygenase in colon cancer.J Transl Med. 2009 Aug 20;7:71. doi: 10.1186/1479-5876-7-71.
957 Comparative proteomics of colon cancer stem cells and differentiated tumor cells identifies BIRC6 as a potential therapeutic target.Mol Cell Proteomics. 2011 Dec;10(12):M111.011353. doi: 10.1074/mcp.M111.011353. Epub 2011 Jul 25.
958 2'-benzoyloxycinnamaldehyde induces apoptosis in human carcinoma via reactive oxygen species.J Biol Chem. 2004 Feb 20;279(8):6911-20. doi: 10.1074/jbc.M309708200. Epub 2003 Dec 3.
959 BMP3 suppresses colon tumorigenesis via ActRIIB/SMAD2-dependent and TAK1/JNK signaling pathways.J Exp Clin Cancer Res. 2019 Oct 28;38(1):428. doi: 10.1186/s13046-019-1435-1.
960 Clinical and molecular characterization of individuals with recurrent genomic disorder at 10q22.3q23.2.Clin Genet. 2010 Aug;78(2):162-8. doi: 10.1111/j.1399-0004.2010.01373.x. Epub 2010 Feb 9.
961 The usability of a 15-gene hypoxia classifier as a universal hypoxia profile in various cancer cell types.Radiother Oncol. 2015 Sep;116(3):346-51. doi: 10.1016/j.radonc.2015.06.028. Epub 2015 Jul 10.
962 A gene signature of 8 genes could identify the risk of recurrence and progression in Dukes' B colon cancer patients.Oncol Rep. 2007 May;17(5):1089-94.
963 Genetic and epigenetic inactivation of mitotic checkpoint genes hBUB1 and hBUBR1 and their relationship to survival.Cancer Res. 2002 Jan 1;62(1):13-7.
964 BVES regulates EMT in human corneal and colon cancer cells and is silenced via promoter methylation in human colorectal carcinoma.J Clin Invest. 2011 Oct;121(10):4056-69. doi: 10.1172/JCI44228. Epub 2011 Sep 12.
965 Alternative splicing of the OCC-1 gene generates three splice variants and a novel exonic microRNA, which regulate the Wnt signaling pathway.RNA. 2017 Jan;23(1):70-85. doi: 10.1261/rna.056317.116. Epub 2016 Oct 21.
966 Suppression of core 1 Gal-transferase is associated with reduction of TF and reciprocal increase of Tn, sialyl-Tn and Core 3 glycans in human colon cancer cells.PLoS One. 2013;8(3):e59792. doi: 10.1371/journal.pone.0059792. Epub 2013 Mar 25.
967 Anticancer activity of synthetic ()-kusunokinin and its derivative ()-bursehernin on human cancer cell lines.Biomed Pharmacother. 2019 Sep;117:109115. doi: 10.1016/j.biopha.2019.109115. Epub 2019 Jun 17.
968 Hcrcn81 is upregulated by rapamycin treatment in human colorectal adenocarcinoma cells.Mol Med Rep. 2013 Apr;7(4):1257-60. doi: 10.3892/mmr.2013.1317. Epub 2013 Feb 8.
969 Cables1 is a tumor suppressor gene that regulates intestinal tumor progression in Apc(Min) mice.Cancer Biol Ther. 2013 Jul;14(7):672-8. doi: 10.4161/cbt.25089. Epub 2013 May 31.
970 Are oestrogens and genetic predisposition etiologic factors in the development of clear cell carcinoma of the peritoneum?.Med Hypotheses. 2013 Feb;80(2):167-71. doi: 10.1016/j.mehy.2012.11.021. Epub 2012 Dec 21.
971 Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis.Cancer Res. 2007 Aug 15;67(16):7703-12. doi: 10.1158/0008-5472.CAN-07-0991.
972 The plant alkaloid cryptolepine induces p21WAF1/CIP1 and cell cycle arrest in a human osteosarcoma cell line.Int J Oncol. 2007 Oct;31(4):915-22.
973 The miR-28-5p-CAMTA2 axis regulates colon cancer progression via Wnt/-catenin signaling.J Cell Biochem. 2021 Sep;122(9):945-957. doi: 10.1002/jcb.29536. Epub 2019 Nov 10.
974 Identification of a protective haplogenotype within CAPN10 gene influencing colorectal cancer susceptibility.J Gastroenterol Hepatol. 2007 Dec;22(12):2298-302. doi: 10.1111/j.1440-1746.2007.04843.x. Epub 2007 Jun 7.
975 CARMA3 is overexpressed in colon cancer and regulates NF-B activity and cyclin D1 expression.Biochem Biophys Res Commun. 2012 Sep 7;425(4):781-7. doi: 10.1016/j.bbrc.2012.07.152. Epub 2012 Aug 2.
976 TUCAN, an antiapoptotic caspase-associated recruitment domain family protein overexpressed in cancer.J Biol Chem. 2001 Aug 24;276(34):32220-9. doi: 10.1074/jbc.M100433200. Epub 2001 Jun 14.
977 CARD9 prevents lung cancer development by suppressing the expansion of myeloid-derived suppressor cells and IDO production.Int J Cancer. 2019 Oct 15;145(8):2225-2237. doi: 10.1002/ijc.32355. Epub 2019 May 6.
978 Curcumin -D-Glucuronide Plays an Important Role to Keep High Levels of Free-Form Curcumin in the Blood.Biol Pharm Bull. 2017;40(9):1515-1524. doi: 10.1248/bpb.b17-00339.
979 Caspase14 expression is associated with triple negative phenotypes and cancer stem cell marker expression in breast cancer patients.J Surg Oncol. 2017 Nov;116(6):706-715. doi: 10.1002/jso.24705. Epub 2017 Jun 1.
980 Integral analyses of survival-related long non-coding RNA MIR210HG and its prognostic role in colon cancer.Oncol Lett. 2019 Aug;18(2):1107-1116. doi: 10.3892/ol.2019.10435. Epub 2019 Jun 4.
981 Overexpression of caveolin-1 in experimental colon adenocarcinomas and human colon cancer cell lines.Oncol Rep. 2004 May;11(5):957-63.
982 CBLL1 is highly expressed in non-small cell lung cancer and promotes cell proliferation and invasion.Thorac Cancer. 2019 Jun;10(6):1479-1488. doi: 10.1111/1759-7714.13097. Epub 2019 May 23.
983 HP1 suppresses metastasis of human cancer cells by decreasing the expression and activation of MMP2.Int J Oncol. 2014 Dec;45(6):2541-8. doi: 10.3892/ijo.2014.2646. Epub 2014 Sep 9.
984 CBX3 promotes colon cancer cell proliferation by CDK6 kinase-independent function during cell cycle.Oncotarget. 2017 Mar 21;8(12):19934-19946. doi: 10.18632/oncotarget.15253.
985 Unphosphorylated STAT5A stabilizes heterochromatin and suppresses tumor growth.Proc Natl Acad Sci U S A. 2013 Jun 18;110(25):10213-8. doi: 10.1073/pnas.1221243110. Epub 2013 Jun 3.
986 m(6)A modification-mediated CBX8 induction regulates stemness and chemosensitivity of colon cancer via upregulation of LGR5.Mol Cancer. 2019 Dec 18;18(1):185. doi: 10.1186/s12943-019-1116-x.
987 Requirement of cell cycle and apoptosis regulator 1 for target gene activation by Wnt and beta-catenin and for anchorage-independent growth of human colon carcinoma cells.J Biol Chem. 2009 Jul 31;284(31):20629-37. doi: 10.1074/jbc.M109.014332. Epub 2009 Jun 11.
988 Noncoding Effects of Circular RNA CCDC66 Promote Colon Cancer Growth and Metastasis.Cancer Res. 2017 May 1;77(9):2339-2350. doi: 10.1158/0008-5472.CAN-16-1883. Epub 2017 Mar 1.
989 Dro1/Ccdc80 inactivation promotes AOM/DSS-induced colorectal carcinogenesis and aggravates colitis by DSS in mice.Carcinogenesis. 2018 Sep 21;39(9):1176-1184. doi: 10.1093/carcin/bgy077.
990 KP-CoT-23 (CCDC83) is a novel immunogenic cancer/testis antigen in colon cancer.Int J Oncol. 2012 Nov;41(5):1820-6. doi: 10.3892/ijo.2012.1601. Epub 2012 Aug 22.
991 Expression of GIV/Girdin, a metastasis-related protein, predicts patient survival in colon cancer.FASEB J. 2011 Feb;25(2):590-9. doi: 10.1096/fj.10-167304. Epub 2010 Oct 25.
992 The Effect of Pyrroloquinoline Quinone on the Expression of WISP1 in Traumatic Brain Injury.Stem Cells Int. 2017;2017:4782820. doi: 10.1155/2017/4782820. Epub 2017 Aug 16.
993 Retroviral cyclin enhances cyclin-dependent kinase-8 activity.J Virol. 2012 May;86(10):5742-51. doi: 10.1128/JVI.07006-11. Epub 2012 Feb 29.
994 GCIP/CCNDBP1, a helix-loop-helix protein, suppresses tumorigenesis.J Cell Biochem. 2007 Apr 15;100(6):1376-86. doi: 10.1002/jcb.21140.
995 Identification of specific and common diagnostic antibody markers for gastrointestinal cancers by SEREX screening using testis cDNA phage library.Oncotarget. 2018 Jan 1;9(26):18559-18569. doi: 10.18632/oncotarget.24963. eCollection 2018 Apr 6.
996 Autumn Royal and Ribier Grape Juice Extracts Reduced Viability and Metastatic Potential of Colon Cancer Cells.Evid Based Complement Alternat Med. 2018 Jan 14;2018:2517080. doi: 10.1155/2018/2517080. eCollection 2018.
997 Clinical significance of transmembrane 4 superfamily in colon cancer.Br J Cancer. 2003 Jul 7;89(1):158-67. doi: 10.1038/sj.bjc.6601015.
998 Antitumor Activity of TLR7 Is Potentiated by CD200R Antibody Leading to Changes in the Tumor Microenvironment.Cancer Immunol Res. 2018 Aug;6(8):930-940. doi: 10.1158/2326-6066.CIR-17-0454. Epub 2018 Jul 18.
999 Enhanced therapeutic effects against murine colon carcinoma induced by a Colon 26/Ag85A-CD226 tumor cell vaccine.Oncol Rep. 2015 Oct;34(4):1795-804. doi: 10.3892/or.2015.4137. Epub 2015 Jul 20.
1000 Colon cancer cells secrete exosomes to promote self-proliferation by shortening mitosis duration and activation of STAT3 in a hypoxic environment.Cell Biosci. 2019 Aug 6;9:62. doi: 10.1186/s13578-019-0325-8. eCollection 2019.
1001 Effects of parafibromin expression on the phenotypes and relevant mechanisms in the DLD-1 colon carcinoma cell line.Asian Pac J Cancer Prev. 2013;14(7):4249-54. doi: 10.7314/apjcp.2013.14.7.4249.
1002 Down-regulation of liver-intestine cadherin enhances noscapine-induced apoptosis in human colon cancer cells.Expert Rev Anticancer Ther. 2017 Sep;17(9):857-863. doi: 10.1080/14737140.2017.1344097. Epub 2017 Jun 27.
1003 Protocadherin LKC, a new candidate for a tumor suppressor of colon and liver cancers, its association with contact inhibition of cell proliferation.Carcinogenesis. 2002 Jul;23(7):1139-48. doi: 10.1093/carcin/23.7.1139.
1004 Loss of cadherin related family member 5 (CDHR5) expression in clear cell renal cell carcinoma is a prognostic marker of disease progression.Oncotarget. 2017 Aug 24;8(43):75076-75086. doi: 10.18632/oncotarget.20507. eCollection 2017 Sep 26.
1005 Knockdown of PFTAIRE Protein Kinase 1 (PFTK1) Inhibits Proliferation, Invasion, and EMT in Colon Cancer Cells.Oncol Res. 2016;24(3):137-44. doi: 10.3727/096504016X14611963142218.
1006 EVI1 targets Np63 and upregulates the cyclin dependent kinase inhibitor p21 independent of p53 to delay cell cycle progression and cell proliferation in colon cancer cells.Int J Biochem Cell Biol. 2013 Aug;45(8):1568-76. doi: 10.1016/j.biocel.2013.04.032. Epub 2013 May 9.
1007 Epigenetic Status of CDO1 Gene May Reflect Chemosensitivity in Colon Cancer with Postoperative Adjuvant Chemotherapy.Ann Surg Oncol. 2019 Feb;26(2):406-414. doi: 10.1245/s10434-018-6865-z. Epub 2018 Oct 11.
1008 Induction of nonspecific cross-reacting antigen mRNA by interferon-gamma and anti-fibronectin receptor antibody in colon cancer cells.J Gastroenterol. 1997 Apr;32(2):200-5. doi: 10.1007/BF02936368.
1009 Induction of KIAA1199/CEMIP is associated with colon cancer phenotype and poor patient survival.Oncotarget. 2015 Oct 13;6(31):30500-15. doi: 10.18632/oncotarget.5921.
1010 S100A4-induced cell motility and metastasis is restricted by the Wnt/-catenin pathway inhibitor calcimycin in colon cancer cells.Mol Biol Cell. 2011 Sep;22(18):3344-54. doi: 10.1091/mbc.E10-09-0739. Epub 2011 Jul 27.
1011 Differential involvement of destrin and cofilin-1 in the control of invasive properties of Isreco1 human colon cancer cells.Int J Cancer. 2007 Nov 15;121(10):2162-71. doi: 10.1002/ijc.22911.
1012 Up-regulation of CHAF1A, a poor prognostic factor, facilitates cell proliferation of colon cancer.Biochem Biophys Res Commun. 2014 Jun 27;449(2):208-15. doi: 10.1016/j.bbrc.2014.05.006. Epub 2014 May 15.
1013 Association of CHFR promoter methylation with disease recurrence in locally advanced colon cancer.Clin Cancer Res. 2011 Jul 1;17(13):4531-40. doi: 10.1158/1078-0432.CCR-10-0763. Epub 2011 May 6.
1014 MicroRNA 429 regulates the expression of CHMP5 in the inflammatory colitis and colorectal cancer cells.Inflamm Res. 2018 Dec;67(11-12):985-996. doi: 10.1007/s00011-018-1194-z. Epub 2018 Oct 17.
1015 Productive in vitro infection of human umbilical vein endothelial cells and three colon carcinoma cell lines with HIV-1.Immunol Cell Biol. 1995 Apr;73(2):140-5. doi: 10.1038/icb.1995.22.
1016 Synergy between dihydromyricetin intervention and irinotecan chemotherapy delays the progression of colon cancer in mouse models.Food Funct. 2019 Apr 17;10(4):2040-2049. doi: 10.1039/c8fo01756e.
1017 Distinct substrate specificities of human GlcNAc-6-sulfotransferases revealed by mass spectrometry-based sulfoglycomic analysis.J Biol Chem. 2018 Sep 28;293(39):15163-15177. doi: 10.1074/jbc.RA118.001937. Epub 2018 Aug 9.
1018 DNA Replication and Sister Chromatid Cohesion 1 (DSCC1) of the Replication Factor Complex CTF18-RFC is Critical for Colon Cancer Cell Growth.J Cancer. 2019 Oct 15;10(24):6142-6153. doi: 10.7150/jca.32339. eCollection 2019.
1019 CIAPIN1 confers multidrug resistance through up-regulation of MDR-1 and Bcl-L in LoVo/Adr cells and is independent of p53.Oncol Rep. 2011 Apr;25(4):1091-8. doi: 10.3892/or.2011.1148. Epub 2011 Jan 14.
1020 A role for CITED2, a CBP/p300 interacting protein, in colon cancer cell invasion.FEBS Lett. 2007 Dec 22;581(30):5904-10. doi: 10.1016/j.febslet.2007.11.072. Epub 2007 Dec 3.
1021 CIZ1 regulates the proliferation, cycle distribution and colony formation of RKO human colorectal cancer cells.Mol Med Rep. 2013 Dec;8(6):1630-4. doi: 10.3892/mmr.2013.1716. Epub 2013 Oct 8.
1022 Creatine kinase brain overexpression protects colorectal cells from various metabolic and non-metabolic stresses.J Cell Biochem. 2011 Apr;112(4):1066-75. doi: 10.1002/jcb.23020.
1023 Gene trapping identifies chloride channel 4 as a novel inducer of colon cancer cell migration, invasion and metastases.Br J Cancer. 2010 Feb 16;102(4):774-82. doi: 10.1038/sj.bjc.6605536. Epub 2010 Jan 19.
1024 Anti-Claudin-1 Conjugated to a Near-Infrared Fluorophore Targets Colon Cancer in PDOX MouseModels.J Surg Res. 2019 Oct;242:145-150. doi: 10.1016/j.jss.2019.04.048. Epub 2019 May 9.
1025 HDAC-4 regulates claudin-2 expression in EGFR-ERK1/2 dependent manner to regulate colonic epithelial cell differentiation.Oncotarget. 2017 Sep 23;8(50):87718-87736. doi: 10.18632/oncotarget.21190. eCollection 2017 Oct 20.
1026 Tetranectin, a plasminogen kringle 4-binding protein. Cloning and gene expression pattern in human colon cancer.Lab Invest. 1992 Aug;67(2):253-62.
1027 DC-SIGN mediates gastric cancer progression by regulating the JAK2/STAT3 signaling pathway and affecting LncRNA RP11-181G12.2 expression.Biomed Pharmacother. 2020 Jan;121:109644. doi: 10.1016/j.biopha.2019.109644. Epub 2019 Nov 19.
1028 Isolation and characterization of a novel gene CLUAP1 whose expression is frequently upregulated in colon cancer.Oncogene. 2004 Dec 9;23(57):9289-94. doi: 10.1038/sj.onc.1208100.
1029 Up-regulation of CNDP2 facilitates the proliferation of colon cancer.BMC Gastroenterol. 2014 May 21;14:96. doi: 10.1186/1471-230X-14-96.
1030 Calponin 3 promotes invasion and drug resistance of colon cancer cells.World J Gastrointest Oncol. 2019 Nov 15;11(11):971-982. doi: 10.4251/wjgo.v11.i11.971.
1031 Enhanced antitumor effect of the combination of tumstatin gene therapy and gemcitabine in murine models.Hum Gene Ther. 2005 Sep;16(9):1075-86. doi: 10.1089/hum.2005.16.1075.
1032 Loss of expression of type IV collagen alpha5 and alpha6 chains in colorectal cancer associated with the hypermethylation of their promoter region.Am J Pathol. 2006 Mar;168(3):856-65. doi: 10.2353/ajpath.2006.050384.
1033 Identification of genes expressed by immune cells of the colon that are regulated by colorectal cancer-associated variants.Int J Cancer. 2014 May 15;134(10):2330-41. doi: 10.1002/ijc.28557. Epub 2013 Nov 13.
1034 Increasing Incidence of Colon Cancer in the Young: Assessing the Tumor Biology.J Am Coll Surg. 2019 Jul;229(1):79-90. doi: 10.1016/j.jamcollsurg.2019.03.022. Epub 2019 Apr 14.
1035 ERK2-Dependent Phosphorylation of CSN6 Is Critical in Colorectal Cancer Development.Cancer Cell. 2015 Aug 10;28(2):183-97. doi: 10.1016/j.ccell.2015.07.004.
1036 Butyrate inhibits pro-proliferative miR-92a by diminishing c-Myc-induced miR-17-92a cluster transcription in human colon cancer cells.Mol Cancer. 2015 Oct 13;14:180. doi: 10.1186/s12943-015-0450-x.
1037 Coronin 2A (CRN5) expression is associated with colorectal adenoma-adenocarcinoma sequence and oncogenic signalling.BMC Cancer. 2015 Sep 15;15:638. doi: 10.1186/s12885-015-1645-7.
1038 Expression of mitochondrial cytochrome c oxidase in human colonic cell differentiation, transformation, and risk for colonic cancer.Cancer Res. 1990 Mar 1;50(5):1596-600.
1039 Chemoprevention of colon and small intestinal tumorigenesis in APC(Min/+) mice by licofelone, a novel dual 5-LOX/COX inhibitor: potential implications for human colon cancer prevention.Cancer Prev Res (Phila). 2011 Dec;4(12):2015-26. doi: 10.1158/1940-6207.CAPR-11-0233. Epub 2011 Sep 1.
1040 Synthesis, docking, cytotoxicity, and LTA(4)H inhibitory activity of new gingerol derivatives as potential colorectal cancer therapy.Bioorg Med Chem. 2017 Feb 1;25(3):1277-1285. doi: 10.1016/j.bmc.2016.12.048. Epub 2016 Dec 29.
1041 Cleavage and polyadenylation specific factor 4 promotes colon cancer progression by transcriptionally activating hTERT.Biochim Biophys Acta Mol Cell Res. 2019 Oct;1866(10):1533-1543. doi: 10.1016/j.bbamcr.2019.07.001. Epub 2019 Jul 10.
1042 Crumbs3 regulates the expression of glycosphingolipids on the plasma membrane to promote colon cancer cell migration.Biochem Biophys Res Commun. 2019 Nov 5;519(2):287-293. doi: 10.1016/j.bbrc.2019.08.161. Epub 2019 Sep 26.
1043 Comparative effectiveness of screening strategies for Lynch syndrome.J Natl Cancer Inst. 2015 Mar 20;107(4):djv005. doi: 10.1093/jnci/djv005. Print 2015 Apr.
1044 The aberrant methylation of TSP1 suppresses TGF-beta1 activation in colorectal cancer.Int J Cancer. 2008 Jul 1;123(1):14-21. doi: 10.1002/ijc.23608.
1045 Trypsin is produced by and activates protease-activated receptor-2 in human cancer colon cells: evidence for new autocrine loop.Life Sci. 2002 Feb 8;70(12):1359-67. doi: 10.1016/s0024-3205(01)01519-3.
1046 The role of CT10 regulation of kinase-like in cancer.Future Oncol. 2014 Dec;10(16):2687-97. doi: 10.2217/fon.14.199.
1047 Investigation of apoptotic effect of juglone on CCL-228-SW 480 colon cancer cell line.J Cancer Res Ther. 2019 Jan-Mar;15(1):68-74. doi: 10.4103/jcrt.JCRT_880_17.
1048 Evaluation of SAT-1, SAT-2 and GalNAcT-1 mRNA in colon cancer by real-time PCR.Mol Cell Biochem. 2007 Apr;298(1-2):59-68. doi: 10.1007/s11010-006-9350-0. Epub 2006 Nov 21.
1049 DDA1 promotes stage IIB-IIC colon cancer progression by activating NFB/CSN2/GSK-3 signaling.Oncotarget. 2016 Apr 12;7(15):19794-812. doi: 10.18632/oncotarget.7847.
1050 Hybrid Method Based on Information Gain and Support Vector Machine for Gene Selection in Cancer Classification.Genomics Proteomics Bioinformatics. 2017 Dec;15(6):389-395. doi: 10.1016/j.gpb.2017.08.002. Epub 2017 Dec 12.
1051 Let?d inhibits colorectal cancer cell proliferation through the CST1/p65 pathway.Int J Oncol. 2018 Aug;53(2):781-790. doi: 10.3892/ijo.2018.4419. Epub 2018 May 23.
1052 Cystatin D locates in the nucleus at sites of active transcription and modulates gene and protein expression.J Biol Chem. 2015 Oct 30;290(44):26533-48. doi: 10.1074/jbc.M115.660175. Epub 2015 Sep 13.
1053 Expression and epigenetic regulation of cystatin B in lung cancer and colorectal cancer.Pathol Res Pract. 2017 Dec;213(12):1568-1574. doi: 10.1016/j.prp.2017.06.007. Epub 2017 Jun 6.
1054 cTAGE: a cutaneous T cell lymphoma associated antigen family with tumor-specific splicing.J Invest Dermatol. 2003 Jul;121(1):198-206. doi: 10.1046/j.1523-1747.2003.12318.x.
1055 CTHRC1 overexpression predicts poor survival and enhances epithelial-mesenchymal transition in colorectal cancer.Cancer Med. 2018 Nov;7(11):5643-5654. doi: 10.1002/cam4.1807. Epub 2018 Oct 9.
1056 The alphaE-catenin gene (CTNNA1) acts as an invasion-suppressor gene in human colon cancer cells.Oncogene. 1999 Jan 28;18(4):905-15. doi: 10.1038/sj.onc.1202348.
1057 Characterization of cathepsin X in colorectal cancer development and progression.Pathol Res Pract. 2014 Dec;210(12):822-9. doi: 10.1016/j.prp.2014.08.014. Epub 2014 Sep 18.
1058 High Expressions of CUL4A and TP53 in Colorectal Cancer Predict Poor Survival.Cell Physiol Biochem. 2018;51(6):2829-2842. doi: 10.1159/000496013. Epub 2018 Dec 18.
1059 Cullin 4B is a novel prognostic marker that correlates with colon cancer progression and pathogenesis.Med Oncol. 2013;30(2):534. doi: 10.1007/s12032-013-0534-7. Epub 2013 May 7.
1060 The Chemokine CXCL16 Is a New Biomarker for Lymph Node Analysis of Colon Cancer Outcome.Int J Mol Sci. 2019 Nov 18;20(22):5793. doi: 10.3390/ijms20225793.
1061 Diagnostic and prognostic values of CXC motif chemokine ligand 3 in patients with colon cancer.Oncol Rep. 2019 Nov;42(5):1996-2008. doi: 10.3892/or.2019.7326. Epub 2019 Sep 19.
1062 Fibroblast-derived CXCL12/SDF-1 promotes CXCL6 secretion and co-operatively enhances metastatic potential through the PI3K/Akt/mTOR pathway in colon cancer.World J Gastroenterol. 2017 Jul 28;23(28):5167-5178. doi: 10.3748/wjg.v23.i28.5167.
1063 CYB5D2 displays tumor suppression activities towards cervical cancer.Biochim Biophys Acta. 2016 Apr;1862(4):556-565. doi: 10.1016/j.bbadis.2015.12.013. Epub 2015 Dec 12.
1064 CYB5R1 links epithelial-mesenchymal transition and poor prognosis in colorectal cancer.Oncotarget. 2016 May 24;7(21):31350-60. doi: 10.18632/oncotarget.8912.
1065 IMP-1 displays cross-talk with K-Ras and modulates colon cancer cell survival through the novel proapoptotic protein CYFIP2.Cancer Res. 2011 Mar 15;71(6):2172-82. doi: 10.1158/0008-5472.CAN-10-3295. Epub 2011 Jan 20.
1066 Membrane topology and search for potential redox partners of colon cancer-specific cytochrome P450 2W1.FEBS Lett. 2016 Feb;590(3):330-9. doi: 10.1002/1873-3468.12063. Epub 2016 Feb 2.
1067 Antitumor activity of mutant bacterial cytosine deaminase gene for colon cancer.World J Gastroenterol. 2011 Jun 28;17(24):2958-64. doi: 10.3748/wjg.v17.i24.2958.
1068 Elevated d-2-hydroxyglutarate during colitis drives progression to colorectal cancer.Proc Natl Acad Sci U S A. 2018 Jan 30;115(5):1057-1062. doi: 10.1073/pnas.1712625115. Epub 2018 Jan 16.
1069 Oncogenic function of DACT1 in colon cancer through the regulation of -catenin.PLoS One. 2012;7(3):e34004. doi: 10.1371/journal.pone.0034004. Epub 2012 Mar 21.
1070 DACT2 is a functional tumor suppressor through inhibiting Wnt/-catenin pathway and associated with poor survival in colon cancer.Oncogene. 2015 May 14;34(20):2575-85. doi: 10.1038/onc.2014.201. Epub 2014 Jul 14.
1071 Depletion of mitochondrial fission factor DRP1 causes increased apoptosis in human colon cancer cells.Biochem Biophys Res Commun. 2012 Apr 27;421(1):81-5. doi: 10.1016/j.bbrc.2012.03.118. Epub 2012 Apr 2.
1072 Jak-STAT3 pathway triggers DICER1 for proteasomal degradation by ubiquitin ligase complex of CUL4A(DCAF1) to promote colon cancer development.Cancer Lett. 2016 Jun 1;375(2):209-220. doi: 10.1016/j.canlet.2016.02.055. Epub 2016 Mar 7.
1073 The phospholipase DDHD1 as a new target in colorectal cancer therapy.J Exp Clin Cancer Res. 2018 Apr 13;37(1):82. doi: 10.1186/s13046-018-0753-z.
1074 Involvement of RNA helicases p68 and p72 in colon cancer.Cancer Res. 2007 Aug 15;67(16):7572-8. doi: 10.1158/0008-5472.CAN-06-4652.
1075 DDX3 as a strongest prognosis marker and its downregulation promotes metastasis in colorectal cancer.Oncotarget. 2015 Jul 30;6(21):18602-12. doi: 10.18632/oncotarget.4329.
1076 Expression of the human antimicrobial peptide -defensin-1 is repressed by the EGFR-ERK-MYC axis in colonic epithelial cells.Sci Rep. 2018 Dec 21;8(1):18043. doi: 10.1038/s41598-018-36387-z.
1077 PNAS-4, a novel pro-apoptotic gene, can potentiate antineoplastic effects of cisplatin.Cancer Chemother Pharmacol. 2009 Dec;65(1):13-25. doi: 10.1007/s00280-009-0998-5. Epub 2009 Apr 22.
1078 Apoptotic Activity of Lactobacillus plantarum DGK-17-Fermented Soybean Seed Extract in Human Colon Cancer Cells via ROS-JNK Signaling Pathway.J Food Sci. 2017 Jun;82(6):1475-1483. doi: 10.1111/1750-3841.13732. Epub 2017 May 10.
1079 The novel G-quadruplex-containing long non-coding RNA GSEC antagonizes DHX36 and modulates colon cancer cell migration.Oncogene. 2017 Mar 2;36(9):1191-1199. doi: 10.1038/onc.2016.282. Epub 2016 Oct 31.
1080 DIXDC1 targets p21 and cyclin D1 via PI3K pathway activation to promote colon cancer cell proliferation.Cancer Sci. 2009 Oct;100(10):1801-8. doi: 10.1111/j.1349-7006.2009.01246.x. Epub 2009 Jun 17.
1081 Dickkopf-4 is frequently down-regulated and inhibits growth of colorectal cancer cells.Cancer Lett. 2009 Apr 18;276(2):152-9. doi: 10.1016/j.canlet.2008.11.003. Epub 2008 Dec 6.
1082 Regulation of the oncogenic function of distal-less 4 by microRNA-122 in hepatocellular carcinoma.Mol Med Rep. 2015 Jul;12(1):1375-80. doi: 10.3892/mmr.2015.3554. Epub 2015 Mar 27.
1083 Progression of colorectal cancers correlates with overexpression and loss of polarization of expression of the htid-1 tumor suppressor.Int J Mol Med. 2008 Jan;21(1):19-31.
1084 Discovery, synthesis and molecular substantiation of N-(benzo[d]thiazol-2-yl)-2-hydroxyquinoline-4-carboxamides as anticancer agents.Bioorg Chem. 2019 Oct;91:103171. doi: 10.1016/j.bioorg.2019.103171. Epub 2019 Jul 30.
1085 Downregulation of Drp1, a fission regulator, is associated with human lung and colon cancers.Acta Biochim Biophys Sin (Shanghai). 2018 Feb 1;50(2):209-215. doi: 10.1093/abbs/gmx137.
1086 Decreased tumorigenicity of a human colon adenocarcinoma cell line by an antisense expression vector specific for c-Src.Cell Growth Differ. 1997 Mar;8(3):269-74.
1087 Developmental pluripotency-associated 4: a novel predictor for prognosis and a potential therapeutic target for colon cancer.J Exp Clin Cancer Res. 2015 Jun 11;34(1):60. doi: 10.1186/s13046-015-0176-z.
1088 Genetic polymorphisms of dihydropyrimidinase in a Japanese patient with capecitabine-induced toxicity.PLoS One. 2015 Apr 27;10(4):e0124818. doi: 10.1371/journal.pone.0124818. eCollection 2015.
1089 The tumor metastasis suppressor gene Drg-1 down-regulates the expression of activating transcription factor 3 in prostate cancer.Cancer Res. 2006 Dec 15;66(24):11983-90. doi: 10.1158/0008-5472.CAN-06-0943.
1090 Cell growth inhibition by 3-deoxysappanchalcone is mediated by directly targeting the TOPK signaling pathway in colon cancer.Phytomedicine. 2019 Aug;61:152813. doi: 10.1016/j.phymed.2018.12.036. Epub 2018 Dec 31.
1091 Loss of the desmosomal cadherin desmoglein-2 suppresses colon cancer cell proliferation through EGFR signaling.Oncogene. 2014 Sep 4;33(36):4531-6. doi: 10.1038/onc.2013.442. Epub 2013 Oct 28.
1092 CSPP-L Associates with the Desmosome of Polarized Epithelial Cells and Is Required for Normal Spheroid Formation.PLoS One. 2015 Aug 4;10(8):e0134789. doi: 10.1371/journal.pone.0134789. eCollection 2015.
1093 DUOX2-mediated production of reactive oxygen species induces epithelial mesenchymal transition in 5-fluorouracil resistant human colon cancer cells.Redox Biol. 2018 Jul;17:224-235. doi: 10.1016/j.redox.2018.04.020. Epub 2018 Apr 23.
1094 Differential expression of DUSP2 in left- and right-sided colon cancer is associated with poor prognosis in colorectal cancer.Oncol Lett. 2018 Apr;15(4):4207-4214. doi: 10.3892/ol.2018.7881. Epub 2018 Jan 26.
1095 Epsin is required for Dishevelled stability and Wnt signalling activation in colon cancer development.Nat Commun. 2015 Mar 16;6:6380. doi: 10.1038/ncomms7380.
1096 E2F4 expression is required for cell cycle progression of normal intestinal crypt cells and colorectal cancer cells.J Cell Physiol. 2009 Nov;221(2):350-8. doi: 10.1002/jcp.21859.
1097 Proteomic Analysis of Liquid Biopsy from Tumor-Draining Vein Indicates that High Expression of Exosomal ECM1 Is Associated with Relapse in Stage I-III Colon Cancer.Transl Oncol. 2018 Jun;11(3):715-721. doi: 10.1016/j.tranon.2018.03.010. Epub 2018 Apr 13.
1098 Downregulation of developmentally regulated endothelial cell locus-1 inhibits the growth of colon cancer.J Biomed Sci. 2009;16(1):33. doi: 10.1186/1423-0127-16-33. Epub 2008 Dec 25.
1099 Expression of EEF1A1 Is Associated with Prognosis of Patients with Colon Adenocarcinoma.J Clin Med. 2019 Nov 7;8(11):1903. doi: 10.3390/jcm8111903.
1100 Reduced expression of EphrinA1 (EFNA1) inhibits three-dimensional growth of HT29 colon carcinoma cells.Cancer Lett. 2002 Jan 25;175(2):187-95. doi: 10.1016/s0304-3835(01)00613-9.
1101 Effects of overexpression of ephrin-B2 on tumour growth in human colorectal cancer.Br J Cancer. 2004 Apr 19;90(8):1620-6. doi: 10.1038/sj.bjc.6601723.
1102 RNA interference-mediated silencing of eukaryotic translation initiation factor 3, subunit B (EIF3B) gene expression inhibits proliferation of colon cancer cells.World J Surg Oncol. 2012 Jun 26;10:119. doi: 10.1186/1477-7819-10-119.
1103 Effect of siRNA-mediated knockdown of eIF3c gene on survival of colon cancer cells.J Zhejiang Univ Sci B. 2013 Jun;14(6):451-9. doi: 10.1631/jzus.B1200230.
1104 hmiR-34c-3p upregulation inhibits the proliferation of colon cancer cells by targeting EIF3D.Anticancer Drugs. 2018 Nov;29(10):975-982. doi: 10.1097/CAD.0000000000000674.
1105 Overexpression of eIF3e is correlated with colon tumor development and poor prognosis.Int J Clin Exp Pathol. 2014 Sep 15;7(10):6462-74. eCollection 2014.
1106 eIF3m expression influences the regulation of tumorigenesis-related genes in human colon cancer.Oncogene. 2011 Jan 27;30(4):398-409. doi: 10.1038/onc.2010.422. Epub 2010 Sep 13.
1107 A network-based analysis of colon cancer splicing changes reveals a tumorigenesis-favoring regulatory pathway emanating from ELK1.Genome Res. 2016 Apr;26(4):541-53. doi: 10.1101/gr.193169.115. Epub 2016 Feb 9.
1108 Functional evidence for Eme1 as a marker of cisplatin resistance.Int J Cancer. 2009 Jun 15;124(12):2997-3001. doi: 10.1002/ijc.24268.
1109 Abrogation of EMILIN1-1 integrin interaction promotes experimental colitis and colon carcinogenesis.Matrix Biol. 2019 Oct;83:97-115. doi: 10.1016/j.matbio.2019.08.006. Epub 2019 Aug 31.
1110 Depletion of endonuclease G selectively kills polyploid cells.Cell Cycle. 2007 May 2;6(9):1072-6. doi: 10.4161/cc.6.9.4218. Epub 2007 May 27.
1111 Alkaline sphingomyelinase: an old enzyme with novel implications.Biochim Biophys Acta. 2006 Mar;1761(3):281-91. doi: 10.1016/j.bbalip.2006.03.007. Epub 2006 Mar 30.
1112 Elevated Expression of ERCC6 Confers Resistance to 5-Fluorouracil and Is Associated with Poor Patient Survival in Colorectal Cancer.DNA Cell Biol. 2017 Sep;36(9):781-786. doi: 10.1089/dna.2017.3768. Epub 2017 Jun 30.
1113 ETV4 and Myeov knockdown impairs colon cancer cell line proliferation and invasion.Biochem Biophys Res Commun. 2006 Jun 23;345(1):216-21. doi: 10.1016/j.bbrc.2006.04.094. Epub 2006 Apr 27.
1114 DNA Methylation Analysis Using Droplet Digital PCR.Methods Mol Biol. 2018;1768:363-383. doi: 10.1007/978-1-4939-7778-9_21.
1115 Exo70 is an independent prognostic factor in colon cancer.Sci Rep. 2017 Jul 11;7(1):5039. doi: 10.1038/s41598-017-05308-x.
1116 FABP7 promotes cell proliferation and survival in colon cancer through MEK/ERK signaling pathway.Biomed Pharmacother. 2018 Dec;108:119-129. doi: 10.1016/j.biopha.2018.08.038. Epub 2018 Sep 13.
1117 Mutation of FADD gene is rare in human colon and stomach cancers.APMIS. 2004 Sep;112(9):595-7. doi: 10.1111/j.1600-0463.2004.apm1120906.x.
1118 A non-secretory form of FAM3B promotes invasion and metastasis of human colon cancer cells by upregulating Slug expression.Cancer Lett. 2013 Jan 28;328(2):278-84. doi: 10.1016/j.canlet.2012.09.026. Epub 2012 Oct 8.
1119 Role of FBXL20 in human colorectal adenocarcinoma.Oncol Rep. 2012 Dec;28(6):2290-8. doi: 10.3892/or.2012.2065. Epub 2012 Sep 27.
1120 F-box and leucine-rich repeat protein 5 promotes colon cancer progression by modulating PTEN/PI3K/AKT signaling pathway.Biomed Pharmacother. 2018 Nov;107:1712-1719. doi: 10.1016/j.biopha.2018.08.119. Epub 2018 Sep 8.
1121 Identification of BCP-20 (FBXO39) as a cancer/testis antigen from colon cancer patients by SEREX.Biochem Biophys Res Commun. 2011 May 6;408(2):195-201. doi: 10.1016/j.bbrc.2011.02.077. Epub 2011 Feb 19.
1122 RACK1 downregulates levels of the pro-apoptotic protein Fem1b in apoptosis-resistant colon cancer cells.Cancer Biol Ther. 2009 Dec;8(23):2297-305. doi: 10.4161/cbt.8.23.10262. Epub 2009 Dec 7.
1123 Identification of human flap endonuclease 1 (FEN1) inhibitors using a machine learning based consensus virtual screening.Mol Biosyst. 2017 Jul 25;13(8):1630-1639. doi: 10.1039/c7mb00118e.
1124 FERMT1 mediates epithelial-mesenchymal transition to promote colon cancer metastasis via modulation of -catenin transcriptional activity.Oncogene. 2017 Mar 30;36(13):1779-1792. doi: 10.1038/onc.2016.339. Epub 2016 Sep 19.
1125 Molecular cloning and characterization of human FGF-20 on chromosome 8p21.3-p22.Biochem Biophys Res Commun. 2000 Aug 2;274(2):337-43. doi: 10.1006/bbrc.2000.3142.
1126 Regulation of FGF-3 gene expression in tumorigenic and non-tumorigenic clones of a human colon carcinoma cell line.J Biol Chem. 2000 Jun 9;275(23):17364-73. doi: 10.1074/jbc.M909316199.
1127 Overexpression of FGF9 in colon cancer cells is mediated by hypoxia-induced translational activation.Nucleic Acids Res. 2014 Mar;42(5):2932-44. doi: 10.1093/nar/gkt1286. Epub 2013 Dec 10.
1128 FKBP14 Promotes The Proliferation And Migration Of Colon Carcinoma Cells Through Targeting IL-6/STAT3 Signaling Pathway.Onco Targets Ther. 2019 Nov 1;12:9069-9076. doi: 10.2147/OTT.S222555. eCollection 2019.
1129 Clinical significance and comparison of flotillin 1 expression in left and right colon cancer.Oncol Lett. 2019 Aug;18(2):997-1004. doi: 10.3892/ol.2019.10401. Epub 2019 May 27.
1130 Enhancement of anti-tumor effect of plasmid DNA-carrying MUC1 by the adjuvanticity of FLT3L in mouse model.Immunopharmacol Immunotoxicol. 2018 Aug;40(4):353-357. doi: 10.1080/08923973.2018.1498099. Epub 2018 Aug 15.
1131 Fibromodulin deficiency reduces collagen structural network but not glycosaminoglycan content in a syngeneic model of colon carcinoma.PLoS One. 2017 Aug 21;12(8):e0182973. doi: 10.1371/journal.pone.0182973. eCollection 2017.
1132 Silibinin inhibits the invasion of IL-6-stimulated colon cancer cells via selective JNK/AP-1/MMP-2 modulation in vitro.J Agric Food Chem. 2012 Dec 26;60(51):12451-7. doi: 10.1021/jf300964f. Epub 2012 Dec 13.
1133 Forkhead Box Protein J1 (FOXJ1) is Overexpressed in Colorectal Cancer and Promotes Nuclear Translocation of -Catenin in SW620 Cells.Med Sci Monit. 2017 Feb 17;23:856-866. doi: 10.12659/msm.902906.
1134 Knockdown of FOXK1 alone or in combination with apoptosis-inducing 5-FU inhibits cell growth in colorectal cancer.Oncol Rep. 2016 Oct;36(4):2151-9. doi: 10.3892/or.2016.5041. Epub 2016 Aug 25.
1135 Loss of FOXN3 in colon cancer activates beta-catenin/TCF signaling and promotes the growth and migration of cancer cells.Oncotarget. 2017 Feb 7;8(6):9783-9793. doi: 10.18632/oncotarget.14189.
1136 Increase of rat colon carcinoma cells tumorigenicity by alpha(1-2) fucosyltransferase gene transfection.Glycobiology. 1997 Mar;7(2):221-9. doi: 10.1093/glycob/7.2.221.
1137 The biosynthesis of the selectin-ligand sialyl Lewis x in colorectal cancer tissues is regulated by fucosyltransferase VI and can be inhibited by an RNA interference-based approach.Int J Biochem Cell Biol. 2011 Jan;43(1):130-9. doi: 10.1016/j.biocel.2010.10.004. Epub 2010 Oct 19.
1138 Post-translational glycoprotein modifications regulate colon cancer stem cells and colon adenoma progression in Apc(min/+) mice through altered Wnt receptor signaling.J Biol Chem. 2014 Nov 7;289(45):31534-49. doi: 10.1074/jbc.M114.602680. Epub 2014 Oct 1.
1139 LSD1-mediated epigenetic modification contributes to proliferation and metastasis of colon cancer.Br J Cancer. 2013 Aug 20;109(4):994-1003. doi: 10.1038/bjc.2013.364. Epub 2013 Jul 30.
1140 Ethanol-Mediated Stress Promotes Autophagic Survival and Aggressiveness of Colon Cancer Cells via Activation of Nrf2/HO-1 Pathway.Cancers (Basel). 2019 Apr 10;11(4):505. doi: 10.3390/cancers11040505.
1141 Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition?.BMC Cancer. 2010 May 5;10:180. doi: 10.1186/1471-2407-10-180.
1142 MiR-4262 promotes cell apoptosis and inhibits proliferation of colon cancer cells: involvement of GALNT4.Am J Transl Res. 2018 Dec 15;10(12):3969-3977. eCollection 2018.
1143 De novo expression of human polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6) in colon adenocarcinoma inhibits the differentiation of colonic epithelium.J Biol Chem. 2018 Jan 26;293(4):1298-1314. doi: 10.1074/jbc.M117.812826. Epub 2017 Nov 29.
1144 Associations between vitamin D-binding protein isotypes, circulating 25(OH)D levels, and vitamin D metabolite uptake in colon cancer cells.Cancer Prev Res (Phila). 2014 Apr;7(4):426-34. doi: 10.1158/1940-6207.CAPR-13-0269. Epub 2014 Jan 28.
1145 Downregulation of miR-199a/b-5p is associated with GCNT2 induction upon epithelial-mesenchymal transition in colon cancer.FEBS Lett. 2017 Jul;591(13):1902-1917. doi: 10.1002/1873-3468.12685. Epub 2017 Jun 10.
1146 Clinical relevance of the differential expression of the glycosyltransferase gene GCNT3 in colon cancer.Eur J Cancer. 2015 Jan;51(1):1-8. doi: 10.1016/j.ejca.2014.10.021. Epub 2014 Nov 11.
1147 Neoexpression of N-cadherin in E-cadherin positive colon cancers.Int J Cancer. 2004 Sep 20;111(5):711-9. doi: 10.1002/ijc.20317.
1148 Augmenter of liver regeneration gene expression in human colon cancer cell lines and clinical tissue samples.J BUON. 2015 Jan-Feb;20(1):84-91.
1149 PSF3 marks malignant colon cancer and has a role in cancer cell proliferation.Biochem Biophys Res Commun. 2010 Feb 5;392(2):150-4. doi: 10.1016/j.bbrc.2009.12.174. Epub 2010 Jan 6.
1150 Epigenetic silencing of glutaminase 2 in human liver and colon cancers.BMC Cancer. 2013 Dec 14;13:601. doi: 10.1186/1471-2407-13-601.
1151 Absence of GNAI2 codon 179 oncogene mutations in inflammatory bowel disease.Inflamm Bowel Dis. 2000 May;6(2):103-6. doi: 10.1097/00054725-200005000-00006.
1152 GOLPH3 expression promotes the resistance of HT29 cells to 5fluorouracil by activating multiple signaling pathways.Mol Med Rep. 2018 Jan;17(1):542-548. doi: 10.3892/mmr.2017.7877. Epub 2017 Oct 25.
1153 The clinical significance of circulating GPC1 positive exosomes and its regulative miRNAs in colon cancer patients.Oncotarget. 2017 Aug 24;8(60):101189-101202. doi: 10.18632/oncotarget.20516. eCollection 2017 Nov 24.
1154 Phospholipase D activation mediates growth and migration of colon cancer cells interacting with cancer-associated fibroblasts.Cell Mol Biol (Noisy-le-grand). 2018 Nov 30;64(14):84-88.
1155 Aberrant promoter methylation and tumor suppressive activity of the DFNA5 gene in colorectal carcinoma.Oncogene. 2008 Jun 5;27(25):3624-34. doi: 10.1038/sj.onc.1211021. Epub 2008 Jan 28.
1156 In vitro-fermented raw and roasted walnuts induce expression of CAT and GSTT2 genes, growth inhibition, and apoptosis in LT97 colon adenoma cells.Nutr Res. 2017 Nov;47:72-80. doi: 10.1016/j.nutres.2017.09.004. Epub 2017 Sep 18.
1157 Can colorectal cancer be prevented or treated by oral hormone replacement therapy?.Curr Mol Pharmacol. 2009 Nov;2(3):285-92. doi: 10.2174/1874467210902030285.
1158 Livin promotes colon cancer progression by regulation of H2A.X(Y39ph) via JMJD6.Life Sci. 2019 Oct 1;234:116788. doi: 10.1016/j.lfs.2019.116788. Epub 2019 Aug 22.
1159 Integrative epigenome analysis identifies a Polycomb-targeted differentiation program as a tumor-suppressor event epigenetically inactivated in colorectal cancer.Cell Death Dis. 2014 Jul 17;5(7):e1324. doi: 10.1038/cddis.2014.283.
1160 Adenovirus-mediated ribonucleotide reductase R1 gene therapy of human colon adenocarcinoma.Clin Cancer Res. 2003 Oct 1;9(12):4553-61.
1161 FAK and HAS inhibition synergistically decrease colon cancer cell viability and affect expression of critical genes.Anticancer Agents Med Chem. 2013 May;13(4):584-94. doi: 10.2174/1871520611313040008.
1162 A transcriptional regulatory role of the THAP11-HCF-1 complex in colon cancer cell function.Mol Cell Biol. 2012 May;32(9):1654-70. doi: 10.1128/MCB.06033-11. Epub 2012 Feb 27.
1163 Fucosylation Deficiency in Mice Leads to Colitis andAdenocarcinoma.Gastroenterology. 2017 Jan;152(1):193-205.e10. doi: 10.1053/j.gastro.2016.09.004. Epub 2016 Sep 14.
1164 Detection of differentially expressed HES-6 gene in metastatic colon carcinoma by combination of suppression subtractive hybridization and cDNA library array.Cancer Lett. 2003 Aug 20;198(2):229-39. doi: 10.1016/s0304-3835(03)00313-6.
1165 Niclosamide inhibits colon cancer progression through downregulation of the Notch pathway and upregulation of the tumor suppressor miR-200 family.Int J Mol Med. 2016 Sep;38(3):776-84. doi: 10.3892/ijmm.2016.2689. Epub 2016 Jul 22.
1166 Chromosome 5 allele loss at the glucocorticoid receptor locus in human colorectal carcinomas.Biochem Biophys Res Commun. 1988 Jan 29;150(2):591-8. doi: 10.1016/0006-291x(88)90434-2.
1167 Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer.J Pathol. 2007 Oct;213(2):131-9. doi: 10.1002/path.2216.
1168 Methylation of the Tumor Suppressor Genes HIC1 and RassF1A Clusters Independently From the Methylation of Polycomb Target Genes in Colon Cancer.Ann Surg Oncol. 2017 Feb;24(2):578-585. doi: 10.1245/s10434-015-5024-z. Epub 2015 Dec 15.
1169 Huntingtin-interacting protein 1 is overexpressed in prostate and colon cancer and is critical for cellular survival.J Clin Invest. 2002 Aug;110(3):351-60. doi: 10.1172/JCI15529.
1170 Differential expression of S19 ribosomal protein, laminin-binding protein, and human lymphocyte antigen class I messenger RNAs associated with colon carcinoma progression and differentiation.Cancer Res. 1992 Feb 15;52(4):791-6.
1171 Comparative study of gene expression by cDNA microarray in human colorectal cancer tissues and normal mucosa.Int J Oncol. 2006 Jul;29(1):83-94.
1172 DNA hypermethylation and histone hypoacetylation of the HLTF gene are associated with reduced expression in gastric carcinoma.Cancer Sci. 2003 Aug;94(8):692-8. doi: 10.1111/j.1349-7006.2003.tb01504.x.
1173 Receptor for hyaluronan-mediated motility and CD44 expressions in colon cancer assessed by quantitative analysis using real-time reverse transcriptase-polymerase chain reaction.Jpn J Cancer Res. 1999 Sep;90(9):987-92. doi: 10.1111/j.1349-7006.1999.tb00846.x.
1174 The Prognostic Value of m6A RNA Methylation Regulators in Colon Adenocarcinoma.Med Sci Monit. 2019 Dec 11;25:9435-9445. doi: 10.12659/MSM.920381.
1175 Oncogenic heterogeneous nuclear ribonucleoprotein D-like promotes the growth of human colon cancer SW620 cells via its regulation of cell-cycle.Acta Biochim Biophys Sin (Shanghai). 2018 Sep 1;50(9):880-887. doi: 10.1093/abbs/gmy085.
1176 A novel oncogenic BTK isoform is overexpressed in colon cancers and required for RAS-mediated transformation.Oncogene. 2016 Aug 18;35(33):4368-78. doi: 10.1038/onc.2015.504. Epub 2016 Jan 25.
1177 Interferon regulatory factor 1 and a variant of heterogeneous nuclear ribonucleoprotein L coordinately silence the gene for adhesion protein CEACAM1.J Biol Chem. 2018 Jun 15;293(24):9277-9291. doi: 10.1074/jbc.RA117.001507. Epub 2018 May 2.
1178 HNRNPLL, a newly identified colorectal cancer metastasis suppressor, modulates alternative splicing of CD44 during epithelial-mesenchymal transition.Gut. 2018 Jun;67(6):1103-1111. doi: 10.1136/gutjnl-2016-312927. Epub 2017 Mar 30.
1179 hnRNPM induces translation switch under hypoxia to promote colon cancer development.EBioMedicine. 2019 Mar;41:299-309. doi: 10.1016/j.ebiom.2019.02.059. Epub 2019 Mar 7.
1180 HOXA3 promotes tumor growth of human colon cancer through activating EGFR/Ras/Raf/MEK/ERK signaling pathway.J Cell Biochem. 2018 Mar;119(3):2864-2874. doi: 10.1002/jcb.26461. Epub 2017 Dec 12.
1181 Overexpression of HOXA4 and HOXA9 genes promotes self-renewal and contributes to colon cancer stem cell overpopulation.J Cell Physiol. 2018 Feb;233(2):727-735. doi: 10.1002/jcp.25981. Epub 2017 Jul 11.
1182 The Significant Pathways and Genes Underlying the Colon Cancer Treatment by the Traditional Chinese Medicine PHY906.Evid Based Complement Alternat Med. 2017;2017:8753815. doi: 10.1155/2017/8753815. Epub 2017 May 15.
1183 Hyperthermia effects on Hsp27 and Hsp72 associations with mismatch repair (MMR) proteins and cisplatin toxicity in MMR-deficient/proficient colon cancer cell lines.Int J Hyperthermia. 2015;31(5):464-75. doi: 10.3109/02656736.2015.1026848. Epub 2015 Jun 4.
1184 HSP110 promotes colorectal cancer growth through STAT3 activation.Oncogene. 2017 Apr 20;36(16):2328-2336. doi: 10.1038/onc.2016.403. Epub 2016 Nov 7.
1185 Methylation status at HYAL2 predicts overall and progression-free survival of colon cancer patients under 5-FU chemotherapy.Genomics. 2015 Dec;106(6):348-54. doi: 10.1016/j.ygeno.2015.10.002. Epub 2015 Oct 21.
1186 The human 1-8D gene (IFITM2) is a novel p53 independent pro-apoptotic gene.Int J Cancer. 2009 Dec 15;125(12):2810-9. doi: 10.1002/ijc.24669.
1187 KLF4-mediated negative regulation of IFITM3 expression plays a critical role in colon cancer pathogenesis.Clin Cancer Res. 2011 Jun 1;17(11):3558-68. doi: 10.1158/1078-0432.CCR-10-2729. Epub 2011 Apr 29.
1188 Increased IFRD1 Expression in Human Colon Cancers Predicts Reduced Patient Survival.Dig Dis Sci. 2017 Dec;62(12):3460-3467. doi: 10.1007/s10620-017-4819-0. Epub 2017 Nov 1.
1189 Long noncoding RNA HOTAIR silencing inhibits invasion and proliferation of human colon cancer LoVo cells via regulating IGF2BP2.J Cell Biochem. 2019 Feb;120(2):1221-1231. doi: 10.1002/jcb.27079. Epub 2018 Oct 18.
1190 Colorectal Cancer Metastases Settle in the Hepatic Microenvironment Through 51 Integrin.J Cell Biochem. 2015 Oct;116(10):2385-96. doi: 10.1002/jcb.25189.
1191 Interferon-gamma mediates gene expression of IL-18 binding protein in nonleukocytic cells.Biochem Biophys Res Commun. 2000 Jan 27;267(3):960-3. doi: 10.1006/bbrc.1999.2064.
1192 Screening of Differentiation-Specific Molecular Biomarkers for Colon Cancer.Cell Physiol Biochem. 2018;46(6):2543-2550. doi: 10.1159/000489660. Epub 2018 May 5.
1193 Delivery of a Modified mRNA Encoding IL-22 Binding Protein (IL-22BP) for Colon Cancer Gene Therapy.J Biomed Nanotechnol. 2018 Jul 1;14(7):1239-1251. doi: 10.1166/jbn.2018.2577.
1194 NOD-scidIl2rg (tm1Wjl) and NOD-Rag1 (null) Il2rg (tm1Wjl) : a model for stromal cell-tumor cell interaction for human colon cancer.Dig Dis Sci. 2014 Jun;59(6):1169-79. doi: 10.1007/s10620-014-3168-5. Epub 2014 May 6.
1195 Interleukin-34 sustains pro-tumorigenic signals in colon cancer tissue.Oncotarget. 2017 Dec 15;9(3):3432-3445. doi: 10.18632/oncotarget.23289. eCollection 2018 Jan 9.
1196 Cytotoxic, Anti-Proliferative and Apoptosis Activity of l-Amino Acid Oxidase from Malaysian Cryptelytrops purpureomaculatus (CP-LAAO) Venom on Human Colon Cancer Cells.Molecules. 2018 Jun 8;23(6):1388. doi: 10.3390/molecules23061388.
1197 Humoral autoimmune response to IGF2 mRNA-binding protein (IMP2/p62) and its tissue-specific expression in colon cancer.Scand J Immunol. 2013 Apr;77(4):255-60. doi: 10.1111/sji.12032.
1198 ING2 is upregulated in colon cancer and increases invasion by enhanced MMP13 expression.Int J Cancer. 2009 Sep 15;125(6):1306-15. doi: 10.1002/ijc.24437.
1199 ING4 is negatively correlated with microvessel density in colon cancer.Tumour Biol. 2012 Dec;33(6):2357-64. doi: 10.1007/s13277-012-0498-9. Epub 2012 Sep 28.
1200 Therapeutic advantage of genetically engineered Salmonella typhimurium carrying short hairpin RNA against inhibin alpha subunit in cancer treatment.Ann Oncol. 2018 Sep 1;29(9):2010-2017. doi: 10.1093/annonc/mdy240.
1201 INO80 haploinsufficiency inhibits colon cancer tumorigenesis via replication stress-induced apoptosis.Oncotarget. 2017 Dec 6;8(70):115041-115053. doi: 10.18632/oncotarget.22984. eCollection 2017 Dec 29.
1202 Multiple defects in negative regulation of the PKB/Akt pathway sensitise human cancer cells to the antiproliferative effect of non-steroidal anti-inflammatory drugs.Biochem Pharmacol. 2009 Sep 15;78(6):561-72. doi: 10.1016/j.bcp.2009.05.001. Epub 2009 May 9.
1203 Insulin-induced gene 2 expression correlates with colorectal cancer metastasis and disease outcome.IUBMB Life. 2016 Jan;68(1):65-71. doi: 10.1002/iub.1461. Epub 2015 Dec 10.
1204 PINCH-2 presents functional copy number variation and suppresses migration of colon cancer cells by paracrine activity.Int J Cancer. 2015 May 15;136(10):2273-83. doi: 10.1002/ijc.29273. Epub 2014 Oct 30.
1205 Overexpression of IQGAP1 in advanced colorectal cancer correlates with poor prognosis-critical role in tumor invasion.Int J Cancer. 2010 Jun 1;126(11):2563-74. doi: 10.1002/ijc.24987.
1206 IRAK2 counterbalances oncogenic Smurf1 in colon cancer cells by dictating ER stress.Cell Signal. 2018 Aug;48:69-80. doi: 10.1016/j.cellsig.2018.05.001. Epub 2018 May 9.
1207 STAT3 is activated in multicellular spheroids of colon carcinoma cells and mediates expression of IRF9 and interferon stimulated genes.Sci Rep. 2019 Jan 24;9(1):536. doi: 10.1038/s41598-018-37294-z.
1208 Insulin receptor substrate-4 is overexpressed in colorectal cancer and promotes retinoblastoma-cyclin-dependent kinase activation.J Gastroenterol. 2018 Aug;53(8):932-944. doi: 10.1007/s00535-018-1432-8. Epub 2018 Jan 20.
1209 The iroquois homeobox gene 5 is regulated by 1,25-dihydroxyvitamin D3 in human prostate cancer and regulates apoptosis and the cell cycle in LNCaP prostate cancer cells.Clin Cancer Res. 2008 Jun 1;14(11):3562-70. doi: 10.1158/1078-0432.CCR-07-4649.
1210 Antitumor activity of HPA3P through RIPK3-dependent regulated necrotic cell death in colon cancer.Oncotarget. 2018 Jan 9;9(8):7902-7917. doi: 10.18632/oncotarget.24083. eCollection 2018 Jan 30.
1211 Chemokine (C-C Motif) Ligand 5 is Involved in Tumor-Associated Dendritic Cell-Mediated Colon Cancer Progression Through Non-Coding RNA MALAT-1.J Cell Physiol. 2015 Aug;230(8):1883-94. doi: 10.1002/jcp.24918.
1212 Epigenetic inactivation of the novel candidate tumor suppressor gene ITIH5 in colon cancer predicts unfavorable overall survival in the CpG island methylator phenotype.Epigenetics. 2014 Sep;9(9):1290-301. doi: 10.4161/epi.32089. Epub 2014 Aug 4.
1213 Analysis of KRAP expression and localization, and genes regulated by KRAP in a human colon cancer cell line.J Hum Genet. 2007;52(12):978-984. doi: 10.1007/s10038-007-0204-8. Epub 2007 Oct 13.
1214 Jade family PHD finger 3 (JADE3) increases cancer stem cell-like properties and tumorigenicity in colon cancer.Cancer Lett. 2018 Aug 1;428:1-11. doi: 10.1016/j.canlet.2018.04.012. Epub 2018 Apr 13.
1215 JARID2 inhibits leukemia cell proliferation by regulating CCND1 expression.Int J Hematol. 2015 Jul;102(1):76-85. doi: 10.1007/s12185-015-1797-x. Epub 2015 May 5.
1216 Lysyl-tRNA synthetase-expressing colon spheroids induce M2 macrophage polarization to promote metastasis.J Clin Invest. 2018 Nov 1;128(11):5034-5055. doi: 10.1172/JCI99806. Epub 2018 Oct 8.
1217 Activation of cPLA2 is required for leukotriene D4-induced proliferation in colon cancer cells.Carcinogenesis. 2005 Nov;26(11):1988-98. doi: 10.1093/carcin/bgi159. Epub 2005 Jun 23.
1218 Interaction of 14-3-3 with KCMF1 suppresses the proliferation and colony formation of human colon cancer stem cells.World J Gastroenterol. 2013 Jun 28;19(24):3770-80. doi: 10.3748/wjg.v19.i24.3770.
1219 Role of JMJD2B in colon cancer cell survival under glucose-deprived conditions and the underlying mechanisms. Oncogene. 2018 Jan 18;37(3):389-402.
1220 Repositioning FDA-Approved Drugs in Combination with Epigenetic Drugs to Reprogram Colon Cancer Epigenome.Mol Cancer Ther. 2017 Feb;16(2):397-407. doi: 10.1158/1535-7163.MCT-16-0588. Epub 2016 Dec 15.
1221 Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targets.Cancer Res. 2002 Jul 15;62(14):4041-7.
1222 Kruppel-like factor 2 mediated anti-proliferative and anti-metastasis effects of simvastatin in p53 mutant colon cancer.Biochem Biophys Res Commun. 2019 Apr 16;511(4):772-779. doi: 10.1016/j.bbrc.2019.02.127. Epub 2019 Mar 2.
1223 Ascl2 activation by YAP1/KLF5 ensures the self-renewability of colon cancer progenitor cells.Oncotarget. 2017 Nov 27;8(65):109301-109318. doi: 10.18632/oncotarget.22673. eCollection 2017 Dec 12.
1224 The Circadian Clock Gene Bmal1 Controls Intestinal Exporter MRP2 and Drug Disposition.Theranostics. 2019 Apr 13;9(10):2754-2767. doi: 10.7150/thno.33395. eCollection 2019.
1225 Mucin 16 and kallikrein 13 as potential prognostic factors in colon cancer: Results of an oncological 92-multiplex immunoassay.Tumour Biol. 2019 Jul;41(7):1010428319860728. doi: 10.1177/1010428319860728.
1226 Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.J Exp Clin Cancer Res. 2015 Dec 1;34:145. doi: 10.1186/s13046-015-0261-3.
1227 Clinical value of a diagnostic score for colon cancer based on serum CEA, CA19-9, cytokeratin-1 and mucin-1.Br J Biomed Sci. 2018 Jul;75(3):122-127. doi: 10.1080/09674845.2018.1456309. Epub 2018 May 8.
1228 Transcriptional deregulation of the keratin 18 gene in human colon carcinoma cells results from an altered acetylation mechanism.Nucleic Acids Res. 2002 Aug 1;30(15):3312-22. doi: 10.1093/nar/gkf462.
1229 L1TD1 - a prognostic marker for colon cancer.BMC Cancer. 2019 Jul 23;19(1):727. doi: 10.1186/s12885-019-5952-2.
1230 Anti-cancer effect of lactic acid bacteria expressing antioxidant enzymes or IL-10 in a colorectal cancer mouse model.Int Immunopharmacol. 2017 Jan;42:122-129. doi: 10.1016/j.intimp.2016.11.017. Epub 2016 Nov 29.
1231 REG Controls Hippo Signaling and Reciprocal NF-B-YAP Regulation to Promote Colon Cancer.Clin Cancer Res. 2018 Apr 15;24(8):2015-2025. doi: 10.1158/1078-0432.CCR-17-2986. Epub 2018 Feb 6.
1232 Phytohemagglutinin-L (PHA-L) lectin surface binding of N-linked beta 1-6 carbohydrate and its relationship to activated mutant ras in human pancreatic cancer cell lines.Cancer Lett. 1996 Oct 22;107(2):285-91. doi: 10.1016/0304-3835(96)04386-8.
1233 Induction of LEF1 by MYC activates the WNT pathway and maintains cell proliferation.Cell Commun Signal. 2019 Oct 17;17(1):129. doi: 10.1186/s12964-019-0444-1.
1234 The tumor-associated antigen 90K/Mac-2-binding protein secreted by human colon carcinoma cells enhances extracellular levels of promatrilysin and is a novel substrate of matrix metalloproteinases-2, -7 (matrilysin) and -9: Implications of proteolytic cleavage.Biochim Biophys Acta. 2010 Mar;1800(3):336-43. doi: 10.1016/j.bbagen.2009.07.030. Epub 2009 Aug 7.
1235 Cloning and expression of the mRNA of human galectin-4, an S-type lectin down-regulated in colorectal cancer.Eur J Biochem. 1997 Aug 15;248(1):225-30. doi: 10.1111/j.1432-1033.1997.00225.x.
1236 Suppression of tumor growth by galectin-7 gene transfer.Cancer Res. 2004 Aug 15;64(16):5672-6. doi: 10.1158/0008-5472.CAN-04-0985.
1237 Galectin-9 Expression Predicts Favorable Clinical Outcome in Solid Tumors: A Systematic Review and Meta-Analysis.Front Physiol. 2018 Apr 26;9:452. doi: 10.3389/fphys.2018.00452. eCollection 2018.
1238 DNA methylation-dependent repression of PDZ-LIM domain-containing protein 2 in colon cancer and its role as a potential therapeutic target.Cancer Res. 2010 Mar 1;70(5):1766-72. doi: 10.1158/0008-5472.CAN-09-3263. Epub 2010 Feb 9.
1239 LIN28B promotes the progression of colon cancer by increasing B-cell lymphoma 2 expression.Biomed Pharmacother. 2018 Jul;103:355-361. doi: 10.1016/j.biopha.2018.04.002. Epub 2018 Apr 24.
1240 Downregulation of hepatic lipase is associated with decreased CD133 expression and clone formation in HepG2 cells.Int J Mol Med. 2018 Oct;42(4):2137-2144. doi: 10.3892/ijmm.2018.3756. Epub 2018 Jul 4.
1241 Loss of Hugl-1 expression associates with lymph node metastasis in endometrial cancer.Oncol Res. 2007;16(9):431-5. doi: 10.3727/000000007783980855.
1242 Overexpression of lamin B1 induces mitotic catastrophe in colon cancer LoVo cells and is associated with worse clinical outcomes.Int J Oncol. 2018 Jan;52(1):89-102. doi: 10.3892/ijo.2017.4182. Epub 2017 Nov 1.
1243 High mRNA expression of splice variant SYK short correlates with hepatic disease progression in chemonaive lymph node negative colon cancer patients.PLoS One. 2017 Sep 28;12(9):e0185607. doi: 10.1371/journal.pone.0185607. eCollection 2017.
1244 A gene encoding a family with sequence similarity 84, member A (FAM84A) enhanced migration of human colon cancer cells.Int J Oncol. 2006 Aug;29(2):341-7.
1245 Serum extracellular vesicles contain SPARC and LRG1 as biomarkers of colon cancer and differ by tumour primary location.EBioMedicine. 2019 Dec;50:211-223. doi: 10.1016/j.ebiom.2019.11.003. Epub 2019 Nov 18.
1246 Down-regulation of LRP1B in colon cancer promoted the growth and migration of cancer cells.Exp Cell Res. 2017 Aug 1;357(1):1-8. doi: 10.1016/j.yexcr.2017.04.010. Epub 2017 Apr 11.
1247 Loss of LSR affects epithelial barrier integrity and tumor xenograft growth of CaCo-2 cells.Oncotarget. 2017 Jun 6;8(23):37009-37022. doi: 10.18632/oncotarget.10425.
1248 Anti-Cancerous Potential of Polysaccharide Fractions Extracted from Peony Seed Dreg on Various Human Cancer Cell Lines Via Cell Cycle Arrest and Apoptosis.Front Pharmacol. 2017 Mar 3;8:102. doi: 10.3389/fphar.2017.00102. eCollection 2017.
1249 Water-soluble variant of human Lynx1 induces cell cycle arrest and apoptosis in lung cancer cells via modulation of 7 nicotinic acetylcholine receptors.PLoS One. 2019 May 31;14(5):e0217339. doi: 10.1371/journal.pone.0217339. eCollection 2019.
1250 Expression of histone deacetylase 1 and metastasis-associated protein 1 as prognostic factors in colon cancer.Oncol Rep. 2011 Aug;26(2):343-8. doi: 10.3892/or.2011.1312. Epub 2011 May 20.
1251 MACROD2 expression predicts response to 5-FU-based chemotherapy in stage III colon cancer.Oncotarget. 2018 Jun 29;9(50):29445-29452. doi: 10.18632/oncotarget.25655. eCollection 2018 Jun 29.
1252 Differential regulation and predictive potential of MacroH2A1 isoforms in colon cancer.Am J Pathol. 2012 Jun;180(6):2516-26. doi: 10.1016/j.ajpath.2012.02.027. Epub 2012 Apr 27.
1253 Therapeutic targeting of the mitotic spindle checkpoint through nanoparticle-mediated siRNA delivery inhibits tumor growth in vivo.Cancer Lett. 2011 May 28;304(2):128-36. doi: 10.1016/j.canlet.2011.02.014. Epub 2011 Mar 5.
1254 Expression of the mitotic checkpoint gene MAD2L2 has prognostic significance in colon cancer.Int J Cancer. 2007 Jan 1;120(1):207-11. doi: 10.1002/ijc.22155.
1255 MAEL expression links epithelial-mesenchymal transition and stem cell properties in colorectal cancer.Int J Cancer. 2016 Dec 1;139(11):2502-11. doi: 10.1002/ijc.30388. Epub 2016 Aug 29.
1256 RNA-binding protein quaking, a critical regulator of colon epithelial differentiation and a suppressor of colon cancer.Gastroenterology. 2010 Jan;138(1):231-40.e1-5. doi: 10.1053/j.gastro.2009.08.001. Epub 2009 Aug 15.
1257 Expression analysis of LC3B and p62 indicates intact activated autophagy is associated with an unfavorable prognosis in colon cancer.Oncotarget. 2017 May 2;8(33):54604-54615. doi: 10.18632/oncotarget.17554. eCollection 2017 Aug 15.
1258 p38 MAPK activation selectively induces cell death in K-ras-mutated human colon cancer cells through regulation of vitamin D receptor.J Biol Chem. 2004 May 21;279(21):22138-44. doi: 10.1074/jbc.M313964200. Epub 2004 Mar 22.
1259 Knockout of MARCH2 inhibits the growth of HCT116 colon cancer cells by inducing endoplasmic reticulum stress.Cell Death Dis. 2017 Jul 27;8(7):e2957. doi: 10.1038/cddis.2017.347.
1260 Reversal of drug resistance using hammerhead ribozymes against multidrug resistance-associated protein and multidrug resistance 1 gene.Int J Oncol. 2002 Nov;21(5):1021-6.
1261 MASTL induces Colon Cancer progression and Chemoresistance by promoting Wnt/-catenin signaling.Mol Cancer. 2018 Aug 1;17(1):111. doi: 10.1186/s12943-018-0848-3.
1262 Revisiting the thiosemicarbazonecopper(II) reaction with glutathione. Activity against colorectal carcinoma cell lines.J Inorg Biochem. 2018 Mar;180:69-79. doi: 10.1016/j.jinorgbio.2017.12.005. Epub 2017 Dec 8.
1263 The Mbd4 DNA glycosylase protects mice from inflammation-driven colon cancer and tissue injury.Oncotarget. 2016 May 10;7(19):28624-36. doi: 10.18632/oncotarget.8721.
1264 Effect of RTKN on progression and metastasis of colon cancer in vitro.Biomed Pharmacother. 2015 Aug;74:117-23. doi: 10.1016/j.biopha.2015.07.012. Epub 2015 Aug 8.
1265 Depletion of Mediator Kinase Module Subunits Represses Superenhancer-Associated Genes in Colon Cancer Cells.Mol Cell Biol. 2018 May 15;38(11):e00573-17. doi: 10.1128/MCB.00573-17. Print 2018 Jun 1.
1266 G protein-coupled receptor kinase 5 mediates Tazarotene-induced gene 1-induced growth suppression of human colon cancer cells.BMC Cancer. 2011 May 17;11:175. doi: 10.1186/1471-2407-11-175.
1267 MAP1D, a novel methionine aminopeptidase family member is overexpressed in colon cancer.Oncogene. 2006 Jun 8;25(24):3471-8. doi: 10.1038/sj.onc.1209383. Epub 2006 Mar 27.
1268 Loss of microfibril-associated protein 5 (MFAP5) expression in colon cancer stroma.Virchows Arch. 2020 Mar;476(3):383-390. doi: 10.1007/s00428-019-02649-y. Epub 2019 Aug 18.
1269 miR-136 targets MIEN1 and involves the metastasis of colon cancer by suppressing epithelial-to-mesenchymal transition.Onco Targets Ther. 2017 Dec 22;11:67-74. doi: 10.2147/OTT.S113359. eCollection 2018.
1270 Expression profiling and interferon-beta regulation of liver metastases in colorectal cancer cells.Clin Exp Metastasis. 2002;19(6):541-50. doi: 10.1023/a:1020325327461.
1271 Lycopene, sulforaphane, quercetin, and curcumin applied together show improved antiproliferative potential in colon cancer cells in vitro.J Food Biochem. 2019 Apr;43(4):e12802. doi: 10.1111/jfbc.12802. Epub 2019 Feb 11.
1272 Association of Mixed Lineage Kinase Domain-Like Protein Expression With Prognosis in Patients With Colon Cancer.Technol Cancer Res Treat. 2017 Aug;16(4):428-434. doi: 10.1177/1533034616655909. Epub 2016 Jul 18.
1273 MMP25 (MT6-MMP) is highly expressed in human colon cancer, promotes tumor growth, and exhibits unique biochemical properties.J Biol Chem. 2007 Jul 27;282(30):21998-2010. doi: 10.1074/jbc.M701737200. Epub 2007 May 18.
1274 In Vitro Dissolution, Cellular Membrane Permeability, and Anti-Inflammatory Response of Resveratrol-Encapsulated Mesoporous Silica Nanoparticles.Mol Pharm. 2017 Dec 4;14(12):4431-4441. doi: 10.1021/acs.molpharmaceut.7b00529. Epub 2017 Nov 27.
1275 Knockdown of MON1B Exerts Anti-Tumor Effects in Colon Cancer In Vitro.Med Sci Monit. 2018 Oct 28;24:7710-7718. doi: 10.12659/MSM.911002.
1276 MORC2 promotes development of an aggressive colorectal cancer phenotype through inhibition of NDRG1.Cancer Sci. 2019 Jan;110(1):135-146. doi: 10.1111/cas.13863. Epub 2018 Dec 21.
1277 N-Acetylcysteine Serves as Substrate of 3-Mercaptopyruvate Sulfurtransferase and Stimulates Sulfide Metabolism in Colon Cancer Cells.Cells. 2019 Aug 4;8(8):828. doi: 10.3390/cells8080828.
1278 A mutant allele of MRE11 found in mismatch repair-deficient tumor cells suppresses the cellular response to DNA replication fork stress in a dominant negative manner.Mol Biol Cell. 2008 Apr;19(4):1693-705. doi: 10.1091/mbc.e07-09-0975. Epub 2008 Feb 6.
1279 Cloning and characterization of a human ribosomal protein gene with enhanced expression in fetal and neoplastic cells.Nucleic Acids Res. 1987 Nov 11;15(21):8919-34. doi: 10.1093/nar/15.21.8919.
1280 The oncogenic effects of p53-inducible gene 3 (PIG3) in colon cancer cells.Korean J Physiol Pharmacol. 2017 Mar;21(2):267-273. doi: 10.4196/kjpp.2017.21.2.267. Epub 2017 Feb 21.
1281 Myocardin-related transcription factor A (MRTF-A) mediates doxorubicin-induced PERP transcription in colon cancer cells.Biochem Biophys Res Commun. 2018 Sep 10;503(3):1732-1739. doi: 10.1016/j.bbrc.2018.07.106. Epub 2018 Aug 2.
1282 Decreased expression of MS4A12 inhibits differentiation and predicts early stage survival in colon cancer.Neoplasma. 2017;64(1):65-73. doi: 10.4149/neo_2017_108.
1283 Exosomes from BM-MSCs increase the population of CSCs via transfer of miR-142-3p.Br J Cancer. 2018 Sep;119(6):744-755. doi: 10.1038/s41416-018-0254-z. Epub 2018 Sep 17.
1284 Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) and Microsatellite Instability in Patients with Colorectal Cancer and Its Clinical Features.Curr Mol Med. 2016;16(9):829-839. doi: 10.2174/1566524016666161124103020.
1285 MiR-590-3p promotes proliferation and metastasis of colorectal cancer via Hippo pathway.Oncotarget. 2017 Jul 22;8(35):58061-58071. doi: 10.18632/oncotarget.19487. eCollection 2017 Aug 29.
1286 Higher farnesyl diphosphate synthase activity in human colorectal cancer inhibition of cellular apoptosis.Oncology. 2004;67(5-6):351-8. doi: 10.1159/000082918.
1287 One-carbon genetic variants and the role of MTHFD1 1958G>A in liver and colon cancer risk according to global DNA methylation.PLoS One. 2017 Oct 2;12(10):e0185792. doi: 10.1371/journal.pone.0185792. eCollection 2017.
1288 Overexpression of S100A4 in human cancer cell lines resistant to methotrexate. BMC Cancer. 2010 Jun 1;10:250. doi: 10.1186/1471-2407-10-250.
1289 Functions and regulation of MUC13 mucin in colon cancer cells.J Gastroenterol. 2014 Oct;49(10):1378-91. doi: 10.1007/s00535-013-0885-z. Epub 2013 Oct 7.
1290 Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomas.J Transl Med. 2018 Sep 20;16(1):259. doi: 10.1186/s12967-018-1632-2.
1291 Mus81 knockdown sensitizes colon cancer cells to chemotherapeutic drugs by activating CHK1 pathway.Clin Res Hepatol Gastroenterol. 2017 Oct;41(5):592-601. doi: 10.1016/j.clinre.2017.01.011. Epub 2017 Mar 11.
1292 MVP-mediated exosomal sorting of miR-193a promotes colon cancer progression.Nat Commun. 2017 Feb 17;8:14448. doi: 10.1038/ncomms14448.
1293 Epigenetically regulated miR-1247 functions as a novel tumour suppressor via MYCBP2 in methylator colon cancers.Br J Cancer. 2018 Nov;119(10):1267-1277. doi: 10.1038/s41416-018-0249-9. Epub 2018 Oct 15.
1294 Colon cancer cell-derived 12(S)-HETE induces the retraction of cancer-associated fibroblast via MLC2, RHO/ROCK and Ca(2+) signalling.Cell Mol Life Sci. 2017 May;74(10):1907-1921. doi: 10.1007/s00018-016-2441-5. Epub 2016 Dec 24.
1295 Human colon cancer cells highly express myoferlin to maintain a fit mitochondrial network and escape p53-driven apoptosis.Oncogenesis. 2019 Mar 8;8(3):21. doi: 10.1038/s41389-019-0130-6.
1296 Diverse roles of arrest defective 1 in cancer development.Arch Pharm Res. 2019 Dec;42(12):1040-1051. doi: 10.1007/s12272-019-01195-0. Epub 2019 Dec 7.
1297 Downregulation of microRNA-1 and microRNA-145 contributes synergistically to the development of colon cancer.Int J Mol Med. 2015 Dec;36(6):1630-8. doi: 10.3892/ijmm.2015.2364. Epub 2015 Oct 9.
1298 Ectopic Expression of miR-147 Inhibits Stem Cell Marker and Epithelial-Mesenchymal Transition (EMT)-Related Protein Expression in Colon Cancer Cells.Oncol Res. 2019 Mar 29;27(4):399-406. doi: 10.3727/096504018X15179675206495. Epub 2018 Feb 9.
1299 NCAPH plays important roles in human colon cancer.Cell Death Dis. 2017 Mar 16;8(3):e2680. doi: 10.1038/cddis.2017.88.
1300 NDC80 promotes proliferation and metastasis of colon cancer cells.Genet Mol Res. 2016 May 6;15(2). doi: 10.4238/gmr.15028312.
1301 Protein analysis of NCA-50 shows identity to NCA cDNA deduced sequences and indicates posttranslational modifications.Biochem Biophys Res Commun. 1988 Jun 30;153(3):1105-15. doi: 10.1016/s0006-291x(88)81342-1.
1302 Characterization of human colon cancer antigens recognized by autologous antibodies.Int J Cancer. 1998 May 29;76(5):652-8. doi: 10.1002/(sici)1097-0215(19980529)76:5<652::aid-ijc7>3.0.co;2-p.
1303 Netrin-4 Mediates Corneal Hemangiogenesis but Not Lymphangiogenesis in the Mouse-Model of Suture-Induced Neovascularization.Invest Ophthalmol Vis Sci. 2017 Mar 1;58(3):1387-1396. doi: 10.1167/iovs.16-19249.
1304 Up-regulation of plasma membrane-associated ganglioside sialidase (Neu3) in human colon cancer and its involvement in apoptosis suppression.Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10718-23. doi: 10.1073/pnas.152597199. Epub 2002 Jul 29.
1305 Nuclear factor of activated T-cell activity is associated with metastatic capacity in colon cancer.Cancer Res. 2014 Dec 1;74(23):6947-57. doi: 10.1158/0008-5472.CAN-14-1592. Epub 2014 Oct 15.
1306 ROS-induced cleavage of NHLRC2 by caspase-8 leads to apoptotic cell death in the HCT116 human colon cancer cell line.Cell Death Dis. 2017 Dec 14;8(12):3218. doi: 10.1038/s41419-017-0006-7.
1307 FAM129B, an antioxidative protein, reduces chemosensitivity by competing with Nrf2 for Keap1 binding.EBioMedicine. 2019 Jul;45:25-38. doi: 10.1016/j.ebiom.2019.06.022. Epub 2019 Jun 28.
1308 Nidogen 1 and 2 gene promoters are aberrantly methylated in human gastrointestinal cancer.Mol Cancer. 2007 Feb 28;6:17. doi: 10.1186/1476-4598-6-17.
1309 Downregulation of NIT2 inhibits colon cancer cell proliferation and induces cell cycle arrest through the caspase-3 and PARP pathways.Int J Mol Med. 2015 May;35(5):1317-22. doi: 10.3892/ijmm.2015.2125. Epub 2015 Mar 4.
1310 The multifaceted nature of NLRP12.J Leukoc Biol. 2014 Dec;96(6):991-1000. doi: 10.1189/jlb.3RU0514-265RR. Epub 2014 Sep 23.
1311 Coding variants in NOD-like receptors: An association study on risk and survival of colorectal cancer.PLoS One. 2018 Jun 21;13(6):e0199350. doi: 10.1371/journal.pone.0199350. eCollection 2018.
1312 NLRP6 function in inflammatory monocytes reduces susceptibility to chemically induced intestinal injury.Mucosal Immunol. 2017 Mar;10(2):434-445. doi: 10.1038/mi.2016.55. Epub 2016 Jun 29.
1313 Expression of the nm23 homologues nm23-H4, nm23-H6, and nm23-H7 in human gastric and colon cancer.J Pathol. 2005 Apr;205(5):623-32. doi: 10.1002/path.1724.
1314 Lentivirus-mediated knockdown of NOB1 suppresses the proliferation of colon cancer cells.Z Gastroenterol. 2014 May;52(5):429-35. doi: 10.1055/s-0033-1356338. Epub 2014 May 13.
1315 Therapeutic effect of the treatment for colorectal cancer with adenoviral vectors mediated estrogen receptor gene therapy combined with thermotherapy.J Cancer Res Clin Oncol. 2014 Apr;140(4):623-32. doi: 10.1007/s00432-014-1611-9. Epub 2014 Feb 15.
1316 Clinical Significance of NADPH Oxidase 5 in Human Colon Cancer.Anticancer Res. 2019 Aug;39(8):4405-4410. doi: 10.21873/anticanres.13611.
1317 NADPH Oxidase 1 Activity and ROS Generation Are Regulated by Grb2/Cbl-Mediated Proteasomal Degradation of NoxO1 in Colon Cancer Cells.Cancer Res. 2016 Feb 15;76(4):855-65. doi: 10.1158/0008-5472.CAN-15-1512. Epub 2016 Jan 18.
1318 High efficiency reconstitution of a human-mouse chimeric Fab of CAb-1 antibody specific to human colon cancer.Scand J Immunol. 2008 Jul;68(1):12-21. doi: 10.1111/j.1365-3083.2008.02087.x. Epub 2008 May 13.
1319 Overexpression of Nitrogen Permease Regulator Like-2 (NPRL2) Enhances Sensitivity to Irinotecan (CPT-11) in Colon Cancer Cells by Activating the DNA Damage Checkpoint Pathway.Med Sci Monit. 2018 Mar 9;24:1424-1433. doi: 10.12659/msm.909186.
1320 Role of membrane Hsp70 in radiation sensitivity of tumor cells.Radiat Oncol. 2015 Jul 22;10:149. doi: 10.1186/s13014-015-0461-1.
1321 Nr-CAM is a target gene of the beta-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis.Genes Dev. 2002 Aug 15;16(16):2058-72. doi: 10.1101/gad.227502.
1322 Nardilysin controls intestinal tumorigenesis through HDAC1/p53-dependent transcriptional regulation.JCI Insight. 2018 Apr 19;3(8):e91316. doi: 10.1172/jci.insight.91316. eCollection 2018 Apr 19.
1323 Frequent inactivation of axon guidance molecule RGMA in human colon cancer through genetic and epigenetic mechanisms.Gastroenterology. 2009 Jul;137(1):176-87. doi: 10.1053/j.gastro.2009.03.005. Epub 2009 Mar 18.
1324 In vitro and in vivo treatment of colon cancer by VIP antagonists.Regul Pept. 2002 Nov 15;109(1-3):127-33. doi: 10.1016/s0167-0115(02)00195-7.
1325 Nesfatin-1/Nucleobindin-2 Is a Potent Prognostic Marker and Enhances Cell Proliferation, Migration, and Invasion in Bladder Cancer.Dis Markers. 2018 Sep 19;2018:4272064. doi: 10.1155/2018/4272064. eCollection 2018.
1326 Validation and development of MTH1 inhibitors for treatment of cancer.Ann Oncol. 2016 Dec;27(12):2275-2283. doi: 10.1093/annonc/mdw429. Epub 2016 Nov 8.
1327 High NUSAP1 expression predicts poor prognosis in colon cancer.Pathol Res Pract. 2018 Jul;214(7):968-973. doi: 10.1016/j.prp.2018.05.017. Epub 2018 May 22.
1328 miR-34a Regulates Multidrug Resistance via Positively Modulating OAZ2 Signaling in Colon Cancer Cells.J Immunol Res. 2018 Aug 2;2018:7498514. doi: 10.1155/2018/7498514. eCollection 2018.
1329 O-GlcNAcylation is a novel regulator of lung and colon cancer malignancy.Biochim Biophys Acta. 2011 Apr;1812(4):514-9. doi: 10.1016/j.bbadis.2011.01.009. Epub 2011 Jan 19.
1330 Inhibition of the liver enriched protein FOXA2 recovers HNF6 activity in human colon carcinoma and liver hepatoma cells.PLoS One. 2010 Oct 13;5(10):e13344. doi: 10.1371/journal.pone.0013344.
1331 Interactions between XIAP associated factor 1 and a nuclear co-activator, CBP, in colon cancer cells.Digestion. 2008;77(2):79-86. doi: 10.1159/000121441. Epub 2008 Mar 21.
1332 Olfactory Receptor Family 7 Subfamily C Member 1 Is a Novel Marker of Colon Cancer-Initiating Cells and Is a Potent Target of Immunotherapy.Clin Cancer Res. 2016 Jul 1;22(13):3298-309. doi: 10.1158/1078-0432.CCR-15-1709. Epub 2016 Feb 9.
1333 Reduction of Orc6 expression sensitizes human colon cancer cells to 5-fluorouracil and cisplatin.PLoS One. 2008;3(12):e4054. doi: 10.1371/journal.pone.0004054. Epub 2008 Dec 29.
1334 Colon cancer bears overexpression of OTUB1.Pathol Res Pract. 2014 Nov;210(11):770-3. doi: 10.1016/j.prp.2014.05.008. Epub 2014 May 22.
1335 MicroRNA 32 promotes cell proliferation, migration, and suppresses apoptosis in colon cancer cells by targeting OTU domain containing 3.J Cell Biochem. 2019 Nov;120(11):18629-18639. doi: 10.1002/jcb.28874. Epub 2019 Jul 24.
1336 Protein-arginine deiminase 2 suppresses proliferation of colon cancer cells through protein citrullination.Cancer Sci. 2017 Apr;108(4):713-718. doi: 10.1111/cas.13179. Epub 2017 Apr 12.
1337 Formulation and evaluation of anticancer and antiangiogenesis efficiency of PLA-PEG nanoparticles loaded with galbanic acid in C26 colon carcinoma, in vitro and in vivo.J Cell Physiol. 2019 May;234(5):6099-6107. doi: 10.1002/jcp.27346. Epub 2018 Oct 30.
1338 New platinum (II) and palladium (II) complexes of coumarin-thiazole Schiff base with a fluorescent chemosensor properties: Synthesis, spectroscopic characterization, X-ray structure determination, in vitro anticancer activity on various human carcinoma cell lines and computational studies.J Photochem Photobiol B. 2018 Jan;178:428-439. doi: 10.1016/j.jphotobiol.2017.11.030. Epub 2017 Nov 22.
1339 PAK5-mediated E47 phosphorylation promotes epithelial-mesenchymal transition and metastasis of colon cancer.Oncogene. 2016 Apr 14;35(15):1943-54. doi: 10.1038/onc.2015.259. Epub 2015 Jul 27.
1340 MicroRNA-429 inhibits the migration and invasion of colon cancer cells by targeting PAK6/cofilin signaling.Oncol Rep. 2015 Aug;34(2):707-14. doi: 10.3892/or.2015.4039. Epub 2015 Jun 8.
1341 Palladin, an actin-associated protein, is required for adherens junction formation and intercellular adhesion in HCT116 colorectal cancer cells.Int J Oncol. 2010 Oct;37(4):909-26. doi: 10.3892/ijo_00000742.
1342 Zinc finger protein 278, a potential oncogene in human colorectal cancer.Acta Biochim Biophys Sin (Shanghai). 2008 Apr;40(4):289-96. doi: 10.1111/j.1745-7270.2008.00405.x.
1343 PAX2 protein induces expression of cyclin D1 through activating AP-1 protein and promotes proliferation of colon cancer cells.J Biol Chem. 2012 Dec 28;287(53):44164-72. doi: 10.1074/jbc.M112.401521. Epub 2012 Nov 7.
1344 PBX3 hypermethylation in peripheral blood leukocytes predicts better prognosis in colorectal cancer: A propensity score analysis.Cancer Med. 2019 Jul;8(8):4001-4011. doi: 10.1002/cam4.2321. Epub 2019 May 29.
1345 PAF and EZH2 induce Wnt/-catenin signaling hyperactivation.Mol Cell. 2013 Oct 24;52(2):193-205. doi: 10.1016/j.molcel.2013.08.028. Epub 2013 Sep 19.
1346 Berberine regulates the microRNA-21-ITG4-PDCD4 axis and inhibits colon cancer viability.Oncol Lett. 2018 Apr;15(4):5971-5976. doi: 10.3892/ol.2018.7997. Epub 2018 Feb 8.
1347 The apoptosis linked gene ALG-2 is dysregulated in tumors of various origin and contributes to cancer cell viability.Mol Oncol. 2008 Apr;1(4):431-9. doi: 10.1016/j.molonc.2007.08.002. Epub 2007 Aug 19.
1348 Pharmacological Inhibition of Casein Kinase 2 Enhances the Effectiveness of PI3K Inhibition in Colon Cancer Cells.Anticancer Res. 2018 Nov;38(11):6195-6200. doi: 10.21873/anticanres.12973.
1349 Oncogenic role of PDK4 in human colon cancer cells.Br J Cancer. 2017 Mar 28;116(7):930-936. doi: 10.1038/bjc.2017.38. Epub 2017 Feb 16.
1350 Enigma negatively regulates p53 through MDM2 and promotes tumor cell survival in mice.J Clin Invest. 2010 Dec;120(12):4493-506. doi: 10.1172/JCI42674. Epub 2010 Nov 8.
1351 Functional interaction of Ugene and EBV infection mediates tumorigenic effects.Oncogene. 2011 Jun 30;30(26):2921-32. doi: 10.1038/onc.2011.16. Epub 2011 Feb 14.
1352 The role of PEG3 in the occurrence and prognosis of colon cancer.Onco Targets Ther. 2019 Jul 25;12:6001-6012. doi: 10.2147/OTT.S208060. eCollection 2019.
1353 Reduced expression of PER3 is associated with incidence and development of colon cancer.Ann Surg Oncol. 2012 Sep;19(9):3081-8. doi: 10.1245/s10434-012-2279-5. Epub 2012 Feb 17.
1354 PES1 is transcriptionally regulated by BRD4 and promotes cell proliferation and glycolysis in hepatocellular carcinoma.Int J Biochem Cell Biol. 2018 Nov;104:1-8. doi: 10.1016/j.biocel.2018.08.014. Epub 2018 Aug 29.
1355 Impairment of peroxisomal biogenesis in human colon carcinoma.Carcinogenesis. 1999 Jun;20(6):985-9. doi: 10.1093/carcin/20.6.985.
1356 Phosphoglycerate kinase 1 as a promoter of metastasis in colon cancer.Int J Oncol. 2013 Aug;43(2):586-90. doi: 10.3892/ijo.2013.1971. Epub 2013 May 31.
1357 PHF21B as a candidate tumor suppressor gene in head and neck squamous cell carcinomas.Mol Oncol. 2015 Feb;9(2):450-62. doi: 10.1016/j.molonc.2014.09.009. Epub 2014 Oct 13.
1358 The Prognostic Relevance of Sentinel Lymph Node Metastases Assessed by PHGR1 mRNA Quantification in Stage I to III Colon Cancer.Transl Oncol. 2018 Apr;11(2):436-443. doi: 10.1016/j.tranon.2018.01.015. Epub 2018 Feb 21.
1359 MiR-199a-5p and miR-375 affect colon cancer cell sensitivity to cetuximab by targeting PHLPP1.Expert Opin Ther Targets. 2015;19(8):1017-26. doi: 10.1517/14728222.2015.1057569. Epub 2015 Jun 24.
1360 Identification and development of long non-coding RNA-associated regulatory network in colorectal cancer.J Cell Mol Med. 2019 Aug;23(8):5200-5210. doi: 10.1111/jcmm.14395. Epub 2019 May 29.
1361 PIASy stimulates HIF1 SUMOylation and negatively regulates HIF1 activity in response to hypoxia.Oncogene. 2010 Oct 14;29(41):5568-78. doi: 10.1038/onc.2010.297. Epub 2010 Jul 26.
1362 Characterization of the human polymeric immunoglobulin receptor (PIGR) 3'UTR and differential expression of PIGR mRNA during colon tumorigenesis.J Biomed Sci. 2003 Nov-Dec;10(6 Pt 2):792-804. doi: 10.1159/000073967.
1363 17-Hydroxy Wortmannin Restores TRAIL's Response by Ameliorating Increased Beclin 1 Level and Autophagy Function in TRAIL-Resistant Colon Cancer Cells.Mol Cancer Ther. 2019 Jul;18(7):1265-1277. doi: 10.1158/1535-7163.MCT-18-1241. Epub 2019 May 15.
1364 Interaction between physical activity, PITX1 rs647161 genetic polymorphism and colorectal cancer risk in a Korean population: a case-control study.Oncotarget. 2018 Jan 10;9(7):7590-7603. doi: 10.18632/oncotarget.24136. eCollection 2018 Jan 26.
1365 Circulating PIWI-Interacting RNAs piR-5937 and piR-28876 Are Promising Diagnostic Biomarkers of Colon Cancer.Cancer Epidemiol Biomarkers Prev. 2018 Sep;27(9):1019-1028. doi: 10.1158/1055-9965.EPI-18-0318. Epub 2018 Jul 5.
1366 Piwil2 modulates the proliferation and metastasis of colon cancer via regulation of matrix metallopeptidase 9 transcriptional activity.Exp Biol Med (Maywood). 2012 Oct;237(10):1231-40. doi: 10.1258/ebm.2012.011380. Epub 2012 Oct 26.
1367 Multistage risk models and the age pattern in familial polyposis coli.Cancer Invest. 1984;2(6):443-8. doi: 10.3109/07357908409048517.
1368 The human PKP2/plakophilin-2 gene is induced by Wnt/-catenin in normal and colon cancer-associated fibroblasts.Int J Cancer. 2018 Feb 15;142(4):792-804. doi: 10.1002/ijc.31104. Epub 2017 Oct 31.
1369 Group III phospholipase A(2) promotes colitis and colorectal cancer.Sci Rep. 2017 Sep 25;7(1):12261. doi: 10.1038/s41598-017-12434-z.
1370 PLD4 promotes M1 macrophages to perform antitumor effects in colon cancer cells.Oncol Rep. 2017 Jan;37(1):408-416. doi: 10.3892/or.2016.5216. Epub 2016 Nov 3.
1371 A common gene variant in PLS3 predicts colon cancer recurrence in women.Tumour Biol. 2013 Aug;34(4):2183-8. doi: 10.1007/s13277-013-0754-7. Epub 2013 Apr 3.
1372 A 15-gene signature for prediction of colon cancer recurrence and prognosis based on SVM.Gene. 2017 Mar 10;604:33-40. doi: 10.1016/j.gene.2016.12.016. Epub 2016 Dec 18.
1373 Enhanced Tumoral MLH1-Expression in MLH1-/PMS2-Deficient Colon Cancer Is Indicative of Sporadic Colon Cancer and Not HNPCC.Pathol Oncol Res. 2020 Jul;26(3):1435-1439. doi: 10.1007/s12253-018-00571-3. Epub 2019 Jan 6.
1374 Podocalyxin-Like Protein 1 Regulates TAZ Signaling and Stemness Properties in Colon Cancer.Int J Mol Sci. 2017 Sep 23;18(10):2047. doi: 10.3390/ijms18102047.
1375 Human CAP10-Like Protein 46kDa Gene Promotes Malignancy in Colorectal Cancer.OMICS. 2017 May;21(5):266-274. doi: 10.1089/omi.2017.0037.
1376 The somatic POLE P286R mutation defines a unique subclass of colorectal cancer featuring hypermutation, representing a potential genomic biomarker for immunotherapy.Oncotarget. 2016 Oct 18;7(42):68638-68649. doi: 10.18632/oncotarget.11862.
1377 PPA1 regulates tumor malignant potential and clinical outcome of colon adenocarcinoma through JNK pathways.Oncotarget. 2017 Apr 24;8(35):58611-58624. doi: 10.18632/oncotarget.17381. eCollection 2017 Aug 29.
1378 Circular RNA circ-FOXM1 facilitates cell progression as ceRNA to target PPDPF and MACC1 by sponging miR-1304-5p in non-small cell lung cancer.Biochem Biophys Res Commun. 2019 May 21;513(1):207-212. doi: 10.1016/j.bbrc.2019.03.213. Epub 2019 Apr 4.
1379 Loss of periplakin expression is associated with the tumorigenesis of colorectal carcinoma.Biomed Pharmacother. 2017 Mar;87:366-374. doi: 10.1016/j.biopha.2016.12.103. Epub 2017 Jan 6.
1380 Wild-type and mutant p53 differentially modulate miR-124/iASPP feedback following pohotodynamic therapy in human colon cancer cell line.Cell Death Dis. 2017 Oct 12;8(10):e3096. doi: 10.1038/cddis.2017.477.
1381 Spinophilin loss correlates with poor patient prognosis in advanced stages of colon carcinoma.Clin Cancer Res. 2013 Jul 15;19(14):3925-35. doi: 10.1158/1078-0432.CCR-13-0057. Epub 2013 May 31.
1382 Alterations of the PPP2R1B gene located at 11q23 in human colorectal cancers.Gut. 2000 Aug;47(2):268-71. doi: 10.1136/gut.47.2.268.
1383 Amiloride modulates urokinase gene expression at both transcription and post-transcription levels in human colon cancer cells.Clin Exp Metastasis. 1995 May;13(3):196-202. doi: 10.1007/BF00132208.
1384 DNMT1 and DNMT3B modulate distinct polycomb-mediated histone modifications in colon cancer.Cancer Res. 2009 Sep 15;69(18):7412-21. doi: 10.1158/0008-5472.CAN-09-0116. Epub 2009 Sep 1.
1385 MiR-223-3p promotes the proliferation, invasion and migration of colon cancer cells by negative regulating PRDM1.Am J Transl Res. 2019 Jul 15;11(7):4516-4523. eCollection 2019.
1386 Preferential loss of a polymorphic RIZ allele in human hepatocellular carcinoma.Br J Cancer. 2001 Mar 23;84(6):743-7. doi: 10.1054/bjoc.2000.1667.
1387 Induction of radioprotective peroxiredoxin-I by ionizing irradiation.J Neurosci Res. 2002 Dec 15;70(6):794-8. doi: 10.1002/jnr.10435.
1388 Mitochondrial metabolism in cancer stem cells: a therapeutic target for colon cancer.BMB Rep. 2015 Oct;48(10):539-40. doi: 10.5483/bmbrep.2015.48.10.179.
1389 Dietary mustard seeds (Sinapis alba Linn) suppress 1,2-dimethylhydrazine-induced immuno-imbalance and colonic carcinogenesis in rats.Nutr Cancer. 2012 Apr;64(3):464-72. doi: 10.1080/01635581.2012.658948. Epub 2012 Mar 16.
1390 Impact of protamine I on colon cancer proliferation, invasion, migration, diagnosis and prognosis.Biol Chem. 2018 Feb 23;399(3):265-275. doi: 10.1515/hsz-2017-0222.
1391 Protein arginine methyltransferase 8 gene enhances the colon cancer stem cell (CSC) function by upregulating the pluripotency transcription factor.J Cancer. 2018 Apr 6;9(8):1394-1402. doi: 10.7150/jca.23835. eCollection 2018.
1392 PROX1 promotes metabolic adaptation and fuels outgrowth of Wnt(high) metastatic colon cancer cells.Cell Rep. 2014 Sep 25;8(6):1957-1973. doi: 10.1016/j.celrep.2014.08.041. Epub 2014 Sep 18.
1393 Downregulation of LncRNA-RP11-317J10.2 promotes cell proliferation and invasion and predicts poor prognosis in colorectal cancer.Scand J Gastroenterol. 2018 Jan;53(1):38-45. doi: 10.1080/00365521.2017.1392597. Epub 2017 Oct 26.
1394 PRR14 overexpression promotes cell growth, epithelial to mesenchymal transition and metastasis of colon cancer via the AKT pathway.PLoS One. 2019 Oct 9;14(10):e0218839. doi: 10.1371/journal.pone.0218839. eCollection 2019.
1395 The identification of specific methylation patterns across different cancers.PLoS One. 2015 Mar 16;10(3):e0120361. doi: 10.1371/journal.pone.0120361. eCollection 2015.
1396 Aberrant methylation of ERBB pathway genes in sporadic colorectal cancer.J Appl Genet. 2015 May;56(2):185-92. doi: 10.1007/s13353-014-0253-6. Epub 2014 Nov 1.
1397 Inhibition of PRRX2 suppressed colon cancer liver metastasis via inactivation of Wnt/-catenin signaling pathway.Pathol Res Pract. 2019 Oct;215(10):152593. doi: 10.1016/j.prp.2019.152593. Epub 2019 Aug 11.
1398 Microarray-based identification and RT-PCR test screening for epithelial-specific mRNAs in peripheral blood of patients with colon cancer.BMC Cancer. 2006 Oct 20;6:250. doi: 10.1186/1471-2407-6-250.
1399 Large scale identification of human hepatocellular carcinoma-associated antigens by autoantibodies.J Immunol. 2002 Jul 15;169(2):1102-9. doi: 10.4049/jimmunol.169.2.1102.
1400 Cell cytotoxicity, immunostimulatory and antitumor effects of lipid content of liposomal delivery platforms in cancer immunotherapies. A comprehensive in-vivo and in-vitro study.Int J Pharm. 2019 Aug 15;567:118492. doi: 10.1016/j.ijpharm.2019.118492. Epub 2019 Jul 2.
1401 Downregulated miR-585-3p promotes cell growth and proliferation in colon cancer by upregulating PSME3.Onco Targets Ther. 2019 Aug 14;12:6525-6534. doi: 10.2147/OTT.S203175. eCollection 2019.
1402 Colon cancer cells colonize the lung from established liver metastases through p38 MAPK signalling and PTHLH.Nat Cell Biol. 2014 Jul;16(7):685-94. doi: 10.1038/ncb2977. Epub 2014 Jun 1.
1403 PTPN12 Affects Nasopharyngeal Carcinoma Cell Proliferation and Migration Through Regulating EGFR.Cancer Biother Radiopharm. 2018 Mar;33(2):60-64. doi: 10.1089/cbr.2017.2254.
1404 Tumour-specific methylation of PTPRG intron 1 locus in sporadic and Lynch syndrome colorectal cancer.Eur J Hum Genet. 2011 Mar;19(3):307-12. doi: 10.1038/ejhg.2010.187. Epub 2010 Dec 8.
1405 Loss of PTPRM associates with the pathogenic development of colorectal adenoma-carcinoma sequence.Sci Rep. 2015 Apr 24;5:9633. doi: 10.1038/srep09633.
1406 Tumour suppressor function of protein tyrosine phosphatase receptor-T.Biosci Rep. 2011 Oct;31(5):303-7. doi: 10.1042/BSR20100134.
1407 PTTG1 attenuates drug-induced cellular senescence.PLoS One. 2011;6(8):e23754. doi: 10.1371/journal.pone.0023754. Epub 2011 Aug 17.
1408 CD155 knockdown promotes apoptosis via AKT/Bcl-2/Bax in colon cancer cells.J Cell Mol Med. 2018 Jan;22(1):131-140. doi: 10.1111/jcmm.13301. Epub 2017 Aug 16.
1409 Down-regulated paxillin suppresses cell proliferation and invasion by inhibiting M2 macrophage polarization in colon cancer.Biol Chem. 2018 Oct 25;399(11):1285-1295. doi: 10.1515/hsz-2018-0002.
1410 Inhibition of lysine-specific demethylase 1 by polyamine analogues results in reexpression of aberrantly silenced genes.Proc Natl Acad Sci U S A. 2007 May 8;104(19):8023-8. doi: 10.1073/pnas.0700720104. Epub 2007 Apr 26.
1411 Hypoxia-induced Rab11-family interacting protein4expression promotes migration and invasion of colon cancer and correlates with poor prognosis.Mol Med Rep. 2018 Mar;17(3):3797-3806. doi: 10.3892/mmr.2017.8283. Epub 2017 Dec 15.
1412 A germline mutation in Rab43 gene identified from a cancer family predisposes to a hereditary liver-colon cancer syndrome.BMC Cancer. 2019 Jun 21;19(1):613. doi: 10.1186/s12885-019-5845-4.
1413 Isolation of a novel member of small G protein superfamily and its expression in colon cancer.World J Gastroenterol. 2003 Aug;9(8):1719-24. doi: 10.3748/wjg.v9.i8.1719.
1414 Impaired nonhomologous end-joining in mismatch repair-deficient colon carcinomas.Lab Invest. 2005 Sep;85(9):1130-8. doi: 10.1038/labinvest.3700315.
1415 Peritumoral administration of GPI-anchored TIMP-1 inhibits colon carcinoma growth in Rag-2 gamma chain-deficient mice.Biol Chem. 2009 Sep;390(9):893-7. doi: 10.1515/BC.2009.098.
1416 3'-UTR Polymorphisms in the MiRNA Machinery Genes DROSHA, DICER1, RAN, and XPO5 Are Associated with Colorectal Cancer Risk in a Korean Population.PLoS One. 2015 Jul 6;10(7):e0131125. doi: 10.1371/journal.pone.0131125. eCollection 2015.
1417 Association between chronic kidney disease and cancer mortality: A report from the ALLHAT.Clin Nephrol. 2017 Jan;87 (2017)(1):11-20. doi: 10.5414/CN108949.
1418 RasGAP-derived peptide 38GAP potentiates the cytotoxicity of cisplatin through inhibitions of Akt, ERK and NF-B in colon carcinoma HCT116 cells.Cancer Lett. 2011 Sep 1;308(1):62-70. doi: 10.1016/j.canlet.2011.04.014. Epub 2011 May 13.
1419 RASAL1 induces to downregulate the SCD1, leading to suppression of cell proliferation in colon cancer via LXR/SREBP1c pathway.Biol Res. 2019 Dec 17;52(1):60. doi: 10.1186/s40659-019-0268-x.
1420 RasGRF2 promotes migration and invasion of colorectal cancer cells by modulating expression of MMP9 through Src/Akt/NF-B pathway.Cancer Biol Ther. 2019;20(4):435-443. doi: 10.1080/15384047.2018.1529117. Epub 2018 Oct 25.
1421 HRAS1 minisatellite alleles in colorectal carcinoma: relationship to microsatelite instability.Anticancer Res. 2001 Jul-Aug;21(4A):2855-60.
1422 Expression analysis and association of RBBP6 with apoptosis in colon cancers.J Mol Histol. 2016 Apr;47(2):169-82. doi: 10.1007/s10735-016-9663-6. Epub 2016 Feb 23.
1423 Constructing disease-specific gene networks using pair-wise relevance metric: application to colon cancer identifies interleukin 8, desmin and enolase 1 as the central elements.BMC Syst Biol. 2008 Aug 10;2:72. doi: 10.1186/1752-0509-2-72.
1424 RBP7 is a clinically prognostic biomarker and linked to tumor invasion and EMT in colon cancer.J Cancer. 2019 Aug 27;10(20):4883-4891. doi: 10.7150/jca.35180. eCollection 2019.
1425 Blood transcriptional and microRNA responses to short-term exposure to disinfection by-products in a swimming pool.Environ Int. 2018 Jan;110:42-50. doi: 10.1016/j.envint.2017.10.003. Epub 2017 Nov 6.
1426 RECQL5 is an important determinant for camptothecin tolerance in human colorectal cancer cells.Biosci Rep. 2011 Oct;31(5):363-9. doi: 10.1042/BSR20100108.
1427 Anastomotic recurrence of colon cancer: Genetic analysis challenges the widely held theories of cancerous cells' intraluminal implantation and metachronous carcinogenesis.J Surg Oncol. 2016 Aug;114(2):228-36. doi: 10.1002/jso.24282. Epub 2016 May 9.
1428 Synthesis and Anticancer Activity Evaluation of Hydrolyzed Derivatives of Panaxnotoginseng Saponins.Molecules. 2018 Nov 19;23(11):3021. doi: 10.3390/molecules23113021.
1429 MicroRNA-340 inhibits the proliferation and promotes the apoptosis of colon cancer cells by modulating REV3L.Oncotarget. 2017 Dec 26;9(4):5155-5168. doi: 10.18632/oncotarget.23703. eCollection 2018 Jan 12.
1430 Pectin Oligosaccharides Ameliorate Colon Cancer by Regulating Oxidative Stress- and Inflammation-Activated Signaling Pathways.Front Immunol. 2018 Jun 27;9:1504. doi: 10.3389/fimmu.2018.01504. eCollection 2018.
1431 Response gene to complement 32 expression in macrophages augments paracrine stimulation-mediated colon cancer progression.Cell Death Dis. 2019 Oct 10;10(10):776. doi: 10.1038/s41419-019-2006-2.
1432 Senescence marker protein 30 protects intestinal epithelial cells against inflammation-induced cell death by enhancing Nrf2 activity.Biochim Biophys Acta Mol Basis Dis. 2018 Dec;1864(12):3668-3678. doi: 10.1016/j.bbadis.2018.09.031. Epub 2018 Sep 26.
1433 Subcellular localization of the Galphai3 protein and G alpha interacting protein, two proteins involved in the control of macroautophagy in human colon cancer HT-29 cells.Biochem J. 1999 Jan 15;337 ( Pt 2)(Pt 2):289-95.
1434 Epidermal growth factor receptor-related protein: a potential therapeutic agent for colorectal cancer.Gastroenterology. 2003 May;124(5):1337-47. doi: 10.1016/s0016-5085(03)00264-6.
1435 The tumor suppressor gene RhoBTB1 is a novel target of miR-31 in human colon cancer.Int J Oncol. 2013 Feb;42(2):676-82. doi: 10.3892/ijo.2012.1746. Epub 2012 Dec 20.
1436 RIN1-Ras-ERK pathway plays an important role in carcinogenesis in colon cancer cell line LoVo.Oncol Res. 2011;19(12):527-34. doi: 10.3727/096504012x13340632812514.
1437 Characterisation of tumour-associated antigens in colon cancer.Cancer Immunol Immunother. 2002 Nov;51(10):574-82. doi: 10.1007/s00262-002-0322-2. Epub 2002 Sep 19.
1438 Increased expression of a Myc target gene Mina53 in human colon cancer.Am J Pathol. 2004 Jan;164(1):205-16. doi: 10.1016/S0002-9440(10)63111-2.
1439 RIP3 promotes colitis-associated colorectal cancer by controlling tumor cell proliferation and CXCL1-induced immune suppression.Theranostics. 2019 Jun 2;9(12):3659-3673. doi: 10.7150/thno.32126. eCollection 2019.
1440 Macrophage inhibitory cytokine-1 (MIC-1) and subsequent urokinase-type plasminogen activator mediate cell death responses by ribotoxic anisomycin in HCT-116 colon cancer cells.Biochem Pharmacol. 2009 Nov 1;78(9):1205-13. doi: 10.1016/j.bcp.2009.06.012. Epub 2009 Jun 18.
1441 Ring Finger Protein 14 is a new regulator of TCF/-catenin-mediated transcription and colon cancer cell survival.EMBO Rep. 2013 Apr;14(4):347-55. doi: 10.1038/embor.2013.19. Epub 2013 Mar 1.
1442 Identification of a noncanonical function for ribose-5-phosphate isomerase A promotes colorectal cancer formation by stabilizing and activating -catenin via a novel C-terminal domain.PLoS Biol. 2018 Jan 16;16(1):e2003714. doi: 10.1371/journal.pbio.2003714. eCollection 2018 Jan.
1443 Repression of HIP/RPL29 expression induces differentiation in colon cancer cells.J Cell Physiol. 2006 May;207(2):287-92. doi: 10.1002/jcp.20589.
1444 Enhancement of 5-FU sensitivity by the proapoptotic rpL3 gene in p53 null colon cancer cells through combined polymer nanoparticles.Oncotarget. 2016 Nov 29;7(48):79670-79687. doi: 10.18632/oncotarget.13216.
1445 Calcitriol Supplementation Causes Decreases in Tumorigenic Proteins and Different Proteomic and Metabolomic Signatures in Right versus Left-Sided Colon Cancer.Metabolites. 2018 Jan 11;8(1):5. doi: 10.3390/metabo8010005.
1446 Increased expression of human ribosomal phosphoprotein P0 messenger RNA in hepatocellular carcinoma and colon carcinoma.Cancer Res. 1992 Jun 1;52(11):3067-72.
1447 Rplp1 bypasses replicative senescence and contributes to transformation.Exp Cell Res. 2009 May 1;315(8):1372-83. doi: 10.1016/j.yexcr.2009.02.007. Epub 2009 Feb 20.
1448 Downregulation of RPN2 induces apoptosis and inhibits migration and invasion in colon carcinoma.Oncol Rep. 2018 Jul;40(1):283-293. doi: 10.3892/or.2018.6434. Epub 2018 May 10.
1449 MicroRNA-383 acts as a tumor suppressor in colorectal cancer by modulating CREPT/RPRD1B expression.Mol Carcinog. 2018 Oct;57(10):1408-1420. doi: 10.1002/mc.22866. Epub 2018 Jul 3.
1450 Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes.Sci Rep. 2016 Nov 28;6:37982. doi: 10.1038/srep37982.
1451 Germline mutation of RPS20, encoding a ribosomal protein, causes predisposition to hereditary nonpolyposis colorectal carcinoma without DNA mismatch repair deficiency. Gastroenterology. 2014 Sep;147(3):595-598.e5. doi: 10.1053/j.gastro.2014.06.009. Epub 2014 Jun 15.
1452 RPS24 knockdown inhibits colorectal cancer cell migration and proliferation in vitro.Gene. 2015 Oct 25;571(2):286-91. doi: 10.1016/j.gene.2015.06.084. Epub 2015 Jul 3.
1453 Ubiquitin fusion proteins are overexpressed in colon cancer but not in gastric cancer.Biochim Biophys Acta. 1995 Dec 12;1272(3):147-53. doi: 10.1016/0925-4439(95)00079-8.
1454 The S29 ribosomal protein increases tumor suppressor activity of K rev-1 gene on v-K ras-transformed NIH3T3 cells.Biochim Biophys Acta. 1996 Aug 21;1313(1):41-6. doi: 10.1016/0167-4889(96)00052-3.
1455 RRS1 silencing suppresses colorectal cancer cell proliferation and tumorigenesis by inhibiting G2/M progression and angiogenesis.Oncotarget. 2017 Sep 15;8(47):82968-82980. doi: 10.18632/oncotarget.20897. eCollection 2017 Oct 10.
1456 Knockdown of Rhotekin 2 expression suppresses proliferation and induces apoptosis in colon cancer cells.Oncol Lett. 2017 Dec;14(6):8028-8034. doi: 10.3892/ol.2017.7182. Epub 2017 Oct 13.
1457 Cancer as an evolutionary process at the cell level: an epidemiological perspective.Carcinogenesis. 2003 Jan;24(1):1-6. doi: 10.1093/carcin/24.1.1.
1458 Regulation of COX-2 transcription in a colon cancer cell line by Pontin52/TIP49a.Mol Cancer. 2003 Dec 15;2:42. doi: 10.1186/1476-4598-2-42.
1459 Functional polymorphism in the MicroRNA-367 binding site as a prognostic factor for colonic cancer.Anticancer Res. 2013 Feb;33(2):513-9.
1460 miR-219-5p plays a tumor suppressive role in colon cancer by targeting oncogene Sall4.Oncol Rep. 2015 Oct;34(4):1923-32. doi: 10.3892/or.2015.4168. Epub 2015 Aug 4.
1461 Overexpression of SAMD9 suppresses tumorigenesis and progression during non small cell lung cancer.Biochem Biophys Res Commun. 2014 Nov 7;454(1):157-61. doi: 10.1016/j.bbrc.2014.10.054. Epub 2014 Oct 17.
1462 Heterozygous colon cancer-associated mutations of SAMHD1 have functional significance.Proc Natl Acad Sci U S A. 2016 Apr 26;113(17):4723-8. doi: 10.1073/pnas.1519128113. Epub 2016 Apr 11.
1463 Inhibition of cytokine gene expression and induction of chemokine genes in non-lymphatic cells infected with SARS coronavirus.Virol J. 2006 Mar 29;3:17. doi: 10.1186/1743-422X-3-17.
1464 SASS6 overexpression is associated with mitotic chromosomal abnormalities and a poor prognosis in patients with colorectal cancer.Oncol Rep. 2015 Aug;34(2):727-38. doi: 10.3892/or.2015.4014. Epub 2015 May 28.
1465 Mammaglobin B gene as a novel marker for lymph node micrometastasis in patients with abdominal cancers.Cancer Lett. 2000 Mar 13;150(1):79-84. doi: 10.1016/s0304-3835(99)00378-x.
1466 Secernin-1 contributes to colon cancer progression through enhancing matrix metalloproteinase-2/9 exocytosis.Dis Markers. 2015;2015:230703. doi: 10.1155/2015/230703. Epub 2015 Feb 26.
1467 miR-378 suppresses the proliferation, migration and invasion of colon cancer cells by inhibiting SDAD1.Cell Mol Biol Lett. 2017 Jul 17;22:12. doi: 10.1186/s11658-017-0041-5. eCollection 2017.
1468 Expression of matrix macromolecules and functional properties of EGF-responsive colon cancer cells are inhibited by panitumumab.Invest New Drugs. 2013 Jun;31(3):516-24. doi: 10.1007/s10637-012-9875-x. Epub 2012 Sep 6.
1469 Syndecan-2 cytoplasmic domain regulates colon cancer cell migration via interaction with syntenin-1.Biochem Biophys Res Commun. 2011 May 27;409(1):148-53. doi: 10.1016/j.bbrc.2011.04.135. Epub 2011 May 5.
1470 Banxia Xiexin decoction, a traditional Chinese medicine, alleviates colon cancer in nude mice.Ann Transl Med. 2019 Aug;7(16):375. doi: 10.21037/atm.2019.07.26.
1471 Proinflammatory cytokines down-regulate intestinal selenoprotein P biosynthesis via NOS2 induction.Free Radic Biol Med. 2010 Sep 1;49(5):777-85. doi: 10.1016/j.freeradbiomed.2010.05.035. Epub 2010 Jun 9.
1472 Endogenous axon guiding chemorepulsant semaphorin-3F inhibits the growth and metastasis of colorectal carcinoma.Clin Cancer Res. 2011 May 1;17(9):2702-11. doi: 10.1158/1078-0432.CCR-10-0839. Epub 2011 Feb 24.
1473 A Combined ULBP2 and SEMA5A Expression Signature as a Prognostic and Predictive Biomarker for Colon Cancer.J Cancer. 2017 Apr 9;8(7):1113-1122. doi: 10.7150/jca.17872. eCollection 2017.
1474 Heart Failure Stimulates Tumor Growth by Circulating Factors.Circulation. 2018 Aug 14;138(7):678-691. doi: 10.1161/CIRCULATIONAHA.117.030816.
1475 Localization of urokinase-type plasminogen activator, plasminogen activator inhibitor-1, 2 and plasminogen in colon cancer.Jpn J Cancer Res. 1995 Jan;86(1):48-56. doi: 10.1111/j.1349-7006.1995.tb02987.x.
1476 Growth-inhibitory effects of TGFL3-SEB chimeric protein on colon cancer cell line.Biomed Pharmacother. 2019 Feb;110:190-196. doi: 10.1016/j.biopha.2018.11.025. Epub 2018 Nov 22.
1477 Epigenetic drift towards histone modifications regulates CAV1 gene expression in colon cancer.Gene. 2016 Apr 25;581(1):75-84. doi: 10.1016/j.gene.2016.01.029. Epub 2016 Jan 19.
1478 PTB-associated splicing factor (PSF) is a PPAR-binding protein and growth regulator of colon cancer cells.PLoS One. 2013;8(3):e58749. doi: 10.1371/journal.pone.0058749. Epub 2013 Mar 13.
1479 INPP4B is an oncogenic regulator in human colon cancer.Oncogene. 2016 Jun 9;35(23):3049-61. doi: 10.1038/onc.2015.361. Epub 2015 Sep 28.
1480 Sphingomyelin synthase 2 deficiency inhibits the induction of murine colitis-associated colon cancer.FASEB J. 2017 Sep;31(9):3816-3830. doi: 10.1096/fj.201601225RR. Epub 2017 May 18.
1481 The 6-integrin-ERK/MAP kinase pathway contributes to chemo resistance in colon cancer.Cancer Lett. 2013 Jan 28;328(2):325-34. doi: 10.1016/j.canlet.2012.10.004. Epub 2012 Oct 13.
1482 Absence of the Tks4 Scaffold Protein Induces Epithelial-Mesenchymal Transition-Like Changes in Human Colon Cancer Cells.Cells. 2019 Oct 29;8(11):1343. doi: 10.3390/cells8111343.
1483 The silence of p66(Shc) in HCT8 cells inhibits the viability via PI3K/AKT/Mdm-2/p53 signaling pathway.Int J Clin Exp Pathol. 2015 Aug 1;8(8):9097-104. eCollection 2015.
1484 SHMT1 1420 and MTHFR 677 variants are associated with rectal but not colon cancer.BMC Cancer. 2010 Oct 4;10:525. doi: 10.1186/1471-2407-10-525.
1485 Lack of somatic mutation in the coding sequence of SIAH1 in tumors hemizygous for this candidate tumor suppressor gene.Int J Cancer. 2000 Sep 15;87(6):794-7.
1486 The ceramide moiety of disialoganglioside (GD3) is essential for GD3 recognition by the sialic acid-binding lectin SIGLEC7 on the cell surface.J Biol Chem. 2019 Jul 12;294(28):10833-10845. doi: 10.1074/jbc.RA118.007083. Epub 2019 May 28.
1487 Inhibition of Single Minded 2 gene expression mediates tumor-selective apoptosis and differentiation in human colon cancer cells.Proc Natl Acad Sci U S A. 2005 Sep 6;102(36):12765-70. doi: 10.1073/pnas.0505484102. Epub 2005 Aug 29.
1488 Mdm2 inhibition induces apoptosis in p53 deficient human colon cancer cells by activating p73- and E2F1-mediated expression of PUMA and Siva-1.Apoptosis. 2011 Jan;16(1):35-44. doi: 10.1007/s10495-010-0538-0.
1489 Atypical role of sprouty in p21 dependent inhibition of cell proliferation in colorectal cancer.Mol Carcinog. 2016 Sep;55(9):1355-68. doi: 10.1002/mc.22379. Epub 2015 Aug 21.
1490 Gef gene therapy enhances the therapeutic efficacy of cytotoxics in colon cancer cells.Biomed Pharmacother. 2012 Oct;66(7):563-7. doi: 10.1016/j.biopha.2012.05.004. Epub 2012 Jun 19.
1491 Schlafen-3 decreases cancer stem cell marker expression and autocrine/juxtacrine signaling in FOLFOX-resistant colon cancer cells.Am J Physiol Gastrointest Liver Physiol. 2011 Aug;301(2):G347-55. doi: 10.1152/ajpgi.00403.2010. Epub 2011 May 19.
1492 Epithelial-mesenchymal transition induced by MyoD inhibits growth of high metastatic colorectal cancer.Med Hypotheses. 2019 Sep;130:109285. doi: 10.1016/j.mehy.2019.109285. Epub 2019 Jun 24.
1493 Global gene expression profiling of cells overexpressing SMC3.Mol Cancer. 2005 Sep 12;4:34. doi: 10.1186/1476-4598-4-34.
1494 Insight into the role of PIKK family members and NF-B in DNAdamage-induced senescence and senescence-associated secretory phenotype of colon cancer cells.Cell Death Dis. 2018 Jan 19;9(2):44. doi: 10.1038/s41419-017-0069-5.
1495 Induction of the intestinal stem cell signature gene SMOC-2 is required for L1-mediated colon cancer progression.Oncogene. 2016 Feb 4;35(5):549-57. doi: 10.1038/onc.2015.127. Epub 2015 Apr 27.
1496 Glyceraldehyde-3-phosphate dehydrogenase promotes cancer growth and metastasis through upregulation of SNAIL expression.Int J Oncol. 2017 Jan;50(1):252-262. doi: 10.3892/ijo.2016.3774. Epub 2016 Nov 18.
1497 SND1 affects proliferation of hepatocellular carcinoma cell line SMMC-7721 by regulating IGFBP3 expression.Anat Rec (Hoboken). 2013 Oct;296(10):1568-75. doi: 10.1002/ar.22737. Epub 2013 Jul 22.
1498 Somatostatin inhibits colon cancer cell growth through cyclooxygenase-2 downregulation.Br J Pharmacol. 2008 Sep;155(2):198-209. doi: 10.1038/bjp.2008.268. Epub 2008 Jun 30.
1499 Snf1-related kinase inhibits colon cancer cell proliferation through calcyclin-binding protein-dependent reduction of -catenin.FASEB J. 2012 Nov;26(11):4685-95. doi: 10.1096/fj.12-212282. Epub 2012 Aug 8.
1500 Sorting nexin 1 down-regulation promotes colon tumorigenesis.Clin Cancer Res. 2006 Dec 1;12(23):6952-9. doi: 10.1158/1078-0432.CCR-06-0317.
1501 WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors.Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14717-22. doi: 10.1073/pnas.95.25.14717.
1502 Alterations in the p53-SOCS2 axis contribute to tumor growth in colon cancer.Exp Mol Med. 2018 Apr 6;50(4):1-10. doi: 10.1038/s12276-017-0001-1.
1503 A novel genome-wide in vivo screen for metastatic suppressors in human colon cancer identifies the positive WNT-TCF pathway modulators TMED3 and SOX12.EMBO Mol Med. 2014 Jul;6(7):882-901. doi: 10.15252/emmm.201303799.
1504 MicroRNA-645 is an oncogenic regulator in colon cancer.Oncogenesis. 2017 May 15;6(5):e335. doi: 10.1038/oncsis.2017.37.
1505 Cyclooxygenase-2 inhibitors decrease vascular endothelial growth factor expression in colon cancer cells by enhanced degradation of Sp1 and Sp4 proteins.Mol Pharmacol. 2005 Aug;68(2):317-29. doi: 10.1124/mol.105.011825. Epub 2005 May 9.
1506 Interleukin-6 increases expression of serine protease inhibitor Kazal type 1 through STAT3 in colorectal adenocarcinoma.Mol Carcinog. 2016 Dec;55(12):2010-2023. doi: 10.1002/mc.22447. Epub 2015 Dec 14.
1507 Upregulation of spondin-2 predicts poor survival of colorectal carcinoma patients.Oncotarget. 2015 Jun 20;6(17):15095-110. doi: 10.18632/oncotarget.3822.
1508 SPROUTY-2 represses the epithelial phenotype of colon carcinoma cells via upregulation of ZEB1 mediated by ETS1 and miR-200/miR-150.Oncogene. 2016 Jun 9;35(23):2991-3003. doi: 10.1038/onc.2015.366. Epub 2015 Oct 12.
1509 Reduced migration of MLH1 deficient colon cancer cells depends on SPTAN1.Mol Cancer. 2014 Jan 24;13:11. doi: 10.1186/1476-4598-13-11.
1510 SRPX2 regulates colon cancer cell metabolism by miR-192/215 via PI3K-Akt.Am J Transl Res. 2018 Feb 15;10(2):483-490. eCollection 2018.
1511 Oxidative stress-inducible truncated serine/arginine-rich splicing factor 3 regulates interleukin-8 production in human colon cancer cells.Am J Physiol Cell Physiol. 2014 Feb 1;306(3):C250-62. doi: 10.1152/ajpcell.00091.2013. Epub 2013 Nov 27.
1512 The splicing factor SRSF6 is amplified and is an oncoprotein inlung and colon cancers.J Pathol. 2013 Mar;229(4):630-9. doi: 10.1002/path.4129.
1513 SSBP1 Upregulation In Colorectal Cancer Regulates Mitochondrial Mass.Cancer Manag Res. 2019 Dec 2;11:10093-10106. doi: 10.2147/CMAR.S211292. eCollection 2019.
1514 Mutations in the ST7/RAY1/HELG locus rarely occur in primary colorectal, gastric, and hepatocellular carcinomas.Br J Cancer. 2003 Jun 16;88(12):1909-13. doi: 10.1038/sj.bjc.6600942.
1515 Effect of StarD13 on colorectal cancer proliferation, motility and invasion.Oncol Rep. 2014 Jan;31(1):505-15. doi: 10.3892/or.2013.2861. Epub 2013 Nov 20.
1516 JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.Mol Carcinog. 2013 Feb;52(2):155-66. doi: 10.1002/mc.21841. Epub 2011 Nov 28.
1517 Quantitative proteomics identifies STEAP4 as a critical regulator of mitochondrial dysfunction linking inflammation and colon cancer.Proc Natl Acad Sci U S A. 2017 Nov 7;114(45):E9608-E9617. doi: 10.1073/pnas.1712946114. Epub 2017 Oct 23.
1518 Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance.Proc Natl Acad Sci U S A. 2011 Dec 6;108(49):E1312-20. doi: 10.1073/pnas.1110428108. Epub 2011 Oct 31.
1519 Protection of Human Colon Cells from Shiga Toxin by Plant-based Recombinant Secretory IgA.Sci Rep. 2017 Apr 3;7:45843. doi: 10.1038/srep45843.
1520 Aberrant expression of sonic hedgehog pathway in colon cancer and melanosis coli.J Dig Dis. 2013 Aug;14(8):417-24. doi: 10.1111/1751-2980.12060.
1521 Butyrate mediated regulation of RNA binding proteins in the post-transcriptional regulation of inflammatory gene expression.Cell Signal. 2019 Dec;64:109410. doi: 10.1016/j.cellsig.2019.109410. Epub 2019 Sep 2.
1522 Over-expression of small ubiquitin-related modifier-1 and sumoylated p53 in colon cancer.Cell Biochem Biophys. 2013;67(3):1081-7. doi: 10.1007/s12013-013-9612-x.
1523 Restoration of IGF2 imprinting by polycomb repressive complex 2 docking factor SUZ12 in colon cancer cells.Exp Cell Res. 2015 Nov 1;338(2):214-21. doi: 10.1016/j.yexcr.2015.09.016. Epub 2015 Sep 25.
1524 Novel colon cancer susceptibility variants identified from a genome-wide association study in African Americans.Int J Cancer. 2017 Jun 15;140(12):2728-2733. doi: 10.1002/ijc.30687. Epub 2017 Mar 28.
1525 SYNJ2 variant rs9365723 is associated with colorectal cancer risk in Chinese Han population.Int J Biol Markers. 2016 May 28;31(2):e138-43. doi: 10.5301/jbm.5000182.
1526 Loss of tapasin in human lung and colon cancer cells and escape from tumor-associated antigen-specific CTL recognition.Oncoimmunology. 2017 Jan 3;6(2):e1274476. doi: 10.1080/2162402X.2016.1274476. eCollection 2017.
1527 Association between polymorphisms of TAS2R16 and susceptibility to colorectal cancer.BMC Gastroenterol. 2017 Sep 15;17(1):104. doi: 10.1186/s12876-017-0659-9.
1528 Epigenetic inactivation of T-box transcription factor 5, a novel tumor suppressor gene, is associated with colon cancer.Oncogene. 2010 Dec 9;29(49):6464-74. doi: 10.1038/onc.2010.370. Epub 2010 Aug 30.
1529 Detection of DNA hypermethylation in sera of patients with Crohn's disease.Mol Med Rep. 2014 Feb;9(2):725-9. doi: 10.3892/mmr.2013.1840. Epub 2013 Dec 3.
1530 Molecular dynamics of interaction of Sesamin and related compounds with the cancer marker -catenin: an in silico study.J Biomol Struct Dyn. 2019 Mar;37(4):877-891. doi: 10.1080/07391102.2018.1442250. Epub 2018 Mar 12.
1531 A Wnt kinase network alters nuclear localization of TCF-1 in colon cancer.Oncogene. 2009 Nov 26;28(47):4133-46. doi: 10.1038/onc.2009.271. Epub 2009 Sep 14.
1532 Prevention of Wogonin on Colorectal Cancer Tumorigenesis by Regulating p53 Nuclear Translocation.Front Pharmacol. 2018 Nov 23;9:1356. doi: 10.3389/fphar.2018.01356. eCollection 2018.
1533 C8orf4 is a transforming growth factor B induced transcript downregulated in metastatic colon cancer.Int J Cancer. 2004 Aug 10;111(1):72-5. doi: 10.1002/ijc.20235.
1534 Knockdown of TCTN1 Strongly Decreases Growth of Human Colon Cancer Cells.Med Sci Monit. 2017 Jan 26;23:452-461. doi: 10.12659/msm.899595.
1535 Serological identification of Tektin5 as a cancer/testis antigen and its immunogenicity.BMC Cancer. 2012 Nov 14;12:520. doi: 10.1186/1471-2407-12-520.
1536 Association between colonic screening, subject characteristics, and stage of colorectal cancer.Am J Gastroenterol. 2005 Nov;100(11):2531-9. doi: 10.1111/j.1572-0241.2005.00319.x.
1537 TET1 suppresses colon cancer proliferation by impairing -catenin signal pathway.J Cell Biochem. 2019 Aug;120(8):12559-12565. doi: 10.1002/jcb.28522. Epub 2019 Mar 1.
1538 The mitochondrial retrograde signaling regulates Wnt signaling to promote tumorigenesis in colon cancer.Cell Death Differ. 2019 Oct;26(10):1955-1969. doi: 10.1038/s41418-018-0265-6. Epub 2019 Jan 18.
1539 Transcription factor EB is involved in autophagy-mediated chemoresistance to doxorubicin in human cancer cells.Acta Pharmacol Sin. 2017 Sep;38(9):1305-1316. doi: 10.1038/aps.2017.25. Epub 2017 Jun 12.
1540 TFF2-CXCR4 Axis Is Associated with BRAF V600E Colon Cancer.Cancer Prev Res (Phila). 2015 Jul;8(7):614-9. doi: 10.1158/1940-6207.CAPR-14-0444. Epub 2015 Apr 21.
1541 Oncogenic Ki-ras confers a more aggressive colon cancer phenotype through modification of transforming growth factor-beta receptor III.J Biol Chem. 2001 Jan 12;276(2):1555-63. doi: 10.1074/jbc.M004553200.
1542 Overexpression of the thrombospondin 2 (TSP2) gene modulated by the matrix metalloproteinase family expression and production in human colon carcinoma cell line.Oncol Rep. 2003 Jul-Aug;10(4):881-4.
1543 Alternative splicing of TIA-1 in human colon cancer regulates VEGF isoform expression, angiogenesis, tumour growth and bevacizumab resistance.Mol Oncol. 2015 Jan;9(1):167-78. doi: 10.1016/j.molonc.2014.07.017. Epub 2014 Aug 20.
1544 Role of carrier ligand in platinum resistance of human carcinoma cell lines.Cancer Res. 1993 Feb 15;53(4):799-805.
1545 Amino-terminal enhancer of split gene AES encodes a tumor and metastasis suppressor of prostate cancer.Cancer Sci. 2017 Apr;108(4):744-752. doi: 10.1111/cas.13187. Epub 2017 Apr 12.
1546 Expression of angiogenic growth factors VEGF, bFGF and ANG1 in colon cancer after bevacizumab treatment in vitro: A potential self-regulating mechanism.Oncol Rep. 2017 Jan;37(1):601-607. doi: 10.3892/or.2016.5231. Epub 2016 Nov 8.
1547 The interplay between histone deacetylases and c-Myc in the transcriptional suppression of HPP1 in colon cancer.Cancer Biol Ther. 2014 Sep;15(9):1198-207. doi: 10.4161/cbt.29500. Epub 2014 Jun 11.
1548 Identification of specific modules and significant genes associated with colon cancer by weighted gene coexpression network analysis.Mol Med Rep. 2019 Jul;20(1):693-700. doi: 10.3892/mmr.2019.10295. Epub 2019 May 24.
1549 Tumor suppressor gene NGX6 induces changes in protein expression profiles in colon cancer HT-29 cells.Acta Biochim Biophys Sin (Shanghai). 2012 Jul;44(7):584-90. doi: 10.1093/abbs/gms042. Epub 2012 May 30.
1550 Targeting tumor multicellular aggregation through IGPR-1 inhibits colon cancer growth and improves chemotherapy.Oncogenesis. 2017 Sep 18;6(9):e378. doi: 10.1038/oncsis.2017.77.
1551 TMPRSS4 correlates with colorectal cancer pathological stage and regulates cell proliferation and self-renewal ability.Cancer Biol Ther. 2014 Mar 1;15(3):297-304. doi: 10.4161/cbt.27308. Epub 2013 Dec 12.
1552 SCC-S2 is overexpressed in colon cancers and regulates cell proliferation.Tumour Biol. 2012 Dec;33(6):2099-106. doi: 10.1007/s13277-012-0469-1. Epub 2012 Aug 12.
1553 A novel inflammatory regulator TIPE2 inhibits TLR4-mediated development of colon cancer via caspase-8.Cancer Biomark. 2014;14(4):233-40. doi: 10.3233/CBM-140402.
1554 Hypoxia-induced decoy receptor 2 gene expression is regulated via a hypoxia-inducible factor 1alpha-mediated mechanism.Biochem Biophys Res Commun. 2010 Jan 8;391(2):1274-9. doi: 10.1016/j.bbrc.2009.12.058. Epub 2009 Dec 17.
1555 DcR3 regulates the growth and metastatic potential of SW480 colon cancer cells.Oncol Rep. 2013 Dec;30(6):2741-8. doi: 10.3892/or.2013.2769. Epub 2013 Oct 1.
1556 The study on specific umbilical blood Dc vaccine for Beige nude mice loaded human colorectal carcinoma to induce anti-tumor immunity.Eur Rev Med Pharmacol Sci. 2017 May;21(10):2364-2371.
1557 High expression of Tob1 indicates poor survival outcome and promotes tumour progression via a Wnt positive feedback loop in colon cancer.Mol Cancer. 2018 Nov 17;17(1):159. doi: 10.1186/s12943-018-0907-9.
1558 Lack of mitochondrial topoisomerase I (TOP1mt) impairs liver regeneration.Proc Natl Acad Sci U S A. 2015 Sep 8;112(36):11282-7. doi: 10.1073/pnas.1511016112. Epub 2015 Aug 24.
1559 Targeting PRPK Function Blocks Colon Cancer Metastasis.Mol Cancer Ther. 2018 May;17(5):1101-1113. doi: 10.1158/1535-7163.MCT-17-0628. Epub 2018 Feb 26.
1560 Np73 status in peritoneal and ovarian dissemination of appendicular adenocarcinoids (goblet cells).Clin Transl Oncol. 2019 Oct;21(10):1432-1439. doi: 10.1007/s12094-019-02091-1.
1561 Epigenetic silencing of TPM2 contributes to colorectal cancer progression upon RhoA activation.Tumour Biol. 2016 Sep;37(9):12477-12483. doi: 10.1007/s13277-016-5103-1. Epub 2016 Jun 23.
1562 NTRK1 fusions for the therapeutic intervention of Korean patients with colon cancer.Oncotarget. 2016 Feb 16;7(7):8399-412. doi: 10.18632/oncotarget.6724.
1563 The clinical significance and biological function of tropomyosin 4 in colon cancer.Biomed Pharmacother. 2018 May;101:1-7. doi: 10.1016/j.biopha.2018.01.166. Epub 2018 Feb 22.
1564 Tumor necrosis factor receptor-associated factor family protein 2 is a key mediator of the epidermal growth factor-induced ribosomal S6 kinase 2/cAMP-responsive element-binding protein/Fos protein signaling pathway.J Biol Chem. 2012 Jul 27;287(31):25881-92. doi: 10.1074/jbc.M112.359521. Epub 2012 Jun 8.
1565 An acellular tissue matrix-based drug carriers with dual chemo-agents for colon cancer growth suppression.Biomed Pharmacother. 2019 Sep;117:109048. doi: 10.1016/j.biopha.2019.109048. Epub 2019 Jun 8.
1566 TRIM11, a direct target of miR-24-3p, promotes cell proliferation and inhibits apoptosis in colon cancer.Oncotarget. 2016 Dec 27;7(52):86755-86765. doi: 10.18632/oncotarget.13550.
1567 Role of the focal adhesion protein TRIM15 in colon cancer development.Biochim Biophys Acta. 2015 Feb;1853(2):409-21. doi: 10.1016/j.bbamcr.2014.11.007. Epub 2014 Nov 15.
1568 Molecular Biomarkers of Sessile Serrated Adenoma/Polyps.Clin Transl Gastroenterol. 2019 Dec;10(12):e00104. doi: 10.14309/ctg.0000000000000104.
1569 Increased expression of TRPS1 affects tumor progression and correlates with patients' prognosis of colon cancer.Biomed Res Int. 2013;2013:454085. doi: 10.1155/2013/454085. Epub 2013 May 26.
1570 TRRAP is essential for regulating the accumulation of mutant and wild-type p53 in lymphoma.Blood. 2018 Jun 21;131(25):2789-2802. doi: 10.1182/blood-2017-09-806679. Epub 2018 Apr 13.
1571 Discovery of a diagnostic biomarker for colon cancer through proteomic profiling of small extracellular vesicles.BMC Cancer. 2018 Nov 1;18(1):1058. doi: 10.1186/s12885-018-4952-y.
1572 ARMc8 indicates aggressive colon cancers and promotes invasiveness and migration of colon cancer cells.Tumour Biol. 2015 Nov;36(11):9005-13. doi: 10.1007/s13277-015-3664-z. Epub 2015 Jun 18.
1573 Up-regulated expression of l-caldesmon associated with malignancy of colorectal cancer.BMC Cancer. 2012 Dec 17;12:601. doi: 10.1186/1471-2407-12-601.
1574 A functional variant of IC53 correlates with the late onset of colorectal cancer.Mol Med. 2011;17(7-8):607-18. doi: 10.2119/molmed.2010.00192. Epub 2011 Mar 2.
1575 Membrane protein CNNM4-dependent Mg2+ efflux suppresses tumor progression.J Clin Invest. 2014 Dec;124(12):5398-410. doi: 10.1172/JCI76614. Epub 2014 Oct 27.
1576 Cysteine-Rich Intestinal Protein 1 Silencing Inhibits Migration and Invasion in Human Colorectal Cancer.Cell Physiol Biochem. 2017;44(3):897-906. doi: 10.1159/000485357. Epub 2017 Nov 24.
1577 Divergent roles of p120-catenin isoforms linked to altered cell viability, proliferation, and invasiveness in carcinogen-induced rat skin tumors.Mol Carcinog. 2017 Jul;56(7):1733-1742. doi: 10.1002/mc.22630. Epub 2017 Mar 6.
1578 Differential roles of EPS8 in carcinogenesis: loss of protein expression in a subset of colorectal carcinoma and adenoma.World J Gastroenterol. 2012 Aug 7;18(29):3896-903. doi: 10.3748/wjg.v18.i29.3896.
1579 Expression of endothelial cell-specific molecule-1 regulated by hypoxia inducible factor-1 in human colon carcinoma: impact of ESM-1 on prognosis and its correlation with clinicopathological features.Oncol Rep. 2012 Nov;28(5):1701-8. doi: 10.3892/or.2012.2012. Epub 2012 Sep 3.
1580 DNA methylation biomarker candidates for early detection of colon cancer.Tumour Biol. 2012 Apr;33(2):363-72. doi: 10.1007/s13277-011-0302-2. Epub 2012 Jan 12.
1581 FOXD3 is a tumor suppressor of colon cancer by inhibiting EGFR-Ras-Raf-MEK-ERK signal pathway.Oncotarget. 2017 Jan 17;8(3):5048-5056. doi: 10.18632/oncotarget.13790.
1582 Hypermethylation of the GATA gene family in esophageal cancer.Int J Cancer. 2006 Nov 1;119(9):2078-83. doi: 10.1002/ijc.22092.
1583 The HECT type ubiquitin ligase NEDL2 is degraded by anaphase-promoting complex/cyclosome (APC/C)-Cdh1, and its tight regulation maintains the metaphase to anaphase transition.J Biol Chem. 2013 Dec 13;288(50):35637-50. doi: 10.1074/jbc.M113.472076. Epub 2013 Oct 25.
1584 Promoter hypomethylation contributes to the expression of MUC3A in cancer cells.Biochem Biophys Res Commun. 2010 Jun 25;397(2):333-9. doi: 10.1016/j.bbrc.2010.05.124. Epub 2010 May 27.
1585 Brush border myosin Ia has tumor suppressor activity in the intestine.Proc Natl Acad Sci U S A. 2012 Jan 31;109(5):1530-5. doi: 10.1073/pnas.1108411109. Epub 2012 Jan 18.
1586 RIP140 increases APC expression and controls intestinal homeostasis and tumorigenesis.J Clin Invest. 2014 May;124(5):1899-913. doi: 10.1172/JCI65178. Epub 2014 Mar 25.
1587 3'-UTR and functional secretor haplotypes in mannose-binding lectin 2 are associated with increased colon cancer risk in African Americans.Cancer Res. 2012 Mar 15;72(6):1467-77. doi: 10.1158/0008-5472.CAN-11-3073. Epub 2012 Jan 26.
1588 Polymorphisms of the apoptosis-associated gene DP1L1 (deleted in polyposis 1-like 1) in colon cancer and inflammatory bowel disease.J Cancer Res Clin Oncol. 2010 Jun;136(6):795-802. doi: 10.1007/s00432-009-0719-9. Epub 2009 Nov 19.
1589 Sperm-associated antigen 9 is a novel biomarker for colorectal cancer and is involved in tumor growth and tumorigenicity.Am J Pathol. 2011 Mar;178(3):1009-20. doi: 10.1016/j.ajpath.2010.11.047.
1590 Stromal interaction molecule 2 (STIM2) is frequently overexpressed in colorectal tumors and confers a tumor cell growth suppressor phenotype.Mol Carcinog. 2012 Sep;51(9):746-53. doi: 10.1002/mc.20843. Epub 2011 Aug 30.
1591 Design, synthesis and evaluation of novel sulfonamides as potential anticancer agents.Comput Biol Chem. 2018 Jun;74:294-303. doi: 10.1016/j.compbiolchem.2018.04.006. Epub 2018 Apr 10.
1592 Ets1 and heat shock factor 1 regulate transcription of the Transformer 2 gene in human colon cancer cells.J Gastroenterol. 2013 Nov;48(11):1222-33. doi: 10.1007/s00535-012-0745-2. Epub 2013 Jan 30.